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Abstract 
This Thesis discusses the synthesis, characterisation, and reactivity studies of a range of 
new chiral calcium complexes supported by various polydentate N-donor ligands and their 
suitability as catalysts for intramolecular hydroamination. 
Chapter One outlines the case for developing organocalcium complexes, including a 
general overview of their current application to a variety of heterofunctionalisation 
reactions.  
Chapter Two introduces the chiral ethylene diamines which are extensively used as 
calcium supporting ligands and later as precursors for the synthesis of bisimidazoline and 
potential imoxazoline ligands. Chapter Two provides details of the diamine synthesis and 
includes studies related to racemisation concerns of the chiral centre. 
Chapter Three discusses novel calcium complexes supported by the chiral ethylene 
diamine analogues presented in Chapter Two. Complex synthesis, characterisation, and 
catalytic performance in intramolecular hydroamination is probed and discussed. 
Chapter Four details a range of new bisimidazoline ligands and their employment as 
supporting ligands on calcium. The catalytic performance of the resulting complexes in 
intramolecular hydroamination is subsequently analysed and discussed. 
Chapter Five investigates the attempted development of a total synthetic pathway to a new 
class of imoxazoline ligand and related issues. 
Chapter Six contains all experimental procedures, characterising data pertaining to all new 
compounds and complexes presented in this Thesis. 
Appendices A-K contain additional catalytic figures and tables of crystallographic data for 
all new crystallographically characterised compounds. Summary sheets of every literature 
and new compound presented mentioned in this Thesis are also included, along with copies 
of both printed publications resulting from this Thesis at the time of submission. 
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M  metal atom 
m-  meta substituted 
Me  methyl 
MS  Mass Spectrometry 
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PDI  Polymer Dispercity Indices 
Ph  phenyl 
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iPr  iso-propyl 
py  pyridine 
py-Box  pyridinebisoxazoline 
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R  alkyl or aryl group 
R-BIM  bisimidazoline  
R-MIM  mono-imidazoline imoxazoline precursor 
ROP  Ring-Opening Polymerisation 
S  sinister enantiomer 
sec  second(s) 
vi 
 
ST  styrene 
TBTU  O-(benzotriazol-1-yl)-N,N,N’,N’-tetramethyluronium 
tetrafluoroborate 
tBu  tert-Butyl 
TFPB  tetrakis(3,5-bistrifluoromethylphenly)borate 
THF  tetrahydrofuran 
TMC  trimethylenecarbonate 
TMS  trimethylsilane 
Tpm  HC(3,5-dimethylpyrazole)3 
Ts  tosyl group, (CH3C6H4SO2) 
vs.  Versus 
Viz.  videlicet, that is to say  
X1  mono-anionic σ-bound substituent 
 
Nuclear Magnetic Resonance Spectroscopic Data 
app.  apparent 
br.  broad 
13C-{1H}  proton-decoupled 13C 
COSY  Correlation SpectroscopY 
d  doublet 
δ  chemical shift in ppm 
J  coupling constant 
HMBC  Heteronuclear Multiple Bond Connectivity 
HSQC  Heteronuclear Multiple Quantum Coherence 
Hz  Hertz 
m  multiplet 
MHz  Megahertz 
NMR  Nuclear Magnetic Resonnance 
nOe  nuclear Overhauser effect 
ppm  parts per million 
q  quartet 
quin.  quintet 
vii 
 
s  singlet 
sept.  septet 
t  triplet 
 
Infrared Spectroscopic Data 
br  broad 
cm-1  wave number 
IR  Infrared 
m  medium 
ʋ  frequency 
s  strong 
w  weak 
 
Notes about numbering of literature compounds described in this Thesis 
Literature compounds described in this Thesis are sequentially numbered 1.X, 2.X, 3.X, 
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1.1 The Case for Calcium 
In recent years there has been a renaissance in coordination and catalytic chemistry 
involving the Alkaline Earth (AE) metals; magnesium (Mg), calcium (Ca), strontium (Sr), 
and barium (Ba). Of the heavier AE metals Ca, Sr, and Ba the progress of organocalcium 
literature is beginning to gain momentum. This is expressed by the flurry of publications 
from the area over recent years.  
Of the AE metals the exploitation of magnesium is probably most familiar in the form of 
the eponymous Grignard reagents (RMgX),1 with the other heavier elements of the group 
remaining far less developed. Obstruction of inroads to this area is likely to have stemmed 
from the initial limited availability of suitable synthetic precursors. These problems were 
compounded by the early perception that the heavier AE metals presented no real 
advantage over magnesium.  
Preparation of AE metal organometallics has proved troublesome in the past; however the 
barriers to their utilisation are slowly being eroded. New methods to fulfil the steric 
demands of the metal by judicious use of bulky ligands, the importance of stabilising with  
agostic interactions, and insights into control of ligand redistribution have all allowed 
advance in this promising area.2, 3     
Thus far, the field of organometallic catalysis has been monopolised by the d-block 
Transition metals, particularly the precious metals (Ru, Rh, Pd, Os, Ir, and Pt), where they 
have experienced unparalleled success. In the last decade, three of the Nobel prizes for 
chemistry have been related to Transition-metal-based organometallic complexes and their 
subsequent utilisation in catalysis (Knowles, Noyori, and Sharpless 2001; Chauvin, 
Grubbs, and Schrock 2005; Heck, Negishi, and Suzuki 2010). In spite of such success, 
contemporary research has been driven by the necessity for the future generation of 
alternative, sustainable technology, commonly referred to as “Green Chemistry”.  
Green Chemistry is defined by 12 principles focusing on atom economy and employing 
chemicals of reduced hazard and/or toxicity from sustainable feedstocks. It requires 
products of these reactions to be safer than current alternatives and that reactions yield 
minimal waste.4 In lieu of this, the field of organometallic catalysis is in pursuit of 
alternatives to meet these criteria. When selecting potential catalyst replacements one is 
able to strongly advocate the case for calcium for several excellent reasons.  
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Calcium has been identified as a possible ‘cheap metal for noble tasks’ in the quest for 
alternative catalysts to the ubiquitous precious metals.5, 6 Calcium is the fifth most 
abundant element in the Earth’s crust with aluminium and iron being the only metals that 
occur more readily.7, 8 Its global abundance is reflected in the price of the raw metal when 
compared to that of the precious metals. Current prices for 100 g of raw calcium metal sit 
within affordability at approximately £22. In stark contrast precious metals such as 
platinum and palladium currently cost in the region of £100 for 1 g. Such a dramatic 
difference already highlights a large potential for cost reductions, typically when catalyst 
recovery is often troublesome in already expensive chemical processes.  
Calcium is fundamentally important in nature, present in minerals, habitats like coral reefs, 
and is vital for flora development. In mammals and humans it is utilised in the body’s 
nervous system, blood clotting mechanism and bone structure. The profuse application of 
calcium in nature highlights the environmentally benign nature of the element. Thus the 
impact upon the environment and living systems from its use in organometallic catalysis is 
expected to be greatly reduced compared to more harmful alternatives.  
These benefits are notwithstanding the enticing academic prospects such chemistry 
presents. This once dormant metal is now finding its way into the limelight of catalysis 
through its application to an ever-growing range of reactions. This introduction will focus 
upon the current catalytic applications of calcium in regards to the heterofunctionalisation 
of unsaturated organic molecules. There has also been a significant amount of interest in 
the polymerisation of styrene9-12 and cyclic esters,13-29 Lewis acid catalysis,30-34 and other 
organic transformations.35-43 These areas along with a detailed discussion of the 
coordination chemistry of calcium and the AE metals2, 44-47  lies beyond the scope of this 
Chapter and the reader is therefore direction to the noted references for further information.  
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1.1.1 Taming Calcium 
As Group 2 of the periodic table is descended the metals become larger and more ionic in 
nature. This results in decreasing M-L bond strength and complex reactivity increases.3, 44 
The accompanying side-effect is the increased inclination of the larger AE metals to 
undergo ligand redistribution (Scheme 1) as well as aggregation. Strategies to improve 
complex resistance to redistribution and aggregation typically utilise sterically demanding 
polydentate ligands and co-ligands to help saturate the coordination sphere around the 
metal centre.  
 
Scheme 1 Ligand redistribution also known as Schlenk-type equilibrium                           
(L = mono-anionic supporting ligand; X = mono-anionic substituent). 
Many of the early examples of bulky ligands relied on the β-diketimidato (BDI) 1.1, and 
tri(pyrazolylborate) 1.2 ligands reported by Chisholm et al. (Fig. 1). Whilst they have 
become popular supporting scaffolds the presence of dimeric species and/or products of 
ligand redistribution in solution have been reported.16 
 
Fig. 1 Well-defined calcium β-diketimidato (1.1) and tri(pyrazolylborate)                                    
(1.2) complexes reported by Chisholm et al..  
The most common stabilising anion used is bis(trimethylsilyl)amide ([N(SiMe3)2]-) or a 
derivative thereof.47-52 Bulky silylalkyls, typically of the form [C(SiR2H)]- have also been 
exploited.53-59 Addition of such supporting ligands also eases the AE metals’ notoriously 
poor solubility. 
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The problem of ligand redistribution arguably provides the greatest challenge to the 
development of AE metal catalysts. It is important to overcome since redistribution from 
the generally active heteroleptic species LCaX (X = alkyl or amide co-ligand), gives rise to 
normally unreactive L2Ca, and reactive but unselective CaX2. Thus any redistribution is 
likely to result in loss of the active catalytic species and accompanying ligand effects upon 
substrates. The loss of ligand influence is particularly detrimental to asymmetric catalysis 
where stereodirecting influence is often due to the supporting ligand.  
 
1.2 Calcium in Catalysis 
The heavy AE metals often have parallels drawn between them and lanthanides due to  
their highly ionic, non-directional metal-ligand bond interactions.60, 61 In the case of 
trivalent lanthanides work by Hong and Marks has shown that L2M(X1)2 (M = Ln3+,         
L2 = bidentate anionic ligand, X1 = anionic σ-bound species) systems are able to undertake 
two types of fundamental reactivity.62 The first being σ-bond metathesis and the second, 
the insertion of unsaturated C-C or C-E (E = heteroatom) bonds into a M-X1 σ-bond. It is 
often the case that these two modes of reactivity can be exploited together (Scheme 2). The 
utilisation of this feature with lanthanides led to the development of catalysts successful in 
hydroamination,63-69 hydrophosphination,70, 71 hydrosilylation,72, 73 hydrogenation,74, 75 and 
hydroboration76-78 of unsaturated C=C bonds.  
M X1
Y CR2
L
L
L2MX
1
M X1
Y CHR2
L
L
HX1
R R
X1
YH
-bond
metathesis
substrate
insertion
 
Scheme 2 σ-bond metathesis and unsaturated bond insertion into M-X1 bond as                    
part of a catalytic heterofunctionalisation cycle (L2 = bidentate anionic ligand;                           
M = Ca; X1 = anionic σ-bound species, for example [N(SiMe3)2]- or [C(SiMe3)3]-). 
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When presented with the bonding similarities of both the heavier AE metals and trivalent 
lanthanides, with respect to their non-directional ionic M-L bonds, it poses the question of 
whether the heavy AE metals could be applied in a similar manner as lanthanides to 
heterofunctionalisation catalysis involving insertion and subsequent σ-bond metathesis. 
Whilst a great deal of work was undertaken with lanthanides in heterofunctionalisation 
catalysis during the 1990s it has taken nearly a decade for the above question to be probed 
with the AE metals; primarily as a consequence of the less-developed nature of the 
coordination chemistry of these metals. Studies over the past 7 years have validated the 
aforesaid hypothesis, leading to AE catalyst application to all of the above 
heterofunctionalisation reactions including ring-opening polymerisation (ROP) of lactides, 
styrene polymerisation, and various Lewis-acid catalysed organic transformations. The 
development and use of organocalcium complexes over a variety of heterofunctionalisation 
reactions is now discussed. 
 
1.2.1 Hydroamination 
Hydroamination is defined as the formal addition of an N-H bond across an unsaturated 
bond, and presents itself as a very attractive means to prepare a wide range of nitrogen 
containing compounds via a 100% atom-efficient route. Whilst the unsaturated moiety is 
typically C=C or C≡C, C=O and C=N functionalities have also been hydroaminated (vida 
infra). Successful exploitation of hydroamination has the potential to ease the synthesis of 
chiral amines and azacycles starting from readily available alkenes and primary amines, 
which are useful in the preparation of pharmaceuticals, industrial feedstocks, and fine 
chemicals.  
Whilst hydroamination is a thermodynamically allowed exothermic process, electrostatic 
repulsion between the amine lone pair of electrons and the unsaturated C-C bond results in 
a high activation barrier. The overall negative entropy of the reaction means that heating 
the reaction to overcome the activation energy renders the reaction less favourable. Due to 
these circumstances the intervention of a catalyst is requisite (unless the precursors contain 
activated, electron deficient unsaturated C-C bonds).51, 79  
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The first example of intramolecular hydroamination mediated by calcium was reported by 
Hill et al. in 2005 where the authors utilised Chisholm’s BDI supported calcium      
complex 1.1.51 The study was later expanded to include a more extensive range of 
aminoalkenes in 2009.80 A summary of results from their first endeavour is contained in 
Table 1. The results demonstrate that for a range of simple aminoalkenes near quantitative 
conversion to the cyclic amines was achieved.  
Table 1 Results of hydroaminated aminoalkenes mediated by calcium complex 1.1. 
Entrya Aminoalkene Product(s) Time (h) Temp. (°C)
 
Conv.%b 
1 
 
 
 
0.25 25 >99 
2 
 
 
 
0.25 25 >99 
3 
 
 
 
0.25 25 >99 
4 
 
 
 
6 60 86 
 
  
   
a
 Entries 1-3 used 10 mol% catalyst loading, entry 4, 20 mol% catalyst (10 mol%                
required 72 h to yield 85% conversion). b
 
Determined by 1H NMR in
 
C6D6. 
 
Whilst the formation of pyrrolidines (generally from 2,2-dialkyl-4-penten-1-amine 
derivatives, Table 1) was found to be relatively facile. Larger heterocycles (6-membered 
piperidines or 7-membered hexahydroazepines) are more difficult to form (as predicted by 
Baldwin’s rules)81 and required forcing conditions, i.e. elevated temperatures (up to 80°C) 
for extended periods of 24-72 hours, or with increased catalyst loadings. The authors note 
the magnesium analogue of 1.1 was successful when applied to the same reaction, albeit 
over 5.5 days at 80°C to give 88% of the expected hexahydroazepine product (entry 4, 
Table 1). The reasoning as to why magnesium was more successful was put down to the 
higher stability of the magnesium catalyst at elevated temperatures during long reaction 
durations.51, 80 This proof of concept report served to pioneer further research in the area, 
with notable contributions from Harder,49 Roesky,82-84 Sadow,85 and Hill.86-91  
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Scheme 3 Intramolecular hydroamination (L2 = bidentate anionic ligand; M = Ca;            
X1 = anionic σ-bound species, for example [N(SiMe3)2]- or [C(SiMe3)3]-). 
The mechanism by which intramolecular hydroamination occurs, is akin to many of the 
heterofunctionalisation reactions presented in this chapter, and is derived from the 
lanthanides (Scheme 3). The first step is the sigma-bond metathesis between the amine 
moiety of the incoming aminoalkene and the anionic donor ligand X1 bound to the calcium 
complex (step 1, Scheme 3). Depending on the nature of X1, i.e. its basicity, this step is 
fast. When the protio by-product HX1 displays a similar acidity to that of the aminoalkene 
substrate this reaction is known to exist in equlibrium.3 The nucleophillic attack from the 
electron rich C=C upon the electropositive calcium centre results in the C=C bond 
insertion between the Ca-N σ-bond.  
Calcium complexes are unable to insert into isolated C=C double bonds in intermolecular 
reactions and so substrates are typically activated by way of conjugation e.g. styrene or 
1,3-butadiene. Intramolecular hydroamination can proceed without activated substrates 
since the loss in entropy (-∆S) is less for a single aminoalkene molecule when compared to 
that of the two reactive moieties combining from separate molecules. 
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Scheme 4 Intramolecular 1-3-hydrogen shift during intramolecular                         
hydroamination (L2 = bidentate anionic ligand; M = Ca; X1 = anionic                                  
σ-bound ligand, for example [N(SiMe3)2]- or [C(SiMe3)3]-). 
Evidence to support the proposed mechanism in the form of isolated and characterised 
intermediates has remained elusive for AE mediated hydroamination. One experiment 
involving the deuterium labeling of the aminoalkene amine moiety has however been 
investigated,80 wherein isolation of the cyclic product bearing a CH2D moiety at the       
exo-cyclic methyl position is consistent with the lanthanide mechanism (since mono-
deuteration would occur at the σ-bond metathesis in step 3, Scheme 3). It has been 
suggested that an intramolecular 1,3-hydrogen shift could also be possible during the 
course of the reaction and should not be discounted (Scheme 4). An example complex 
bearing an isolation secondary cyclic amine bound to the metal centre has been reported, 
albeit with magnesium (Scheme 5).80  
 
Scheme 5 Reaction of the Mg analogue of 1.1 with 1-amino-2,2,diphenyl-4-pentene. 
Chapter One – Organocalcium Catalysis 
 
10 
 
 
Scheme 6 Alkene isomerisation during intramolecular hydroamination                                      
(L2 = bidentate anionic ligand; M = Ca; X1 = anionic σ-bound species,                               
for example [N(SiMe3)2]- or [C(SiMe3)3]-). 
Occasional observations of alkene isomerisation have been noted by Hill and co-workers 
when intramolecular deprotonation occurs at the alkene HC=CH2 resulting in protonation 
of the amine moiety (step a, Scheme 6). This is followed by the subsequent protonation at 
the terminal carbon of the aminoalkene chain giving the overall effect of a new position of 
the alkene functionality from its original terminal position (step b, Scheme 6).  
So far investigation of aminoalkenes has been restricted to primary and secondary amines 
bearing C=C unsaturation at the terminal position. Substrates often contain geminal 
substitution at the mid-point of the alkyl chain. The inclusion of germinal substitution is a 
feature of the more reactive substrates and is owed to the Thorpe-Ingold effect (the 
compression of internal bond angles caused by the mutual repulsion of the gem-
substituents promoting cyclisation and reduction in possible molecule conformations).92 
Favoured reactivity of larger germinal substituents has been noted in alternative 
hydroamination systems and is not only restricted to the heavier AE metals.61, 93  
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Examples of aminoalkenes containing multiple C=C double bonds have been reported in 
intramolecular hydroamination,42, 86 as well as aminoalkenes bearing monomethyl or 
dimethyl substitution at the terminal methyene group of the C=C.80 Substitution at the 
terminal alkene (RHC=CR12) results in the complete arrest of cyclisation. Methyl 
substitution at the methyene position (RR1C=CH2) resulted in elongated reaction times 
before full conversion was attained. The increased steric presence imposed by alkyl-
substitution around the terminal alkene is likely to interfere with the ease of insertion of the 
alkene, since this is generally accepted as the rate determining step (step 1, Scheme 3).89 
 
Scheme 7 Intramolecular hydroamination resulting in diastereomeric                                 
products depending upon position of alkylchain substitution mediated                                             
by 1.1 (R = alkyl, R1 = Ph, CH3, R2 = H). 
When investigating regioselectivity with the intramolecular hydroamination of 
aminoalkenes bearing two pro-chiral centres, it was found that variations in substitution 
along the alkyl chain could also dramatically influence the regioselectivity of the resulting 
cyclic amine. Using the typical 2,2-dialkyl-4-penten-1-amine derivatives (where both alkyl 
groups are inequivalent) to illustrate this point, substitution at the β-position of the amine 
had no effect upon the diastereoselectivity of the reaction, however substitution at the       
α-position to the amine gave diastereoselective intramolecular hydroamination         
(Scheme 7).80 Whilst substitution at the α-position to the amine displayed intriguing 
diastereoselectivites, reaction rates and yields were comparable to similar substrates 
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bearing no substitution at this position, unlike the aforesaid terminal alkene substitution 
effect. 
The largest diastereomeric excesses are observed in the products bearing inequivalent 
substitution at the α-position in favour of trans-conformers. Diastereoselectivites of up to 
95% were observed when mediated by 1.1. The magnesium analogue of 1.1 gave 
marginally higher selectivities for identical substrates. The preferred trans-conformation 
can be explained by consideration of the most favourable transition state conformation 
during the insertion step. Of the possible conformations, those which place the most 
sterically demanding R-substituent where it causes the least amount of steric impingement 
upon the metal centre and supporting ligand are the most favourable. A conformation 
which sees R group impingement upon the steric sphere of the metal centre and it’s 
supporting ligand is likely to be less favoured since competing steric interactions are liable 
to raise the energy barrier to reaction. Such interactions are not so prevalent when the 
aminoalkene has substitution at the β-position to the amine, hence less drastic preference 
for a particular isomer is induced. Enantioselectivity when applied to intramolecular 
hydroamination has also been investigated and is discussed in greater detail at the end of 
this section. 
Within the last year Roesky et al. have combined the reactivity of calcium and zirconium 
in a single system that was then applied to intramolecular hydroamination of primary and 
secondary aminoalkenes.94 The stoichiometric reaction of [Cp*2(CH3)Zr(OH)] with 
[Ca{N(SiMe3)2}2(THF)2] results in a new class of catalyst 1.3, containing both Lewis 
acidic centres bridged by an oxygen atom (Fig. 2). The calcium centre adopts a trigonal- 
bipyramidal geometry typical in 5-coordinate systems, where as the zirconium centre 
conforms to distorted tetrahedral geometry. The Zr-O-Ca bond is almost linear at 177 °.  
 
Fig. 2 Bimetallic catalyst system comprised of Zr                                                                    
and Ca for intramolecular hydroamination (1.3). 
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Application of 1.3 to the intramolecular hydroamination of primary aminoalkenes gave 
good yields (80-99%), however reaction times were notably slower when compared to 1.1 
and [Ca{N(SiMe3)2}2(THF)2] under similar reaction conditions. Application of 10 mol% of 
1.3 to a range of secondary aminoalkenes required much higher reaction temperatures   
(110 °C) as well as the presence of an equimolar equivalent of activator 
[PhN(CH3)2H][B(C6F5)4]. The activator was used to protonate a methyl from the zirconium 
(as methane) generating a cationic zirconium species in-situ. This is one of the few 
examples of a calcium catalyst used in the cyclisation of secondary aminoalkenes where 
good conversions were obtained, normally 96-99% over a period of 20-50 hours at 110 °C. 
This is comparable to literature precedence using 1.1, albeit it at greatly elevated 
temperatures (110 °C  vs. room temperature).80 Mechanistic studies suggest that for  
primary aminoalkene substrates the zirconium centre does not participate in the activation 
of the aminoalkene, which still proceeds by coordinating to the calcium centre, liberating 
HN(SiMe3)2. 
 
1.2.1.1 Intermolecular Hydroamination 
Intermolecular hydroamination (Scheme 9) has been successful with catalyst 1.1, 
[Ca{N(SiMe3)2}2]2, and [Ca{CH(SiMe3)2}2(THF)2] for a range of activated alkene 
substrates with various primary and secondary amines (Scheme 8).89, 90 Reactions 
progressed under solvent-free conditions at 60 °C for 2-168 hours yielding 17-95% 
product. The reaction was most successful when the X substituent was either H or Cl and 
the amine deployed was benzylamine (PhCH2NH2) or pyrrolidine (NH(CH2)4). The 
combination of these substrates gave yields of 92% and 95% respectively.    
 
 
Scheme 8 Intermolecular hydroamination (X = H, CH3, OCH3,                                               
Cl; R1=R2 = -(CH2)4-, -(CH2)5-; R1 = H, R2 = (C6H5)CH2-). 
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Intermolecular hydroamination gives products resulting from 2,1-insertion into the C=C 
bond, a phenomenon also observed in intermolecular hydrophosphination (Section 1.2.3), 
(Scheme 10). This occurs due to a favoured conformation during the transition state before 
N-C bond formation and because of factors that stabilise the developing anionic charge 
upon the adjacent carbon (C1)
 
to the calcium centre.
 
A 2,1-insertion mechanism allows the 
adjacent phenyl group to C1 to stabilise the anionic intermediate, lowering the transition 
state energy and consequently making it more favourable. A 1,2-insertion means the 
adjacent carbon to the metal centre, in this case C2, would be devoid of such stabilising 
assistance rendering this conformation less favourable.   
 
 
Scheme 9 Proposed mechanism for the organocalcium mediated intermolecular 
hydroamination (L2 = bidentate mono-anionic ligand; M = Ca; X1 = anionic                      
σ-bound species, for example [N(SiMe3)2]- or [C(SiMe3)3]-).  
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Scheme 10 Preferred 2,1-addition for styrene with calcium (L2 = bidentate                             
mono-anionic ligand; M = Ca; X1 = anionic σ-bound species, for example                         
[N(SiMe3)2]- or [C(SiMe3)3]-). 
The proposed mechanism for intermolecular hydroamination is taken from the mechanism 
postulated for the lanthanides (Scheme 9).62, 95 Calcium’s predominantly ionic bonding 
denotes the reaction pathway is dominated by Coulomb interactions between catalyst and 
substrate. Initiation occurs with rapid reaction between the calcium complex and the 
incoming amine substrate, which causes the formation of a secondary-amine calcium 
complex and the protonation of the mono-anionic species X1 to HX1. Alkene insertion into 
the Ca-N σ-bond is ascribed as the rate-determining step (as calculated from model 
complex studies involving ethylene and ammonia).89 2,1-insertion of the alkene occurs by 
way of a four-centre transition intermediate where significant electron density is located 
over the amine moiety and of the unsaturated carbon adjacent to the calcium centre         
(C1, Scheme 10). As electron density accrues over the adjacent unsaturated carbon (C1), 
nearing the equivalent of one additional electron, electron density is withdrawn from N-Ca 
bond lobe and is dispersed into the newly forming N-C bond.  
Hill and co-workers’ calculations put the energy barrier to the initial deprotonation of the 
amine substrate to form the secondary-amine calcium complex at 36.0 kJ mol-1 and alkene
 
insertion into the Ca-N bond at 69.9 kJ mol-1. Eyring analysis of intermolecular 
hydroamination of styrene with piperidine catalysed by [Ca{N(SiMe3)2}2(THF)2] suggests 
∆G‡ = 100.8 kJ mol-1 (although the authors suggest this value appears somewhat 
overestimated compared to calculations on the model system with ethylene and ammonia). 
The authors add that calcium provides the ideal balance between polarization and 
polarizability which assists the ease of alkene insertion.  
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In further mechanistic support evidence for the formation of calcium-alkene adducts of the 
type postulated during the mechanism has been provided by Schumann et al.96 and Wiecko 
et al..97 Although the latter case involved the barium analogue, complexes 1.4 and 1.5 were 
isolated (Fig. 3). Lanthanide variants of these types of complex are also known.98 
 
Fig. 3 Isolated alkaline earth metal complexes 1.4 and 1.5,                                                  
depicting metal-alkene bonds (M = Mg, Ca, Sr, and Ba). 
 
1.2.1.2 Asymmetric Hydroamination of Alkenes 
Prior to pioneering work with a chiral bisoxazoline (BOX) supported calcium complex     
by Buch and Harder in 2008,49 application of calcium complexes to asymmetric                   
inter-/intramolecular heterofunctionalisation catalysis was non-existent. Whilst efforts at 
the time were being made towards developing and understanding well-defined complexes, 
investigating exchange processes, and improving the library of calcium precursors, taking 
the step to tackle asymmetric catalysis could be regarded as appreciably ambitious. When 
Buch and Harder applied complex 1.6 (Scheme 11) to both hydroamination catalysis (and 
hydrosilylation as discussed in Section 1.2.2.1), selectivities were poor (ca. 4-10% ee).  
 
Scheme 11 Redistribution of [Ca(BOX){N(SiMe3)2}(THF)2] 1.6 to 1.7. 
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The low enantiomeric excess was deemed a result of the prevalent Schlenk-type 
equilibrium already well-known to be operating in systems of this type (Section 1.1.1). The 
formation of the two homoleptic species reduces the quantity of active, stereodirecting 
heteroleptic complex L2CaX1 to its significantly less active, or even entirely inactive L2Ca 
analogue. This is accompanied by the formation of the active, yet non-stereoselective 
CaX12 compound that not only affects catalytic rate but also results in racemic product 
formation (Scheme 11). This truly highlights the importance of suppressing Schlenk-type 
equilibria in asymmetric catalysis systems in order to obtain more stereoselective catalysts.   
To this end Buch and Harder probed the addition of further equivalents of unreactive 
homoleptic BOX complex (1.7, Scheme 11) to cause the equilibrium to shift in favour of 
the formation of active compound 1.6. The addition of 1 equivalent of 1.7 to a solution of 
1.6 resulted in a system largely free of [Ca{N(SiMe3)2}2(THF)2]. Buch and Harder also 
adopted this approach to their studies on hydroamination, though enantiomeric excesses 
only improved from 5% to 6% ee.  
Alongside studies of 1.6 the use of chiral complex 1.8 (Fig. 4) was investigated in 
hydroamination (and hydrosilylation as set out in Section 1.2.2.1), but the authors report 
that it also underwent ligand redistribution in the same manner as 1.6. However when 1.8 
was applied to hydroamination a selectivity of 10% ee was recorded, a mild increase over 
that of 1.6 
 
Fig. 4 Chiral calcium complex 1.8. 
Since 2008, exploits into asymmetric hydroamination have progressed and Sadow et al. 
have reported increased enantioselectivies in hydroamination with chiral 
tris(oxazolinyl)borato calcium complex 1.9 (Fig. 5).85 When applied to intramolecular 
hydroamination of various typical substrates, e.g. 2,2-dimethyl-4-penten-1-amine and     
2,2-diphenyl-4-penten-1-amine precursors (entries 1 and 2, Table 2), both substrates 
displayed complete product conversion in less than 5 minutes at room temperature.  
Chapter One – Organocalcium Catalysis 
 
18 
 
Of the two substrates the gem-diphenyl pyrrolydine was racemic, however the gem-
dimethyl substituted pyrrolidine product gave a calculated enantiomeric excess of 16%. An 
18% ee was also noted for the cyclisation of 2-cyclohexyl-4-penten-1amine (entry 3).  
 
Fig. 5 Tris(oxazolinyl)borato calcium complex 1.9. 
Table 2 Hydroamination of aminoalkenes with calcium complex 1.9. 
Entrya Aminoalkene Product(s) Time Temp. (°C)
 
Conv.%b ee %b 
1 
 
 
 
5 min 25 >99 16 
2 
 
 
 
5 min 25 >99 0 
3 
 
 
 
5 min 25 >99 18 
4 
 
 
 
7 days 80 <10 - 
a
 Entries 1-3 10 mol% catalyst loading, entry 4 1 mol% catalyst.                                
b
 
Determined by 1H NMR. 
 
 
 
 
 
 
 
Chapter One – Organocalcium Catalysis 
 
19 
 
Sadow and co-workers also probed the intramolecular hydromamination of identical 
substrates with the magnesium analogue of 1.9. When the magnesium complex was reacted 
with the substrates from entries 1-3 of Table 2, substantially lower activity was noted 
(Table 3). For reactions to proceed with magnesium elevated temperatures of up to 80 °C 
were necessary for longer durations (upwards of 24 hours) before comparable conversions 
of 80-93% were obtained. Although magnesium displayed lower activity than calcium the 
stereoselectivity was greatly enhanced. Entries 1 and 3 in Table 3 show calculated 
enantiomeric excesses of 27% and 36% respectively.  
Table 3 Hydroamination of aminoalkenes with the magnesium analogue of complex 1.9. 
Entrya Aminoalkene Product(s) Time Temp. (°C)
 
Conv.%b ee %b 
1 
 
 
 
5 days 80 80 27 
2 
 
 
 
12 h 60 >99 0 
3 
 
 
 
26 h 60 93 36 
 
  
    
a
 Entries 1-3 10 mol% catalyst loading. b
 
Determined by 1H NMR.
 
 
 
These results also showed improved enantioselectivity compared to previously reported 
magnesium mediated intramolecular hydroamination reactions, where Hultzsch and co-
workers implemented a diamidobinaphthyl supported magnesium catalyst 1.10 (Fig. 6) to 
attain 14% ee using the 2,2-diphenyl-4-penten-1-amine substrate.99 Both results have been 
superseded as of 2012 where Hultzsch et al. utilised the magnesium complex 1.11 (Fig. 7) 
in a wide variety of intramolecular hydroamination reactions where stereoselectivities were 
very favourable for a wide range of substrates, being recorded between 51-93% ee.100  
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Fig. 6 Diamidobinaphthyl magnesium complex (1.10) achieved                                                   
14% ee in asymmetric intramolecular hydroamination.   
 
Fig. 7 Phenoxyamine magnesium complex (1.11) achieved                                                    
93% ee in asymmetric intramolecular hydroamination.   
The above handful of examples goes to highlight the limited developments within AE 
metal mediated asymmetric heterofunctionalisation reactions, specifically that of 
heteroatom insertion into unsaturated bonds. Of the transformations examined 
hydroamination has been at the frontier of organocalcium driven asymmetric catalysis with 
only one example investigating asymmetric hydrosilylation (Section 1.2.2.1).   
Induced enantioselectivity in asymmetric hydroamination from AE metal based catalysts is 
still generally lower than those experienced by the lanthanides or d-block metals, with 
more success arising from magnesium based complexes (having just accomplished 93% ee 
in intramolecular hydroamination).100 Asymmetric hydroamination with calcium has 
experienced much slower growth compared to magnesium, but has seen improvement from 
6% to 18% ee. It is in this context that the research presented in this Thesis aims                
to understand and develop chiral ligand systems in order to achieve increased levels          
of enantioselectivity with calcium complexes in the intramolecular 
hydroamination/cyclisation of aminoalkenes. 
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1.2.1.3 Intermolecular Hydroamination of Isocyanates and Carbodiimides 
The majority of hydroamination literature has been confined to substrates bearing C=C or 
C≡C unsaturated bonds, however intermolecular hydroamination with complex 1.1 has 
also been expanded to that of carbodiimides (RN=C=NR) Scheme 1288 and isocyanates 
(RN=C=O) Scheme 16.101  
 
Scheme 12 Intermolecular hydroamination of carbodiimides                                                 
mediated by calcium resulting in guanidine formation. 
During discussion of the mechanisms for inter-/intramolecular hydroamination, the highly 
reactive nature of the intermediates was demonstrated by the difficulty experienced when 
trying to achieve their isolation. Conversely, the resulting product from insertion of a 
carbodiimide into the calcium-amine complex has been readily isolated. Hill et al. 
examined a selection of insertion products formed from 1.1 at room temperature in 
hydrocarbon solvents in their report.101 These results reveal a heteroleptic calcium complex 
with a BDI supporting ligand and 1,3-dialkycarbodiimide bound to the metal centre (1.12). 
This also lends supporting evidence for the formation of this type of intermediate during 
catalysis (Scheme 13).102  
 
Scheme 13 1,3-dialkylcarbodiimides insertion into the Ca-N bond to form complex 1.12. 
This was later elaborated upon with the isolation of homoleptic calcium complexes where 
the supporting ligands were both 1,3-dialkylcarbodiimidates, proving that these 
“substrates” were indeed suitable ligands in their own right (Scheme 14). The stability of 
such calcium guanidinate complexes far outweighs other similar catalytic calcium 
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intermediates, with observations that some complexes remain stable in solution for a 
duration of 2 weeks or more under inert conditions.88 
 
Scheme 14 Homoleptic calcium complex 1.13 supported by two 1,3-dialkylcarbodiimides. 
Feil and Harder have reported a homoleptic calcium bis(guanidinate) complex 1.13, a 
result of reaction between calcium amide [Ca{N(SiMe3)2}2(THF)2] and two equivalents of        
1,3-diisopropylcarbodiimide.103 Complex 1.13 could also be formed in a typical manner 
via salt metathesis between the potassium salt of 1,3-diisopropylcarbodiimide with 0.5 
equivalents of CaI2. Whilst the focus of this review is the application of organocalcium 
complexes to catalysis, several excellent reviews have been written discussing the 
synthesis of many of the AE metal precursors presented in this Chapter.2, 44-46 
 
Redistribution of complex 1.13 was mentioned and the authors note that the equilibrium, 
although favouring the heteroleptic complex 1.13, can be shifted by an addition of an 
excess of homoleptic species, resulting in near quantitative formation of the heteroleptic 
species. Most recently Hill et al. have conducted similar investigations on a wider range of 
substrates to form both hetero- and homoleptic species upon the generality of insertion of 
1,3-dialkylcarbodiimides (and isocyanates) into Ca-E bonds (E = N, P,).104  
 
Use of 1.1 in hydroamination reactions involving 1,3-dialkylcarbodiimides was reported by 
Hill and co-workers as a follow up to their earlier studies concerning the calcium 
guanidinate complex 1.12 (Scheme 13)102 in 2008.88 The authors comment upon the rapid 
reaction between the amine and 1,3-dialkylcarbodiimide with most reaching completion in 
5 minutes or less, and with lower than normally observed catalyst loadings (2-4 mol%). 
The scope of their studies included both sterically demanding amines (e.g. 2,6-di-iso-
propylaniline) and carbodiimides (e.g. 1,3-di-tert-butylcarbodiimide). Substrate limitation 
was remarked on by way of the facile nature by which this reaction progressed when the 
amine was an aniline analogue. The authors note that reactions using primary amines were 
unsuccessful.  
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For comparison reactions were carried out using [Ca{N(SiMe3)2}2(THF)2], which is also 
active. Yields from the employment of either catalyst gave good conversions (77-91%), 
however lower yields were noted for sterically demanding carbodiimides i.e. 1,3-di-tert-
butylcarbodiimide and 1,3-di-cyclohexylcarbodiimide. In such instances isolated yields 
were reduced to 37-55%. These could be increased to 46-82% upon conducting the 
reaction at 80 °C as opposed to ambient conditions. 
Reaction products from the aforesaid hydroamination of carbodiimides are reported to 
crystallise from reactions carried out in hexane where single-crystal X-ray diffraction 
techniques, coupled with multi-nuclear NMR spectroscopy have alluded to the guanidine 
products having undergone a 1,3-proton shift during the catalytic cycle (Scheme 15).  
 
Scheme 15 Proposed mechanism for the organocalcium mediated                                                                            
hydroamination of carbodiimides. (L =BDI; M = Ca; X1 = anionic                                               
σ-bound species, for example [N(SiMe3)2]-). 
 
During the catalytic cycle a homoleptic calcium guanidinate intermediate 1.14 is formed 
after insertion of the carbodiimide into the Ca-N bond of [L2Ca-NHR] and prior to 
protonolysis (Fig. 8). Complex 1.14 was also found to be a competent catalyst when 
applied to the substrates 1,3-di-iso-propylcarbodiimide and aniline. The authors suggested 
that whilst evidence indicates the calcium guanidinate species is dimeric in solution, the 
number of calcium centres in the active catalyst is likely to vary as a function of the 
substrate employed. 
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Fig. 8 Homoleptic calcium guanidinate complex 1.14                                                 
suggested as the catalyst resting state. 
A single publication from Hill et al. is current the only example of an organocalcium 
complex applied to the intermolecular hydroamination of isocyanates (Scheme 16).101 In 
this example 5 mol% of complex 1.1 or [Ca{N(SiMe3)2}2(THF)2] resulted in successful 
urea product in yields of 89% and 92% respectively, under mild conditions (25 °C, 2h).  
 
Scheme 16 Intermolecular hydroamination of isocyanates resulting in urea formation. 
Stochiometric reaction between 1.1 and diphenylamine results in the calcium amide 
complex [Ca{ArNC(CH3)CHC(CH3)NAr}(NPh2)(THF)] (Ar = 2,6-di-iso-propylphenyl). 
Addition of one equivalent of 1-adamantyl isocyanate results in the insertion of the aryl-
isocyanate into the Ca-N bond, a reaction that occurs readily at room temperature in 
hydrocarbon solvents. The newly formed calcium ureido complex was subsequently 
isolated and crystallographically characterised (1.15, Fig. 9). A catalytic loading of 5 mol% 
of 1.15 was found to competently hydroaminate 2,6-di-iso-propylisocyanate and 
phenylamine (the constituents of which it was constructed) to 92% yield in 2 hours under 
ambient conditions. The proposed mechanism by which isocyanates are hydroaminated is 
presented in Scheme 17. The authors suggest that it is likely that the resulting urea product 
is able to act as a coordinating ligand which may interfere with the reaction by preventing 
substrate coordination and thus reaction.  
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(a)  
 
 
 
(b) 
 
Fig. 9 (a) Calcium ureido complex 1.15 and (b) ORTEP representation of 1.15                         
thermal ellipsoids at 20% probability and H atoms omitted for clarity.101  
 
 
Scheme 17 Proposed mechanism for the hydroamination of isocyanates.                           
(L =BDI; M = Ca; X1 = anionic co-ligand, e.g. [N(SiMe3)2]-). 
Of the remaining heavier AE metal elements several examples of barium and strontium 
mediated hydroamination reactions have also been reported 42, 82, 87, 88, 90, 101 and a general 
discussion concerning all heavier AE metals in hydroamination has been recently 
highlighted.91     
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1.2.2 Hydrosilylation  
Hydrosilylation is the action of adding a polar Si-H bond to a multiple bond, most 
commonly C=C, C=O, or C=N. In the same manner as hydroamination, the process is a 
highly atom efficient route to incorporating silyl moieties into molecules. The addition of a 
silyl moiety to a vinyl group is a useful transformation however regio- and/or 
stereoselectivity can be troublesome due to unspecificed insertion of the silyl group to 
either carbon of the C=C unsaturation. Two examples of calcium mediated hydrosilylation 
have so far been reported.49, 105  
 
Fig. 10 The first examples of calcium complexes used                                                                          
in the execution of hydrosilylation, 1.16 and 1.17. 
Calcium benzyl complexes 1.16 and 1.17 (Fig. 10) were tested on a selection of substrates 
and the results are summarised in Table 4. The authors highlight that currently the range of 
substrates that AE metals can hydrosilylate remains limited to activated alkenes which 
carry the side-effect of being susceptible to polymerisation reactions.12 This is the reason  
why the authors chose to investigate 1,1-diphenylethylene (DPE) as it fulfils the 
requirement of being an activated alkene whilst having sufficient steric bulk to resist 
polymerisation. 
The homoleptic species 1.17 was the more reactive catalyst (entries 1 and 2 vs. 3 and 6) 
and in most examples product conversion was near quantitative. Reactions proceeded with 
low catalysts loadings (0.5-10 mol%) under moderately mild conditions of 50 °C for up to 
24 hours or significantly less (entries 6, 8, and 9). In many studies solvent effects upon 
reaction performance have not been probed. In this study a change in preferred 
regioselectivity of the resulting product of reaction between PhSiH3 and DPE was seen 
upon solvent exchange from benzene to THF (entries 3 and 4 vs. 10). Although solvent 
effects were not investigated further their study did bring to light a number of other points.  
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Table 4 Hydrosilylation activity of complexes 1.16 and 1.17 upon various alkenes. 
Entry Cat. Cat. 
mol% 
Substrates Product Time 
(h) 
Temp. 
(°C)
 
Conv. 
(%) 
 
1 1.16 5 DPE 
PhSiH3  
16 50 10 
 
2 1.16 5 Styrene 
Ph(CH3)SiH2  
20 50 >98a 
 
3 1.17 2.5 DPE 
PhSiH3  
16 50 >98 
 
4 1.17 10 DPE 
PhSiH3  
2 50 >98 
 
5 1.17 2.5 Ph(CH3)C=CH2 
PhSiH3 
 
24 50 20 
 
6 1.17 2.5 Styrene 
PhSiH3 
 
 
<0.1 20 >98a 
 
7 1.17 0.5 Styrene 
PhSiH3 
 
1.5 50 >98a 
 
8 1.17 2.5 Styrene 
Ph(CH3)SiH2  
<0.1 20 >98a 
 
9 1.17 2.5 Cyclohexadiene 
PhSiH3  
<0.1 20 >98 
 
10b 1.17 2.5 DPE 
PhSiH3  
3 50 >98 
 
a Both diastereoisomers were obtained in an approximate 1:1 ratio.
 
b Reaction in THF.
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Reaction of catalysts 1.16 and 1.17 involving styrene resulted in the desired silane product 
rather than polystyrene. This suggests that alkene hydrosilylation occurs at a faster rate 
than polymerisation, since calcium benzyl complexes are known to polymerise styrene in 
the absence of a silane (vide infra). It was postulated that hydride-rich clusters form part of 
the reactive species responsible for hydrosilylation, although CaH2 was found to lack 
catalytic activity when used directly as a hydrosilylation catalyst. 
 
 
Scheme 18 Proposed mechanisms of intermolecular hydrosilylation concerning the heavier 
AE metals (L2 = bidentate mono-anionic ligand; M = Ca; X1 = anionic σ-bound species,  
for example [N(SiMe3)2]- or [C(SiMe3)3]-).61, 105, 106 
The mechanism of this reaction is still under scrutiny although the favoured mechanisms 
are shown in Scheme 18. Detailed insight into the mechanisms of the heavier AE metals 
remains unclear due to the difficult nature of isolating the highly reactive reaction 
intermediates. In the case of hydrosilylation the proposed AE metal hydride intermediate 
[LCaH], has remained unisolated and the known ease at which AE metal compounds 
undergoing Schlenk-type redistribution render this task significantly more difficult. 
Drawing parallels from lanthanide chemistry it is believed that the true catalytically active 
species involves a lanthanide hydride complex. This is generated as a result of an 
alkyllanthanide compound reacting with a silane substrate.107 The active hydride 
intermediate is referred to as “L2MH” in Scheme 18, and after the formation of this 
reactive intermediate the lanthanide mechanism proceeds in a similar manner as denoted in 
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Scheme 2 with σ-bond metathesis resulting from the insertion of the unsaturated bond of 
the substrate. This is illustrated as “cycle A” in Scheme 18. 
Cycle B of Scheme 18 involves the reaction proceeding through a silanide intermediate. It 
is suggested that the ion pairs [LM]+ and [SiPhH4]- decompose to form the metal silanide 
[LM(SiPhH2)] alongside the liberation of H2. This rational is used to account for the 
observed variations in regiochemistry between polar and non-polar solvents. It has been 
suggested that the two transition states through which σ-bond metathesis occurs between 
LMX1 and RnSiH4-n (dictating product regioselectivity) likely have similar energetics and 
solvent interaction/non-interaction play a large part in dictating the reaction pathway. 
 
Fig. 11 Hydride containing calcium compound 1.18.  
Although the isolation of catalytic intermediates has so far proven fruitless, a dimeric 
calcium compound containing bridging calcium hydride bonds has been observed by 
Harder and Brettar, using complex 1.1 (Fig. 11). Nonetheless the isolation of dimeric 1.18 
supports the possibility that such structures are feasible.    
The dimeric complex 1.18 was also employed in the hydrosilylation of ketones        
(Scheme 19) the results of which are tabulated in Table 5. Hydrosilylation to form the 
desired silyl-ether (R3SiOCHR1R2) was achieved using low catalyst loadings of             
1.25 mol%, of 1.18 under relatively mild conditions (50 °C, 0.25-34 hours) resulting in 
commendable yields (91-96%). The well defined dibenzylcalcium catalyst 1.17 was also 
investigated and demonstrated comparable catalytic performance to 1.18, albeit with 
slightly improved yields (95-98%) at the expense of elongated reaction times.106 
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Scheme 19 Deployment of 1.18 to the hydrosilylation of ketones. 
Table 5 Hydrosilylation of ketones using 1.25 mol% of 1.18 with PhH3Si. Results for 
catalyst 1.17 are given in parentheses for comparison.  
Entry Ketone Time (h) PhHSi(CHOR1R2)2 (%) 
1 Ph(CO)Ph 15 [15] 96 [96] 
2 Ph(CO)CH3 34 [38] 95 [95] 
3 cyclohexanone 3 [3] 91 [96] 
4 PhCH2(CO)CH2Pha 34 [54] 96 [95] 
5 adamantoneb 0.2 [1.5] 95 [98] 
 
a 5 mol% catalyst.
 
b reaction conducted at 20 °C. 
 
It is known that by-products resulting from competing carbonyl enolization and aldol 
condensation can occur (Scheme 20). Whilst the yields of hydrosilylation with 1.18 and 
1.17 were high, the potential for side reactions was investigated further.  
 
Scheme 20 Addition, enolization, and aldol condensation of ketones. 
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A staggered hydrosilylation reaction was undertaken between 1.18 and two equivalents of 
ketone, which resulted in the isolation of X-ray quality single crystals of a ketone bridged 
compound (1.19, Fig. 12). When R1
 
was CH(Ph)2 or adamantly 1.19 was obtained in yields 
of 73% and 67% respectively. All other examples showed significantly lower yields         
(9-25%). It was observed that all dimers were free of coordinated THF presumably due to 
the steric bulk of the more demanding alkoxide group saturating the coordination sphere of 
the metal centre. 
 
Fig. 12 Alkoxide bridged calcium compound 1.19 isolated by Harder et al.. 
Once formed compound 1.19 went onto complete hydrosilylation upon the addition of 
trimethylsilyl chloride (Me3SiCl). Table 6 summarises the results upon quenching with 
Me3SiCl to form the addition product; the targeted silyl-ether (R3SiOCHR1R2). It shows 
that when the ketone is benzophenone or adamantone then the desired silyl-ether (addition 
product) is obtained in near-quantative yields. All other examples exhibit low levels of 
enolization (15-35%) and still lower quantities of the aldol condensation by-product      
(<1-7%). When the ketone is acetone then none of the desired addition product is obtained 
and only enolization (76%) and aldol condensation (24%) by-products are observed.  
Probing the ratios of ketone:silane revealed an intriguing trend and showed that overall, 
regardless of the ketone:silane ratio the favoured reaction product is that of 
[PhSiH(OCHR1R2)2] (Scheme 19). This remains the major product even at elevated ratios 
of 1:2 ketone:silane. At low ketone:silane ratios low quantities of the trialkoxy silyl-ether 
[PhSi(OCHR1R2)3] are obtained.   
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Table 6 Hydrosilylation of ketones by 1.18 and proportions of by-products.  
Entry Ketonea % Addition % Enolization % Aldol Cond.
 
1 Ph(CO)Ph 100 - - 
2 Ph(CO)CH3 85 15 <1 
3 CH3(CO)CH3 - 76 24 
4 cyclohexanone 58 35 7 
5 PhCH2(CO)CH2Ph 68 32 <1 
6 adamantone 100 - - 
 
a All reactions used catalyst 1.18 with the specified ketone for 16 hours at 20 °C 
before quenching with Me3SiCl. 
 
1.2.2.1 Asymmetric Hydrosilylation of Alkenes 
In Section 1.2.1.2, compounds 1.6 and 1.8 (Scheme 11 and Fig. 4) were introduced as the 
first chiral calcium complexes to be applied to intramolecular hydroamination. These two 
complexes were also applied to the first and only example of asymmetric intermolecular 
hydrosilylation along with compound 1.17 (Fig. 10).49 The results of their reaction with 
styrene and phenylsilane into PhCH(SiH2Ph)CH3 is tabulated in Table 7. 
Table 7 Hydrosilylation of styrene and phenylsilane into PhCH(SiH2Ph)CH3.  
Entry Catalyst mol% T (°C) t (h) % Conv.
 
ee % 
1 1.17 2.5 20 <0.1 >98 0 
2 1.6 2.5 50 16 >98 5 
3 1.6a 5 50 16 >98 9 
4 1.8a 5 50 16 >98 9 
 
 
     
a 1:1 mixture of heteroleptic and homoleptic analogue. 
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Entries 3 and 4 were both conducted with a 1:1 mixture of heteroleptic:homoleptic 
complex by addition of the relevant homoleptic compound e.g. 1.7 to the solution of the 
redistributed heteroleptic compound, e.g. 1.6. As briefly mentioned the increase in 
homoleptic compound concentration can steer the redistribution equilibrium to form the 
heteroleptic compound and minimise the presence (<2%) and thus impact of 
[Ca{N(SiMe3)2}2(THF)2]. As with hydroamination the authors also note inactivity of the 
homoleptic species towards hydrosilylation.  
In results that closely mirror those achieved in asymmetric hydroamination, the 
enantioselectivities were low (5-9% ee). Again the low selectivities are attributed to the 
facile ligand redistribution of the catalysts. It also suggests that the true catalytic species 
although proposed as L2MH (Scheme 18) may be CaH2 if L2MH undergoes ligand 
redistribution that heavily favours the formation of homoleptic Ca(L2)2 complex and CaH2. 
Evidence for this is provided by the authors’ observation that addition of PhSiH3 to 
heteroleptic 1.6 resulted in the exclusive formation of homoleptic 1.7 and CaH2 and 
presumably PhSiH2N(SiMe3)2. 
 
1.2.3 Hydrophosphination  
Hydrophosphination is the addition of P-H to an unsaturated C-C bond allowing the 
synthesis of a variety of phosphines that are often utilised as ligands in traditional 
transition metal chemistry. The catalytic cycle for hydrophosphination is presented in 
Scheme 21 and is reminiscent of both those presented for hydroamination (Scheme 9, 
Section 1.2.1) and hydrosilylation (Scheme 18, Section 1.2.2). Like intermolecular 
hydroamination and hydrosilylation, hydrophosphination is entropically disfavoured.        
A consequence of this is substrates suitable for intermolecular hydrophosphination        
(like those used in hydrosilylation) also need to be activated. Steric hindrance around the 
alkene moiety is known to affect substrates that can undergo intermolecular 
hydrophosphination, where sufficient steric impeachment around the substrate unsaturation 
can result in reduced or nil activity.108 For comparison lanthanides are known to facilitate 
both inter- and intramolecular hydrophosphination.109 
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Scheme 21 Proposed mechanism for the organocalcium mediated hydrophosphination            
of styrene. (L2 = bidentate mono-anionic ligand; M = Ca; X1 = anionic σ-bound species, 
for example [N(SiMe3)2]- or [C(SiMe3)3]-).  
Hill et al. published the first example of an organocalcium complex applied to 
intermolecular hydrophosphination in 2007 using the increasingly exploited BDI supported 
calcium complex 1.1.108 Hill and co-workers were able to successfully hydrophosphinate a 
small range of substrates (Table 8). Generally reaction conditions are more forcing for 
these examples of hydrophosphination than those of hydrosilylation or hydroamination.     
Of particular interest is the apparent trend for formation of the syn (cis) addition products 
which are said to be anti-Markovnikov as addition of the phosphine moiety occurs at the 
least sterically hindered/substituted carbon. In systems containing multiple instances of 
C=C bonds hydrophosphination occurs again at the least substituted C=C site leading to 
strict regioselectivity. Reactivity is also dictated by the steric demands of the alkene, more 
hindered substrates such as α-methylstyrene, 1,2-diphenylethyene, and trans-stilbene did 
not readily react under similar conditions to the substrates used in entries 1-4 Table 8.  
The use of more activated alkenes hydrophosphination (i.e. 2-vinyl-pyridine cf. styrene), 
caused vinyl-polymerisation to become more favourable over hydrophosphination. This is 
not entirely unexpected since the polymerisation of 2-vinylpyridine has long been reported 
to be possible with the heavier AE metals.10 This result suggests that competition occurs 
between the rate of substrate insertion into the Ca-C σ-bond and that of the σ-bond 
metathesis step mediated by the phosphine substrate. This preference for polymerisation 
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over hydrophosphination holds true regardless of addition of excessive amounts of the 
phosphine reagent in an attempt to promote hydrophosphination. 
The authors allude that exclusive regioselectivity (2,1-addition) observed with styrene 
(entry 1) is again a result of a preferential geometry of the benzylcalcium intermediate 
[L2CaCHPhCH2(PR2)], which is formed by reaction of the calcium catalyst with a 
molecule of styrene. The insertion between the calcium and the α-carbon to the phenyl 
results in a more stable complex conformation. If addition had occurred at the least 
substituted carbon of the C=C forming [L2CaCH2CHPh(PR2)] the intermediate would be 
less stable and thus more reactive (Scheme 22). The 2,1-addition intermediate is more 
stable than the 1,2-addition intermediate due to the effect of the phenyl substituent on 
stabilising the developing anionic charge. Due to calcium’s ionic bonding when the 
reaction proceeds via a 2,1-addition, the phenyl group is able to assist in stabilising the 
developing anionic charge on the α-carbon to the phenyl ring, adjacent to the calcium 
centre, lowering the activation energy required in the insertion step (Scheme 22).  
 
Table 8 Hydrophosphination of alkenes with Ph2PH and 10 mol% of 1.1 in C6D6.  
Entry Substrate Product(s) T (°C) t (h)
 
Conv. (%) 
1 
 
 
75 20 95 
2 
  
25 24 95 
3 
 
+  
75 24 78 
4 
 
+  
75 13 94a 
  
a 20 mol % catalyst.
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Scheme 22 Preferred 2,1-addition for styrene with calcium (L2 = bidentate                             
mono-anionic ligand; M = Ca; X1 = anionic σ-bound species, for example                         
[N(SiMe3)2]- or [C(SiMe3)3]-). 
In addition Hill and co-workers found that hydrophosphination was unsuccessful between 
diphenylphosphine (Ph2PH) and diphenylethyne (Ph-C≡C-Ph) with 10 mol% 
[Ca{N(SiMe3)2}(THF)2] in C6D6, instead affording the insoluble [Ca(PPh2)2(THF)4].    
This raises two points, the first being that a heteroleptic calcium complex (LCaX) is 
required in the hydrophosphination cycle, not a homoleptic one (L2Ca) as seen by the 
isolation of 1.20 (fig. 13). Secondly [Ca(PPh2)2(THF)4] is known to be catalytically active 
in the hydrophosphination of diphenylethyne and/or diphenylbutadiyne with 
diphenylphosphine.110 The authors reasoned that the suppression of catalytic activity was 
simply due to the complexes low solubility in C6D6, whereas the original report by 
Wasterhausen et al. conducted reactions in THF.  
The proposed reaction mechanism (Scheme 21) has been derived from the isolation of 
complex 1.20 (Fig. 13). 1.20 was proven catalytically active and the addition of 10 mol% 
to a solution of diphenylphosphine and styrene resulted in the successful 
hydrophosphination of the substrates. This evidence lends support to the formation of a 
calcium-phosphine complex able to undergo further reaction. Further evidence for this 
mechanism was provided by reaction of 1.20 with an excess of diphenylethyne               
(Ph-C≡C-Ph) and 1 equivalent of HN(SiMe3)2. It was observed that after 45 minutes at     
75 °C in C6D6 a 1:1 mixture of (E)-PhC(H)-C(PPh2)Ph and the calcium 
bis(trimethylsilyl)amide complex 1.1 was formed.  
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(a)  
N
N
R
R
Ca
1.20
THF
PPh2
R = 2,6-di-iso-propylphenyl
 
(b) 
 
Fig. 13 (a) complex 1.20 and (b) ORTEP representation of 1.20 thermal                 
ellipsoids at 20% probability with H atoms omitted for clarity.108 
These two reactions indicate that initially the calcium catalyst L2MX1 reacts with PHR2 to 
afford L2MPR2 with the concomitant formation of X1H. The newly formed calcium-
phosphine (e.g. 1.20) undergoes further reactivity from the insertion of the alkene or 
alkyne substrate into the Ca-P σ-bond, before the phosphide complex is regenerated by 
further reaction with the phosphine, generating the phosphine product.  
The latest contribution to calcium catalysed intermolecular hydrophosphination of alkenes 
and alkynes was reported by Hu and Cui.111 The authors use a tridentate amidinate 
supported calcium amide, compound 1.21 (Scheme 23). 1.21 proves to be a robust 
complex showing no decomposition or ligand redistribution even at 160 °C which is 
indicative of the excellent stabilising properties of the tridentate amidinate ligand. 
Compound 1.21 is monomeric in the solid state, taking a 5-coordinate calcium centre and 
adopting a tetragonal pyramid geometry.  
The catalytic ability of 1.21 was tested over a range of intermolecular hydrophosphination 
reactions involving 1,3-conjugated dienes, alkynes and sterically hindered alkenes. Like 
preceding hydrophosphination catalysts 1.21 is not active for unactivated C=C substrates, 
for example 1-hexene or 4-hexyne, instead showing moderate activity for activated 
substrates with yields of 72-100% obtained within 2-24 hours at temperatures between    
25 and 75 °C.  
Even so this activity is higher than the previous examples like 1.1 for instance. Of 
particular note is the ability of 1.21 to catalyse the hydrophosphination of α-methylstyrene 
and cis-stilbene, both substrates that complex 1.1 was unable to catalyse. In the tested 
reactions both sterically hindering and electron-donating groups on substrates resulted in 
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lower yields. Also noteworthy is the excellent regioselectivity induced by 1.21 in many of 
the products. As previously discussed all products formed are consistent with                  
2,1-insertions (Scheme 22). The predominance of Z-isomer products is dissimilar to that 
typically achieved with calcium BDI supported complex 1.1. 
 
Scheme 23 Hydrophosphination of alkenes and alkynes with catalyst 1.21. 
 
1.2.3.1 – Hydrophosphination of Carbodiimides 
Hill et al. contributed further findings to the area of hydrophosphination in 2008 
investigating the hydrophosphination of carbodiimides (Scheme 24).112 They showed that 
synthesis of phosphaguanidies was possible in a similar manner to the synthesis of 
guanidine derivatives produced by hydroamination.88 Their study incorporated all the 
heavier AE elements and the catalyst structure employed was again metal analogues of 
complex 1.1 with the other AE congeners. They report the reaction between 
diphenylphosphine and 1,3-di-iso-propylcarbodiimide catalysed by 1.5 mol% of 1.1.  
 
 
Scheme 24 Hydrophosphination of carbodiimides mediated by calcium. 
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The reaction progressed under ambient temperature to give a yield of 99% after 6 hours, 
although it was 90% complete after 1 hour. This is remarkable considering the very mild 
reaction conditions (this reaction does not proceed without a catalyst). 
Catalyst loadings are significantly lower than the typical 10-20 mol% used in many of the 
reactions discussed within this Chapter. This is also the same for the two other calcium 
amides probed, [Ca{N(SiMe3)2}2(THF)2] and THF-free analogue [Ca{N(SiMe3)2}2] which 
were used at 2 and 3 mol% in the same reaction respectively, achieving similar yields of 
>95% in a shorter duration (between 1-4 hours depending on the substrate). Whilst the 
substrates 1,3-di-iso-propylcarbodiimide and 1,3-dicyclopentylcarbodiimide were readily 
converted to their corresponding phosphaguanidine products, the more sterically 
demanding 1,3-di-tert-butylcarbodiimide and 1,3-dicyclohexylcarbodiimide analogues 
proved unreactive under these conditions. It is likely the steric bulk of these substrates 
inhibit the reaction by preventing coordination of the carbodiimide to the calcium centre. 
Changing the phosphine from diphenylphosphine to dicyclohexylphosphine suppressed 
catalytic activity. The authors hypothesise that in this case the reduced acidity of the 
dicyclohexylphosphine compared to that of the diphenylphosphine could be a contributing 
factor meaning the catalyst activation step was left uninitiated. 31P NMR studies were 
undertaken to probe this postulation. They found no resonances relating to the initial 
protonolysis step (formation of L2MPR2).  
The homoleptic calcium amide complexes are more catalytically active than that of 
heteroleptic 1.1. This is in contrast to that of the hydrophosphination of alkenes which 
depended upon a heteroleptic complex as the active species (1.20, Fig. 13 and Scheme 21). 
The catalytic cycle shown in Scheme 25 summarises the proposed reaction mechanism.  
The initiation step is thought to be through the formation of the calcium-alkylphosphine 
(LM-PR2, e.g. 1.20, Fig. 13), since reaction of 1.1 with just the carbodiimide yielded no 
insertion products even under prolonged conditions of 60 °C. Rapid insertion of the 
carbdiimide into the Ca-P σ-bond occurs allowing formation of the phosphaguanidinate 
(step 2, Scheme 25). Isolation and solid state characterisation by single crystal X-ray 
crystallography has been accomplished on the phosphaguanidinate (1.22, Fig. 14). 
Complex 1.22 was also determined to be monomeric in nature in a solution of C6D6.  
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Scheme 25 Proposed mechanism for the organocalcium mediated                       
hydrophosphination of carbodiimides. (L =β-diketimidato ligand 1.1;                                 
M = Ca; X1 = anionic σ-bound species, for example [N(SiMe3)2]-).  
 
 
(a) 
 
 
(b) 
 
Fig. 14 (a) complex 1.22 and (b) ORTEP representation of 1.22 thermal                           
ellipsoids at 50% probability with H atoms omitted for clarity.112  
Interestingly no activity was observed when the isolated analogue of the proposed catalyst 
resting state, complex 1.22, had diphenylphosphine added to it. Based upon behaviour of 
similar systems we might have expected to observe the protonolysis of the 
diphenylphosphine and the σ-bond metathesis step resulting in the formation of the 
phosphaguanidine and the reformation of [LM-PPh2]. Instead no activity was observed 
until additional carbodiimide substrate was added to the mixture whereupon catalytic 
turnover leading to phosphaguanidine product was observed.   
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An equilibrium occurring between the calcium-phosphaguanidinate complex 1.22 and 
HPPh2, as well as 1.20 and the phosphaguanidine product formed at the end of the catalytic 
cycle, was suggested as a rationale for these observations. With these two equilibria 
present in solution, 1.20 is assumed to be present at low concentrations, however readily 
reacts with a molecule of carbodiimide substrate to form 1.22 allowing for catalyst 
turnover and product formation. It was suggested that like all heterofunctionalisations 
concerning calcium they proceed first by substrate insertion followed by σ-bond metathesis 
to yield the product. However in this case there was also a degree of reversibility with 
respect to both steps presented in this reaction mechanism.  
 
1.2.4 Hydrogenation  
The field of hydrogenation has thus far been monopolised by the use of d-block metals and 
so the discovery of an alternative should be regarded as somewhat of a breakthrough. C-H 
bond formation through the addition of hydrogen to an unsaturated bond has so far only 
been investigated using calcium compounds from the heavier AE metals. An extension of 
their hydrosilylation investigations utilising the chiral calcium complex 1.18 (Fig. 11), 
Harder and co-workers reported the first calcium mediated hydrogenation of a number of 
styrene derivatives in 2008.113  
Successful hydrogenation of a range of substrates; 1,1-diphenylethene (DPE),                 
1,3-cyclohexadiene, and α-methylstyrene was effected using compounds 1.17 
([Ca(Me2N(C6H4)CHSiMe3)2(THF)2] and 1.18 ([CaH(BDI)(THF)]2), and no reaction was 
observed with CaH2 (Table 9). Reactions conditions were mild with temperatures ranging 
from ambient to 60 °C, under a 20 bar atmosphere of H2. In a similar fashion to the 
hydrosilylation reactions conducted using the same two catalysts it was noted that the 
reaction outcome was sensitive to solvent polarity. In THF or mixtures of THF / HMPA 
(entries 4-6) reactions proceeded at lower temperatures and with shorter reactions times 
than in benzene. Reactions in benezene were often accompanied with small quantities of 
precipitate, presumably insoluble dimeric material. The source of this dimeric material     
(in the case of DPE being the substrate, 1,1,3,3-tetraphenylbutane) has been suggested as 
the outcome of reaction between a molecule of DPE substrate and (Ph2CCH3)-.  
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The anion (Ph2CCH3)- being a direct result of insertion of a molecule of DPE substrate into 
the catalyst (Scheme 26). For the hydrogenation of styrene (entries 2, 3, and 7) apolar 
solvents were required to prevent the formation of polystyrene; the use of THF or 
THF/HMPA mixtures resulted in the complete suppression of hydrogenation in favour of 
polymerisation.  
Table 9 Hydrogenation of activated alkenes by calcium complexes 1.17 and 1.18.  
Entry Substrate Cat. Cat. 
Mol% 
Solvent T  
(°C)
 
t 
 (h) 
Conv. 
(%) 
Product 
1 DPE 1.18 5 C6H6 60 17 49 Ph2CHCH3 
2 Styrene 1.18 5 C6H6 20 15 97a PhCH2CH3 
3 α-methylstyrene 1.18 5 C6H6 60 25 60 PhCH(CH3)2 
4 DPE 1.17 2.5 C6H6 60 17 41 Ph2CHCH3 
5 DPE 1.17 2.5 THF 20 3.5 92b Ph2CHCH3 
6 DPE 1.17 2.5 THF/ 
HMPAd 
20 1.5 96c Ph2CHCH3 
7 Styrene 1.17 2.5 C6H6 20 15 85e PhCH2CH3 
8 cyclohexadiene 1.17 2.5 C6H6 20 22 96f Cyclohexene 
 
a total conversion >99% with 3% dimeric material. b total conversion 94% with 2% dimeric 
material. c total conversion >99% with 4% dimeric material. d 7% mixture of HMPA
. 
e
 
total 
conversion >99% with 15 oligomeric material. f traces of dimeric material observed
.
 
 
The catalytic cycle presented in Scheme 26 depicts the hydrogenation of styrene with H2, 
as a representative activated alkene. Support for this mechanism was obtained by the 
reaction between complex 1.18 with DPE (Scheme 27). The insertion of one equivalent of 
DPE into the organocalcium complex resulting in complex 1.23, which was isolated and 
characterised via single crystal structure determination.113 In addition, under mild 
conditions (20 °C, 20 bar H2) complex 1.18 was reformed alongside the hydrogenated 
product Ph2CH(CH3). The subsequent hydrogenation step of 1.23 was significantly faster 
in polar solvents such as THF than in benzene (5 min. cf. 15 h).  
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Scheme 26 Proposed mechanism for the organocalcium mediated hydrogenantion of          
styrene. (L2 = bidentate mono-anionic ligand; M = Ca; X1 = anionic σ-bound species,                  
for example [N(SiMe3)2]- or [C(SiMe3)3]-).  
 
Scheme 27 Stochiometric addition of calcium hydride complex 1.18                                      
to DPE and subsequent protonation of the reactive intermediate by H2. 
 
1.2.5 Hydroboration of Alkenes 
Hydroboration is a synthetically useful reaction allowing for the preparation of boron-
functionalised molecules that can subsequently undergo further reaction to create useful 
substrates like alcohols or amines (Scheme 28). Until recently, AE mediated hydroboration 
of alkenes had remained unreported, although it is a known reaction with lanthanides.76-78 
Harder and Spielmann investigated the employment of 1.18 (Fig. 11) but later went on to 
expand their investigations using complexes 1.17 (Fig. 10) and 1.24 (Fig. 15).114  
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Scheme 28 Hydroboration of an alkene with subsequent conversion to an alcohol
.
 
An activated alkene, a common substrate requirement for heterofunctionalisation reactions 
was once again necessary. 1,1-diphenylethylene (DPE) was again chosen as the model 
substrate due to its inert reactivity towards polymerisation. Uncatalysed reaction does not 
readily occur between DPE and catecholborane (1,3,2-benzodioxaborole, HBCat) at room 
temperature, instead requires heating to 100 °C. Under these conditions 96% substrate 
conversion to the boronic ester (Ph2CHCH2Bcat) is achieved in 20 hours. 2.5 mol% of 1.18 
takes 72 hours to achieve the same level of conversion, whilst allowing the reaction to 
proceed under ambient conditions highlighting the influence of the metal. Catalyst 1.17 
achieves 90% conversion in 20 hours at 50 °C. It should be noted that the aforementioned 
reactions took place without addition of solvent. When these reactions are conducted in 
solvent both reaction times increase three-fold and yields drop, in some cases up to 60%.  
 
Fig. 15 Calcium compound 1.24. 
When compounds 1.18, 1.17 and 1.24 were applied to the hydroboration of DPE with 
HBCat they were shown to be catalytically active, however contrary to the expected 
boronic esters (Ph2CHCH2OBCat), the product was a borane: (Ph2CHCH2)3B. From this 
result the authors suggest that these catalysts cannot be regarded as “true” catalyst, but go 
on to liken them to a “Trojan horse” type reaction. In this case the “catalysts” accelerate 
the decomposition of the HBCat to B2(Cat)3 and BH3, with BH3 being the true active 
species. The fact the reactive species is BH3 prohibits any control over chemo-, regio- or 
enantioselectivity through catalyst design. The authors careful analysis of the reaction 
products allowed for the tentative proposal of the mechanism presented in Scheme 29. 
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Scheme 29 Proposed mechanism for the calcium assisted hydroboration of HBCat.  
One of the key intermediate species, L2Ca-BH4 has been prepared by reaction of 1.18 with 
BH3(SMe2). The resulting product has been characterised in the solid state as monomeric  
BDI supported complex [(CH(C(CH3)N(C6H3iPr)2)Ca{BH4}(THF)2], bearing a 
coordinated BH4 moiety and two THF molecules. It takes a tetragonal pyramid 
conformation with the -BH4 capping 3 hydrogens to be a κ3-anionic ligand (1.25, Fig. 16).  
The authors also report that reaction of 1.18 with pinacolborane (4,4,5,5-tetramethyl-1,3,2-
dioxaborolane, HBPin) resulted in the formation of a trimeric species 
[(CH(C(CH3)N(C6H3iPr)2)Ca{H2BPin}]3. Trimeric calcium species are known,29 moreover 
reaction of the trimer with DPE did not result in any reaction. This further exemplifies that 
hydroboration does not occur via reaction between the alkene and H2BPin- anion.  
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In light of the true catalytic species being BH3 and ligand design being currently 
inconsequential, use of calcium borohydride (Ca(BH4)2 provides a cost-effect and less 
moisture sensitive alternative to the aforediscussed complexes. The use of Ca(BH4)2 has 
been shown to be an effective and a remarkably selective catalyst in the presence of 
ethylacetate to produce alcohols from terminal alkenes.115 
 
Fig. 16 Calcium hydroboration intermediate compound 1.25. 
In summary the use of organocalcium compounds over an impressive range of molecular 
reactions has arisen from the rapid expansion of studies concerning this area over recent 
years. Due to its attractive properties as a catalyst development of organocalcium 
compounds continues to swell alongside our knowledge of these systems. Whilst these 
developments have led to a higher degree of understanding, progress concerning 
asymmetric application of organocalcium compounds is severely underdeveloped in 
comparison. To develop high-performing, selective catalysts, a better insight into the 
chemical/structural features necessary to achieve this is urgently required. It is hoped that 
when added to the current asymmetric examples, the work contained within this Thesis 
will help reduce this void in the literature and provide a key starting point for the 
production of the next generation of asymmetric calcium catalysts.  
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2.1 Introduction 
Synthesis of the C2-symmetric bisimidazoline (R-BIM) ligands discussed in Chapter 4 can 
be realised from the condensation of two equivalents of a chiral ethylene diamine with one 
equivalent of diethylmalonimidate dihydrochloride (Scheme 1).1,2 To later probe R-BIMs 
as supporting ligands for calcium complexes, an efficient synthetic pathway for producing 
the aforementioned chiral ethylene diamines is required (referred to as diamine(s) 
henceforth).  
 
Scheme 1 Preparation of bisimidazoline ligands. 
Currently only a small number of commercially available diamines suitable for our 
purposes exist where a popular choice when synthesising chiral imidazoline compounds is 
(R,R)-1,2-diphenylethylenediamine 2.1 (Fig. 1).3-8 A principal aim of this research is to 
fully assess with a view to better understanding the effect of varying the N-R substituent of 
the diamine and R-BIM ligands. Consequently it is crucial to allow the introduction of as 
many different alkyl/aryl groups as possible in the synthetic pathway. Given the rich 
availability of affordable primary amines, a synthetic methodology was developed around 
introduction of the N-R substituent at an early stage. Several routes were considered for 
assembling the library of diamines required. All routes considered are multistep processes 
based upon functional group conversion of an amino acid’s carboxylic acid moiety to 
generate a second amine group. The first method examined exploits the interchange of an 
amino acid’s carboxylic acid moiety to an acid anhydride (Section 2.2.2).  
 
Fig. 1 Commercially available (R,R)-1,2-diphenylethylenediamine (2.1). 
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Fig. 2 Diamines synthesised via an acid anhydride methodology by Mauduit et al.. 
 
Variation of this method has been used by Mauduit et al. to great success producing a 
range of diamines from their corresponding starting tert-butyloxycarbonyl (Boc) protected 
amino acid (Fig. 2).8 The second method involves an aziridine intermediate (Section 2.3),9 
and the third a coupling reaction developed by Jacobsen et al.10 and implemented by Pfaltz 
et al. (Scheme 2).1 The fourth method resulted from the research detailed within this Thesis 
and has since been published by our group (Section 2.4).11 Our method makes use of 
converting an amino acid’s carboxylic acid functionality to an acid chloride before 
undergoing subsequent reaction. 
 
Routes one, three, and four all utilised an amino acid bearing a protecting group bound to 
the primary amine. Common examples of commercially available amino acids used in this 
field include L-valine 2.2, D-phenylglycine 2.3 or L-phenylalanine 2.4 (Fig. 3). Of these 
routes each invokes reactivity at the carboxylic acid moiety, resulting in a more reactive 
intermediate. Further reaction of the newly formed intermediate with a primary amine then 
follows. The protecting group is then removed and the resulting amino-amide need only 
undergo reduction of the amide in order to obtain the diamine.    
 
Scheme 2 Alternative diamine synthesis published by Pfaltz et al.. 
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2.2 2.3 2.4 
  
Fig. 3 Commercially available L-valine 2.2, D-phenylglycine 2.3, and L-phenylalanine 2.4. 
Whilst the route used by Pfaltz et al. in Scheme 2 may appear the most attractive due to its 
high yields, moderately wide substrate application, and short synthetic pathway, it is not 
without its drawbacks. The coupling reagent O-(benzotriazol-1-yl)-N,N,N’,N’-
tetramethyluronium tetrafluoroborate (TBTU) is moderately expensive and used in 
equimolar equivalence thus generating significant quantities of by-products. In accordance 
with the project aim to deliver inexpensive catalysts with minimal environmental impact, it 
was deemed necessary to seek an alternative method to deliver the target diamine. This is 
in part, the reasoning behind pursuing the various different methodologies discussed in this 
Chapter. 
Ultimately neither the acid anhydride nor the aziridine routes delivered the target diamines. 
Instead the development of a new synthetic pathway was implemented. Proceeding via an 
acid chloride intermediate this new approach gave rise to a powerful and versatile synthetic 
strategy as further discussed in Section 2.4. The new pathway successfully led to the 
production of a host of new diamines at reduced cost compared to both Jacobsen’s and 
Pfaltz’s methods. The new methodology was also successful when scaled up. Instances of 
up to 14 g of pure diamine were recorded. When compared to literature reports that often 
deal with scales producing approximately 3 g of isolated diamine, the new methodology 
represents a considerable step forward.  
The following sections discuss the methodologies explored en-route to establishment of the 
new procedure as well as addressing concerns of chiral centre racemisation during the new 
synthesis. 
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2.2 Route One – Acid Anhydride Intermediate 
2.2.1 Amino Acid Protection 
 
Scheme 3 Diamine synthesis via a mixed anhydride. 
The four-step pathway to a diamine via an anhydride intermediate is provided in          
Scheme 3.3, 6, 12 Protection of the amine moiety of the amino acid commonly uses a Boc 
protecting group.1 Choice of an appropriate protecting group is of great importance, 
especially when trying to evade chiral-centre racemisation. With this in mind, the 
phthalimide protecting group is an apt choice since the reaction conditions required for 
amine protection/deprotection are relatively mild. Use of the phthalimide protecting group 
also ensures no acidic protons are left bound to the nitrogen of the amine reducing its 
overall reactivity.13 Discussion relating to synthetic strategies for protection/deprotection 
using phthalimide are discussed herein and in Section 2.4.2 respectively. From this point 
forth all reference to the starting amino acid discussed should be taken as L-valine unless 
specified, since this amino acid was the starting material used in the majority of examples 
when developing the syntheses discussed within this Chapter. 
Protection of the L-valine amine group using phthalic anhydride was undertaken as a one-
pot-reaction on scales up to 100 g with respect to the starting amino acid (Scheme 4). 
Toluene proved to be a suitable solvent due to favourable reagent solubility in the medium 
and its high boiling point which allowed for the reaction to proceed within an acceptable 
duration. As the reaction progresses, water is generated as a by-product. Refluxing in 
toluene facilitates the extraction of water when coupled with Dean-Stark apparatus driving 
the reaction.  
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Scheme 4 Phthalic anhydride protection of L-valine. 
In the case of L-valine, the one-pot reaction was heated at reflux for 18 hours. Ensuing acid 
work-up provided 2.5 in high yields. Phthalimide protection was also successfully 
completed starting from D-phenylglycine 2.3 or L-phenylalanine 2.4 on  100 g scales and 
reflects the success recorded in the literature.12  
Amine protection was complete in two hours in the case of L-phenylalanine. Prolonged 
heating at reflux of D-phenylglycine resulted in the solution becoming increasingly 
coloured. This implies potential chemical changes occurring within the molecule, for 
example decomposition.14 The reason for an extended duration at reflux with L-valine     
(cf. L-phenylalanine or D-phenylglycine) was simply to increase yields. Small yield 
improvements were continually observed until a plateau at 12 hours without detriment to 
product 2.5. Whilst 2.5 was not typically purified further before commencing the next step 
of the synthesis, care was needed to ensure the absence of triethylammonium salt, which 
was problematic in larger reaction scales.15   
 
2.2.2 Amidation of N-phthaloyl valine via an Acid Anhydride Route 
Amidation of the protected amino acid (step 2, Scheme 3), was initially attempted by the 
method described by Haufe et al..12 This method has mild reaction conditions thereby 
reducing the risk of stereocentre racemisation whilst also being versatile, according to the 
work of Mauduit et al. (Fig. 2).8  In this method N-methylmorpholine (NMM) abstracts the 
hydroxyl proton of the carboxylic acid. The resulting carboxy anion attacks the              
iso-butylchloroformate (iBCF) reagent resulting in a mixed anhydride. The addition of a 
primary amine should effect the formation of an amide (e.g. 2.6), carbon dioxide and       
iso-butanol, after nucleophilic attack at the α-carbonyl to the stereocentre (Scheme 5). 
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Scheme 5 Amidation by way of a mixed anhydride intermediate.  
The viability of this reaction pathway was assessed using methylamine, due to its low 
steric demands (cf. tert-butyl amine) and having already been successfully employed in a 
similar reaction.12  
Whilst successful with methylamine, significantly lower yields were obtained when 
performing the same reaction with alternative primary amines. In such instances, the 
formation of an iso-butyl-containing by-product was the major product. The iso-butyl 
structural feature was determined from characteristic resonances present in the 1H NMR 
spectra: a doublet at 0.87 ppm integrating to 6 protons signifying the presence of the two 
methyl groups, and a one proton multiplet at 1.97 ppm, was assigned to the methine. The 
doublet at 3.94 ppm integrates to two protons and is indicative of the CH2 group. These 
resonances compare favourably to those of the starting material iBCF, which are recorded 
at 0.98 ppm (doublet), 2.05 ppm (multiplet), and 4.11 ppm (doublet) respectively.  
Why an amine substrate other than methylamine is unsuccessful could be due to the 
increased steric requirements of the new substrate. It can be envisioned the increase in 
steric demand from the new amine results in attack of the least hindered carbonyl of the 
mixed anhydride (Scheme 6), since the desired point of reaction is restricted by the        
iso-propyl stereo-directing group of the protected amino acid 2.5.  
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Whether this limitation was apparent to the original authors remains to be seen as they 
report no amidation products other than those involving methylamine. As a side note, 
variation of reaction temperature and/or duration proved futile in all cases. In a response to 
these limitations an alternative method to obtain the target diamines was necessary, leading 
to the investigation of route two (Section 2.3). 
 
Scheme 6 Reaction between the mixed anhydride intermediate and the                                     
primary amine resulting in the formation of the observed by-product.  
 
2.3 Route Two – Aziridine Intermediate 
After the problematic pathway described in Section 2.2.1, a second method based upon 
aziridine formation and its successive ring-opening to afford the target diamines was 
pursued. The synthetic pathway investigated is presented in Scheme 7 and is a derivative 
of work published by Masamune et al.,16 Sweeny et al.,17, 18 and Russell et al..9 
The first step describes the reduction of L-valine to its corresponding primary alcohol      
L-valinol and was performed on scales up to 100 g of L-valine (step 1, Scheme 7). The 
proceeding protection of the amine group of the aforementioned L-valinol was undertaken 
with diphenylphosphinyl chloride (Dpp) and preceded smoothly. Moderate yields between 
40-50% of isolated aziridine were recorded and is on a par with literature precedence.17, 18  
Efforts to ring-open the aziridine using 4-fluroaniline 2.7 or 4-methoxyaniline 2.8 were 
low yielding (<30%). Analysis of the crude reaction mixture indicated unreacted aziridine 
and amine starting materials, even under forcing conditions (7 days at vigorous reflux).     
It was therefore concluded that longer reaction times were unlikely to provide significant 
improvements in yield.  
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Much of the work concerning aziridines was carried out using the Dpp protecting group, 
however use of the tosyl group (Ts) has also been reported.19 We questioned whether 
altering the protecting group would have any impact on the ease of aziridine ring-opening 
in a bid to improve floundering yields. Whilst protection using Ts proved problem free the 
deprotection proved troublesome.20 Exchanging the protection group led to greater input 
with respect to purification and no improvements in the yield were seen. 
 
Scheme 7 Aziridine ring-opening to form a diamine. 
 
2.3.1 Catalysed Aziridine Ring-Opening  
Previous attempts at ring-opening the aziridine with a primary amine under reflux 
conditions gave poor yields (<30%) making it prudent to investigate known catalysts for 
this reaction. A few examples arose from the literature, mainly the use of Sn(OTf)2, 
Cu(OTf)2, Yb(OTf)3, and La(OTf)3.21, 22 From these we trialled Cu(OTf)2, and Yb(OTf)3. 
As suggested in the literature 5 mol% of catalyst was added to the reaction                     
(step 4, Scheme 7). No noticeable yield improvements were obtained with either metal-
triflate even if reactions were heated at reflux for 2-3 days. This is in stark contrast to the 
success demonstrated in the literature which reports completion of ring-opening in yields 
of up to 80% when at reflux for only 18 hours.22 From observations using thin layer 
chromatography Yb(OTf)3 catalysed reactions at a faster rate than Cu(OTf)2, however this 
difference was negligible. Increased catalyst loadings of 20 mol% failed to improve upon 
previous yields and pursuit of the synthetic pathway was discontinued accordingly.  
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2.4 Route Three – Acid Chloride Intermediate  
The limited success of routes one and two led to efforts being directed towards the new 
synthetic pathway shown in Scheme 8. The protection step using the phthalimide 
protecting group is as previously described in Section 2.2.1. The new route revolves 
around the amidation of an acid chloride intermediate with a series of primary amines and 
anilines. Thionyl chloride (SOCl2) is a common reagent used to achieve the conversion of 
carboxylic acids to acid chlorides,23-27
 
and addition of an amine to an acid chloride is a well 
known reaction to produce amides.23, 24, 28,29 
 
 
Carboxylic acid conversion to the acid chloride was carried out on scales between 1.5-10 g 
of the N-phthalyol valine 2.5. 1H NMR analysis of the reaction mixture indicated the 
reaction was complete after 2 hours (Scheme 9). The acid chloride was isolated as a pale 
yellow solid and characterised by 1H NMR spectroscopy, and X-ray crystallography.       
1H NMR spectra showed the resonance of the proton at the chiral centre experienced a 
minor downfield shift from 4.63 ppm to 4.74 ppm upon conversion from the carboxylic 
acid to the acid chloride. The resonances related to the protons contained within the phenyl 
moiety of the phthalmide protecting group also experienced a shift downfield, though this 
change is significantly less pronounced (∆δ 0.03-0.04 ppm). All other proton resonances 
remained comparable to the protected L-valine 2.5.  
 
Scheme 8 General preparation of diamines (R = 4-C6H4F (a), 4-C6H4OCH3 (b),                     
4-C6H4CH3 (c), C6H5 (d), 4-C6H4NO2 (e), 3,5-C6H3(CH3)2 (f), CH(CH3)(C6H5) (g), 
CH(CH3)2 (h), C(CH3)3 (i), and 4-C6H4N(CH3)2 (j)).   
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Scheme 9 Carboxylic acid conversion to the corresponding acid chloride.  
Conversion was most successful when carried out in THF using 1.05 equivalents of SOCl2 
with respect to 2.5. Under these conditions reaction scale-up proceeded with ease allowing 
the reaction to be carried out on scales up to 120 g of the starting compound 2.5.          
Once isolated, the acid chloride 1 was easily stable for up to three months when stored 
under an inert atmosphere. 
Isolation of 1 from a mixture of chloroform:hexane as single crystals suitable for X-ray 
analysis led to its structural characterisation as shown in Fig. 4. Examination of the 
structure indicates the phthalimide group is identical to similarly reported literature 
compounds.12 The phthalimide carbonyl bond length O(3)-C(13) of 1.214(10) Å shows a 
negligible elongation compared to O(2)-C(6) recorded as 1.187(9) Å. Both carbonyl bonds 
appear marginally shorter than typical C=O bond lengths in phthalimide moieties of      
1.207 Å (range 1.146-1.388 Å) as reported in the Cambridge Structural Database. The acid 
chloride carbonyl O(1)-C(1) is measured as 1.170(9) Å, which is again approximately     
0.03 Å shorter than the average C=O bond length of 1.202 Å (range 1.136-1.507 Å) in acid 
chloride systems. The length of C(1)-Cl(1) is measured as 1.812(10) Å. This bond length is 
marginally longer than average C-Cl acid chloride bonds (range 1.458-1.833 Å,            
mean = 1.755 Å). Of note is the observed hybridisation around N(1), which is calculated as 
being planar (360(2) ° with the range 358-362 °) (Table 1).   
 
 
 Fig. 4 Molecular structure of 
drawn at 25% probability
Table 1 Selected bond angles of 
Atoms 
N(1)-C(6)-O(2)
N(1)-C(13)-O(3)
C(2)-N(1)-C(6)
C(2)-N(1)-C(13)
C(6)-N(1)-C(13)
 
2.4.1  Amidation via an Acid Chloride
The amidation procedure shown in 
overall synthesis as outlined in
in at this stage of the synthesis 
The most efficient yields were obtained 
amidation proceeded by dissolving
(2.7-2.16, Table 2) as a triethylamine
pre-dissolved in a mixture
p-methylaniline 2.9. Ten derivatives were prepared
procedure. Both aliphatic and electron withdrawing/donatin
employed to encompass a representative cross
of the N-R substituent.  
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protected acid chloride compound 1. Thermal ellipsoids 
 with hydrogen atoms are omitted for 
protected acid chloride compound 1. 
Angle (°) Atoms Angle (°)
 123.4(8) C(1)-C(2)-N(1) 111.9(7)
 125.1(8) Cl(1)-C(1)-C(2) 112.1(7)
 122.9(6) Cl(1)-C(1)-O(1) 118.7(8)
 123.6(6) O(1)-C(1)-C(2) 129.2(9)
 113.1(7)  
 
 
Scheme 10 is the concluding part of step two in the 
 Scheme 8. Variation of the diamine N-R substituent is built 
through the simple variation of the primary
starting from 15 g of protected acid chloride
 1 in anhydrous THF with addition of the 
 mixture. In cases where the amine was a solid 
 of THF/Et3N, for example, p-methoxyaniline
 in order to assess the generality of the 
g aromatic groups were 
-section of steric and/or electronic properties
 
64 
clarity. 
 
 
 
 
 
 
 amine enlisted. 
 1. The 
selected amine 
it was 
 2.8 and                 
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The chiral primary amine ((S)-(-)-1-phenylethylamine) 2.14 was decisive for determining 
if racemisation at the stereocentre was occurring. This is further detailed in Section 2.5.  
The reaction was found to proceed immediately on addition of the primary amine, with a 
large quantity of precipitate generated (Et3NCl). Addition of N,N-dimethylaminopyridine 
(DMAP) as a catalyst for the amidation reaction is reported in the literature.4 The addition 
of 10 mg of DMAP to our reactions also gave improved yields, but only with the 4-C6H4F, 
aniline, iso-propyl, and tert-butyl, derivatives 2a, 2d, 2h, and 2i respectively. 
Improvements were the most notable when forming protected amide 2d, where yields were 
increased from 60% to 90%. Interestingly the addition of DMAP to the amidation 
involving 4-C6H4OCH3 2b consistently resulted in a slight decrease in overall yield.      
This effect was not seen in other electron-withdrawing groups such as 4-N(CH3)2 2j. After 
isolating the amidated product 2a-j the compound underwent deprotection without further 
purification. 
 
Scheme 10 Amidation of protected acid chloride 1 to its corresponding amide.      
Table 2 Primary amines used to synthesise protected amides 2a-j.  
 
F
NH2
 
O
NH2
 
 
NH2
 
 
NH2
 
 
NO2
NH2
 
2.7 2.8 2.9 2.10 2.11 
N
NH2
 
 
NH2
 
 
NH2
 
 
NH2
 
 
NH2
 
2.12 2.13 2.14 2.15 2.16 
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2.4.2 Removal of Phthalamide Protecting Group 
To attain the desired amino-amide deprotection of the phthalimide group must occur     
(step 3, Scheme 8). The chosen method is a modification of that presented by Sen and 
Roach (Scheme 11),30 which is itself a derivative of the synthesis proposed by Ing and 
Manske in 1926.31 The deprotecting reagent hydrazine is relatively mild and afforded the 
amino-amides in good yield at ambient temperature (3a-j, Scheme 11). This method 
proved comparable to alternative methods, e.g. NaBH4 under alcoholic conditions, 
followed by the addition of acetic acid which is then heated at 80 °C giving the deprotected 
amino-amide with no reported loss in optical activity.13 However, hydrazine remained the 
preferred reagent in this report owing to the milder reaction conditions. 
 
Scheme 11 Phthalimide removal with hydrazine (R = 4-C6H4F (a), 4-C6H4OCH3 (b),                     
4-C6H4CH3 (c), C6H5 (d), 4-C6H4NO2 (e), 3,5-C6H3(CH3)2 (f), CH(CH3)(C6H5) (g), 
CH(CH3)2 (h), C(CH3)3 (i), and 4-C6H4N(CH3)2 (j)).   
Upon addition of hydrazine formation of a precipitate was observed within 60 minutes. 
The reaction was allowed to continue for a further 18 hours before acid workup. The 
insertion of hydrazine into the phthalimide moiety of the protected amides 2a-j releases the 
desired amino-amide 3a-j (Scheme 12) and results in the formation of phthalylhydrazide 
2.17. This is able to undergo acid catalysed hydrolysis, forming phthalic acid 2.19, which 
is the white precipitate observed during deprotection.31, 32  
After removal of the phthalic acid by filtration, the amino-amides 3a-j were regularly 
obtained as their corresponding HCL salts in yields of  ≥90% when starting with up to 30 g 
of 2a-j. The HCl salts of 3a-j were characteristically cream coloured in appearance with 
the exception of 3e which was intensely yellow. After work-up the purity of 3a-j was such 
that further purification was not necessary before proceeding with the reduction stage 
(Section 2.4.3).   
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Scheme 12 Hydrazinolysis of the protected amino-amide 2a-j. 
It is worthy to highlight that during work-up, the product amino-amides 3a-j were obtained 
as the hydrochloride salts. Neutralisation and thus, purification of the amino-amides was 
found to be strongly affected by pH. If the pH was too acidic or too basic the amino-amide 
remained in the aqueous phase. This gave rise to low yields of low purity product after 
extraction with dichloromethane. The precise pH range was found to be amino-amide 
specific, but generally a value between pH 7-8 allowed for adequate extraction of the 
amino-amide into dichloromethane. Amino-amide 4-C6H4OCH3 3b was one such example 
that strictly remained in the aqueous phase and could not be extracted into organic solvents 
even when adhering to strict control of the pH. In this case the organic phase only 
contained a trace amount of the amino-amide. Accordingly, the aqueous fraction was 
evaporated under reduced pressure and the remaining solid then dissolved in THF and 
filtered to remove NaCl (the by-product of neutralising the HCl amino-amide salts with 
NaOH(aq)). The amino-amide was dried in vacuo and was of sufficient purity to proceed to 
the reduction stage without further workup.  
1H NMR spectroscopy was a powerful tool in determining the successful deprotection of 
2a-j to 3a-j. The 1H NMR spectra of 3a-j all have a clear absence of resonances pertaining 
to aromatic bound protons of the phthalimide protecting group. The doublet resonance 
characteristic of the proton bound to the carbon at the stereocentre displays a dramatic shift 
upfield upon conversion from 2a-j to 3a-j (with the exception of C6H5 bearing 3d).        
The difference in chemical shift experienced is typically in the region of ∆δ -0.80 ppm   
(2a-j = 4.57-4.19 ppm, mean = 4.45 ppm; 3a-j = 5.27-2.20 ppm, mean = 3.64 ppm). 
Compound 3d is the only example to display an upfield chemical shift for this resonance 
(H2NCHCH(CH3)2), although the chemical shift difference is in line with normal trends   
ca. ∆δ +0.80 ppm. Such a significant change in the frequency of this resonance indicates 
that the proton at the stereocentre it is now subject to a different chemical environment 
when compared to its protected state viz. the chiral-centre proton now has an NH2 group 
adjacent opposed to the more electron-withdrawing phthalimide moiety. 
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It is also apparent that the multiplet characteristic of the iso-propyl methine experiences a 
change in chemical environment upon undergoing deprotection, which is to be expected. 
Though less pronounced than that of the proton situated at the stereocentre the change in 
chemical shift in 1H NMR spectra is typically upfield; ∆δ -0.57 ppm (2a-j = 2.93-          
2.70 ppm, mean = 2.87 ppm; 3a-j = 2.44-2.09 ppm, mean = 2.30 ppm). All remaining 
resonances in the 1H NMR spectra remained static between conversion from protected 2 to 
deprotected amide 3. 
 
2.4.3 Amide Reduction 
Reduction of 3a-j’s amide moiety to its corresponding amine is the final synthetic step to 
realise the target diamines 4a-j (Scheme 13). LiAlH4 was found to be unsuitable, with only 
starting material being recovered from the reaction mixture. The lack of reaction with 
LiAlH4 was surprising and is very tentatively owed to the formation of unreactive 
aluminium complexes by way of the basic LiAlH4 reacting with the acidic proton of the 
secondary amide.33 The highly reactive nature of LiAlH4 also prompts concern over 
potential racemisation of the chiral-centre of the secondary amide being reduced, since a 
literature example is known where this has been the case.34  
 
Scheme 13 Amino-amide 3a-j reduction to their corresponding diamine 4a-j. 
Borane (BH3·THF) was found to be a suitable reducing reagent.35 Studies by Brown and 
Heim show the rate of reduction is fastest with tertiary amides and slowest with primary 
amides. In the case of the secondary amides Brown and Heim noted that the nature of the 
N-R substituent did have an effect on the rate of reduction. Aliphatic substituents tended to 
react at a faster rate than those bearing aromatic substituents. Substituents in the ortho 
position of the aromatic substituent were found to exhibit a greatly retarded rate of 
reaction, whereas substituents at the para position had little effect upon the rate. These 
observations indicate this procedure should be applicable to the wide range of amides 
produced thus far.  
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Brown and Heim explain that when reducing secondary amides to their corresponding 
amines the quantity of borane added needs to provide six “active hydrides” for successful 
reduction, where an “active hydride” is equivalent to one B-H bond.35 One hydride to react 
with the hydrogen on the nitrogen of the secondary amine, a further two reactive hydrides 
to provide the hydrogens required for the formation of the new CH2 group and another 
three hydrides (one equivalent of BH3) which forms an adduct with the newly reduced 
molecule (Scheme 14). Compounds 3a-j also bear a primary amine moiety which is able to 
coordinate with a molecule of borane. This necessitates the need for an additional 
equivalent of the reagent during reaction.  
 
Scheme 14 Amide to amine reduction using BH3.THF. 
Literature reductions of tertiary and secondary amides were essentially complete after one 
hour at reflux starting from 2 g of substrate, whilst our reactions were heated to reflux for 
48 hours since we observed heating at reflux for longer durations led to notably increased 
yields. This was especially true with increasing scale (2 g to ≥8 g). Specifically it was 
found that yields of 4a-j could be improved with vigorous reflux for 96 hours. Under these 
conditions yields were often ≥ 85%. With iso-propyl and tert-butyl diamines (4h and 4i) 
consistent yields of up to 94% were exhibited. Durations of reflux greater than 96 hours 
did not promote yields. Yield improvements were also afforded when using four 
equivalents of borane instead of three.  
Larger scale reactions (>3-4 g amino amide 3a-j) resulted in the handling of large 
quantities of 1 M borane solution, giving rise to less control over heat transfer. 
Consequently more concentrated borane sources were sought; the most successful being 
the in situ preparation of borane from sodium borohydride and chlorotrimethylsilane as 
described by Whiting et al. (Scheme 15).36 This was established as superior to using 10 M 
BH3(SMe2). 
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Whiting et al. describe the reduction of a tertiary amide to its corresponding amine by 
creating a suspension of NaBH4 in THF and adding SiMe3Cl to the mixture, which was 
then heated at reflux for two hours before adding the amino amide substrate. Interestingly 
after amino amide addition the reaction was allowed to proceed for 64 hours suggesting 
that extended reaction times may not be uncommon in these types of reactions.   
 
Scheme 15 Amide to amine reduction using borane in-situ. 
Using the generation of BH3.THF in-situ we were able to successfully synthesise diamines 
4a-j. This could be performed on scales up to 20 g and still give high yields of product that 
required minimal purification after workup. It is anticipated that further increases in 
reduction scale would be entirely feasible. Interestingly just as Brown and Heim observed, 
our studies also showed no significant yield variations between varying para substituents 
of the aromatic N-R substituents of the secondary amide. This supports the theory that 
under these reaction conditions electronic variation through altering the electron 
donating/withdrawing properties of the para substituent has little effect on the overall 
yield.     
Purification of diamines 4a-j was achieved using column chromatography over silica. 
Diamines 4a-j were characterised by 1H NMR, 13C NMR, and IR spectroscopies and mass 
spectrometry. Studies alluded that the only major by-product from the reduction reaction 
was unreacted amino-amide (3a-j), which could be recovered during diamine purification 
and re-reduced. Identification of diamines 4a-j was elementary from the starting amino-
amides 3a-j. High-resolution mass spectra of the purified diamines 4a-j were in excellent 
agreement of theoretical weights and contained no fragments attributed to the starting 
amino-amide.  
1H NMR spectra of 4a-j show notable difference in recorded resonance patterns compared 
to pre-reduction compounds 3a-j. The most notable difference is the inclusion of two new 
resonances with accompanying fine structure caused by the new diasterotopic CH2 
environment in the diamine molecule.  In aromatic N-R substituents the resonances for the 
CH2 moiety are typically at 3.26 and 2.80 ppm. In non-aromatic substituents 4g-i the 
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analogous resonances are seen at 2.60 and 2.44-2.20 ppm. In both cases the fine structure 
of the resonances are either an apparent quartet or triplet integrating to one proton per 
resonance.  
In keeping with previous trends the proton bound to the carbon at the chiral centre records 
a resonance with a mutiplet fine structure that shifts further upfield upon conversion from 
the amino-amide to diamine. In aromatic substituents the change in chemical shift is 
upfield; ∆δ -1.19 ppm (3a-f, 3j = 5.27-3.48 ppm, mean = 3.97 ppm; 4a-f, 4j = 3.03-       
2.72 ppm, mean = 2.78 ppm). In the non-aromatic substituents the change in chemical shift 
is also upfield although within a narrower range and less pronounced; ∆δ -0.72 ppm           
(3a-f, 3j = 3.22-3.12 ppm, mean = 3.18 ppm; 4a-f, 4j = 2.47-2.44 ppm, mean = 2.45 ppm). 
As noted in the conversion of 2a-j to 3a-j, the methine of the iso-propyl experiences a 
change in resonance chemical shift. The same is true when amino-amides 3a-j are reduced 
to diamines 4a-j. Again the resonance assigned to the methine hydrogen experiences a 
further shift upfield. For diamines bearing aromatic N-R substituents the change in 
chemical shift is upfield; ∆δ -0.64 ppm (3a-f, 3j = 2.44-2.09 ppm, mean = 2.32 ppm;      
4b-f, 4j = 1.70-1.66 ppm, mean = 1.68 ppm. In the non-aromatic N-R substituents the 
change in chemical shift is also upfield and in keeping with trends, is within a narrower 
range and less pronounced; ∆δ -0.73 ppm (3a-f, 3j = 3.22-3.12 ppm, mean = 3.18 ppm;  
4a-f, 4j = 2.47-2.44 ppm, mean = 2.45 ppm). What arises from analysis of the changes in 
the stereocentre proton and methine proton is that upon progression from protected amide 
2a-j to amino-amide 3a-j and eventually diamine 4a-j, is that these characteristic 
resonances shift progressively upfield with only one exception, the C6H5 bearing 
compound 3d. 
For the first time the resonances of the CH3 groups of the iso-propyl moiety displayed a 
notable change in recorded resonance between conversion from the amino-amide to 
diamine. Whilst there has been very marginal chemical shift differences of the two 
indicative doublets resonance ca. 1.1 and 0.90 ppm of 2a-j and 3a-j, the CH3 groups in all 
compounds except 4d (N-R = C6H5) and 4g (N-R = CH(CH3)(C6H5)) display an apparent 
triplet fine structure at approximately 0.98 ppm distinguishing it noticeably from its amino-
amide analogue. Shift changes pertaining to both aromatic and non-aromatic N-R 
substituents could not be generalised and were often compound specific.  
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13C{H} spectra showed that once formed diamines 4a-j exhibit a resonance between       
49-48 ppm from the methylene carbon (CH2) environment (determined from 2D 1H-13C 
correlation HSQC experiments). This observation lends support to the formation of the 
diamine along with an absence of a carbonyl resonance, which should not be present in the 
final diamine (the lack of carbonyl resonance is reaffirmed by the IR spectra that show no 
absorption between the typical range for an amide C=O of 1640-1695 cm-1)
. 
Expected 
aromatic and non-aromatic resonances relating to the individual N-R substituents were 
observed where expected, depending upon the nature of the substituent. 
 
2.5 Racemisation of the Chiral Centre 
Announced in the mid-1950’s as a miracle cure for morning sickness in expectant mothers, 
thalidomide (2.17) has since become iconic with the devastating teratogenic effects seen in 
the offspring of the mothers who were prescribed the drug.37, 38 Unknown at the time the 
therapeutic enantiomer racemised in-vivo forming the teratogenic-inducing enantiomer as 
well.39 And it was during reduction of a carbonyl group in the α-position to the chiral 
centre that the 2-aminopyrroline ligand 2.18 also underwent racemisation.40 Due to the 
compelling structural parallels between 2.17 and 2.18 when compared to compounds 1,   
2a-j, and 3a-j it would be prudent to explore their potential of racemisation as well.  
 
Fig. 5 Thalidomide (2.17), 2-aminopyyroline (2.18), Protected L-valine (1), amidation                        
(2a-j), and deprotection (3a-j) compounds share structural similatrities.   
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With regards to 1, 2a-j, and 3a-j, the most significant feature is the potential for 
tautomerism to occur in the molecule resulting in racemisation of the chiral-centre. Since 
tautomerism can be base catalysed (by abstraction of a proton at the α-position to the 
carbonyl) the acidity of the proton bound to the chiral centre could be of significant 
importance. As this proton is within close proximity to an electronegative nitrogen atom its 
acidity is likely to be increased, opening it up to attack from a base/nucleophile. Of lesser 
importance, the carbon atom at the centre of chirality is also adjacent to the nitrogen atom, 
potentially increasing the chance of nucleophilic attack.  
In order to assess the enantiopurity of the diamines, studies were undertaken to look for 
signs of racemisation. This was pursued in two different manners, the first exploiting the 
use of R-(-)-α-acetylmandelic acid (2.21, Fig. 6), which is known to form intimate         
ion-pairs that are used to determine enantiomeric excess.41 This is the same tactic used in 
Chapters 3 and 4 to allow the determination of enantiomeric excess of the pyrollidine 
products from hydroamination. To accomplish this two solutions of pure diamine 4a       
(N-R = 4-C6H4F) and 4i (N-R = C(CH3)3) were made in chloroform-d1 and 1.5 equivalents 
of chiral acid 2.21 added. Both samples were then studied by NMR spectroscopy to 
observe if classical “doubling” of the resonance signals occurred due to the formation of 
diasterisomeric ion-pairs between 2.21 and the diamine.42 NMR spectra showed no such 
doubling effect suggesting that the diamine was enantiopure. 
 
Fig. 6 R-(-)-α-acetylmandelic acid. 
To confirm these findings a second methodology was chosen that involved the inclusion of 
a second (enantiopure) stereocentre into a diamine at the amidation stage. The advantage of 
this experiment was the ability to analyse the molecule after each subsequent step of the 
synthesis until the final diamine had been rendered. If racemisation was taking place 
during the synthesis by utilising this approach it should be trivial to identify by virtue of 
diastereomer formation (distinguishable by NMR spectroscopy) at which step racemisation 
was occurring, thus allowing the issue to be suitably addressed.  
 The typical diamine synthesis was undertaken using
(Table 2) in place of previous examples. After each stage of the synthesis 
indicated the presence of only a single diastereomer
1H NMR studies on the final dia
clarity between 3.90-0.60 ppm 
The outcome from both experiments allowed for confident progression towards using the 
diamine library synthesised 
which are later discussed in Chapter 4.  The enantiopure diamines 
their suitability as supporting ligand
stereoselectivity in hydroamination.
 
Fig. 7 1H NMR spectra of 
h 
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 chiral amine NH2CH(CH
. Example spectra recorded from 
mine 4g are presented in Fig. 7 and 
in Fig. 8.  
for the synthesis of the C2-symmetric bisimidazoline analogues
4a-j were
s in calcium complexes and the resulting complexes’
 This is covered in detail in Chapter 3.
diamine 4g for evidence of diastereoisomers
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3)(C6H5) 2.14 
1H NMR spectra 
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 also tested for 
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 Fig. 8 1H NMR spectra enlargement
Since the chiral supporting ligands 
ligands had occurred then the ability of the ligand to transfer select chiral information to 
the catalytically active site in catalysis
be visually explained using the bisimidazoline supp
Chapter 4 with the aid of reaction quadrants (Figs. 9 and 10). By dividing the space 
surrounding the complex into quadran
element of the bisimidazoline ligand helps to reduce th
approaches.  
In Fig. 9, if the substrate approac
around it is identical. However, when looking at substrate approach to bind with the metal 
centre in quadrants A and D it is 
Quadrants A and D are mirror images of one another so substrate approach should be 
identical in each. The presence of this symmetry element limits the number of substrate 
vector approaches and potential transition states where chiral information is transferred 
from the complex to the substrate. The outcome of fewer transition state conformations 
should lead to higher enantioselectivity. 
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are used in asymmetric catalysis, if racemisation of 
 would have been severely compromised
orted calcium complexes from 
ts it becomes easier to see how
e number of 
hes from either quadrant B or C then the environment 
apparent the quadrants are related by symmetry. 
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Fig. 9 Fig. 10 
 
Figs. 9 & 10 Reaction quadrants for a C2 symmetric and                                                            
non-C2 symmetric bisimidazoline-calcium complex. 
If quadrants A and D were not symmetry-related (Fig. 10), then it can be envisioned that 
the substrate could approach to bind with the metal centre from many additional vectors. 
This happens because there is a change in the stereochemistry of the iso-propyl moiety.     
It acts as a “steric shield” around a certain proportion of the metal centre face. When the 
stereochemistry changes (between Figs. 9 and 10) it results in one face of the metal centre 
being significantly more open to binding with the substrate. As substrate approach is less 
defined, new substrate approach vectors can be taken leading to more potential transition 
states and less stereoselectivity from the complex on the substrate. This will ultimately 
lower recorded enantiomeric excess.  
When this principle is applied to the diamine based ligands used in Chapters Three and 
Four on calcium, if the complexes contain ligands of both R and/or S-configuration then 
opposing, competing stereochemical information will be imparted onto the reacting 
substrates leading to a mixture of R and S products. As a result, this will compromise 
recorded enantiomeric excesses.  
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3.1 Introduction 
Whilst Hill et al. had shown calcium’s potential for catalytic intramolecular 
hydroamination in 2005 (Scheme 1),1 it wasn’t until 2008 when Buch and Harder 
published the first example of a chiral bisoxazoline (BOX) supported calcium complex 
[Ca(BOX){N(SiMe3)2}(THF)2] (Fig. 1, 1.6) demonstrating stereoselectivity, even if 
markedly low (ca. 4-6% ee).2 As discussed previously in Chapter 1, Section 1.2.1.2, the 
low enantiomeric excess obtained was deemed to be a direct result of ligand redistribution 
within the system. The formation of inactive homoleptic [Ca(BOX)2], as well as active, but 
non-stereoselective [Ca{N(SiMe3)2}2(THF)2] will not only affect catalytic rates but also 
result in racemic products being formed. 
 
Scheme 1 Asymmetric hydroamination catalysis (R’ = Me A and Ph B). 
Targeted development towards improved chiral calcium systems was not reported until 
2010. Sadow et al. employed the chiral tris(oxazolinyl)borato calcium complex 1.9 (Fig. 1) 
in asymmetric hydroamination where enantioselectivies of up to 18% were noted.3 The 
magnesium analogue of 1.9 out-performed its calcium counterpart when applied to the 
same hydroamination reactions yielding enantiomeric excesses of up to 36%. This is not an 
isolated case of magnesium attaining higher stereoselectivity than calcium when applied to 
asymmetric hydroamination. Preceding improvements with calcium reported by Sadow et 
al., magnesium was already recorded as achieving greater enantiomeric excesses of 14% 
(cf. Buch and Harder’s 4-6% ee). As of 2012 Hultzsch et al. utilised the magnesium 
complex 1.11 (Fig. 2) in a wide variety of intramolecular hydroamination reactions where 
stereoselectivities were very favourable for a wide range of substrates recorded between 
51-93% ee.4  
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Fig. 1 Literature examples of chiral calcium complexes 1.6 and 1.9. 
This trend highlights that the progress of calcium compounds for asymmetric 
hydroamination is underdeveloped when compared to magnesium. As Group 2 is 
descended complexes show a greater propensity to undergo ligand redistribution, which is 
why magnesium complexes are typically more defined than calcium, and why there are 
currently no strontium or barium compounds reported in asymmetric hydroamination.  
The low enantiomeric excesses reported with calcium in asymmetric hydroamination is    
in-part related to the scarcity of calcium-specific publications in this field, affirming the 
research areas current infant state. It is in this light the contributions contained within this 
Thesis and the parts of this work that have been published, provide valuable insight for the 
field.5, 6 The employment of chiral ethylene diamine (NNR) supported calcium complexes 
as discussed within became the third published example of such a system applied to the 
asymmetric hydroamination of simple aminoalkenes. It is hoped that building upon these 
discussed developments the feat of synthesising a high-performing catalyst for asymmetric 
hydroamination is realised in the not too distant future.   
 
Fig. 2 Phenoxyamine magnesium complex (1.11) achieved                                                     
93% ee in asymmetric intramolecular hydroamination.   
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3.2 Preparation of Calcium Complexes Supported by Diamine Ligands 
Preparation of the diamine calcium complexes was achieved by reaction of the protio-
ligand (4a-d, h, i) with [Ca{N(SiMe3)2}2(THF)2] in benzene-d6 or toluene (Scheme 2). The 
compounds were isolated as yellow/orange precipitates that were only soluble in THF, 
being insoluble in hydrocarbon solvents and unstable in chlorinated solvents.  
 
Scheme 2 Preparation of the NNR calcium complexes (R = 4-C6H4F (5a),                           
4-C6H4OCH3 (5b), 4-C6H4CH3 (5c), 4-C6H5 (5d), iPr (5e), and tBu (5f)). 
The method of synthesising complexes 5a-f is often exploited due to the facile preparation 
of the AE metal amide [Ca{N(SiMe3)2}2(THF)2], their solubility in a range of solvents, and 
the production of the volatile by-product HN(SiMe3)2.7, 8 Whilst the diamine and calcium 
amide are both soluble in a range of solvents the resulting complexes exhibit very limited 
solubility, which is also reflected in the literature.2, 3, 5, 6, 8, 9 Solubility issues coupled with 
the highly reactive nature of calcium complexes often impedes their isolation and detailed 
characterisation. This phenomenon is also observed with the bisimidazoline (R-BIM) 
calcium complexes of Chapter 4. It can be imagined that when the complexes are dissolved 
in donor solvents such as THF, that lability increases due to binding competition between 
ligand and donor solvent.  
Solubility of complexes 5a-f in hydrocarbon solvents is further hindered by the inclusion 
of KI traces, a by-product of [Ca{N(SiMe3)2}2(THF)2] synthesis. Inclusions of KI can be 
avoided through extraction of [Ca{N(SiMe3)2}2(THF)2] into hexane upon work up. 
In a bid to improve the solubility of the diamine calcium complexes in hydrocarbon 
solvents, exchange of the coordinating amide [N(SiMe3)2]- was replaced with benzyl 
[CH2(C6H5)]- and tert-butyl benzyl [CH2(4-C6H4tBu)]- ligands.10 Both alternatives were 
prepared according to literature procedures before being reacted with a chosen diamine in 
the same manner as depicted in Scheme 2. With respect to solubility both the aromatic 
calcium complexes were less soluble in commonly used solvents systems than the original 
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[Ca(NNR){N(SiMe3)2}(THF)n]. Whilst the tert-butyl benzyl bearing complex displayed 
greater solubility than its benzyl analogue the improvement was unsubstantial when 
compared to the original calcium amide.    
 
3.3 Spectroscopic Characterisation  
Detailed characterisation was heavily restricted for the [Ca(NNR){N(SiMe3)2}(THF)n] 
complexes 5a-f due to their aforesaid solubility limitations and labile nature in ethereal 
solvents. Working in ethereal solutions with calcium compounds also carries the potential 
for ether cleavage. Ether cleavage is most typically observed in dibenzyl AE metal 
compounds [Ca{CH2(C6H5)}2], where the benzyl ligand reacts readily with a proton in the 
α-position to the oxygen of the ether to form toluene. Whilst predominantly observed in 
benzyl containing AE compounds, the “Big R” supported  [Ca{CH(TMS)3}2] is also 
known to react with ethers.11 In contrast use of the hexamethyldisilazane anion 
[N(SiMe3)2]- demonstrates no such evidence of ether cleavage. NMR studies of the diamine 
calcium systems in THF-d8 testify to this with the absence of resonances pertaining to ring-
opened THF in NMR spectra. 
In order to determine the extent of base coordination in THF-d8 during analysis it was 
necessary to exchange the coordinating THF with pyridine (py). To prepare the pyridine 
complex analogues of 5a-f, HNNR (4a-d, h, i) was added to [Ca{N(SiMe3)2}2(py)2] in 
benzene.7 The reaction proceeded for 18 hours under ambient temperature followed by 
solvent and volatile by-product removal under reduced pressure to 4.0×10-2 mbar. The 
vacuum was monitored to ensure consistency between samples since it is known that 
prolonged exposure to reduced pressure can remove coordinated pyridine.6 The 
[Ca(NNR){N(SiMe3)2}(py)n] products 6a-f were typically yellow/orange and obtained in 
good yields (≥60%).  
Like the THF adducts 5a-f, the pyridine analogues 6a-f were found to be only sparingly 
soluble in hydrocarbon solvents and underwent decomposition in chlorinated solvents. 
Whilst the majority of calcium complexes published to date have been analysed in 
benzene-d6, the need for analysis in THF-d8 or mixtures thereof, is not unusual with 
calcium complexes and again reflects their insoluble nature.12-14  
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The NMR spectra of complexes 6a-f in THF-d8 were broad at ambient temperature. The 
fluxional process presumably arising from the lability of the NNR ligands and the pyridine 
exchanging with THF, could not be completely ‘‘frozen out’’ using low temperature NMR 
analyses, within our instrumental capability (500 MHz, -90 °C).  
Nevertheless 1H NMR spectra of each complex showed three distinct signals (although 
devoid of discernible fine structure) for the ethyl backbone of the diamine ligand. Signals 
were typically recorded between 3.00-2.80 ppm and 2.63-2.45 ppm for the CH2 proton 
nuclei and for the proton at the chiral centre, between 2.60-2.57 ppm with the exception of 
complex 6c which records a downfield shift of 2.72 ppm. The proton nuclei corresponding 
to the methine and the two methyl groups of the iso-propyl moiety display characteristic 
resonances. The methine proton gives a signal between 1.66-1.55 ppm, the exception being 
6e where the presence of two iso-propyl groups within the molecule records a broader 
range of 1.67-1.47 ppm. In complexes 6b, e, and f, the methyl protons are typically 
recorded as two separate resonances with integration indicating three protons per 
environment. Complexes 6a, c, and d however exhibit an apparent singlet for the two 
groups suggesting the methyl groups are in near-identical chemical environments for these 
examples. Generally signals for the methyl groups are recorded between 1.07-0.76 ppm. 
Differences in solvent between the data recorded for the protio-diamine and the diamine of 
the calcium complex nullifies direct comparison. 
Parallel observations of distinctive resonances for the coordinated ligands are noted with 
respect to the 13C{1H} NMR spectra of complexes 6a-f. The carbon nucleus at the chiral 
centre deviates very little between each complex, typically observed at 60.4-57.5 ppm with 
the adjacent CH2 carbon nucleus recorded between 60.4-47.2 ppm. Resonance signals 
pertaining to the iso-propyl moiety are observed between 36.7-33.0 ppm for the methine 
and two signals are recorded for the two methyl groups between 20.5-19.7 and 18.6-17.9 
ppm respectively. 
The indication of a single [N(SiMe3)2]- moiety was evident from the relative integration of 
the signal at ca. 0 ppm in the 1H NMR spectra. Nonetheless, traces of two additional 
bis(trimethylsilyl)amide species of comparable chemical shift appear evident in all 
complexes. One such source can be speculated as being residual HN(SiMe3)2. Although a 
volatile by-product of the complexation reaction it has proven persistent when trying to 
remove it in its entirety, even through recrystallisation or extensive durations in vacuo.   
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The same phenomenon was observed during the synthesis of the R-BIM calcium 
complexes (Chapter 4, Section 4.3.2). The identity of the second bis(trimethylsilyl) species 
has remained undetermined. It is known that the presence of an excess of an acidic ligand 
can result in nitrogen-silicon bond cleavage to form ammoniate complexes of the form 
[L2M(NH4)(H2N(SiMe3)].15 However reaction between liberated HN(SiMe3)2 and the 
protio-diamine/R-BIM ligand to give H2N(SiMe3) and Me3SiL and any subsequent 
protonolysis products is unlikely. This is due to the basic nature of the ligands and 
therefore an alternative side reaction is in operation or liberated HN(SiMe3)2 could be 
acting as a donor ligand and in exchange with THF and/or pyridine.
 
  
The presence of the fluorine nucleus in complex 6a allows for exploitation of this NMR 
handle. 19F NMR spectroscopy reveals a broad single resonance at -141.57 ppm, denoting a 
single environment, lending evidence to the structure not being a mixture of products.  
The relative intensity of the coordinated pyridine in complexes 6a-f was also intriguing. 
When the alkyl-substituted diamines 6e and f were investigated, the number of pyridine 
ligands was less reproducible, ranging from 0.3–0.6 equivalents. This suggests that the 
pyridine is only weakly bound to the calcium. Attempts to prepare the base-free complex 
[Ca(NNR){N(SiMe3)2}] by subjecting the complex to extended periods under vacuum were 
unsuccessful in all cases. In contrast approximately one molar equivalent of coordinated 
pyridine was observed in complexes 6a-d, which decreased only marginally after extended 
periods in vacuo. It is currently unclear as to the observed differences in pyridine 
coordination between alkyl and aryl systems although it can be hesitantly suggested that 
the difference may lie in the variation of steric constraints imposed by the different          
N-substituents of the diamines. 
Given the different degrees that pyridine coordinates to the calcium and the extremity of 
the NNR ligand lability, the possibility of complexes 6a-f existing as dimers or oligomers 
cannot be discounted even with the success of the bulky [N(SiMe3)2]- ligand in preventing 
such an occurrence in other systems.16 In all likelihood the actual structure of complexes 
6a-f could be an exchanging mixture of monomeric and oligomeric species. Such an 
occurrence is not unexpected given the inclination of similar Grignard reagents to undergo 
facile redistribution processes.17  
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Synthesis of three homoleptic complexes [Ca(NNR)2] (R = 4-C6H5F 7a, Ph 7b, and tBu 7c) 
was achieved through combination of two equivalents of protio-ligand NNR (4a, d, and i) 
with one equivalent of [Ca{N(SiMe3)2}2(py)2] in toluene. The reaction was allowed to 
proceed for 18 hours at ambient temperature before the resulting complex was isolated as 
yellow/orange precipitates and dried in vacuo. As with the heteroleptic complexes 5a-f and 
6a-f, the homoleptic complexes 7a-c were only soluble in THF.  
Synthesis of the homoleptic complexes results in the liberation of two equivalents of 
HN(SiMe3)2 and pyridine. In an attempt to remove these by-products compounds 7a-c were 
dried in vacuo for an extended period of time. After such time only trace amounts of 
pyridine were observed in corresponding NMR spectra. The near quantitative removal of 
pyridine in the homoleptic complexes 7a-c is in stark contrast to that of heteroleptic 
complexes 6a-f where removal of pyridine is never total. As previously noted with the 
heteroleptic complexes, small quantities of bis(trimethyl)silyl amide species
 
remained 
present. The remaining presence of bis(trimethyl)silylamide species
 
is characteristic in both 
homoleptic and heteroleptic NNR calcium complexes and is mirrored in the observations of 
the R-BIM calcium complexes discussed in Chapter 4 Section 4.3.2. Pursuit of further 
purification to remove all traces of the bis(trimethyl)silyl amide again proved unsuccessful. 
Comparison of spectroscopic data between the heteroleptic (6a, d, and f) and homoleptic 
analogues 7a-c reveals that both species have rather different spectroscopic signatures. 
This evidence supports speculation that the heteroleptic species 6a-f show little to no 
formation of homoleptic species in solution. Whilst differences in chemical shift are trivial 
with respect to the iso-propyl stereodirecting group, resonances attributed to the ethylene 
backbone exhibit chemical shift variations of greater note. The differences are pronounced 
in both 1H (up to ∆δ 0.2 ppm downfield cf. heteroleptic complex) and 13C{1H} spectra   
(up to ∆δ 5 ppm upfield cf. heteroleptic complex) with the exception of the alkyl 
complexes. Comparison of the 13C NMR data of the tert-butyl complex 7c when compared 
to its heteroleptic derivative 6f, displays significantly less pronounced chemical shift 
divergence (∆δ 0.2 ppm upfield cf. heteroleptic complex) than the aromatic complexes.  
Dissimilarities in chemical shift are also observed in resonance signatures of the specific 
N-R substituents. Comparison of the 1H and 13C{1H} NMR spectra of the phenyl 
substituent(s) of 6d and 7b is the most distinctive of all examples. Variation between 
resonances of the N-R substituent in the heteoleptic and corresponding homoleptic 
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complex varies to the same degree as resonances for the ethylene backbone (∆δ 0.2 ppm in 
the 1H NMR spectra and ∆δ 5 ppm in the 13C{1H} NMR spectra). As previously observed 
the resonances of the N-R substituent of the alkyl complexes 6f and 7c show a chemical 
shift divergence to a lesser degree than in the aromatic examples.   
The 19F NMR spectrum of [Ca(NNArF)2] 7a records a signal at -130.64 ppm (293 K) 
compared to -141.62 ppm of the heteroleptic analogue [Ca(NNArF){N(SiMe3)2}(py)] 6a at 
(293 K). At a reduced temperature of 263 K 6a shows minimal temperature dependence of 
the chemical shift (-141.62 ppm), whereas at the same temperature the spectra of the 
homoleptic analogue 7a now gives two separate resonances at -141.09 ppm and -130.64 
ppm. This denotes a distinct difference in fluorine environments between the heteroleptic 
and homoleptic compounds. The absence of fluorine resonances attributed to the 
homoleptic complex in the spectra of the heteroleptic complex further supports the 
presence of the heteroleptic species only. 
The analysis of IR data obtained from the diamine ligands and subsequent heteroleptic and 
homoleptic complexes is less revealing with respect to structural data not already deduced 
from NMR spectroscopic techniques. We were unable to ascribe which amine moiety is 
favoured for deprotonation when coordinated to calcium as absorption for primary and 
secondary amines N-H stretches overlap and are characteristically broad. C-N absorptions 
of both primary and secondary amines also occupy the same band of absorbance:        
1350-1200 cm-1 for aromatics and 1250-1000 cm-1 for aliphatic amines. However one 
absorption at 1260  (± 2 cm-1) is common to all heteroleptic and homoleptic complexes and 
signifies a C-N stretch of the amine but is not indicative of whether it arises from a primary 
or secondary amine. Addition of the pyridine complicates the region since it also produces 
an absorption signal resulting from its amine moiety.  
Other absorptions of note are those relating to the aromatic C-F bond of diamine NNArF 4a, 
heteroleptic complex 6a and homoleptic analogue 7a. Absorption between 1250-1100 cm-1 
is identifiable even with aromatic C-H in-plane bending observed between 1250-950 cm-1. 
The stronger absorbance of the C-F stretch is seen at 1216 cm-1 in 4a, 1219 cm-1 in 6a 
and 1218 cm-1 in 7a. Absorbencies relating to other structural features such as phenyl 
derivatives, alkyl moieties of the ligand backbone, and the iso-propyl group were observed 
within their typical regions. 
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3.4 DFT 
In order to gain an insight into the structure of the proposed mononuclear species 5a-f 
(Scheme 2) and determine which of the amine moieties is preferentially deprotonated the 
structures of [Ca(NNR){N(SiMe3)2}(py)] (R = 4-C6H4F 7acalc, Ph 7bcalc, and tBu 7ccalc) 
were calculated using density functional methods by Dr. Benjamin Ward. The computed 
structures of heteroleptic complexes 7acalc-ccalc are displayed in Fig. 3. It was calculated 
that the structures of 7acalc-ccalc with the diamine deprotonated at the secondary amine were 
approximately 13 kcal mol-1 (~54 kJ mol-1) more stable than when the diamine ligand was 
deprotonated at the primary amine (Fig. 4, conformation a vs. b) 
 
 
 
7acalc 
 
 
7bcalc 
 
 
7ccalc 
 
Fig. 3 Calculated structures of [Ca(NNR){N(SiMe3)2}(py)] complexes 7acalc-ccalc. 
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Fig. 4 Preferred deprotonation of the diamine at the secondary amine (a),                                        
and less favoured deprotonation at the primary amine moiety (b). 
 
The structure of compounds  [Ca(NNAr-F){N(SiMe3)2}(py)] 7acalc and 
[Ca(NNPh){N(SiMe3)2}(py)] 7bcalc are isostructural and indicate a significant deviation of 
the amido nitrogen from the expected trigonal planar geometry. The sum of the angles 
subtended around the nitrogen of the N-R moiety being 339.5 ° for 7acalc and 336.4 ° for 
7bcalc. This is in contrast to the sum of angles around the nitrogen of the N-R in           
[Ca(NNtBu){N(SiMe3)2}(py)] 7ccalc which total 358.1 °, indicating a trigonal planar 
geometry. The consequence of the non-planar conformation in 7acalc and 7bcalc is that the 
phenyl ring is orientated to provide a chiral environment at the calcium centre. This may 
explain the effective stereocontrol in hydroamination catalysis, particularly in the case       
of 7bcalc. 
 
Amides (-NR2) are known to be anionic, 2 or 4 electron donors since they are able to form 
σ-bonds but can also donate the p-orbital lone pair into an empty d-orbital of a metal. This 
creates additional π-bonding interactions between the ligand and the metal and results in 
the amide taking a trigonal planar geometry to accommodate the orbital overlap. In the 
case of calcium we do not expect there to be any significant π-bonding between the 
diamine and calcium centre due to the 3d-orbitals being significantly high in energy to be 
rendered inaccessible. Therefore there is less electronic preference for the nitrogen to adopt 
a trigonal planar geometry.   
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3.5 Intramolecular Hydroamination Catalysis  
As detailed in Chapter 1 Section 1.2.1 and illustrated in Scheme 1, hydroamination be it 
inter- or intramolecular is defined as the formal addition of an N-H bond across an 
unsaturated bond. Hydroamination presents itself as a very attractive means to prepare a 
wide range of nitrogen containing compounds via a 100% atom-efficient route. Coupled 
with the successful mediation of this reaction with organocalcium complexes and reports 
that stereoselectivity can be achieved, albeit low levels, makes this reaction an ideal 
candidate to which we are able to measure and compare the performance of our newly 
developed calcium catalysts.   
All intramolecular hydroamination catalysis experiments were conducted using the novel 
complexes [Ca(NNR){N(SiMe3)2}(THF)n] 5a-j. These were generated in-situ from the 
respective ligand and [Ca{N(SiMe3)2}2(THF)2] before being reacted with catalytic 
substrates A and B (Scheme 1). Progress of the hydroamination reaction with each catalyst 
was monitored by 1H NMR spectroscopy at regular intervals appropriate to the reaction 
duration. During each reaction the introduction of resonances corresponding to the cyclised 
pyrrolidine emerge and increase in intensity as a function of time, whilst resonances 
relating to the starting 2,2-dialkylpent-4-en-1-amine (referred to as aminoalkene 
henceforth) substrate lessen in intensity with product conversion. An example 1H NMR 
spectra stack plot from the complete catalytic conversion of substrate B by complex 
[Ca(NNtBu){N(SiMe3)2}(THF)n] 5f is presented in Fig. 5 overleaf. 
With each spectrum the product conversion is calculated from comparison of the 
integration of notable resonances corresponding to the aminoalkene precursor and resulting 
pyrrolidine product.1 Typically in the starting aminoalkene the two multiplets at 5.40 ppm 
and 4.95 ppm (ratio 1:2 calculated via integration) are chosen. These two resonances 
pertain to the -CH=CH2 double bond present in the aminoalkene. These signals are 
compared to the emerging doublet ca. 1.00 ppm, which is attributed to the exo-methyl 
group coupling with the hydrogen nucleus in the newly formed pyrrolidine. The 
aminoalkene only forms the cyclised pyrrolidine during intramolecular hydroamination, 
and no isomerisation or other by-products were observed.18 
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Fig. 5 1H NMR stack plot of spectra from the cyclisation of substrate B (‡) to                              
its corresponding pyrrolidine product (*) with [Ca(NNtBu){N(SiMe3)2}(THF)n]                        
5f in C6D6 at 293 K. Spectra proceed from top (t = 0 h) to bottom (t = 6 h). 
From product conversion data conversion curves can be constructed. One such example is 
shown in Fig. 6. All additional conversion curves for this Chapter are supplied in Appendix 
A. The method employed for initial rate determination involved the collection of 1H NMR 
spectra at staggered intervals during catalytic reactions. The time intervals between spectra 
collection were reaction dependent, ranging from every 10 minutes to every 30 minutes or 
more in slower reactions, until no further conversion was observed. The conversion curves 
were curve fitted to an exponential decay function y=Ae-bx. The initial rate was given by 
the slope at the origin (x=0) and was determined by differentiation of the equation:      
dy/dx = -A/b for x = 0. The resulting initial rate figures are listed in Table 1.  
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Fig. 6 Example conversion curve for the catalytic hydroamination of substrate B             
using 10 mol% [Ca(NNPh){N(SiMe3)2}(THF)] 5d in C6D6 at 293 K. 
Enantioselectivities were determined using 1H NMR spectroscopy, with the aid of adding 
an excess of chiral derivatising agent R-(-)-α-acetylmandelic acid 2.21 (Fig. 7)19, 20
 
to the 
pyrrolidine containing reaction mixture. This occasions a characteristic “doubling” of each 
resonance in the 1H NMR spectra, as typified by the presence of stereoisomers as discussed 
in Chapter 2, Section 2.5.21  
 
Fig. 7 R-(-)-α-acetylmandelic acid 2.21 used for ee determination. 
Once R-(-)-α-acetylmandelic acid 2.21 was added to the pyrrolidine mixture the doublet 
resonance caused by the exo-methyl moiety of the pyrrolidine product (ca. 1.00 ppm) 
appeared as two doublets corresponding to the two diastereomeric ion-pairs. Enantiomeric 
excess is determined from comparison of the integration of each pair of resonances using 
line-fitting software as part of the Mestre-C or iNMR software packages. Fig. 8 displays 
two examples of an expanded section of a 1H NMR spectra displaying the now doubled-
doublet of the methyl signal of the pyrrolidine. In Spectrum (a), the combined integration 
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of peaks 0 and 1 is equal to the sum of 2 and 3, denoting the sample is racemic. This is to 
be expected since the catalyst used in this example was the non-stereoselective 
[Ca{N(SiMe3)2}2.(THF)2] compound. Fig. 8, Spectrum (b), depicts the corresponding 
region of the 1H NMR spectra where the characteristic doubled-doublet methyl resonance 
of the pyrrolidine product is observed for enantiomeric excess determination. In the case of 
Spectrum (b), the sum of integration from peaks 0 and 1 is not equal to the sum of 2 and 3, 
and differences in integration signify an enantiomeric excess of 26%. This value was 
achieved with catalyst 5d ([Ca(NNPh){N(SiMe3)2}(THF)]) when applied to the 
hydroamination of substrate B.  
 
Fig. 8 (a) 1H NMR spectra from racemic catalytic reaction of [Ca{N(SiMe3)2}(THF)2]  
with substrate A with R-(-)-α-acetylmandelic acid, (b) 1H NMR spectra from catalytic 
reaction between 5d, [Ca(NNPh){N(SiMe3)2}(THF)] and substrate B with the addition                
of R-(-)-α-acetylmandelic acid 2.21. Enantiomeric excess calculated at 26%. 
a) 
b) 
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3.5.1 Catalytic Performance and Enantioselectivity  
The performance and enantioselectivities of the tested catalyst systems are presented in 
Table 1. All examples proceeded at significantly slower rates than that of 
[Ca{N(SiMe3)2}2(THF)2], which is to be expected when adding a sterically demanding 
spectator ligand. For reference use of [Ca{N(SiMe3)2}(THF)2] as the catalyst sees substrate 
A (Scheme 1) converted to 99% pyrrolidine in 23-29 hours under ambient conditions 
(entry 1), whilst substrate B rapidly achieves >99% conversion with the reaction reaching 
completion before collection of 1H NMR data can be accomplished (ca. 7 minutes,       
entry 11). 
Interestingly when complex 5a is employed as a catalyst no catalytic activity is observed 
(entries 2, 3, and 12). At ambient temperatures this is also the case with compounds 5b and 
5d, with substrate A only (entries 4 and 7 respectively). At elevated temperatures (50 °C) 
5b and 5d do display catalytic activity. Thus compound 5a remains unique in the fact that 
it shows no catalytic activity even at elevated temperatures (up to 80°C) for prolonged 
durations. All homoleptic complexes (7a-c) tested as catalysts also displayed no catalytic 
activity. Since NMR data suggests that preparation of the heteroleptic complex 6a appears 
devoid of its homoleptic analogue, redistribution of the complex would not appear to be 
the cause of this examples inaction with the THF analogue 5a. 
Most noteworthy is the phenyl N-R substituent catalyst 5d with substrate B, in which the 
chiral pyrrolidine is formed in a 26% ee (entry 9). This degree of enantioselectivity 
represents a remarkable increase from the 5-10% obtained with the calcium BOX 
complexes2 and is higher than with the most recent calcium complexes reported by    
Sadow et al.3 Catalyst 5b displays a marginally lower ee of 21% (entry 14), but 
interestingly is also only active with substrate B at ambient temperature. Both these 
examples do display activity with substrate A at 50 °C even if conversions of 35% and 
40% respectively are markedly low (entries 5 and 8). Even then poor yields at elevated 
temperatures are accompanied with a racemic mix of pyrrolidine product.  
An explanation to why catalysts 5b and 5d show significantly higher selectivity than others 
currently remains unclear. The observation of the complexes that record induced selectivity 
(entries 6, 9, and 14-16) favour the geminal-phenyl aminoalkene (substrate B), suggests 
that π-π stacking/interactions between substrate and the supporting ligand’s aromatic N-R 
substituent might be important during the catalytic cycle. The lack of such a ligand-
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substrate interaction between the catalyst and substrate A may also explain why the 
aromatic N-R substituted ligands display predominantly poor selectivities with this 
substrate. From the DFT calculations of complexes 7acalc and 7bcalc discussed in Section 
3.4, the deviation from linearity of the amine and typical trigonal-planar orientation, 
causing favourable chiral orientation of the phenyl ring might be an important factor of the 
success of both complexes 5b and 5d. 
Table 1 Asymmetric hydroamination of amino-olefins using 10 mol% catalyst in C6D6. 
Entry Catalyst N-R Substrate Temp (K) Initial Rate/ 
 mol dm-3 s-1
 
Conv.%a ee%b 
1 [Ca]e - A 293 5.0(2)×10-5 >99 0 
2 5a 4-C6H4F A 293 -   - - 
3 5a 4-C6H4F A  353d -   - - 
4 5b 4-C6H4OCH3 A 293 -   - - 
5 5b 4-C6H4OCH3 A 323 2.4(1)×10-7   40 0 
6 5c 4-C6H4CH3 A 293 1.1(1)×10-6   82 8 
7 5d C6H5 A 293 -   - - 
8 5d C6H5 A 323 5.2(2)×10-6   35 0 
9 5e iPr A 293 2.3(1)×10-6 >99 12 
10 5f tBu A 293 5.9(8)×10-7   90 0 
11 [Ca]e - B 293 c >99 0 
12 5a 4-C6H4F B 293 -   - - 
13 5a 4-C6H4F B  353d -   - - 
14 5b 4-C6H4OCH3 B 293 5.6(3)×10-5   96 21 
15 5c 4-C6H4CH3 B 293 4.3(2)×10-6   93 8 
16 5d C6H5 B 293 3.0(1)×10-5   80 26 
17 5e iPr B 293 4.9(2)×10-5 >99 5 
18 5f tBu B 293 1.1(1)×10-4 >99 6 
        
a Determined from 1H NMR spectra upon no further observable conversion. b
 
Determined by 
1H NMR spectroscopy using R-(-)-α-acetylmandelic acid.19 c Reaction complete <7 min, 
rate unrecorded. d Attempt at 323 K recorded no activity, yield or selectivity. e Complex 
[Ca] = [Ca{N(SiMe3)2}2(THF)2]. 
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Excluding the racemic examples (entries 1-5, 7-9, and 10-13), enantiomeric excess ranged 
from 5-26%. Whilst catalysts 5b and 5d yielded the highest enantioselectivities (entries 14 
and 16) with substrate B, catalyst 5e remains the only example to show preference for 
substrate A (entry 9). Catalyst 5e’s alkyl (tert-butyl) N-R substituent, opposed to the 
aromatic examples discussed may prompt consideration that aromatic N-R substituents are 
better suited for substrate B, and diamines bearing alkyl substituents for substrate A, 
however this appears unfounded. Supporting evidence is seen with catalyst 5f. Whilst 
bearing an iso-propyl N-R substituent observation shows a preference for substrate B 
(entry 10 cf. 18), 4-C6H4CH3 substituent bearing complex 5c also contravenes this 
postulation by showing the same selectivities for both substrates (8% ee, entries 6 and 15). 
Whilst acquisition of applaudable enantioselectivities is highly desirable, attention must be 
exercised as to the rate and yield of product attainment. All active catalysts at ambient 
temperature displayed good product yield of ≥80% and reduced yields were only seen in 
cases where elevated reaction temperatures were used (entries 5 and 8). At raised 
temperatures complex stability over long reaction times becomes questionable. Examples 
are known were poor reactivity was attributed to complex decomposition at elevated 
reaction temperatures over long reaction periods.22  
Of the two examples that attained the highest enantiomeric excesses (entries 14 and 16), 
both display comparable initial rates of 5.6(3)×10-5 and 3.0(1)×10-5 mol dm-3 s-1 
respectively (Substrate B range = 4.3(2)×10-6–1.1(1)×10-4 mol dm-3 s-1; average = 
4.99×10-5 mol dm-3 s-1). Both rates are on a par to other entries contained in Table 1; 
however entry 14 with catalyst 5b shows an increase in yield (96%) opposed to entry 16 
with catalyst 5d (80%). In practical terms diamine reaction times (till recorded conversion) 
tended to proceed over a period of 72 hours.  
Comparison of the catalytic performance of the calcium diamine complexes 5a-f to 
existing calcium examples and the closely related lanthanides in hydroamination can be 
conducted by looking at several key areas: catalyst loading, reaction conditions and time, 
yield, and enantioselectivities. Several recent reviews cover a wide range of aminoalkene 
substrates explored with lanthanide complexes, and the reader is directed to these for 
further reading.18, 23-25 
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The use of 10 mol% of catalyst in our studies was chosen deliberately, owing to it being a 
common quantity for catalyst loading in hydroamination reactions carried out using 
calcium compounds.1-3 Examples where catalyst loadings of 2-5 mol% have been 
successfully employed with calcium are also known.22, 26 In a few cases higher quantities 
are acknowledged, however loadings above 15-20 mol% are not known and examples 
using 20 mol% tend only to be employed in cases where unacceptable yields were obtained 
with lower quantities. It should also be mentioned that the highest catalyst loadings are 
confined to substrates of longer chain length than either substrate A or B, presumably to 
increase rates of forming larger ring sizes. With regards to its lighter congener magnesium, 
a similar range of catalyst loadings have been employed i.e. 2-10 mol%.27 In lanthanide 
mediated hydroamination, generally lower catalyst loadings are routinely employed, 
ranging from 1-5 mol%.18, 23, 25 
When comparing the reaction times of the diamine systems 5a-f, this is the first study to 
investigate initial rates, as many reports only quote observed reaction time in relation to 
hours/days. Irrespective of this, it is clear compounds 5a-f perform at a significantly slower 
rate when put side by side to other known calcium examples.1-3, 22, 26, 28-31 The majority of 
literature calcium catalysts deliver rapid conversions, especially with aminoalkene 
substrates A and B. Final yields are regularly achieved in two hours or significantly less 
e.g. 20-30 minutes. Comparison of catalysts 5a-f with the lanthanides results in a similar 
trend where reactivity of the diamines is significantly diminished upon comparison. The 
greater abundance of lanthanide literature naturally leads to a wider range of reported 
reaction times where examples showing comparable rates to the diamines in 
hydroamination exist, i.e. several days to reach final yield.32 On average the lanthanides 
experience similarly high reactivity as some of the calcium and other AE metal catalysts 
do, converting substrates within several hours, not days. With regards to substrate A the 
lanthanides typically cyclise this substrate in 12 hours and substrate B (already observed as 
the more easily cyclised substrate) in 2 hours or less. 
The ability to execute hydroamination reactions under ambient temperatures is very 
appealing and is a common trait shared between the AE metals and lanthanides alike. The 
use of increased reaction temperatures, for example 60-80 °C is less regular in both though 
should not be considered infrequent. Raised reaction temperatures are necessary for 
substrates that form 6-membered (or larger) heterocyclic compounds or bear more 
sterically demanding substituents than substrates A and B. In any case, increases in 
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reaction temperature lead to faster reaction times and improvements in yield, albeit to the 
detriment of enantiomeric excess in the case of the lanthanides. Upon first inspection it 
would appear that the case of catalyst 5a (entries 3, 4, 12, and 13, Table 1) showing 
complete inactivity even at temperatures of 80 °C, is not an isolated example.22, 26 Even so, 
the literature examples reported stunted reactivity when using substrates bearing either 
mono- or dimethyl substitution at the terminal alkene, or upon substrates aiming to form  
7-membered rings. Both features are identified as factors that impede reactivity due to 
sterics, though neither of these factors are present in the simpler substrates A and B and so 
the lack of activity recorded by 5a with these substrates should be regarded as abnormal 
until other examples emerge from the literature.  
The employment of lanthanides in hydroamination has been very successful, and rightly so 
when observing very consistent product yields of ≥95%. The AE metals also demonstrate 
many examples of near quantitative conversion over a range of substrates.28 Yet, it would 
appear the range of conversion is more disperse than that observed in the lanthanides. In 
calcium and AE metals, the typical conversion range could be extended to 85-99%. In light 
of this the yields experienced by the diamine catalysts 5a-f are very agreeable with the 
majority of examples. The only exceptions are the noticeably poor yields of entries 5      
and 8 of Table 1. 
As revealed, the enantiomeric excess of 26% achieved by diamine supported catalyst 5d 
(entry 16, Table 1) represents the leading figure in this field at the time of writing. 
Currently literature examples of calcium mediated asymmetric hydroamination remain 
sparse with two previous reports. One from Buch and Harder2 (4-10% ee) and another 
from Sadow et al.3 (18% ee), which are discussed in greater detail in Chapter 1, Section 
1.2.1.2. The improvement in obtained enantiomeric excess by calcium compound 5d 
represents a sizeable increase over the literature, however when compared to magnesium it 
is still significantly behind.  
Magnesium mediated hydroamination frequently achieves higher enantiomeric excesses in 
comparison to calcium aided hydroamination. Sadow et al. provided an excellent 
comparative investigation by probing the magnesium analogue of the calcium system 
which achieved 18% ee. When compared side by side in identical reactions the magnesium 
catalyst achieved enantiomeric excesses of 27-36%. More recently even these moderate 
enantiomeric excesses have been dwarfed by the report from Hultzsch et al. demonstrating 
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enantiomeric excesses of up to 93% in hydroamination reactions.4 Examples of lanthanide 
catalysts in asymmetric hydroamination is significantly more developed and generally 
outperforms the aforementioned calcium examples, including our own in asymmetric 
hydroamination. There is a significant range of recorded enantiomeric excesses when 
utilising lanthanides, from racemic up to 87% ee, though commonly averaging between  
45-60% ee.18, 20, 23, 24 
In conclusion, chiral 1,2-diamines as supporting ligands for calcium complexes have been 
shown as moderately efficient stereodirecting scaffolds. Whilst there is clearly room for 
improvement the significant increase in obtained enantiomeric excesses compared to 
previously cited literature examples remains promising. Whilst further investigation of 
complex structure is warranted, expanding the understanding of the mechanism behind 
hydroamination may prove fruitful and help shed further insight into the notion of 
important ligand/substrate interactions being an influential factor on stereoselectivity.  
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4.1 Introduction 
In 2008 Buch and Harder’s bisoxazoline (BOX) supported calcium complex 1.6 was the 
first reported example of asymmetric hydroamination mediated by an AE metal (Fig. 1).1 
Although a positive step forward with organocalcium chemistry the recorded enantiomeric 
excesses were notably poor (5-10% ee). Our aim was to build upon this result, principally 
through judicial ligand selection/modification where we elected to employ          
bisimidazolines as the starting scaffold. As can be seen, both the oxazoline (a) and  
imidazoline (b) ligand frameworks are structurally similar (Fig. 2). 
 
Fig. 1 [Ca(BOX){N(SiMe3)2}(THF)2] complex (1.6). 
Since their first implementation in asymmetric catalysis in 1986,2 oxazolines have emerged 
as highly successful supporting ligands for a wide range of catalysis reactions. A sub-class 
of the oxazoline is the bisoxazoline which has become popular since its establishment in 
the early 1990’s by the likes of Evans3 and Corey.4 Pronounced success led to their 
classification as a privileged ligand and so it seems sensible and fitting that the first ligand 
deployed on calcium for asymmetric hydroamination was a BOX. Comprehensive reviews 
have been written about the implementation of BOXs in asymmetric catalysis and provide 
greater breadth of the area
.
5-7
 
 
Fig. 2 Oxazoline (a) and 2-imidazoline (b) motifs. 
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The BOX complex 1.6 used by Buch and Harder is one of the simpler oxazoline 
derivatives sporting two oxazoline rings bridged by a single carbon linker. Many 
poly(oxazoline) variations exist, for example bis(oxazolinyl)phenyl (PheBOX) 4.1 and 
bis(oxazolinylphenyl)amines (BOPA) 4.2 (Fig. 3). 
 
N
H
O N N O
R R
4.2
 
Fig. 3 PheBOX (4.1) and BOPA (4.2). 
The presence of a C2-symmtery axis (or higher, e.g. C3) in many of the polyoxazoline 
ligands is a feature that can aid success in asymmetric catalysis. It has the potential to 
enhance enantioselectivity by reducing the number of diastereomeric transition states by 
invoking symmetry to render transition states equivalent (Chapter 1, Section 2.5).  
Coordination between the BOX and selected metal takes place through the donor nitrogen 
atom present in each oxazoline ring. Binding at this point places the stereodirecting groups 
within close proximity of the metal centre allowing for effective transfer of chiral 
information onto the catalytic substrate at the reaction centre. The trivial synthesis of 
BOXs from chiral amino alcohols permits a degree of structural variety, allowing the 
ligand to be fine tuned to suit its application. The stereodirecting groups can be varied and 
the bridge can be diverse in complexity (Scheme 1).8, 9 
 
Scheme 1 Preparation of BOXs. 
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Whilst oxazolines are structurally similar to imidazolines, imidazolines offer the advantage 
of the additional N-R moiety allowing for alteration of electronic, in addition to steric, 
properties of the ligand which cannot be achieved in BOXs. This advantage has been 
discussed in the literature on several occasions, however reports into systematic alterations 
of this group and subsequent effects upon the reactivity of their metal complexes has so far 
remained elusive.10-12  
Although the first example of a 2-imidazoline ((b), Fig. 2) was published in 1888, there is 
only a small number of reports exploiting its bisimidazoline sub-class in asymmetric 
catalysis.12 One of the first examples of a bisimidazoline employed in asymmetric catalysis 
was reported by Casey et al. who used a variety of the ligands coupled with PdCl2. These 
complexes were applied to asymmetric alkylation reactions in which favourable yields of 
>90% and enantiomeric excesses of >70% were observed. Bisimidazoline complex 4.3 
(Fig. 4) was directly compared with its BOX supported analogue 4.4. Complex 4.3 was 
found to out-perform BOX complex 4.4 with respect to both yield and stereoselectivity.13 
Here the authors attributed the increased basic nature of the bisimidazoline compared to its 
corresponding BOX to have induced a shorter Pd-N bond length (though no structural 
verification of this was undertaken). They postulated that a shorter Pd-N bond length 
would result in drawing the stereodirecting groups closer to the metal centre and thus 
impart a stronger influence upon incoming substrates. It should also be highlighted that 
they suspected the increased backbone rigidity was also a contributing factor to improved 
enantiomeric excess. 
4.3
N
NN
Ni
Bu
i
Bu
Pd
Cl Cl
4.4
N
OO
Ni
Bu
i
Bu
Pd
Cl Cl
 
Fig. 4 Bisimidazoline complex 4.3 and BOX complex 4.4                                                
reported in Pd mediated allylic alkylation. 
Another example from 2007 illustrates Beller et al. deploying a N,N,N-
pyridinebis(imidazoline) ligand on a ruthenium complex which was later applied to 
asymmetric transfer hydrogenation of a prochiral ketone.14, 15 Results showed that the 
complexes bearing R-BIMs consistently out-performed similar BOXs supported complexes 
on both yield and ee. The same group also explored asymmetric epoxidation using a Pybox 
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bisimidazoline, where they recognised the potential advantages of fine-tuning the N-R 
substituent.16 However, this only resulted in moderate enantiomeric excesses (43-71% ee), 
which were substrate dependant. Sadly no BOXs were directly tested for comparison. 
Around the same time Arai et al.17 and Pfaltz et al.18 were developing bisimidazoline 
supported copper triflate complexes for asymmetric cyclopropanation of styrene      
(Scheme 2), which provided both groups with good yields and high enantiomeric excesses 
of up to 86%.  
 
Scheme 2 Cyclopropanation of styrene. 
2007 also saw You et al. report the use of bisimidazoline supported copper complexes used 
for asymmetric nitroaldol (Henry) reactions (Scheme 3). The bisimidazoline complexes 
they developed showed excellent enantioselectivities (93-98% ee) with both aromatic and 
aliphatic substrates. The authors remarked that BOXs based around tert-butyl 
stereodirecting groups were comparatively successful at this reaction. Yet the downside is 
the initial synthetic costs of starting from the tert-butyl amino acid derivative, which was 
less cost effective than the bisimidazolines You et al. synthesised. 
 
Scheme 3 Asymmetric nitroaldol (Henry) reaction. 
The use of bisimidazolines as supporting ligands was also demonstrated by Iwasawa et al. 
through nickel catalysed coupling of CO2 with alkynes (Scheme 4).19 Of note is the 
bisoxazolines used (4.5) during this study do not contain the typically included 
stereocentre (cf. 4.3), which is often included by design from synthesis using a chiral 
amino acid as detailed in Section 4.2. This reaction was concerned with regioselectivity 
rather than stereoselectivity of the final products and in this respect the ligand proved very 
successful. They also demonstrated that the regioselective preference could be tailored 
through variation of the N-R substituent and bridge structure. 
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Scheme 4 Nickel catalysed coupling of CO2 with alkynes. 
A select few examples of bisimidazolines employed as organocatalysts are known. 
Tsogoeve and Göbel et al. published the novel diprotonated bisimidazoline 4.6 (Fig. 5)20 
that clearly demonstrates the incorporation of commercially available diamine 2.1, 
previously mentioned in Chapter 2. The organocatalyst 4.6 was tested in chiral Brønsted-
acid asymmetric Diels-Alder reactions where a significant acceleration of the reaction was 
noted though recorded enantioselectivities were low to moderate. In 2008 Göbel et al. 
published an update to their work with newly designed diprotonated ligands that again 
accelerated reaction times producing good yields, but experienced no improvement upon 
aforementioned enantioselectivtities. It was noted that counter ion choice was of significant 
importance.21 Overall the enantioselectivities of the bisoxazolines investigated by        
Göbel et al. compare poorly to the 70% enantiomeric excess recorded with oxazoline 
derivatives, however reactivity was increased by approximately 50 fold. 
 
Fig. 5 Novel diprotonated R-BIM from Göbel et al.                                                       
TFPB = tetrakis(3,5-bistrifluoromethylphenly)borate. 
It becomes clear the majority of the literature concerning the application of systems 
bearing bisimidazoline ligands, whether supporting ligands on d-block metals or catalysts 
in their own right has predominantly developed in the last ten years. It is therefore 
understandable that bisimidazoline ligands have been not been exploited with AE metals 
until now.  
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Our studies of bisimidazoline supported calcium complexes serve to probe several areas of 
interest simultaneously: will the additional N-R substituents improve the catalytic 
performance of the complex compared to Buch and Harder’s BOX counterpart 1.6? Will 
systematic variation of the electronic and associated steric properties of the N-R substituent 
result in improved ligand performance or aid ligand redistribution suppression?  
Since the area of bisimidazolines remains significantly underdeveloped compared to BOXs 
any studies involving bisimidazolines will increase the knowledge of these ligands leading 
to their potential application to a wider field other than AE metals.  
 
4.2 Ligand Synthesis and Characterisation 
Although many adaptations of the bisimidazoline scaffold exist the targeted bisimidazoline 
systems of this study consist of two imidazoline rings bridged by a single CH2 link         
(8a-j, Scheme 5). In essence we aim to prepare the imidazoline analogues of the BOX type 
synthesised in Scheme 1. This type of bisimidazoline scaffold will be abbreviated as      
“R-BIM” henceforth. Strategies to prepare R-BIMs are similar in nature to those used for 
obtaining the related BOX analogues. Our chosen methodology to synthesise the target    
R-BIMs is derived from work published by Pfaltz et al. involving the condensation of two 
equivalents of diamine with an imino ether (Scheme 5). Not only is this a proven method 
but it also makes use of our previously developed synthetic pathway for producing chiral 
diamines (Chapter 2, Section 2.4).18  
 
Scheme 5 Preparation of bisimidazoline ligands (R = 4-C6H4F (4a/8a), 4-C6H4OCH3 
(4b/8b), 4-C6H4CH3 (4c/8c), C6H5 (4d/8d), 4-C6H4NO2 (4e/8e), 3,5-C6H3(CH3)2             
(4f/8f), CH(CH3)(C6H5) (4g/8g), iPr (4h/8h), tBu (4i/8i), 4-C6H4N(CH3)2 (4j/8j). 
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4.2.1 Ligand Bridge Component 
As described in Scheme 5, reaction of a selected diamines 4a-j with diethyl malonimidate 
dihydrochloride 4.7 aims to successfully synthesis the target R-BIMs 8a-j.18 The two 
equivalents of diamine are provided from the diamine synthesis as detailed in Chapter 2, 
Section 2.4 and acquisition of the imino ether 4.7 can be accomplished using the synthesis 
described by Göbel et al. in Scheme 6.22 Göbel et al. achieved the synthesis of the imino 
ether starting from malononitrile 4.8 in anhydrous 1,4-dioxane, to which ethanol is added 
at 0 °C over a period of 12 hours. During this time HCl gas is sparged through the system 
resulting in the product 4.7 precipitating from the reaction medium as a white solid that can 
be isolated in yields of >90%. Although stored under an inert atmosphere (since hydrolysis 
is known with these types of molecules)23, 24 4.7 displayed a shelf-life of approximately 1.5 
months, showing signs of decolouration thereafter (white to an increasing yellow hue). 
After such times where colouration was apparent reaction yields of R-BIM synthesis were 
reduced. Storage of 4.7 away from light sources improved the longevity.  
 
Scheme 6 Preparation of diethyl malonimidate dihydrochloride (4.7). 
The idea of converting a nitrile group to an imidate has been known since 1825 and is 
often referred to as the Pinner reaction.24 Many variations of this reaction have taken place 
over the years but the use of either methanol or ethanol remains the most popular choice. 
The necessary methanol or ethanol can either been added as a reagent using an ethereal 
solvent as the reaction medium,25 or having the methanol/ethanol fulfilling the role of both 
reagent and solvent.26 Whilst the present method above is acid catalysed the reaction can 
also be base catalysed. This is typically with sodium metal in ethanol to form the neutral 
imino ether.27 
With regards to conducting the Pinner reaction in an ethereal solvent, 1,4-dioxane is  
common and consequently it is unsurprising the use of THF has also been reported.25        
It could be assumed that diethyl ether would likely allow the preparation of 4.7, however 
much to our surprise rather than isolating imino ether 4.7 the monoimidate 4.9 is isolated 
instead (Scheme 7).28 In this circumstance, extended reaction times and excess addition of 
Chapter Four - Chiral Bisimidazoline Supported Calcium Complexes 
110 
 
ethanol fail to yield 4.7 when diethyl ether was the solvent medium. The ability to 
synthesise the mono-imidate 4.9 paves the way for some potentially exciting new ligand 
synthesis developments, which are discussed in Chapter 5.  
 
Scheme 7 Preparation of a mono-substituted imidate 4.9. 
Over the course of our studies several improvements to the procedure described in     
Scheme 6 were found. The reaction proceeded without issue at ambient temperature 
instead of 0 °C, and ethanol did not have to be added over an elongated period of time but 
could be added stoichiometrically at the start of the reaction. Our studies show the solution 
need only be sparged with HCl(g) for 2-3 hours, contrasting the reported 18 hours. Greatest 
yield improvements were noted when the HCl(g) was dry. This was achieved by liberating 
HCl gas from oven dried ammonium chloride using concentrated sulphuric acid. 1H and 
13C NMR studies were conducted on the purified product 4.7 and were complimentary with 
literature values.22 IR spectroscopy proved to be a powerful technique in assessing purity 
since the absorbance pertaining to the nitrile bond is very characteristic (ca. 2265 cm-1) in 
4.9
 
compared to that of the imide bond in both 4.7 and 4.9 (ca. 1650-1665 cm-1).   
Pflatz’s method allowed successful preparation of R-BIMs 8a-j (Scheme 5) on a starting 
scale of 1-2 g of diamine substrate. Yields of isolated R-BIM were moderate in all cases 
(~35%). Further improvements were not seen through extension of reaction times nor 
conducting the coupling reactions in higher boiling point solvents, for example chloroform, 
1,2-dichloroethane, or chlorobenzene.29 Regardless of which solvent was used, isolated 
yields of the air and moisture stable R-BIMs did not exceed 40%.  
Reactions were typically clean and pure R-BIM was obtained by basic workup followed by 
column chromatography over silica. Purification was straightforward since it only required 
the separation of the R-BIM from unreacted diamine starting material. Using column 
chromatography over a silica gel matrix was sufficient in all but two cases. The ArNO2-BIM 
8e was recovered through crystallisation from hot toluene, which was subsequently stored 
at -18 °C overnight before filtering the solid (orange) and drying in vacuo. The iPr-BIM 8h 
was obtained by precipitation from a mixture of warm hexane/dichlormethane.   
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During purification of the R-BIMs 1H NMR data contained resonances that were easily 
identifiable as either R-BIM or residual diamine. The difference in chemical shifts was 
most pronounced and distinguishable for the proton attached at the chiral centre and the 
diasterotopic protons of the adjacent methylene (CH2) group. For example ArF-BIM 8a 
displays 1H NMR resonances at 3.75 (NCH2), 3.64 (NCH2CH) and 3.39 (NCH2) ppm, 
compared to diamine 4a which has resonances at 3.38 (NCH2), 3.27 (NCH2CH) and 3.03 
(NCH2) ppm respectively. The 13C NMR spectra of the newly formed R-BIMs also show a 
new resonance typically recorded between 165-160 ppm which is attributed to the carbon 
environment of the newly formed imide (C=N). This recorded resonance is also consistent 
with observations made when forming BOXs.30, 31 
The significant shift of recorded resonances in the 1H NMR spectra is also mirrored in the 
13C NMR spectra for the carbon at the chiral centre and the carbon of the adjacent 
methylene group. A downfield shift is observed for all resonances. For example in        
ArF-BIM 8a resonances at 65.2 (NCH2CH) and 55.8 (NCH2) ppm, compared to diamine 4a 
resonances of 57.6 (NCH2CH) and 44.2 (NCH2) ppm respectively. These relative changes 
in chemical shift are observed for all R-BIM derivatives compared to their starting diamine 
analogue with only small variations which are N-R substituent dependent.  
The IR spectrum of the isolated R-BIMs indicates the formation of the imine C=N by the 
strong absorption recorded in the region between 1569-1623 cm-1. This absorbance is 
distinctly absent from the diamines. There are also small changes in absorbance in the 
region 3300-3700 cm-1 of the R-BIMs compared to their diamine analogues, which is 
assumed to be a result of the change of the primary and secondary amine of the diamine 
into the imidazoline of the R-BIM.  
Whilst R-BIMs 8a-j are unsubstituted at the bridge carbon, substitution at this point is 
possible. For example, simple derivations would be mono- or dimethyl substituition (4.10 
and 4.11, Fig. 6).32, 33  
 
 
 
 
NH
EtO
.2HClNH
OEt
4.11
 
Fig. 6 Diimidate bridge variations 4.7, 4.10, and 4.11. 
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Upon complexation with calcium the R-BIM is deprotonated becoming an anionic ligand, 
along with the elimination of HN(SiMe3)2. The remaining hydrogen at the bridge is 
sterically unimposing, potentially increasing the chances of attack at this position and the 
ensuing ligand decomposition. The mono-methyl substitution present in compound 4.10 
would still allow complexation of an anionic ligand with calcium, but the more sterically 
demanding methyl could help prevent undesired side reactions. Conversely use of the 
dimethyl substituted bridge 4.11 is likely to result in rather different chemical behaviour of 
the complex since there is no longer a proton to abstract from the R-BIM tautomer. The 
ligand would remain neutral and the calcium atom would retain two bound N(SiMe3)2 
groups, i.e. [Ca(R-BIM){N(SiMe3)2}2(THF)n], resulting in significantly different 
behaviour compared to its mono-amide counterpart [Ca(R-BIM){N(SiMe3)2}(THF)].   
 
4.2.2 Structural Tautomers and Evidence of Diastereoisomerism 
From 1H NMR studies on the R-BIM ligands it is believed that the uncomplexed R-BIM 
ligands exist in either tautomeric form (a or c, Fig. 7). This is unsurprising since an 
analogous form is seen in the structurally related BOXs.34, 35 In tautomers a and c the 
bridge carbon is sp2 hybridised and the nitrogen moieties contain a long pair in a p-orbital. 
This conformation results in conjugation over a planar 6π-system between the two 
imidazoline rings. The additional stability this conformation brings likely renders them 
preferable to b. 1H NMR data also supports this by showing only one proton (calculated 
from integration) bound to the bridge carbon. The resonance from this proton arises 
between 3.70-3.58 ppm, however it is not observed in most cases. This suggests very broad 
signals as the molecule exchanges between tautomeric forms a-c (Fig. 7). Low temperature 
1H NMR studies were untaken in an endeavour to see if the exchange could be “frozen 
out” to support this theory, however at temperatures of -60 °C in CDCl3, the exchange 
could not be sufficiently slowed to recorded this.  
 
Fig. 7 R-BIM suggested tautomeric forms. 
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When investigating possible racemisation occurrence during the development of the 
diamine synthesis in Chapter 2, Section 2.5, a diamine with two stereocentres was prepared 
(4g). Investigating possible racemisation/epimerisation we utilised the typical R-BIM 
synthesis seen in Scheme 5 and incorporated bis-chiral diamine 4g into the synthesis with 
the aim of recovering a single diastereoisomer of the N-R = PhMeH-BIM product 8g 
(Scheme 8). The resulting product was a white solid with a recorded yield of 34% which is 
comparable with the isolated yields of R-BIMs 8a-j. As with previous 1H NMR studies on 
the bis-chiral diamine 4g, studies on PhMeH-BIM 8g showed no evidence of 
diasteroisomers in the form of resonance duplication at close chemical shifts.36  Whilst 4 
chiral centres exist in PhMeH-BIM 8g diastereoisomerism can occur in the presence of one 
of more chiral centres. In the case of R-BIMs 8a-j (exclusive of 8g) this could result in S,S, 
R,R, or S,R, R,S conformations  
 
Scheme 8 Preparation of R-BIM 8g. 
 
4.3 Chiral Calcium Complexes Supported by Bisimidazolines  
4.3.1 Complex Synthesis 
Preparation of the R-BIM calcium complexes 9a-j was achieved by reaction of the protio-
ligand 8a-j with [Ca{N(SiMe3)2}2(THF)2] in benzene-d6. For larger scales toluene or 
nondeuterated benzene was used. For pyridine analogues 10a-j [Ca{N(SiMe3)2}2(py)2] was 
used (Scheme 9). In all cases yellow/orange precipitates were obtained that were only 
soluble in THF-d8, being insoluble in hydrocarbon solvents and unstable in chlorinated 
solvents. This is in stark contrast compared to calcium BOX complexes that were soluble 
and characterised in benzene-d6.1 Despite this, the low solubility experienced with calcium 
complexes 9a-j and 10a-j is in keeping with the solubility issues experienced with the 
diamine supported calcium complexes as previously detailed in Chapter 3.1, 29, 37-39 
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Scheme 9 Preparation of [Ca(R-BIM){N(SiMe3)2}(py)2] complexes 10a-j                         
(R = 4-C6H4F (10a), 4-C6H4OCH3 (10b), 4-C6H4CH3 (10c), C6H5 (10d), 4-C6H4NO2 (10e), 
3,5-C6H3(CH3)2 (10f), CH(CH3)(C6H5) (10g), iPr (10h), tBu (10i), 4-C6H4N(CH3)2 (10j). 
All hydroamination catalysis experiments were conducted using complexes               
[Ca(R-BIM){N(SiMe3)2}(THF)] 9a-j, however, for complete characterisation it was 
necessary to exchange the coordinating THF with pyridine in order to determine the extent 
of base coordination in THF-d8. To prepare the pyridine analogues protio-R-BIM ligand 
was added to [Ca{N(SiMe3)2}2(py)2] in benzene. The reaction proceeded for 18 hours at 
ambient temperature followed by solvent and volatile by-product removal under reduced 
pressure to 4.0×10-2 mbar. This was done to ensure a level of consistency between each 
sample and since prolonged exposure to vacuum conditions can remove coordinated 
pyridine.40 The remaining product, typically orange, was then dissolved in THF-d8 for 
further analysis. 
Synthesis of homoleptic [Ca(R-BIM)2] complexes 11a-j was achieved by reaction of two 
equivalents of protio-ligand (8a-j) with one equivalent of  [Ca{N(SiMe3)2}2(py)2] in either 
benzene or toluene. The reaction was allowed to proceed for 18 hours at ambient 
temperature before the resulting complex was dried in vacuo and subsequently dissolved in 
THF-d8 for analysis. Under these conditions ≥90% conversion was noted but with mild 
heating at 40 °C overnight ≥97% conversion was achieved on all examples. Extended 
heating did not see higher conversions nor display evidence of decomposition, suggesting a 
moderate level of complex stability. This observed stability is on par with that generally 
observed with comparable calcium complexes that are stable for at 60 °C reasonable 
durations.41, 42 
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The formation of homoleptic complexes 11a-j results in two equivalents of liberated 
HN(SiMe3)2 and pyridine respectively. In order to remove these by-products complexes 
11a-j were dried in vacuo. As a result only trace amounts of pyridine were observed in 
NMR spectra with small quantities of HN(SiMe3)2. The persistent presence of HN(SiMe3)2 
even after recrystallisation attempts is characteristic in both homoleptic and heteroleptic  
R-BIM calcium complexes, and mirrors observation of the diamine calcium complexes 
discussed in Chapter 3.  The homoleptic complex solubility was noticeably greater than the 
heteroleptic analogues, especially in hydrocarbon solvents. 
  
4.3.2 Complex Characterisation 
NMR spectra of the heteroleptic species 10a-j in THF-d8, were well-defined at ambient 
temperature (in stark contrast to the diamine complexes [Ca(NNR){N(SiMe3)2}(py)n] 6a-f 
of Chapter 3) but showed a distinct mixture of the heteroleptic species 10a-j and the 
corresponding homoleptic complex 11a-j. This redistribution is illustrated in Scheme 10 
and has been previously discussed in Chapter 1, Section 1.1.1.  
 
Scheme 10 Redistribution of [Ca(R-BIM){N(SiMe3)2}(py)] to [Ca{N(SiMe3)2}2(py)2] and 
[Ca(R-BIM)2] (R = 4-C6H4F (10a/11a), 4-C6H4OCH3 (10b/11b), 4-C6H4CH3 (10c/11c), 
C6H5 (10d/11d), 4-C6H4NO2 (10e/11e), 3,5-C6H3(CH3)2 (10f/11f), CH(CH3)(C6H5) 
(10g/11g), iPr (10h/11h), tBu (10i/11i), 4-C6H4N(CH3)2 (10j/11j). 
Superimposed 1H or 13C NMR spectra of a chosen heteroleptic complex                      
[Ca(R-BIM){N(SiMe3)2}(py)] with its homoleptic analogue [Ca(R-BIM)2] showed feature 
resonances were distinctly shifted upon comparison. This was most noticeable with the   
iso-propyl groups of the stereodirecting groups within a complex. An example stack plot of 
the 1H NMR spectra from complex [Ca(ArOMe-BIM){N(SiMe3)2}(py)] 10b and its 
homoleptic analogue [Ca(ArOMe-BIM)2] 11b are shown in Fig. 8.  
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Fig. 8 Stacked 1H NMR spectra of [Ca(ArOMe-BIM){N(SiMe3)2}(py)] 10b                            
(top trace) and [Ca(ArOMe-BIM)2] 11b (bottom trace) in THF-d8 at 293 K. 
Resonance analysis of the iso-propyl groups of the heteroleptic complex 10b gives signals 
at 2.06 and 1.86 ppm for the methine of the iso-propyl moieties and 0.88, 0.85, 0.80, and 
0.75 ppm for the iso-propyl methyl groups. This compares to the resonances of homoleptic 
complex 11b at 2.05 and 1.65 for the methine, and at 1.04, 0.92, 0.89, and 0.80 ppm for the 
methyl groups respectively. The resonances in the region of 4.5-2.5 ppm are regularly 
assigned to the protons bound to the carbon of the chiral centre and the adjacent methylene 
(CH2) group. This region in the 1H NMR spectra can display complicated resonance 
patterns resulting from the overlap of the multiplet signal of the proton at the chiral centre 
and the apparent triplet/doublet of doublets fine structure of the adjacent CH2 
diastereotopic protons.  
There are however exceptions. The NMR data indicates that the bound R-BIM ligands of 
the homoleptic complexes [Ca(iPr-BIM)2] 11h and [Ca(ArNMe2-BIM)2] 11j exist in one 
uniform chemical environment. For example 11h shows a singlet resonance at 3.71 ppm 
caused by the protons at each ligands bridge head and integration confirms two protons in 
(10b) 
(11b) 
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that environment. This is clearly different to the bridge proton resonance at 3.31 ppm that 
integrates to one proton in the heteroleptic analogue [Ca(iPr-BIM){N(SiMe3)2}(py)] 10h.  
The uniform ligand environment of these examples is also reflected in the IR spectra of the 
heteroleptic and related homoleptic complexes (10h/11h and 10j/11j). When comparing IR 
spectra of aforementioned hetero- and homoleptic complexes all recorded absorbance 
frequencies vary less than 10 cm-1 between the absorbance in the heteroleptic species and 
then its homoleptic analogue. This difference is far greater in all other comparisons of 
heteo- and homoleptic calcium complexes. 
Examining the resonances attributed to coordinated pyridine in the 1H NMR spectra of 
[Ca(R-BIM){N(SiMe3)2}(py)] 10a-j showed that one equivalent of pyridine was bound, 
and that there is no or little deviation upon variation of the N-R substituent. This contrasts 
Bush and Harders’ BOX complex 1.6, which had two equivalents of base coordinated, 
although this was THF as opposed to pyridine. The inclusion of one equivalent of bound 
pyridine is also observed with the diamine calcium complexes [Ca(NNR){N(SiMe3)2}(py)] 
6a-d. The exceptions were the iso-propyl and tert-butyl diamine complexes 6e and 6f, 
which are the only examples to show sub-stoichiometric quantities (0.3-0.6) of pyridine 
coordinated (Chapter 3, Section 3.3). 
NMR spectroscopic analysis of the heteroleptic complexes 10a-j demonstrated three 
distinctive trimethylsilane environments (1H NMR δ = 0.04, 0.03, and 0.02 ppm. 13C NMR 
δ = 6.0, 2.7, and 1.4 ppm). Whilst HN(SiMe3)2 is expected to be a volatile by-product even 
after repeated recrystallisation attempts and extensive drying in vacuo all traces were 
unable to be removed. We suppose the cause of this is due to similar reasons these 
environments were observed with the heteroleptic diamine complexes 6a-f. One resonance 
from bound [N(SiMe3)2]- in the heteroleptic complex, and one from residual free 
HN(SiMe3)2, of which some may re-coordinated to the calcium centre and the final 
resonance from the trimethylsilane environments present in the redistribution product
 
[Ca{N(SiMe3)2}2(py)2].    
The R-BIM complexes also display no evidence of ether-cleavage whilst in THF-d8, this 
was also the case for the diamine complexes of Chapter 3 but has been observed in the 
literature.37 
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4.4 Complex Redistribution 
Ligand redistribution equilibria as shown in Scheme 10 were expected due to the nature of 
AE metal complexes (Chapter 1 Section 1.1.1) and Buch and Harder also report such 
behaviour with calcium BOX complexes.1 In the case of Buch and Harders’ 
[Ca(BOX){N(SiMe3)2}(THF)2] complex 1.6 (Fig. 1) they observed that the redistribution 
ratio of heteroleptic:homoleptic was 80:20 respectively.   
 
Scheme 10 Redistribution of [Ca(R-BIM){N(SiMe3)2}(py)] to [Ca{N(SiMe3)2}2(py)2] and 
[Ca(R-BIM)2] (R = 4-C6H4F (10a/11a), 4-C6H4OCH3 (10b/11b), 4-C6H4CH3 (10c/11c), 
C6H5 (10d/11d), 4-C6H4NO2 (10e/11e), 3,5-C6H3(CH3)2 (10f/11f), CH(CH3)(C6H5) 
(10g/11g), iPr (10h/11h), tBu (10i/11i), 4-C6H4N(CH3)2 (10j/11j). 
Variation of the R-BIM N-R substituent showed a significant effect on the favoured 
equilibrium position at ambient temperature as tabulated in Table 1 and graphically 
represented in Fig. 9. Some complexes existed as an equal distribution between 
heteroleptic complex 10 and homoleptic complex 11 for example 10a/11a (entry 1), and 
10f/11f (entry 6). All other examples have an equilibrium position that favours heteroleptic 
formation. This varies from 60-100% with respect to proportion of heteroleptic species 
present in solution (THF-d8). Both iso-propyl 10h and tert-butyl 10i bearing complexes 
showed a strong preference towards the formation of the heteroleptic species at 94:6 and 
80:20 10:11 respectively (entries 8 and 9).  
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Table 1 Redistribution of [Ca(R-BIM){N(SiMe3)2}(py)] 10 to [Ca(R-BIM)2] 11 and 
[Ca{N(SiMe3)2}2(py)2] in THF-d8 at 298 K. 
Entry Complex N-R 10:11a Kb ∆G kJ mol-1 
1 10a 4-C6H4F 48:52 1.17 -0.39 
2 10b 4-C6H4OCH3 100:0 0 - 
3 10c 4-C6H4CH3 64:36 0.32 2.8 
4 10d C6H5 99:1 0.01 11.2 
5 10e 4-C6H4NO2 -c - - 
6 10f 3,5-C6H3(CH3)2 46:54 1.18 -0.39 
7 10g CH(CH3)(C6H5) 80:20 0.26 3.3 
8 10h iPr 94:6 0.06 6.7 
9 10i tBu 80:20 0.06 6.7 
10 10j 4-C6H4N(CH3)2 60:40 0.67 0.99 
 
 
    
a Determined by integration of 1H NMR spectra. b
 
Equilibrium constant 
determined at 298 K. c Complex insoluble. 
 
  
Fig. 9 Redistribution of [Ca(R-BIM){N(SiMe3)2}(py)] 10 to [Ca(R-BIM)2] 11 and                      
[Ca{N(SiMe3)2}2(py)2] in THF-d8 at 298 K. Entry numbers correspond to Table 1. 
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When analysing steric and electronic variations of the R-BIM ligands and corresponding 
effect upon equilibrium position, it is relevant to recall that the redistribution equilibrium 
can be steered towards the desired heteroleptic complex by the presence of a higher 
concentration of the homoleptic species in relation to heteroleptic. Le Chatelier’s principle 
denotes that upon addition of a higher quantity of homoleptic species the equilibrium will 
shift to oppose this change. The result of this will be to shift the equilibrium point to form 
more of the heteroleptic species. Buch and Harder investigated this principle in relation to 
the calcium BOX complexes. They detected that after addition of 1 extra equivalent of 
homoleptic BOX complex they were able to shift the equilibria towards heteroleptic 
complex formation. This resulted in a reduction in the quantity of active calcium salt 
[Ca{N(SiMe3)2}2(THF)2] present to approximately 2-3% when compared to solutions 
without additional homoleptic complex. Although able to coerce the equilibrium position 
in such a manner, catalytic performance of these mixtures showed no significant 
improvement on the enantiomeric excess obtained in hydroamination.1 Due to the 
structural similarities of the BOXs and R-BIMs it is likely we would observe the same 
outcome following this approach, which is why structural variation of the ligand was 
explored instead. 
Before discussion the electron-donating or withdrawing nature of a R-BIM’s aromatic N-R 
substituent it is pertinent to categorise them according to their Hammett values (σx), which 
are listed in Table 2.43 
Table 2 Hammett σx values for R-BIM aromatic N-R substituents.    
Entry R-BIM N-R σxa   
1 8e 4-C6H4NO2 0.78  Electron- 
withdrawing 2 8a 4-C6H4F 0.06  
3 8d C6H5 0.00   
4 8f 3,5-C6H3(CH3)2 - 0.07b  
Electron-
donating 
5 8c 4-C6H4CH3 -0.17  
6 8b 4-C6H4OCH3 -0.27  
7 8j 4-C6H4N(CH3)2 -0.83  
 
 
    
a All values are σp with the exception of Entry 4, which is σm.                         
b σm value is for the meta mono-substituted CH3 derivative.  
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Aromatic electron-donating substituent examples include ArOMe-BIM complex 10b and 
ArNMe2-BIM complex 10j, which show ratios of 100:0 and 60:40 respectively for 10:11. 
The remaining electron-donating substituents of complexes 10c (ArMe-BIM), 10f          
(Ar3,5Me-BIM), and electron-neutral Ph-BIM (10d) demonstrate a similarly wide range of 
equilibrium positions from 46:54 to 99:1 with no discernible pattern.  
Tentatively it appears that less sterically demanding substituents side with equilibrium 
positions favouring heteroleptic formation as seen in entries 4, 8, and 9. This is supported 
by the increased proportion of heteroleptic complex present in solution when comparing 
ArMe-BIM 10c to Ar3,5Me-BIM
 
10f. These two examples show a dramatic shift in 
preference for heteroleptic formation from 46:54 to 64:36 (entries 3 and 6) within a typical 
error range of 2%.  
Whilst a further shift towards heteroleptic formation in the equilibrium occurs when 
moving from ArMe-BIM 10c, to the marginally smaller analogue Ph-BIM
 
10d. We observe 
a change in equilibrium position from 64:36 to 99:1 in favour of the heteroleptic species 
(entry 3 vs. 4, Table 1). On these simple observations alone the same trend can be applied 
to the alkyl N-R substituents iPr-BIM and tBu-BIM: entries 8 and 9. It is important to be 
aware that whilst this evidence appears to support the notion that smaller N-R substituents 
on the R-BIM could lead to more favourable heteroleptic formation, the difference in steric 
demands between two substituents is often negligible. For example the ArMe-BIM is not 
too dissimilar in its steric demands when compared to Ph-BIM. The added methyl group of 
the ArMe-BIM is also orientated at a direction and distance appreciably far away from the 
metal centre so as not to impart a stereodirecting role. It is more likely that a complex 
interplay of steric and electronic factors dictate the equilibrium positions observed and 
have yet to be understood fully.  
Indeed when examining the relative electron-withdrawing and donating N-R substituents’ 
effect on the redistribution equilibrium, the observation that less sterically hindering 
substituents tend to result in an equilibrium preference for heteroleptic complex formation 
is less clear-cut. This is supported by comparison of the equilibrium data for ArMe-BIM 
complex 10c, 64:36 and ArOMe-BIM 10b, 100:0 (10:11).  They are arguably similar in 
structure yet different equilibrium positions advocate that the electron-donating nature of 
the 4-C6H4OCH3 substituent in complex 10b could be influencing the equilibrium position.  
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It could be envisioned that donating electron density through the ligand towards the metal 
centre creates a stronger binding ligand better able to resist the rate at which the 
redistribution equilibrium is achieved. The equilibrium position for 10h is 60:40 (10h:11h) 
yet the amino group is electron-donating like the methoxy group of 10b. Thus we would 
also expect to observe a slower rate at which the ligand redistribution equilibrium is 
reached however this is not the case as all equilibrium positions were established within 
similar times.  
1H NMR investigations established that all complexes had reached their respective 
equilibrium position within 10 minutes of complexation occurring. This evidence supports 
observations of fast reaction rates when protio-ligands 8a-j are reacted with the calcium 
starting material [Ca{N(SiMe3)2}2(THF)2)] or [Ca{N(SiMe3)2}2(py)2)] and is in agreement 
with the facile nature of the BOX complexes synthesis. Whilst the R-BIMs, diamine and 
BOX ligands all displayed rapid complexation, some literature examples have required 
more forcing conditions, and heating for an extended duration to ensure complexation.41  
Since the electron-withdrawing ArNO2-BIM 10i was insoluble we were unable to determine 
an equilibrium position, leaving the single electron-withdrawing ArF-BIM complex 10a. 
This was one of only two examples displaying a partiality for homoleptic complex 
formation in solution. Initial comparison of this result to others suggests 10a’s steric 
demands could be compared with that of ArMe-BIM 10c, which displays a much higher 
affinity for heteroleptic formation. Probing correlations related to 10a’s electron-
withdrawing nature shows a slightly higher preference for heteroleptic formation over a 
marginally electron-donating derivative, for example Ar3,5Me-BIM
 
10f (48:52 compared 
with 46:54 (10:11) respectively). Electron-withdrawing N-R substituents would lead to a 
weaker donating ability of the coordinating nitrogen atoms of the R-BIM ligand. This in 
turn would lead to a weaker coordinating ligand and a complex that would be more 
susceptible to redistribution reaching redistribution equilibrium faster than stronger bound 
ligands.  
At this juncture it becomes appropriate to ask whether the obtained enantioselectivities 
with a catalyst is dependent upon the redistribution equilibrium position (10:11) or the rate 
at which that equilibrium position is achieved. If electron-donating groups aid resistance to 
complex redistribution, then we hope to observe higher enantiomeric excesses and slower 
catalytic rates. The slower catalytic rates would suggest a lower quantity of 
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[Ca{N(SiMe3)2}2(THF)2] present, which is well known to catalyse the hydroamination of 
aminoalkenes rapidly.29, 44
 
For electron-withdrawing groups lower stereoselectivity would 
be expected alongside increased reaction rates for the opposite reasons. However slow 
reaction rates (cf. [Ca{N(SiMe3)2}2(THF)2)] would still be anticipated since we are 
employing a bulky spectator ligand. Redistribution by-product [Ca(R-BIM)2] is 
catalytically inactive and in keeping with observations homoleptic diamine complexes 
(Ca(NNR) (7a-c) Chapter 3) and the observations of Buch and Harder.1 
 
 
 
 
 
 
 
  
Fig. 10 Alternative N-R substituents to consider for R-BIM library (4.12-4.16). 
It is apparent that whilst trends may imply certain structural/electronic features help dictate 
redistribution trends, a larger ligand library would require testing to see if these initial 
observations hold true. Comparison of less sterically demanding N-R alkyl derivatives, 
such as methyl and ethyl compared to tert-butyl and iso-propyl. Conversely increasing the 
steric demand, of N-R with groups such as adamantylamine 4.12 (Fig. 10). When studying 
steric effects of more relatively electron-neutral examples (σx ~0, Table 2), alterations in 
appended ring size might also help test aforementioned observations. For example, 
substituting aniline in the R-BIM synthesis with the five-membered ring cyclopenta-2,4-
diene-1amine 4.13, to see if the smaller ring had a preference for an equilibrium position 
towards heteroleptic formation. Cyclic nonaromatic derivatives would also be interesting 
to consider for comparison with the more extensively studied aromatic analogues, for 
example the use of cyclohexanamine 4.14 or cyclopentanamine 4.15. Due to the insoluble 
nature of the heteroleptic and homoleptic ArNO2-BIM
 
bearing complexes
 
10e and 11e, a 
suitable alternative to compare to ArF-BIM complexes 10a/11a would be 
pentafluoroaniline 4.16, due to its electron-withdrawing nature.  
∆G293 values were calculated from the equilibrium coefficients, which were found to be 
small and almost negligible.  
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4.5 DFT 
In order to gain insight into the proposed mononuclear species                                                 
[Ca(R-BIM){N(SiMe3)2}(THF)] and [Ca(R-BIM)2] (R = 4-C6H4F, Ph,  and tBu), their 
structures were calculated using density functional methods. Only example structures of 
the heteroleptic complex [Ca(Ph-BIM){N(SiMe3)2}(THF)] 12a and homoleptic complex 
[Ca(Ph-BIM)2] 12b are presented in Fig. 11 since all variations were found to be 
isostructural. 
 
12a 
 
 
12b 
 
Fig. 11 Calculated structure of heteroleptic [Ca(ArPh-BIM){N(SiMe3)2}(THF)] 12a            
and homoleptic [Ca(Ph-BIM)2] 12b. 
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From calculated structural data undertaken by Dr. Benjamin Ward, variation of the R-BIM 
N-R substitution (R = 4-C6H4F, 4-C6H4OCH3, 4-C6H4CH3, Ph, and tBu) results in no 
marked electronic influence on the charge of the nitrogen donor atoms, nor the calcium 
centre. The Mulliken charge of the R-BIM nitrogen donors demonstrates negligible 
deviation ranging between -1.282 to -1.283 e. The Mulliken charge of the calcium centre 
records a similarly negligible variation, with examples ranging over 1.095 to 1.099 e. 
There is also minimal variation of Ca-NBIM bond length upon R-BIM N-R variation     
(range = 2.391-2.426 Å) suggesting that the steric demands of the N-R substituent are of 
more concern with respect to catalytic reactivity than electronics would appear to be.  
 
Table 3 Experimental and calculated redistribution of [Ca(R-BIM){N(SiMe3)2}(THF)]    
to [Ca(R-BIM)2] (R = 4-C6H4F 10a/11a, Ph 10d/11d, and tBu 10i/11i)  and 
[Ca{N(SiMe3)2}2(THF)2] at 298 K.  
Entry Complex N-R Experimental  
∆G kJ mol-1 
Calculated 
∆G kJ mol-1 
1 10a/11a 4-C6H4F -0.4 6.9 
2 10d/11d C6H5 11.2 6.3 
3 10i/11i tBu 6.7 16.7 
  
 
  
  
 
  
 
Calculated ∆G of exchange between [Ca(R-BIM){N(SiMe3)2}(THF)] 10 to [Ca(R-BIM)2] 
11 (R = 4-C6H4F, Ph, and tBu) and [Ca{N(SiMe3)2}2(THF)2] at 298K were also calculated. 
These were compared against the experimentally determined values listed in Table 1, 
Section 4.4. A comparison of the calculated and experimentally determined values is 
tabulated in Table 3. The calculated values ∆G are within typical error margins of 2-3 kcal 
(8-12 kJ) commonly accepted for DFT calculations. When compared to the experimentally 
determined values, the calculated values are of a similar magnitude to the experimentally 
determined values.  
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4.6 Catalytic Performance  
Table 4 Asymmetric hydroamination of amino-alkenes using 10 mol%                       
[Ca(R-BIM){N(SiMe3)2}(THF)] in C6D6 at 293 K. 
Entry Complex N-R Substratee Initial Rate/  
mol dm-3 s-1
 
Conv.%a Timef ee%b 
1 [Ca]c - A 5.0(2)×10-5 >99 23h 0 
2 9a 4-C6H4F A 6.8(3)×10-8 3 3.5d 9 
3 9b 4-C6H4OCH3 A 7.2(3)×10-7 32 24d 0 
4 9c 4-C6H4CH3 A 5.1(5)×10-7 8 7d 0 
5 9d C6H5 A 9.5(4)×10-8 4 6.5d 0 
6 9e 4-C6H4NO2 A Insoluble - - - 
7 9f 3,5-C6H3(CH3)2 A 8.5(4)×10-7 64 17d 10 
8 9g CH(CH3)(C6H5) A - - - - 
9 9h iPr A - - - - 
10 9i tBu A 7.3(4)×10-7 18 7d 12 
11 9j 4-C6H4N(CH3)2 A - - - - 
12 [Ca]c - B -d >99 <7m 0 
13 9a 4-C6H4F B 1.8(1)×10-5 >99 39h 9 
14 9b 4-C6H4OCH3 B 9.7(4)×10-5 >99 5.5h 6 
15 9c 4-C6H4CH3 B 1.0(1)×10-4 95 7h 5 
16 9d C6H5 B 1.1(1)×10-5 60 39h 0 
17 9e 4-C6H4NO2 B Insoluble - - - 
18 9f 3,5-C6H3(CH3)2 B 3.1(1)×10-4 >99 7h 0 
19 9g CH(CH3)(C6H5) B - - - - 
20 9h iPr B - - - - 
21 9i tBu B 6.4(3)×10-5 >99 6.5h 12 
22 9j 4-C6H4N(CH3)2 B - - - - 
 
a Determined from 1H NMR spectra. b
 
Determined by 1H NMR spectroscopy using (R)-(-)-
O-acetylmandelic acid.45 c [Ca] = [Ca{N(SiMe3)2(THF)2]. d Reaction complete  
<7 minutes, rate undetermined. e Substrate A = 1-amino-2,2,dimethyl-4-pentene and 
substrate B = 1-amino-2,2,diphenyl-4-pentene (Scheme 11). f Time until conversion 
ceased, determined from 1H NMR spectra. 
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The application of complexes [Ca(R-BIM){N(SiMe3)2}(THF)] 9a-j to hydroamination 
catalysis produced mixed results (Table 4), with conversion ranging from 0-32% with a 
handful of examples exhibiting 60% or higher (>90%). From data obtained there appears to 
be little “middle-ground” with conversion tending to side with more extreme differences. 
When looking at this data related to the substrate used, these trends can be deciphered with 
more ease.  
 
4.6.1 Enantiomeric Excess Determination 
The enantiomeric excessess of hydroamination pyrrolidine product (Table 4) were 
determined using the same 1H NMR procedure as discussed in Chapter 3, Section 3.5. An 
excess of chiral derivatising agent R-(-)-α-acetylmandelic acid 2.21 (Fig. 12)45, 46
 
was 
added to the pyrrolidine product containing reaction mixture and determination of 
enantiomeric excess was deduced from integration of characteristic resonances using line-
fitting software as part of the Mestre-C or iNMR software packages. 
 
Fig. 12 R-(-)-α-acetylmandelic acid 2.21 used for ee determination. 
 
4.6.2  Kinetics of Catalysis 
Calculation of rate data from product conversion curves is presented in Table 4 and was 
pursued to allow quantitative comparison of catalytic activity between the various R-BIM 
supported calcium complexes employed in hydroamination (Scheme 11). When reacted 
with [Ca{N(SiMe3)2}2(THF)2] substrates A and B display largely different reactivity rates 
even without the presence of a bulky supporting ligand. Substrate A exhibits 99% 
conversion between 23-29 hours (dependent on ambient temperature fluctuations) and 
substrate B consistently achieves >99% conversion rapidly, completing the reaction before 
collection of 1H NMR data can be accomplished (ca. 7 minutes with equipment at Cardiff 
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University). Unsurprisingly catalytic reactions of [Ca(R-BIM){N(SiMe3)2}(THF)] with 
substrate A were significantly slower than with substrate B. This is also in agreement with 
observations recorded with the calcium diamine complexes [Ca(NNR){N(SiMe3)2}(THF)] 
discussed in Chapter 3.  
 
Scheme 11 Asymmetric hydroamination catalysis (R’ = Me A, Ph B, H C). 
The method employed for initial rate determination involved the collection of 1H NMR 
spectra at staggered intervals during catalytic reactions (an example conversion curve 
recorded and used to determine initial rate is provided in Fig. 13).  The time intervals 
between spectra collection were reaction dependant ranging from every 3 minutes to 30 
minutes or more for slower reactions. This was undertaken until no further conversion was 
calculated by 1H NMR. The conversion curves were curve fitted to an exponential decay 
function y=Ae-bx. The initial rate, given by the slope at the origin (x=0), was determined by 
differentiation of the equation: dy/dx = -A/b. All accompanying conversion curves for 
reactions discussed in this chapter are supplied in Appendix B. 
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Fig. 13 Conversion for the catalytic hydroamination of substrate B using                            
10 mol% [Ca(tBu-BIM){N(SiMe3)2}(THF)] 9i in C6D6 at 293 K. 
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All catalysis results listed in Table 4 were conducted using 10 mol% catalyst to allow for 
comparison of results with literature results, as 10 mol% is a common loading.1, 42, 44, 47, 48 
Curious about effects of catalyst quantity upon hydroamination, catalytic reactions using 5, 
10, and 20 mol% of 9a, c, and i, were monitored (Table 5), with representative conversion 
curves are provided in Fig. 14. 
Table 5 Asymmetric hydroamination of amino-olefin substrate B using 5, 10, or 20 mol% 
[Ca(R-BIM){N(SiMe3)2}(THF)] in C6D6 at 293 K. 
Entry Complex mol% catalyst Initial Rate/ mol dm-3 s-1
 
 
1 9a 5 -  
2 9a 10 1.8(1)×10-5  
3 9a 20 4.0(3)×10-5  
4 9c 5 2.5(1)×10-6  
5 9c 10 1.0(1)×10-4  
6 9c 20 2.2(4)×10-4  
7 9i 5 -  
8 9i 10 6.4(3)×10-6  
9 9i 20 1.1(1)×10-4  
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Fig. 14 Conversion for the catalytic hydroamination of substrate B using 5, 10,                       
and 20 mol% of [Ca(ArMe-BIM){N(SiMe3)2}(THF)] 9c in C6D6 at 293 K. 
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The trend of doubling catalyst concentration leading to approximate doubling of the initial 
rate is consistent with a first order reaction with respect to catalyst and is in agreement with 
those findings published by Marks.31 Marks investigated hydroamination using 
bisoxazoline complexes of lanthanides (4.17, Fig. 15).  
 
Fig. 15 Bis(oxazolinato)lanthanide complex [Sm(BIM){N(SiMe3)2}2] 4.17.  
 
4.6.3. Catalyst Performance Analysis 
Complexes 9e, g, h, and j, show no catalytic activity with either substrate (entries 6/17, 
8/19, 9/20, and 11/22 Table 4). It would appear that when employing                          
[Ca(R-BIM){N(SiMe3)2}(THF)] type complexes to catalytic conversion of substrate B, if 
they do not catalyse its cyclisation, then it would not cyclise substrate A under ambient 
conditions either. 
Pondering if these complexes evoked a higher energy barrier to catalysis, the catalytic 
performance of complexes 9g, h, and j with substrates A and B was investigated at 50 °C 
and 80 °C. Unlike the calcium diamine catalysts evaluated at elevated temperatures 
(Chapter 3 Section 3.5.1), the R-BIM complexes that had no catalytic activity at ambient 
temperature displayed no activity at temperatures up to 80 °C for prolonged durations     
(up to 14 days). Complex [Ca(ArNMe2-BIM){N(SiMe3)2}(THF)] 9j displayed increasing 
amounts of precipitate during monitoring at 80 °C. It is assumed this was from 
decomposition of the complex and was only observed in this particular complex. 
Rationalisation of these findings proves difficult due to ever-present contradictions. The 
three examples themselves have no obviously common structural parallels with respect to 
various steric and/or electronic attributes.  
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When examining them individually complex [Ca(iPrR-BIM){N(SiMe3)2}(THF)] 9h could 
be imagined to show similar catalytic performance to that of 9i, the tert-butyl analogue due 
to their comparable chemical structures. Comparison of their catalytic performance data is 
conflicting, with 9h showing no catalytic activity whereas complex 9i arguably 
demonstrates the best combination of selectivity and rate figures of all complexes over 
both substrates (entries 10 and 21).  
Complex redistribution equilibria that favour the heteroleptic complex are common traits 
of the non-active complexes 9g and 9j. However this characteristic cannot be so simply 
attributed to their poor activity since complexes 9b-d, 9f and 9i do not support this (entries 
3-5, 7, 10, 14-16, 18, and 21). When looking at steric and/or electronic properties of an    
R-BIM there is currently no clear correlation as to why these three complexes exhibit no 
catalytic activity. These trends also have no correlation to applicable diamine supported 
calcium catalysts since the iso-butyl bearing [Ca(NNiPr){N(SiMe3)2}(THF)] 5e is 
catalytically active in intramolecular hydroamination. Diamine based catalysts where N-R 
is PhMeH or ArNMe2 were not synthesised and so cannot be compared to their R-BIM 
equivalents.   
Of the remaining complexes that recorded catalytic activity several interesting patterns 
emerge. The complex that catalysed both substrates fastest was 9f (entries 7 and 18) 
followed by complex 9c (entries 4 and 15). From this point the order of quickest initial rate 
changes depending on substrate. For substrate A fastest to slowest proceeds: Ar3,5Me-BIM 
(9f) > ArMe-BIM (9c) > ArOMe-BIM (9b)> tBu-BIM (9i) > ArF-BIM (9a) > Ph-BIM (9d), 
and for substrate B: Ar3,5Me-BIM (9f) > ArMe-BIM (9c) > tBu-BIM (9i) > ArOMe-BIM (9b) 
> Ph-BIM (9d) > ArF-BIM (9a).  
It would appear the redistribution equilibria position could be in part responsible, since 
Ar3,5Me-BIM 9f has the lowest proportion of heteroleptic complex in solution at 298 K 
(46:54, entry 6,Table 1). Data then signifies that the reactivity generally decreases 
independent of substrate, as the redistribution equilibrium shifts to a greater proportion of 
heteroleptic complex (Table 6). Whilst this generally holds true complex                 
[Ca(ArF-BIM){N(SiMe3)2}(THF)] 9a is the exception with a redistribution equilibrium 
favouring formation of the homoleptic species, yet demonstrating a poor initial rate with 
both substrates in respect to the other R-BIM complexes analysed.  
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Explanation for this anomaly might arise from the electron-withdrawing nature of the N-R 
substituent. In the case of complex 9a electronics opposed to redistribution equilibrium 
position may bear an over-riding influence on catalytic performance. 
Table 6 Apparent initial rate dependence on ligand redistribution ratios 10:11. 
Rank Substrate A N-R 10:11 Substrate B 10:11 N-R 
(Fastest) 9f 3,5-C6H3(CH3)2 46:54 9f 46:54 3,5-C6H3(CH3)2 
2nd 9c 4-C6H4CH3 64:36 9c 64:36 4-C6H4CH3 
3rd 9i tBu 80:20 9b 100:0 4-C6H4OCH3 
4th 9b 4-C6H4OCH3 100:0 9i 80:20 tBu 
5th 9d C6H5 99:1 9a 48:52 4-C6H4F 
 (Slowest) 9a 4-C6H4F 48:52 9d 99:1 C6H5 
   
 
Treatment of product conversion and ee data by ranking the performance of the catalysts 
(Tables 7 and 8) shows no correlations between ligand redistribution equilibrium or trends 
relating to steric and/or electronic demands.  
Table 7 Hydroamination product conversion dependence on ligand redistribution ratios 
10:11. 
Rank Substrate A Conv. % 10:11 Substrate B Conv. % 10:11 
1st  9f 64 46:54 9f, 9a, 9b, 9i 99 various 
2nd 9b 32 100:0 9c 95 64:36 
3rd 9i 18 80:20 9d 60 99:1 
4th 9c 8 64:36 - - - 
5th 9d 4 99:1 - - - 
6th 9a 3 48:52 - - - 
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Table 8 Hydroamination enantioselectivity dependence on redistribution ratios 10:11. 
Rank Substrate A ee % 10:11 Substrate B ee % 10:11 
1st  9i 12 80:20 9i 12 80:20 
2nd 9f 10 46:54 9a 9 48:52 
3rd 9a 9 48:52 9b 6 100:0 
4th 9c, 9b, 9d 0 various 9c 5 64:36 
5th - - - 9d, 9f 0 various 
   
 
It is apparent that inconsistencies to the predicted behaviour have emerged. Complexes that 
redistribute to favour formation of active, yet non-stereospecific, [Ca{N(SiMe3)2}2(THF)2]  
and inactive [Ca(R-BIM)2] do display faster initial rates as a result of increased 
concentration of [Ca{N(SiMe3)2}2(THF)2]. On the other hand this does not always result in 
high substrate conversion. The data also fails to reflect anticipated results with respect to 
enantioselectivity. It is expected that solutions containing higher proportions of 
[Ca{N(SiMe3)2}2(THF)2] should show lower enantiomeric excess when compared to those 
with lower quantities of the non-stereoselective calcium complex. 
Comparison of the R-BIM ee data with the diamine complexes of Chapter 3 goes to 
highlight another unexpected trend when evaluating complexes 9a, 9f, and 9i. All other 
catalytically active complexes, R-BIM or diamine, have shown an inclination for faster 
initial rates, higher conversion and better ee with substrate B (discounting examples of 
non-selective results). Complexes 9a and 9i appear not to show substrate preference giving 
the same ee for both substrate A and B. Complex 9f being the only example to show 
preference for substrate A over B.  
Justification of the results from complexes 9a and 9i can be rationalised through 
consideration of the limits of accuracy of the data when working with conversions as low 
as 3% (complex 9a). At such low conversions error is likely to be compounded compared 
to higher conversions. Whilst every effort was made to minimise error, the result of 9% ee 
could vary up to ± 3%. It could be a similar cause for the same substrate enantiomeric 
excesses of complex 9i or purely coincidental. Reasoning for why complex         
[Ca(Ar3,5Me-BIM){N(SiMe3)2}(THF)] 9f invokes a preference for substrate A over the 
normal trend for substrate B remains unclear but could possibly be due to steric demands 
during a catalysis transition step. Since complex 9f is the only example to be substituted at 
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the meta positions of the aromatic N-R substituent. It would be interesting to scrutinize 
other meta substituted examples to see if they demonstrated similar substrate preference 
behaviour.  
In context of the BOX calcium complexes tested by Buch and Harder both types of 
calcium complex (R-BIM or BOX) show redistribution equilibria that are not typically 
50:50 (heteroleptic:homoleptic), both catalyse hydroamination at a slower rate than 
[Ca{N(SiMe3)2}2(THF)2], and both complexes generally favour substrate B over       
substrate A. Whilst Buch and Harder experienced enantiomeric excesses between 4-6% 
with the phenyl BOX calcium complex (1.6, Fig. 1), enantiomeric excesses with the         
R-BIM calcium complexes showed improved enantiomeric excesses up to 12%.  
When evaluating the success of the aforementioned [Ca(R-BIM){N(SiMe3)2}(THF)] 
complexes they have shown improvements on some of the early literature examples with 
respect to selectivity, however lag behind others, i.e. enantioselectivities of 18% from a 
trisoxazoline complex reported by Sadow and co-workers,39 and the 26% ee induced by 
phenyl diamine complex 6d of Chapter 3.40 It is interesting that whilst the highest 
enantiomeric excess was achieved with a diamine bearing a phenyl N-R substituent, in the 
case of the R-BIM complexes the most favourable N-R substituent for overall catalytic 
performance (rate/selectivity) is tert-butyl. Like many of the discussed results this 
highlights that there appears to be no crossover between N-R substituents of the diamine 
and its R-BIM calcium complex counterpart, i.e. [Ca(NNPh){N(SiMe3)2}(py)n] and   
[Ca(Ph-BIM){N(Si(Me3)2}(THF)] both displaying the highest enantiomeric excesses.  
From this discussion we can determine that R-BIMs are currently, unlikely to be the 
optimum ligand for inducing greatly improved selectivity, i.e. >26% ee. However whilst 
research involving organocalcium complexes applied to hydroamination catalysis is still in 
its infancy, they provide valuable models for investigations concerning ligand alteration 
and subsequent effects upon catalytic performance. The modular nature of these ligands 
still has room for exploitation; the extension of synthesised and tested examples of varying 
N-R substituents, alternative bridge motifs and stereodirecting group alterations are all 
conceivable and may still yield more desirable enantiomeric excesses. 
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In review, the employment of R-BIMs with variation of the N-R substituent has 
successfully improved the enantiomeric excesses obtained in intramolecular 
hydroamination of substrates A and B when compared to the initial attempts by Buch and 
Hard with calcium BOX complexes. Whilst variation of the N-R substituent can affect the 
ligand redistribution position it appears to have little effect upon the rate at which this 
equilibrium is achieved. The employment of one particular N-R substituent has not 
resulted in significant improvement upon catalytic performance when compared to the 
library tested. 
Whilst the data collected doesn’t allow for discrete behaviour patterns to be deciphered, it 
dismisses the assumption that complexes exhibiting a ligand redistribution equilibrium 
favouring formation of the heteroleptic species give better catalytic performance. In 
addition, it would seem that additional factors dictate the conversion and ee of a reaction. 
Certainly NMR evidence suggests that what was thought to be discrete, liberated HNSiMe3 
isn’t necessarily the case since there is a possibility it may act as a donor ligand in solution.
 
This finding points towards the possibility of previously unforeseen interactions taking 
place with the calcium centre which are likely to impact on overall catalytic performance.  
Although these studies direct us to believe that the redistribution equilibrium position is of 
lesser importance than first postulated at the beginning of this Thesis. It does raise the 
question of whether the rate of which ligand redistribution is established plays a more 
significant role with respect to catalytic performance. Further investigation to probe this 
postulation is likely to take the form of employing supporting ligands that are more 
kinetically inert than either the diamines or R-BIMs. For example, ligand scaffolds that 
only undergo rearrangement upon forcing conditions such as significant heating.  
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5.1 Introduction 
There is a constant quest for innovative ligand development or variation of existing 
platforms for their evaluation as supporting ligands in functional metal complexes. In this 
Thesis two types of ligand, bisoxazoline (BOX, (a), Fig. 1) and bisimidazoline (R-BIM, 
(c), Fig. 1) ligands have been referred to and compared upon a multitude of occasions. 
During the course of synthesising the R-BIMs presented in Chapter 4, Section 4.2, we 
noted that a small modification to the R-BIM synthesis could lead to the potential 
development of a new ligand class. The new ligand class deemed “imoxazoline” (IMOX) 
would essentially be a BOX/R-BIM structural hybrid bearing one oxazoline and 
imidazoline ring within its structure ((b), Fig. 1).  
 
 
  
Fig. 1 BOX (a), IMOX (b), and R-BIM (c). 
Although possessing C1 symmetry the IMOX ligand structure contains a pseudo C2-axis of 
symmetry trisecting the methylene bridge, giving a coordination environment similar in 
nature to the BOX and BIM parent ligands. Like both BOX and R-BIMs the 
stereodirecting groups of the IMOX (iso-propyl as depicted in Fig. 1) are still within close 
proximity of the metal binding centre and able to provide steric shielding and impart chiral 
information upon substrates that would either be bound to, or approaching the metal centre.  
The modular construction of an IMOX could present a significant advantage over 
traditional BOX and R-BIMs with respect to variation of the stereodirecting groups. The 
two stereodirecting groups being identical is currently a pre-requisite for BOX and R-BIM 
ligands, however through judicious selection of the components required to assemble an 
IMOX (a diamine and an amino alcohol), it is theoretically possible to have two different 
stereodirecting groups. For example one iso-propyl moiety bound to the oxazoline ring and 
a tert-butyl group bound to the imidazoline of the IMOX. 
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 If synthetically successful with IMOXs, implementation of inequivalent stereodirecting 
groups could theoretically also be transferred to BOX and R-BIM ligands through the 
sequential construction of oxazoline or imidazoline rings. This flexibility over 
stereodirecting group selection would provide access to a previously unexplored area, 
where the fine tuning the ligand by mixing stereodirecting groups is rendered a real 
possibility.  
The retention of the imidazoline N-R moiety within the IMOX would still allow for the 
rich variation of electronic and/or steric properties of the ligand akin to those discussed 
with R-BIMs, whilst likely to display properties between those of the BOX and BIM 
ligands. Again the flexibility of the IMOX platform at this point has the potential for ligand 
fine-tuning towards desirable features, resulting from the inclusion of a particular N-R 
substituent.  
At this moment the effects on ligand performance when varying stereodirecting groups and 
the many potential variations of the N-R substituent remains to be seen, but provides an 
exciting academic prospect to explore. As IMOX ligands are unreported in the literature 
their application as a ligand to a much wider field of chemistry other than calcium assisted 
hydroamination would also be of potential significance. This would be most significant for 
asymmetric catalysis where BOX and R-BIM ligands have already demonstrated a wealth 
of success. This would also go hand-in-hand with being able to draw parallels between the 
performance of IMOXs with BOX and R-BIM ligands.  
 
5.2 Ligand Precursor Synthesis and Characterisation 
Achievement of the desired IMOX ligands is dependent upon the formation of the        
ethyl 2-cyanoacetimidate hydrochloride compound 4.9. Reaction of 4.9 with one 
equivalent of diamine (4a-f) allows for the formation of the required imidazoline ring. 
Upon ring-closing the mono-imidazoline species (R-MIM 13a-f) is produced. Fashioning 
the oxazoline unit is proposed by reaction of the R-MIM with an amino alcohol, for 
example L-valinol as shown in Scheme 1 overleaf.    
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Scheme 1 Proposed synthetic route to IMOXs. 
 
5.2.1 Ethyl 2-Cyanoacetimidate Hydrochloride Synthesis 
Whilst designing the synthetic pathway to the desired R-BIMs discussed in Chapter 4, 
Section 4.2.1, it was noted that subtle modification of the reaction conditions described by 
Göbel et al. (Scheme 2) used to synthesise the imidate 4.7 would instead yield the      
mono-imidate 4.9.1,2 
 
Fig. 2 Diimidate 4.7 and mono-substituted imidate 4.9. 
Starting with malononitrile (4.8) in anhydrous diethyl ether, ethanol was then added at 
room temperature. HCl gas was sparged through the system for 4 hours where 4.9 
precipitates from the solution upon formation. After filtration and drying in vacuo a white 
solid in near quantitative yield is obtained.  
 
Scheme 2 Preparation of a mono-substituted imidate 4.9. 
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The production of the mono-imidate 4.9 is surprising considering the diimidate analogue 
4.7 is formed in either 1,4-dioxane or THF, both ethereal solvents.3  It was postulated that 
under the above conditions the insoluble nature of the mono-imidate salt 4.9 in diethyl 
ether results in the cessation of the reaction prohibiting the second nitrile group conversion 
to an imidate; whereas the monoimidate is partially soluble in 1,4-dioxane/THF, thus 
facilitating conversion into the diimidate 4.7.  
The resulting mono-imidate salt 4.9 was stored under an inert atmosphere in an opaque 
container to reduce exposure to light sources. These actions were necessary to prolong the 
shelf life of the material, which was observed to discolour at a faster rate than 4.7. The 
longevity of 4.9 was typically 3 weeks compared to the 6 weeks of diimidate 4.7. Once 
compound discolouration was evident for either, decreased yields were typical with their 
use in subsequent reactions. Containment within an inert atmosphere is required to prevent 
imidate hydrolysis (Scheme 3). Hydrolysis of such imidate compounds to the 
corresponding amide is known in the literature.4-7 Hydrolysis is catalysed in the presence 
of water and the formation of the amide is generally fast and goes to completion. This is 
especially true in the case of low number aliphatic chains such as 4.7 and 4.9, which tend 
to be more hydroscopic than longer chain examples.4  
 
Scheme 3 Hydrolysis of an imidate to the resulting amide. 
Distinguishing between the mono-imidate 4.9 and diimidate 4.7 proves straightforward 
when comparing spectroscopic data. IR spectroscopy shows a very prominent band at   
2265 cm-1 which arises from the C≡N present in 4.9. As expected this band is absent in the 
IR spectrum of 4.7. There are also small variations in absorbance frequency of the C=N for 
4.9 at 1651 cm-1 compared to 4.7 at 1662 cm-1. Comparison of 1H NMR spectra brings to 
light a moderate change in chemical shift arising from the different environments around 
the two protons bound to the bridge carbon. In 4.9 the resonance corresponding to these 
two protons (adjacent to the nitrile group) is observed at 4.01 ppm compared to 4.21 ppm 
for the same protons in 4.7.  
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13C NMR of both compounds show significant differences. The inclusion of the C≡N 
frequency of 4.9 at 115.1 ppm is noticeably absent in the spectra of 4.7. Both compounds 
show a large difference in resonances attributed to the carbon atom at the bridge, recorded 
at 24.5 ppm (4.9) and 41.2 ppm (4.7). Less significant chemical shifts are observed for the 
C=N carbons, being detected at 164.3 ppm (4.9) and 166.5 ppm (4.7).   
 
Fig. 3 decomposition product 15. 
 
Whilst the solid state structure of 4.9 could not be confirmed directly, crystals suitable for 
X-ray diffraction were grown by David Collis of the hydrolysis product 15 (Fig. 3). 
Compound 15 is the related dimethyl substituted derivative of 4.9. The molecular structure 
of 15 presented in Fig. 4 was solved by Dr. Benjamin Ward. Until this point all imidate salt 
examples presented in this Thesis have been unsubstituted at the bridge carbon. 15 is a 
derivative of an alternative dimethyl substituted bridge that was being explored at the time 
within the group, utilising the same synthetic procedure as discussed at the beginning of 
this Section.8  The molecular structure of 15 concisely shows substitution has only 
occurred at one nitrile group and that the resulting imidate group has undergone    
hydrolysis (Scheme 3). 
 
 
Fig. 4 Molecular structure of mono substituted imide hydrolysis                                             
product 15. Elliposids are drawn at 25% probability. H atoms are                                         
omitted  for clarity with the exception of those bound to N(1). 
Chapter Five – A Potential New Class of Ligand – Imoxazolines 
145 
 
The crystallographic data from 15 shows only one notable deviation from expected bond 
lengths. This comes from the bond length between N(1)-C(1). N-C bond lengths are 
commonly 1.47 Å, though in the case of 15 this bond length is measured as 1.332(2) Å. 
Explanation for this shorter bond length, more consistent with sp2 hybridised atoms     
(N=C 1.29 Å) is due to usual amide resonance present within the molecule. The 
delocalisation of electron density present within this functional group results in an increase 
of sp2 character opposed to sp3 resulting in a shorter, stronger bond.  
 
5.2.2  Mono-imidazoline IMOX Precursors 
The mono-imidate 4.9 was reacted with 1 equivalent of diamine 4a-f under typical 
conditions as described in step 2 of Scheme 4, resulting in the formation of mono-
imidazolines (R-MIMs) 13a-f. Yields for this reaction were fair, ranging between 30-40%, 
which is mirrored in the R-BIM formation proceeding via an analogous synthetic pathway. 
 
Scheme 4 Synthesis of R-MIMs 13a-f. 
Analysis of the crude products from reaction between 4.9 and diamines 4a-f indicated the 
presence of the desired R-MIM (13a-f, Table 1) with the only by-product being unreacted 
diamine. Of the spectroscopic methods, IR and 13C NMR spectra gave the most insight for 
structural deduction. Using IR spectroscopy noticeable changes in absorbance frequencies 
were prominent between starting material 4.9 and the products 13a-f. The absorbance 
assigned to the C≡N shifts significantly from 2265 cm-1 in 4.9 to between 2172-2194 cm-1 
in 13a-f. Bands related to the C=N showed less pronounced changes though common 
occurred at lower absorbance frequencies by 30-40 cm-1.  
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Table 1 R-MIMs 13a-f synthesised with various N-R substituents. 
 
 
Entry Compound R R’
 
 
1 13a F H  
2 13b OCH3 H  
3 13c CH3 H  
4 13d H H  
5 13e NO2 H  
6 13f H CH3  
      
 
13C NMR spectra showed several significant chemical shift variations between 13a-f, and 
their starting diamine analogues and 4.9. The chemical shift of C≡N in 4.9 was observed at 
115.1 ppm, however in 13a-f it is recorded between 123-126 ppm. This shift signifies a 
loss of electron density around this nucleus, most likely due to the newly introduced 
resonance within 13. Frequency changes between the C=N in 4.9 and 13a-f were not as 
pronounced tending to be 1-2 ppm downfield with respect to 4.9. Nevertheless recorded 
signals for the carbon atom at the bridge were noticeably different. In 4.9 the resonance for 
the bridge carbon was recorded at 24.5 ppm, whereas in 13a-f the same carbon nuclei had a 
resonance between 36-37 ppm, suggesting a large change in chemical environment around 
this point.  
The 1H NMR spectra of 13a-f are very similar to their related R-BIM analogues. The 
resonances assigned in 13a-f to the proton at the chiral centre and two hydrogen nuclei of 
the CH2 moiety were shifted upfield by as much as 1 ppm, when compared to the relevant 
diamine starting material. Changes in resonances for the aromatic proton nuclei were less 
significant and those assigned to the iso-propyl moiety less again. For the mono-
imidazoline 13a 19F NMR studies recorded a resonance of -114.81 ppm compared to the 
starting diamine 4a, which records a signal at -128.11 ppm for the same fluorine nuclei of 
the 4-C6H4F N-R substituent. These data support the formation of 13a, which was further 
supported by X-ray analysis of its solid state structure as depicted in Fig. 5 (vida infra).  
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Purification of 13a-f proved straightforward through recrystallisation from an equal 
mixture of warm dichloromethane/hexane allowed to cool to -16 °C. From this technique 
X-ray quality single crystals were obtained and the molecular structures of R-MIMs 13a-c 
and 13f are highlighted in Fig. 5. All crystallographic data for these R-MIMs are contained 
within Appendices D-G. 
 
5.2.2.1 R-MIM Molecular Structures 
Resulting from analysis of the molecular structures of compounds 13a-c and 13f (Fig. 5) it 
is apparent that each example supports the resonance form previously shown in       
Scheme 4. This agrees with the favoured conformation seen in BOXs and also provides 
strong supporting evidence that the same resonance conformation is likely prevalent in                    
R-BIM structures.  
Comparison of the molecular structures of 13a-c and 13f reveals them to be isostructural. 
However the asymmetric unit of both ArOMe-MIM 13b and ArMe-MIM 13c contain            
4 independent molecules whereas ArF-MIM 13a and Ar3,5Me-MIM 13f only contain 2. 
Selected bond lengths and angles of all compounds are tabulated in Tables 2 and 3 for 
comparison, with accompanying values from other independent molecules included in 
parentheses. 
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(13a) (13b) 
  
 
 
  
(13c) (13f) 
  
Fig. 5 Molecular structures of R-MIMS 13a-c and 13f. Elliposids are drawn at 25% 
probability. H atoms are omitted for clarity with the exception of C(2) and N(2). 
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Table 2 Selected bond lengths of R-MIMs 13a-c and 13f. All lengths are quoted in Å. 
Compound N-R C(1)-N(1)  N(2)-C(3)  C(3)-N(3)  N(3)-C(9)  
13a 4-C6H4F 1.155(6) 
[1.153(6)]* 
1.353(6) 
[1.357(6)] 
1.374(6) 
[1.366(6)] 
1.435(6) 
[1.415(6)] 
13b 4-C6H4OCH3 1.159(7) 
[1.143(7)] 
[1.146(7)] 
[1.162(7)] 
1.365(7) 
[1.351(7)] 
[1.361(7)] 
[1.340(7)] 
1.373(6) 
[1.370(6)] 
[1.371(6)] 
[1.373(7)] 
1.420(6) 
[1.440(7)] 
[1.433(7)] 
[1.416(7)] 
13c 4-C6H4CH3 1.140(8) 
[1.165(8)] 
[1.155(8)] 
[1.158(8)] 
1.368(7) 
[1.349(7)] 
[1.352(7)] 
[1.359(7)] 
1.363(8) 
[1.375(8)] 
[1.372(7)] 
[1.353(8)] 
1.425(8) 
[1.411(7)] 
[1.408(7)] 
[1.439(7)] 
13f 3,5-C6H3(CH3)2 1.158(6) 
[1.150(6)] 
1.359(5) 
[1.350(5)] 
1.360(6) 
[1.380(6)] 
1.411(6) 
[1.426(6)] 
 
* Figures in parentheses are from other independent molecules in the asymmetric unit. 
 
Of all C≡N lengths, ArOMe-MIM 13b was measured at 1.140(8) Å, marginally shorter    
than the average of 1.154 Å (range = 1.140(8)-1.165(8) Å), which is not significantly 
different to typical C≡N lengths of 1.141 Å (range = 1.110-1.668 Å). All compound bond 
angles between N(1)-C(1)-C(2) were between 177.3(5)-179.3(6) ° indicating a slight 
deviation from true linearity. 
Evaluation of the bond lengths and angles within the imidazoline ring were uniform 
(within error) between each compound. The bond angle N(2)-C(3)-N(3) was the most 
acute within the imidazoline ring, showing a minor distortion from typical tetrahedral 
angles of 109.4 °, instead being measured as 108.5 °. This is within the average range of 
between 107.6(5)-109.6(5) °. In literature related compounds the typical bond angle for 
N(2)-C(3)-N(3) is 107.80 ° (range = 96.23-115.12 °). The C-N bond lengths of each 
imidazoline from compounds 13a-c and 13f record and average length of 1.361 Å       
(range = 1.340(7)-1.380(6) Å), which shows no significant deviation from related bond 
lengths that average  1.377 Å (range = 1.225-1.567 Å).  
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Table 3 Selected bond angles of R-MIMs 13a-c and 13f. All angles are quoted in °. 
Compound N-R N(1)-C(1)-C(2) C(3)-N(2)-C(5) C(3)-N(3)-C(4)  
13a 4-C6H4F 177.3(5) 
[177.6(5)]* 
111.1(3) 
[112.3(4)] 
110.1(4) 
[111.3(4)] 
13b 4-C6H4OCH3 179.2(7) 
[178.8(6)] 
[179.3(6)] 
[178.8(6)] 
111.0(4) 
[112.3(5)] 
[111.0(5)] 
[110.8(5)] 
110.0(4) 
[109.6(5)] 
[109.4(5)] 
[110.9(5)] 
13c 4-C6H4CH3 177.8(6) 
[179.8(7)] 
[177.6(6)] 
[178.9(6)] 
109.9(5) 
[112.3(5)] 
[111.0(5)] 
[110.8(5)] 
110.5(5) 
[109.6(5)] 
[109.4(5)] 
[110.9(5)] 
13f 3,5-C6H3(CH3)2 177.6(5) 
[176.2(5)] 
112.5(4) 
[110.6(4)] 
110.8(4) 
[109.5(4)] 
 
    
* Figures in parentheses are from other independent molecules in the asymmetric unit. 
 
The bond lengths of both C(1)-C(2) and C(2)-C(3) were identical in all compounds within 
error. The average length for C(1)-C(2) being 1.401 Å (range 1.381(9)-1.416(6) Å) and 
1.373 Å (range = 1.341(8)-1.387(7) Å) for C(2)-C(3). Both bond lengths are shorter than 
typical C-C bond lengths contained in similar moieties which average at 1.50 Å          
(range = 1.400-1.606 Å). The shorter bond lengths of C(1)-C(2) and C(2)-C(3) are more 
comparable to C=C bonds in simple alkenes. These have an average length of 1.339 Å 
(range = 1.315-1.391 Å) reflecting sp2 hybridisation between the atoms. This evidence 
supports the delocalisation of electron density over this area of the molecule. The average 
bond angle between C(1)-C(2)-C(3) is 121.3 ° (range = 119.3(6)-124.2(4) °) with    
Ar3,5Me2-MIM 13f displaying the largest angle of 124.2 °. This angle is typically larger than 
comparable compounds in the CSD, which demonstrate an average angle of 113.9 ° over a 
range of 108.7-127.3 °. 
All other bond angles contained within the R-MIM structures 13a-c and 13f, notably the 
phenyl and isopropyl moieties have unexceptional bond lengths and angles.  
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5.3 Attempted IMOX Ligand Synthesis 
Successful isolation of pure monocyclised imidazoline intermediates (R-MIMs) 13a-f 
allowed progression to the final step of the proposed IMOX synthesis. The final step 
requires the activation of the remaining nitrile moiety and subsequent ring closure with a 
suitable amino-alcohol to form the oxazoline unit (step 3, Scheme 1). 
Preliminary investigations showed that to activate the nitrile group of the R-MIM to react 
with L-valinol would require the presence of a Lewis acid catalyst.  From the literature it is 
known that both Cd(OAc)2,9 ZnCl210 and Zn-clusters11 can be used in the successful 
formation of oxazolines between nitriles and amino-alcohols. The Lewis acidic metals 
activate the nitrile group towards nucleophilic attack from the amine of the amino-alcohol. 
These reactions were typically undertaken in refluxing chlorobenzene for ≥12 hours under 
inert conditions. 
Addition of 10 mol% Cd(OAc)2 to the reaction mixture of ArF-MIM 13a and L-valinol as 
described by the literature was explored (Scheme 5). Experimental progress was monitored 
after several days; upon there being no evidence of reaction progress (concluded via NMR 
techniques of reaction interval aliquots) the reaction was allowed to proceed for 7 days. 
Concluding such time analysis of the crude reaction mixture was undertaken. 1H NMR 
spectra of the crude mixture showed complex overlap of resonances, signifying the 
presence of many reaction products. This was confirmed by TLC, which indicated the 
existence of at least 5 species. Nominal resolution mass spectrometry gave indications of 
starting materials and unidentifiable fragments with no signals corresponding to the target 
IMOX, or fragments thereof.  
 
Scheme 5 Proposed Cd(OAc)2 catalysed oxazoline formation to generate an IMOX ligand. 
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Upon separation of the reaction mixture large quantities of starting materials 13a and       
L-valinol were isolated, along with small quantities (<100 mg) of an unidentified species. 
The unknown compound was obtained by Kate Smith and Mass spectrometry and IR 
analysis of the unidentified compound was undertaken. These techniques revealed that 
instead of isolating the desired IMOX, a compound with m/z = 221.14 and no absorbance 
in the C≡N region at 2176 cm-1 had been isolated. These results indicated that an analogue 
of 13a was probable due to a comparable m/z and lack of the distinctive absorbance of the 
C≡N. NMR studies were undertaken in an effort to reveal the identity of the unknown 
compound. All data obtained alluded to the likely formation of compound 16 (Fig. 6).  
 
Fig. 6 Cd(OAc)2 aided IMOX synthesis by-product 16. 
Whilst the NMR spectra of 16 and 13a share a high proportion of common resonances, 
additions of a singlet signal integrating to 3 hydrogen nuclei arises at 2.25 ppm in the 1H 
NMR spectra of 16. 2D NMR alludes to its correspondence to an additional signal in the 
13C NMR at 12.9 ppm, thereby confirming the presence of the methyl group in place of the 
nitrile group of 13a. 19F NMR also supports the proposal of an analogue of 13a, as the 
resonance of the fluorine nuclei in the 4-C6H4F N-R substituent experiences a shift from    
-114.81 ppm in 13a upfield to -109.9 ppm in 16. Whilst this could be considered a small 
shift, it still signifies a variance in structure between both compounds.  
If the IMOX had been successfully synthesised then sizable differences would be observed 
in various analytical data, for example mass spectra of the molecular ion. Any addition of 
the new oxazoline frequencies in the NMR spectra would be stark in the 1H NMR 
spectrum, where three additional resonances are typically recorded between 3.4-4.5 ppm 
(solvent dependent) and give a similar fine structure to the CH2 and CH of an imidazoline 
ring. All evidence at this time supports the formation of 16. 
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The employment of ZnCl2 and a tetranuclear zinc cluster published by Ohshima et al.   
(Fig. 7)11 was subsequently investigated. In both cases even forcing conditions for several 
weeks failed to yield the target IMOX. All spectroscopic data confirms that only starting 
materials were returned upon work-up/purification.  
 
Fig. 7 Tetranuclear zinc cluster as prepared by Ohshima et al. (R = CF3). 
In a move away from previous attempts to activate the nitrile group of 13a-f (in an effort to 
improve its reactivity with the L-valinol), interfunctional group conversion of the nitrile to 
an imidate in a similar manner to preparing compound 4.7 (Fig. 2) was attempted.          
The ArF-MIM 13a was subjected to the same reaction conditions as used in the synthesis 
of 4.7, where the hydrolysis product 14 (Fig. 8) was the only product obtained. Hydrolysis 
product 14 was obtained in near quantitative yields suggesting hydrolysis was total. The 
formation of 14 is likely due to water entering the system during the reaction, possibly 
during the generation of the HCl(g) though currently the source remains unconfirmed. 
 
Fig. 8 Hydrolysis product 14. 
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Careful analysis of the data was needed to confirm the structure of 14 when mass 
spectrometry recorded almost exclusively 264.1512 m/z. Strong evidence from the          
13C NMR and IR support the introduced carbonyl group with a resonance at 165.4 ppm and 
corresponding absorbance at 1668 cm-1.
 
The typical C≡N absorbance at 2176 cm-1 is absent 
and replaced by the presence of an amide group in the IR spectra. This explains why the 
resonance of the carbonyl is noticeably upfield compared to typical C=O frequencies 
(ca.180 ppm). The additional electron density around the C=O from the amide resonance 
forms and mono-imidazoline ligand provides supplementary shielding, inducing a lower 
recorded chemical shift.  
 
Scheme 6 Proposed base catalysed procedure for imidate intermediate formation. 
In conclusion it should be made clear that at the time of writing a total synthetic pathway 
towards the target IMOXs remained incomplete, as previously discussed synthetic 
pathways were unsuccessful in completing the final step of IMOX ligand formation 
(Scheme 1). For future endeavours exploitation of the base catalysed method12 to form the 
imidate may prove more fortuitous than the acid catalysed methods discussed in this 
Chapter (Scheme 6). If the base catalysed method were to be successful it is hoped that the 
imidate intermediate could then undergo cyclisation with an amino-alcohol to form the 
desired oxazoline unit creating the new IMOX ligand.   
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6.1 General Methods and Instrumentation 
All manipulations of air and moisture sensitive species were performed under an 
atmosphere of argon or dinitrogen using standard Schlenk or glove box techniques. 
Solvents were dried by passing through an alumina drying column incorporated into a 
MBraun SPS800 solvent purification system, except in the case of tetrahydrofuran (THF), 
which was dried over potassium and distilled under argon. All solvents were degassed and 
stored under argon in Teflon valve ampoules. Chloroform-d was passed through a column 
of basic alumina before being stored over 4 Å molecular sieves prior to use. 
Dichloromethane-d2 was dried over CaH2, and benzene-d6, toluene-d8 and THF-d8 were 
dried over potassium under an argon atmosphere before being vacuum transferred, freeze 
pump thaw degassed and stored in a glove box. All other reagents were purchased from 
commercial suppliers and used as received unless otherwise stated.  
Air sensitive samples for NMR spectroscopy were prepared in a glovebox under a 
dinitrogen atmosphere using 5 mm Nolan NMR tubes equipped with J. Young Teflon 
valves. All other samples were prepared in Wilmad 5 mm NMR tubes. NMR spectra were 
recorded on Bruker Avance DPX 250, 400, 500, or Jeol Eclipse 300 spectrometers. NMR 
spectra are quoted in ppm and were referenced internally relative to the residual protio-
solvent (1H) or solvent (13C) resonances, or externally to CFCl3 (19F); all coupling 
constants are quoted in Hertz. In all cases, NMR assignments were confirmed by the use of 
two-dimensional 1H-1H or 1H-13C correlation experiments (COSY, HSQC and HMBC). 
Mass spectra were recorded on a Waters LCT Premier XE or Waters GCT Premier mass 
spectrometer by the Mass Spectrometry Service at the School of Chemistry, Cardiff 
University or by the EPSRC National Mass Spectrometry Service Centre, Swansea. 
Infrared spectra were prepared as liquid films on NaCl plates, or as KBr pellets and were 
recorded on a Jasco 660-Plus FT/IR spectrometer. Infrared data are quoted in 
wavenumbers (cm-1). 
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6.2 Experimental and Characterisation Data for Chapter Two 
6.2.1 Preparation of N-phthaloyl valine [2.5] 
 
To a solution of L-valine (100 g 854 mmol) in toluene (1.5 l), phthalic anhydride (139.07 
g, 939 mmol) and triethylamine (119.2 ml 854 mmol) were added. The mixture was heated 
to reflux for 18 hours before being allowed to cool to room temperature. The product was 
washed using HCl (2 M, 2 × 500 ml) and further washed with a brine solution (2 × 250 
ml). The aqueous fractions were combined and further washed with toluene (250 ml) 
before being reduced in volume under reduced pressure to realise a white crystalline solid 
(75% yield). 
1H NMR data (CDCl3, 400.1 MHz, 293 K): δH = 7.87 (2 H, m, PhtH), 7.74 (2 H, m, PhtH), 
4.63 (1 H, d, 3JHH = 8.4 Hz, PhtCH), 2.75 (1 H, m, CH(CH3)2), 1.16 (3 H, d, 3JHH = 6.7 Hz, 
CH(CH3)2), 0.91 (3 H, d, 3JHH = 6.7 Hz, CH(CH3)2) ppm. All data corresponds to that 
reported by Haufe et al..1  
 
6.2.2 Preparation of N-phthaloylvalinoylchloride [1] 
 
To a solution of N-phthaloylvaline 2.5 (85 g, 344 mmol) in dry THF (500 ml), SOCl2 
(23.35 ml, 361.2 mmol) was added drop wise under a flow of argon. The solution was 
heated to reflux for 4 hours before allowing to cool to room temperature, and drying the 
solid in vacuo, yielding a pale yellow solid. The reaction gave near quantitative yields and 
the N-phthalylvalinoylchoride was used without further purification. 
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1H NMR data (CDCl3, 400.1 MHz, 293 K) δH = 7.90 (2 H, m, PhtH), 7.80 (2 H, m, PhtH), 
4.74 (1 H, d, 3JHH = 8.4 Hz, PhtCH), 2.74 (1 H, m, CH(CH3)2), 1.15 (3 H, d, 3JHH = 6.7 Hz, 
(CH3)2CH), 0.91 (3 H, d, 3JHH = 6.7 Hz, (CH3)2CH) ppm. 
 
6.2.3 Preparation of N-phthaloyl protected amino amides [2a-j] 
 
Protected valinoylchloride (1) (15 g, 56.4 mmol) was dissolved in dry THF (300 ml) and a 
solution of the desired amine (55.3 mmol) and triethylamine (8.67 ml, 62.1 mmol) added 
sequentially to the solution of protected valinoylchloride under a flow of argon.             
N,N-dimethylaminopyride (DMAP) can be added in catalytic amounts at this stage to give 
higher yields. The solution was allowed to stir at room temperature for 18 hours before 
being reduced in volume under reduced pressure. The product was dissolved in NaOH 
(10% solution, 75 ml) and extracted into dichloromethane (3 × 100 ml) before being dried 
over Na2SO4. After drying the solid in vacuo, the protected amide was obtained in a        
50-90% yield compound depending. 
 
6.2.3.1 [2a] 
 
1H NMR data (CDCl3, 400.1 MHz, 293 K): δH = 7.90 (2 H, m, PhtH), 7.78 (2 H, m, PhtH), 
7.53 (2 H, dd, 3JHH = 9.1 Hz, ArH), 7.00 (2 H, app. t, 3JHH = 8.6 Hz, ArH), 4.52 (1 H, d, 
3JHH = 11.6 Hz, PhtCH), 2.90 (1 H, m, CH(CH3)2), 1.16 (3 H, d, 3JHH = 6.6 Hz, CH(CH3)2), 
0.89 (3 H, d, 3JHH = 6.6 Hz, CH(CH3)2) ppm. 
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6.2.3.2 [2b]  
 
1H NMR data (CDCl3, 250.1 MHz, 293 K): δH = 7.87 (2 H, m, PhtH), 7.76 (2 H, m, PhtH), 
7.46 (2 H, d, 3JHH = 9.0 Hz, ArH), 6.83 (2 H, d, 3JHH = 9.0 Hz, ArH), 4.50 (1 H, d,          
3JHH = 11.6 Hz, PhtCH), 3.76 (3 H, s, 4-C6H5OCH3), 2.91 (1 H, m, CH(CH3)2), 1.16 (3 H, 
d, 3JHH = 6.5 Hz, CH(CH3)2), 0.89 (3 H, d, 3JHH = 6.5 Hz, CH(CH3)2) ppm. 
 
6.2.3.3 [2c] 
 
1H NMR data (CDCl3, 400.1 MHz, 293 K): δH = 7.89 (2 H, m, PhtH), 7.77 (2 H, m, PhtH), 
7.44 (2 H, d, 3JHH = 8.3 Hz, ArH), 7.10 (2 H, d, 3JHH = 8.3 Hz, ArH), 4.51 (1 H, d,         
3JHH = 11.6 Hz, PhtCH), 2.91 (1 H, m, CH(CH3)2), 2.29 (3 H, s, 4-C6H4CH3), 1.16 (3 H, d, 
3JHH = 6.5 Hz, CH(CH3)2), 0.89 (3 H, d, 3JHH = 6.5 Hz, CH(CH3)2) ppm. 
 
6.2.3.4 [2d] 
 
1H NMR data (CDCl3, 400.1 MHz, 293 K): δH = 7.89 (2 H, m, PhtH), 7.73 (2 H, m, PhtH), 
7.56 (2 H, d, 3JHH = 8.5 Hz, ArH), 7.30 (2 H, app. t, 3JHH = 7.5 Hz, ArH), 7.09 (1 H, app. t, 
3JHH = 7.5 Hz, ArH), 4.52 (1 H, d, 3JHH = 11.6 Hz, PhtCH), 2.93 (1 H, m, CH(CH3)2), 1.17 
(3 H, d, 3JHH = 6.5 Hz, CH(CH3)2), 0.90 (3 H, d, 3JHH = 6.5 Hz, CH(CH3)2) ppm. 
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6.2.3.5 [2e] 
 
1H NMR data (CDCl3, 400.1 MHz, 293 K): δH = 8.20 (2 H, m, PhtH), 7.92 (2 H, m, PhtH), 
7.75 (2 H, d, 3JHH = 9.1 Hz, ArH), 4.57 (1 H, d, 3JHH = 11.6 Hz, PhtCH), 2.89 (1 H, m, 
CH(CH3)2), 1.16 (3 H, d, 3JHH = 6.5 Hz, CH(CH3)2), 0.91 (3 H, d, 3JHH = 6.5 Hz, 
CH(CH3)2) ppm. 
 
6.2.3.6 [2f] 
 
1H NMR data (CDCl3, 250.1 MHz, 293 K): δH = 7.86 (2 H, m, PhtH), 7.76 (2 H, m, PhtH), 
7.20 (2 H, s, o-C6H3(CH3)2), 6.73 (1 H, p-C6H3(CH3)2), 4.51 (1 H, d, 3JHH = 11.5 Hz, 
PhtCH), 2.93 (1 H, m, CH(CH3)2), 2.28 (6 H, s, 3,5-C6H3(CH3)2), 1.16 (3 H, d,               
3JHH = 6.5 Hz, CH(CH3)2), 0.89 (3 H, d, 3JHH = 6.5 Hz, CH(CH3)2) ppm. 
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6.2.3.7 [2g] 
 
1H NMR data (CDCl3, 250.1 MHz, 293 K): δH = 7.88-7.82 (2 H, m, PhtH), 7.72-7.70       
(2 H, m, PhtH),  7.40-7.32 (2 H, m, ArH), 7.30-7.24 (3 H, m, ArH), 5.10 (1 H, app. quin., 
3JHH = 7.2 Hz, HNCH(CH3)(C6H5), 4.41 (1 H, d, 3JHH = 11.3 Hz, PhtCH), 2.87 (1 H, m, 
CH(CH3)2), 1.50 (3 H, d, 3JHH = 6.9 Hz, HNCH(CH3)(C6H5), 1.17 (3 H, d, 3JHH = 6.6 Hz, 
CH(CH3)2), 0.86 (3 H, d, 3JHH = 6.6 Hz, CH(CH3)2) ppm. 
 
6.2.3.8 [2h]  
 
1H NMR data (CDCl3, 400.1 MHz, 293 K): δH = 7.80 (2 H, m, PhtH), 7.69 (2 H, m, PhtH),  
4.29 (1 H, d, 3JHH = 11.4 Hz, PhtCH), 3.97 (1 H, app. sept., 3JHH = 6.7 Hz, CH(CH3)2), 2.73 
(1 H, m, CH(CH3)2), 1.17 (3 H, d, 3JHH = 6.6 Hz, CH(CH3)2), 1.09 (3 H, d, 3JHH = 6.7 Hz, 
CH(CH3)2), 1.02 (3 H, d, 3JHH = 6.7 Hz, CH(CH3)2), 0.77 (3 H, d, 3JHH = 6.6 Hz, 
CH(CH3)2) ppm. 
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6.2.3.9 [2i] 
 
1H NMR data (CDCl3, 400.1 MHz, 293 K): δH = 7.81 (2 H, m, PhtH), 7.69 (2 H, m, PhtH),  
4.19 (1 H, d, 3JHH = 11.4 Hz, PhtCH), 2.70 (1 H, m, CH(CH3)2), 1.27 (9 H, s, C(CH3)3), 
1.03 (3 H, d, 3JHH = 6.6 Hz, CH(CH3)2), 0.76 (3 H, d, 3JHH = 6.6 Hz, CH(CH3)2) ppm. 
 
6.2.3.10 [2j]  
 
1H NMR data (CDCl3, 400.1 MHz, 293 K): δH = 7.87 (2 H, m, PhtH), 7.75 (2 H, m, PhtH),  
7.41 (2 H, d, 3JHH = 9.0 Hz, ArH), 6.67 (2 H, d, 3JHH = 9.0 Hz, ArH), 4.49  (1 H, d,                 
3JHH = 11.5 Hz, PhtCH), 2.93 (1 H, m, CH(CH3)2), 2.89 (6 H, s, p-C6H4N(CH3)2), 1.16        
(3 H, d, 3JHH = 6.6 Hz, CH(CH3)2), 0.89 (3 H, d, 3JHH = 6.6 Hz, CH(CH3)2) ppm. 
 
6.2.4 Preparation of deprotected N-phthaloyl protected amino amides [3a-j] 
 
The protected N-phthaloyl amino amide 2a-j (36.6 mmol) was dissolved in ethanol       
(250 ml) and to it, hydrazine monohydrate (9.60 ml, 51.2mmol) was added. The reaction 
was allowed to stir at room temperature for 18 hours before concentrated HCl (37%,        
50 ml) was added and the solution allowed to stir vigorously for 1 hour. After such time 
the solution was reduced in volume under reduced pressure and dissolved in distilled water 
(50 ml).The solution was then made to a neutral pH using NaOH (10%) and washed with 
dichloromethane (3 × 50 ml). Deprotected amides soluble in dichloromethane were dried 
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over Na2SO4 and the solid dried in vacuo. Water soluble deprotected amides were reduced 
in volume and re-dissolved in THF, filtered to remove insoluble impurities and again dried 
under reduced pressure. The products were typically obtained as white or light orange 
solids in 60-94% yield.  
 
6.2.4.1 [3a]  
 
1H NMR data (D2O, 400.1 MHz, 293 K): δH = 6.97 (2 H, m, ArH), 6.87 (2 H, m, ArH), 
3.81 (1 H, d, 3JHH = 2.2 Hz, H2NCH), 2.09 (1 H, m, CH(CH3)2), 1.09 (3 H, d, 3JHH = 6.9 
Hz, CH(CH3)2) ppm. 
 
6.2.4.2 [3b]  
 
1H NMR data (CDCl3, 400.1 MHz, 293 K): δH = 7.50 (2 H, d, 3JHH = 8.8 Hz, ArH), 6.86   
(2 H, d, 3JHH = 8.8 Hz, ArH), 3.78 (3 H, s, 4-C6H5OCH3), 3.38 (1 H, d, 3JHH = 3.4 Hz, 
H2NCH), 2.44 (1 H, m, CH(CH3)2), 1.04 (3 H, d, 3JHH = 6.9 Hz, CH(CH3)2), 0.87 (3 H, d, 
3JHH = 6.9 Hz, CH(CH3)2) ppm. 
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6.2.4.3 [3c] 
 
1HNMR data (D2O, 400.1 MHz, 293 K): δH = 7.37 (2 H, d, 3JHH = 8.0 Hz, ArH), 7.29 (2 H, 
d, 3JHH = 8.0 Hz, ArH), 3.97 (1 H, d, 3JHH = 6.2 Hz, H2NCH), 2.35 (1 H, m, CH(CH3)2), 
2.34 (3 H, s, 4-C6H4CH3), 1.12 (6 H, d, 3JHH = 6.9 Hz, CH(CH3)2) ppm. 
 
6.2.4.4 [3d] 
 
1H NMR data (CDCl3, 400.1 MHz, 293 K): δH = 7.59 (2 H, app. d, 3JHH = 8.6 Hz, ArH), 
7.30 (2 H, app. t, 3JHH = 7.5 Hz, ArH), 7.08 (1 H, app. t, 3JHH = 7.5 Hz, ArH), 5.27 (1 H, 
app. s, H2NCH), 2.40 (1 H, m, CH(CH3)2), 1.02 (3 H, d, 3JHH = 6.9 Hz, CH(CH3)2), 0.86   
(3 H, d, 3JHH = 6.9 Hz, CH(CH3)2) ppm. 
 
6.2.4.5 [3e]  
 
1H NMR data (D2O, 400.1 MHz, 293 K): δH = 8.21 (2 H, d, 3JHH = 9.1 Hz, ArH), 7.70 (2 H, 
d, 3JHH = 9.1 Hz, ArH), 4.05 (1 H, d, 3JHH = 5.7 Hz, H2NCH), 2.34 (1 H, m, CH(CH3)2), 
1.12 (3 H, d, 3JHH = 6.9 Hz, CH(CH3)2), 1.09 (3 H, d, 3JHH = 6.9 Hz, CH(CH3)2) ppm. 
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6.2.4.6 [3f] 
 
1H NMR data (D2O, 400.1 MHz, 293 K): δH = 7.05 (2 H, s, o-C6H3(CH3)2), 6.93 (1 H,      
p-C6H3(CH3)2), 3.87 (1 H, d, 3JHH = 6.2 Hz, H2NCH), 2.28 (1 H, m, CH(CH3)2), 2.25 (6 H, 
s, C6H3(CH3)2), 1.05 (6 H, d, 3JHH = 6.9 Hz, CH(CH3)2) ppm. 
 
6.2.4.7 [3g]  
 
1H NMR data (CDCl3, 400.1 MHz, 293 K): δH = 7.37-7.34 (4 H, m, ArH), 7.30-7.26 (1 H, 
m, ArH), 5.16 (1 H, m,
 
HNCH(CH3)(C6H5), 3.22 (1 H, d, 3JHH = 3.8 Hz, H2NCH), 2.32 (1 H, 
m, CH(CH3)2), 1.51 (3 H, d, 3JHH = 6.9 Hz, HNCH(CH3)(C6H5), 1.00 (3 H, d, 3JHH = 6.9 Hz, 
CH(CH3)2), 0.88 (3 H, d, 3JHH = 6.9 Hz, CH(CH3)2) ppm. 
 
6.2.4.8 [3h]  
 
1H NMR data (CDCl3, 400.1 MHz, 293 K): δH = 4.00 (1 H, app. sept., 3JHH = 6.6 Hz, 
CH(CH3)2), 3.12 (1 H, d, 3JHH = 4.8 Hz, H2NCH), 2.21 (1 H, m, CH(CH3)2), 1.09 (6 H,      
2  dd, 3JHH = 7.0 Hz, CH(CH3)2, 0.91 (3 H, d, 3JHH = 6.9 Hz, CH(CH3)2), 0.75 (3 H, d,   
3JHH = 6.9 Hz, CH(CH3)2) ppm. 
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6.2.4.9 [3i] 
 
1H NMR data (CDCl3, 400.1 MHz, 293 K): δH = 3.03 (1 H, d, 3JHH = 3.9 Hz, CH(CH3)2), 
2.20 (1 H, m, CH(CH3)2), 1.28 (9 H, s, C(CH3)3), 0.90 (3 H, d, 3JHH = 6.9 Hz, CH(CH3)2), 
0.75 (3 H, d, 3JHH = 6.9 Hz, CH(CH3)2) ppm.  
 
6.2.4.10 [3j] 
 
1H NMR data (CDCl3, 400.1 MHz, 293 K): δH = 7.44 (2 H, d, 3JHH = 8.9 Hz, ArH), 6.67    
(2 H, d, 3JHH = 8.9 Hz, ArH), 3.48 (1 H, d, 3JHH = 3.6 Hz, H2NCH), 2.87 (6 H, s,                 
p-C6H4N(CH3)2), 2.36 (1 H, m, CH(CH3)2), 1.00 (3 H, d, 3JHH = 6.9 Hz, CH(CH3)2), 0.87 
(3 H, d, 3JHH = 6.9 Hz, CH(CH3)2) ppm. 
 
6.2.5 Preparation of Diamines NNR [4a-j]  
 
To a suspension of NaBH4 (5.58 g, 147.5 mmol) in THF (250 ml), SiMe3Cl (23.57 ml, 
184.3 mmol) was added and heated to reflux under an inert atmosphere for 2 hours. The 
reaction was allowed to cool to room temperature and then further cooled to -78 °C before 
addition of the amino amide 3a-j (36.7 mmol, ca. 7 g), which was pre-dissolved in dry 
THF. The mixture was then heated to reflux under inert conditions for 4 days. After such 
time the solution was allowed to cool to room temperature and further cooled to 0 °C. 
Methanol (10 ml) and water (10 ml) were sequentially added to destroy any excess borane. 
After the effervescence subsided, the solution was reduced in volume under reduced 
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pressure, dissolved in NaOH (10%, 50 ml) and the product extracted with dichloromethane 
(3 × 50 ml). The organic layers were combined and dried over Na2SO4 before removing the 
solvent under reduced pressure. The crude diamine was purified using column 
chromatography over silica gel, typically using ethyl acetate and methanol (5-10% v/v). 
Once purified the diamines were obtained as orange to dark orange/red oils with typical 
yields of >70%.2 NMR analysis after adding O-acetylmandelic acid 2.21 indicated the 
presence of only a single enantiomer. 
 
6.2.5.1 [4a] 
 
1H NMR data (CDCl3, 500.1 MHz, 293 K): δH = 6.82 (2 H, app. t, 3JHH = 8.8 Hz,               
m-C6H4F), 6.57 (2 H, dd, 3JHH = 8.8 Hz, 3JHF = 4.3 Hz, o-C6H4F), 3.38 (1 H, dd, 3JHH = 3.4 
Hz, 2JHH = 14.0 Hz, NCH2), 3.27 (1 H, dd, 3JHH = 3.4 Hz, 2JHH = 14.0 Hz, NCH2), 3.03      
(1 H, m, H2NCH), 2.04 (1 H, m, (CH3)2CH), 1.05 (6 H, app. t, 3JHH = 6.5 Hz, CH(CH3)2), 
ppm. 19F NMR data (CDCl3, 282.8 MHz, 293 K): δF = -128.11 (s, p-C6H4F) ppm. 13C{1H} 
NMR data (CDCl3, 125.7 MHz, 293 K): δC = 156.1 (d, 1JCF = 235.9 Hz, p-C6H4F), 143.5   
(d, 4JCF = 1.7 Hz, ipso-C6H4F), 115.8 (d, 2JCF = 22.3 Hz, m-C6H4F), 113.9 (d, 3JCF = 7.3 Hz, 
o-C6H4F), 57.6 (H2NCH), 44.2 (CH2), 29.2 ((CH3)2CH), 18.8 (CH3 isopropyl), 18.8 (CH3 
isopropyl) ppm. IR data (NaCl disc, cm-1): 3345 (s), 3252 (m), 2965 (br. s), 2556 (w), 2458 
(w), 1652 (w), 1609 (w), 1575 (m), 1529 (s), 1507 (s), 1470 (s), 1381 (w), 1321 (m), 1261 
(s), 1216 (s), 1156 (w), 1135 (w), 1104 (s), 1086 (w), 1014 (w), 916 (w), 872 (w), 821 (s), 
799 (m), 754 (w), 706 (w), 692 (w). Accurate mass ES-MS for [HNNArF+H]+: m/z = 
196.1372 (calc. for C11H17N2F: 196.1376). 
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6.2.5.2 [4b] 
 
1H NMR data (CDCl3, 500.1 MHz, 293 K): δH = 6.77 (2 H, d, 3JHH = 8.9 Hz,                      
o-C6H4OCH3), 6.60 (2 H, d, 3JHH = 8.9 Hz, m-C6H4OCH3), 3.70 (3 H, s, C6H4OCH3), 3.18 
(1 H, dd, 3JHH = 3.4 Hz, 2JHH = 11.6 Hz, NCH2), 2.78 (1 H, dd, 3JHH = 3.4 Hz, 2JHH = 11.6 
Hz, NCH2), 2.71 (1 H, m, H2NCH), 1.66 (1 H, m, (CH3)2CH), 0.95 (6 H, dd, 3JHH = 9.8 Hz, 
3JHH = 6.8 Hz, CH(CH3)2), ppm. 13C{1H} NMR data (CDCl3, 125.7 MHz, 293 K):            
δC = 152.0 (p-C6H4OCH3), 143.0 (ipso-C6H4OCH3), 114.8 (o-C6H4OCH3), 114.2 (m-
C6H4OCH3), 55.7 (OCH3), 56.1 (H2NCH), 49.2 (CH2), 32.4 ((CH3)2CH), 19.3 (CH3 
isopropyl), 17.7 (CH3 isopropyl) ppm. IR data (NaCl disc, cm-1): 3364 (br. m), 3028 (w), 2956 
(s), 2904 (s), 2871 (s), 2830 (s), 2066 (w), 1844 (w), 1618 (m), 1588 (m), 1518 (br. s), 
1465 (s), 1442 (m), 1408 (w), 1386 (w), 1367 (w), 1295 (br. w), 1234 (br. s), 1179 (m), 
1109 (w), 1076 (w), 1038 (s), 1003 (w), 910 (w), 820 (s), 747 (w), 722 (w), 424 (s), 404 
(s). Accurate mass ES-MS for [HNNArOMe+H]+: m/z = 209.1652 (calc. for                    
C12H21N2O: 209.1654). 
 
6.2.5.3 [4c]  
 
1H NMR data (CDCl3, 500.1 MHz, 293 K): δH = 7.00 (2 H, d, 3JHH= 8.2 Hz, o-C6H4CH3), 
6.58 (2 H, d, 3JHH = 8.2 Hz, m-C6H4CH3), 3.23 (1 H, dd, 3JHH = 3.4 Hz, 2JHH = 12.0 Hz, 
NCH2), 2.84 (1 H, dd, 3JHH = 3.4 Hz, 2JHH = 12.0 Hz, NCH2), 2.75 (1 H, m, H2NCH), 2.25 
(3 H, s, C6H4CH3), 1.69 (1 H, m, (CH3)2CH), 0.97 (6 H, dd, 3JHH = 9.4 Hz, 3JHH = 6.8 Hz, 
CH(CH3)2), ppm. 13C{1H} NMR data (CDCl3, 125.7 MHz, 293 K): δC = 146.3             
(ipso-C6H4CH3), 129.6 (o-C6H4CH3), 126.4 (p-C6H4CH3), 113.1 (m-C6H4CH3), 56.1 
(H2NCH), 48.2 (CH2), 32.3 ((CH3)2CH), 20.3 (C6H4CH3), 19.2 (CH3 isopropyl), 17.8         
(CH3 isopropyl) ppm. IR data (NaCl disc, cm-1): 3365 (br. m), 3029 (w), 2956 (s), 2905 (s), 
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2871 (s), 2831 (s), 2065 (w), 1844 (w), 1733 (w), 1618 (m), 1588 (m), 1511 (s), 1464 (s), 
1408 (m), 1386 (m), 1376 (m), 1296 (m), 1234 (s), 1179 (m), 1109 (w), 1076 (w), 1038 (s), 
911 (w), 820 (s), 731 (w), 436 (br. s). Accurate mass ES-MS for [HNNArMe+H]+:             
m/z = 193.1697 (calc. for C12H21N2: 193.1705). 
 
6.2.5.4 [4d] 
 
1H NMR data (CDCl3, 500.1 MHz, 293 K): δH = 7.18 (2 H, app. t, 3JHH= 7.4 Hz, m-C6H5), 
6.70 (1 H, app. t, 3JHH = 7.4 Hz, p-C6H5), 6.65 (2 H, d, 3JHH = 7.7 Hz, o-C6H5), 3.25 (1 H, 
dd, 3JHH = 3.2 Hz, 2JHH = 11.9 Hz, NCH2), 2.85 (1 H, app. t, 2JHH = 11.9 Hz, NCH2), 2.76 
(1 H, m, H2NCH), 1.69 (1 H, m, (CH3)2CH), 0.98 (3 H, d, 3JHH = 9.6 Hz, CH(CH3)2), 0.96 
(6 H, d, 3JHH = 9.6 Hz, CH(CH3)2) ppm. 13C{1H} NMR data (CDCl3, 125.7 MHz, 293 K): 
δC = 148.6 (ipso-C6H5), 129.1 (m-C6H5), 117.2 (p-C6H5), 112.9 (o-C6H5), 56.0 (H2NCH), 
47.9 (CH2), 32.4 ((CH3)2CH), 19.2 (CH3 isopropyl), 17.8 (CH3 isopropyl) ppm. IR data         
(NaCl disc, cm-1): 3370 (br. m), 3050 (m), 3021 (m), 2958 (s), 2871 (s), 2602 (w), 1918 
(w), 1734 (m), 1675 (m), 1603 (s), 1506 (s), 1466 (m), 1442 (w), 1431 (w), 1387 (w), 1368 
(w), 1321 (m), 1251 (m), 1179 (m), 1153 (w), 1068 (w), 1046 (w), 1028 (w), 991 (w), 868 
(m), 749 (s), 692 (s), 408 (br. s). Accurate mass ES-MS for [HNNAr+H]+: m/z = 178.1465 
(calc. for C11H18N2: 178.1470). All data corresponds to that reported in-part by Mauduit    
et al. and Russell et al..3, 4 
 
6.2.5.5 [4e]  
 
1H NMR data (CDCl3, 500.1 MHz, 293 K): δH = 8.04 (2 H, d, 3JHH = 9.2 Hz, m-C6H4NO2), 
6.50 (2 H, d, 3JHH = 9.2 Hz, o-C6H4NO2), 3.28 (1 H, app. ddd, 2JHH = 12.1 Hz, 3JHH =       
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9.5 Hz, 3JHH = 3.8 Hz, H2NCH), 2.88 (1 H, app. ddd, 2JHH = 12.1 Hz, 3JHH = 6.4 Hz, 3JHH = 
3.8 Hz, H2NCH), 2.72 (1 H, m, H2NCH), 1.66 (1 H, m, CH(CH3)2), 0.96 (6 H, dd, 3JHH = 
6.8 Hz, 3JHH = 6.8 Hz, CH(CH3)2) ppm. 13C{1H} NMR data (CDCl3, 125.7 MHz, 293 K): 
δC = 153.6 (p-C6H4NO2), 137.6 (ipso-C6H4NO2), 126.0 (m-C6H4NO2), 111.0 (o-C6H4NO2), 
55.9 (H2NCH), 46.6 (CH2), 32.7 ((CH3)2CH), 19.1 (CH3 isopropyl), 17.7 (CH3 isopropyl) ppm. 
IR data (NaCl disc, cm-1): 3368 (s), 3300 (s), 3230 (s), 3179 (s), 3125 (m), 3041 (m), 2955 
(s), 2925 (m), 2905 (m), 2868 (m), 2403 (br. w), 2221 (w), 1920 (w), 1769 (m), 1601 (s), 
1562 (m), 1504 (m), 1468 (s), 1376 (m), 1367 (m), 1306 (br. s), 1182 (s), 1159 (m), 1131 
(w), 1113 (s), 1035 (w), 1012 (m), 997 (m), 964 (w), 928 (w), 887 (m), 827 (s), 796 (w), 
784 (w), 754 (s), 695 (m), 655 (m), 629 (w), 599 (w), 577 (w), 534 (m), 489 (s), 423 (m). 
Accurate mass ES-MS for [HNNArNO2+H]+: m/z = 224.1389 (calc. for C11H18N3O2: 
224.1399). 
 
6.2.5.6 [4f] 
 
1H NMR data (CDCl3, 400.1 MHz, 293 K): δH = 6.40 (1 H, p-C6H3(CH3)2), 6.31 (2 H, s,   
o-C6H3(CH3)2), 3.25 (1 H, dd, 2JHH = 12.0, 3JHH = 3.6 Hz, NCH2) 2.85 (1 H, dd, 2JHH = 12.0, 
3JHH = 9.2 Hz, NCH2), 2.76 (1 H, m, H2NCH), 2.28 (6 H, s, C6H3(CH3)2), 1.70 (1 H, m, 
CH(CH3)2), 1.01 (3 H, d, 3JHH = 6.8 Hz, CH(CH3)2), 0.99 (3 H, d, 3JHH = 6.8 Hz, 
CH(CH3)2) ppm. 13C{1H} NMR data (CDCl3, 125.7 MHz, 293 K): δC = 148.7               
(ipso-C6H3(CH3)2), 138.6 (m-C6H3(CH3)2), 119.1 (p-C6H3(CH3)2), 110.8 (o-C6H3(CH3)2), 
56.0 (H2NCH), 48.0 (CH2), 32.3 ((CH3)2CH), 21.3 (C6H3(CH3)2), 19.2 (CH3 isopropyl), 17.6 
(CH3 isopropyl) ppm. IR data (NaCl disc, cm-1): 3375 (br. m), 3020 (m), 2958 (br. s), 2729 
(w), 1736 (m), 1602 (s), 1507 (s), 1468 (s), 1367 (m), 1338 (m) 1303 (w), 1243 (w), 1190 
(s), 1097 (w), 1034 (w), 990 (w), 952 (w), 852 (m), 820 (s), 691 (s), 436 (br. s). Accurate 
mass ES-MS for [HNNAr3,5Me+H]+: m/z = 207.1862 (calc. for C13H23N2: 207.1861). 
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6.2.5.7 [4g] 
 
1H NMR data (CDCl3, 500.1 MHz, 293 K): δH = 7.28-7.22 (4 H, m, ArH), 7.15 (1 H, m, 
ArH), 3.67 (1 H, q, 3JHH = 6.5 Hz, HNCH(CH3)(C6H5), 2.47 (1 H, t, 3JHH = 3.7 Hz, NCH2), 
2.45-2.42 (1 H, m, H2NCH), 2.25 (1 H, dd, 3JHH = 12.6 Hz, 4JHH = 2.5 Hz, NCH2), 1.49 (1 H, 
m, CH(CH3)2), (3 H, d, 3JHH = 6.6 Hz, HNCH(CH3)(C6H5), 0.80 (3 H, d, 3JHH = 6.8 Hz, 
CH(CH3)2), 0.76 (3 H, d, 3JHH = 6.8 Hz, CH(CH3)2) ppm. 13C{1H} NMR data (CDCl3, 
125.7 MHz, 293 K): δC = 127.9 (m-C6H5), 126.3 (o-C6H5), 126.2 (p-C6H5), 58.5 
(HNCH(CH3)(C6H5)), 56.6 (H2NCH), 52.0 (NCH2), 31.8 (CH(CH3)2), 24.1 
(HNCH(CH3)(C6H5)), 19.1 (CH3 isopropyl), 17.1 (CH3 isopropyl) ppm. IR data (KBr disc, cm-1): 
3393 (m), 3313 (m), 3077 (w), 3058 (w), 3027 (m), 2961 (br. m), 2689 (br. m), 2588 (br. 
m), 2203 (br. m) 1958 (w), 1885 (w), 1821 (w), 1726 (w), 1633 (m), 1603 (m), 1556 (s), 
1469 (m), 1449 (m), 1365 (br. m), 1301 (m), 1265 (w), 1231 (w), 1211 (w), 1157 (m), 
1131 (m), 1063 (w), 1040 (w), 1029 (w), 943 (w), 916 (w), 815 (m), 765 (s), 738 (m), 701 
(s), 577 (m) 543 (m), 520 (w), 466 (w), 423 (w). Accurate mass ES-MS for 
[HNNArMeH+H]+: m/z = 207.1859 (calc. for C12H23N2: 207.1861). 
 
6.2.5.8 [4h]  
 
1H NMR data (CDCl3, 500.1 MHz, 293 K): δH = 2.67 (1 H, m, HN(CH(CH3)2), 2.60 (1 H, 
dd, 3JHH = 3.2 Hz, 2JHH = 11.3 Hz, NCH2), 2.46 (1 H, m, H2NCH), 2.21 (1 H, app. t,       
2JHH = 11.3 Hz, NCH2), 1.49 (1 H, m, CH(CH3)2), 0.97 (6 H, d, 3JHH = 6.2 Hz, CH(CH3)2), 
0.81 (6 H, d, 3JHH = 9.0 Hz, CH(CH3)2) ppm. 13C{1H} NMR data (CDCl3, 125.7 MHz, 293 
K): δC = 56.1 (H2NCH), 50.5 (CH2), 49.0 (NHCH(CH3)2), 32.3 (CH(CH3)2), 22.3 
(NHCH(CH3)2), 22.1 (NHCH(CH3)2), 19.1 (CH3 isopropyl), 17.7 (CH3 isopropyl) ppm. IR data 
(NaCl disc, cm-1): 3668 (w), 3350 (m), 2962 (s), 2873 (m), 2251 (br. w), 1587 (m), 1497 
(w), 1468 (m), 1414 (w), 1383 (m), 1368 (m), 1338 (w), 1321 (w), 1261 (m), 1168 (w), 
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1071 (br. m), 1013 (m), 909 (s), 868 (w), 811 (br. m), 731 (s), 646 (m). Accurate mass    
ES-MS for [HNNiPr+H]+: m/z = 145.1700 (calc. for C8H21N2: 145.1705). 
 
6.2.5.9 [4i] 
 
1H NMR data (CDCl3, 500.1 MHz, 293 K) δH = 2.62 (1 H, dd, 3JHH = 3.4 Hz, 2JHH =      
10.9 Hz, NCH2), 2.47 (1 H, m, H2NCH), 2.26 (1 H, dd, 3JHH = 3.4 Hz, 2JHH = 10.9 Hz, 
NCH2), 1.57 (1 H, m, (CH3)2CH)) 1.07 (9 H, s, C(CH3)3), 0.89 (6 H, app. t, 3JHH = 6.9 Hz, 
CH(CH3)2) ppm. 13C{1H} NMR data (CDCl3, 125.7 MHz, 293 K) δC = 57.1 (H2NCH), 50.2 
(C(CH3)3), 46.3 (CH2), 32.4 ((CH3)2CH), 28.9 ((CH3)3CH), 19.3 (CH3 isopropyl), 17.7     
(CH3 isopropyl) ppm. IR data (NaCl disc, cm-1): 3366 (br. m), 3297 (br. m), 2961 (s), 2929 
(s), 2871 (s), 2283 (w), 1658 (m), 1579 (m), 1519 (w), 1467 (m), 1388 (m), 1363 (m), 1317 
(w), 1230 (m), 1169 (w), 1091 (w), 1024 (w), 878 (w), 805 (w), 716 (w). Accurate mass 
ES-MS for [HNNtBu+H]+: m/z = 158.1782 (calc. for C9H22N2: 158.1783). 
 
6.2.5.10 [4j]  
 
1H NMR data (CDCl3, 500.1 MHz, 293 K): δH = 6.74 (2 H, d, 3JHH = 8.8 Hz,                     
o-C6H4N(CH3)2), 6.62 (2 H, d, 3JHH = 8.8 Hz, m-C6H4N(CH3)2), 3.19 (1 H, dd, 3JHH = 3.2 
Hz, 2JHH = 11.8 Hz, NCH2), 2.81 (6 H, br. s, N(CH3)2, 2.78 (1 H, dd, 3JHH = 2.4 Hz, 2JHH = 
12.7 Hz, NCH2), 2.72 (1 H, m, H2NCH), 1.66 (1 H, m, (CH3)2CH)), 0.95 (6 H, dd, 3JHH = 
9.9 Hz, 3JHH = 6.8 Hz, CH(CH3)2) ppm. 13C{1H} NMR data (CDCl3, 125.7 MHz, 293 K) 
δC = 144.0 (p-C6H4N(CH3)2), 141.1 (ipso-C6H4N(CH3)2), 115.9 (o-C6H4N(CH3)2), 114.5 
(m-C6H4N(CH3)2), 56.1(H2NCH), 49.2 (CH2), 42.2 (C6H4N(CH3)2), 32.3 ((CH3)2CH), 19.2 
(CH3 isopropyl), 17.7 (CH3 isopropyl) ppm. IR data (NaCl disc, cm-1): 3355 (br. s), 3029 (m), 
2956 (br. s), 2871 (s), 2834 (s), 2790 (s), 2241 (w), 2044(w), 1839 (br. w), 1618 (m), 1588 
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(m), 1519 (s), 1472 (s), 1417 (w), 1404 (w), 1386 (m), 1367 (m), 1320 (s), 1255 (s), 1211 
(m), 1160 (w), 1140 (m), 1084 (w), 1036 (m), 944 (s), 873 (w), 815 (s), 733 (w), 438      
(br. s). Accurate mass ES-MS for [HNNArNMe2+H]+: m/z = 222.1967 (calc. for C13H24N3: 
222.1970). 
 
6.3 Experimental and Characterisation Data for Chapter Three 
6.3.1  Preparation of [Ca{N(SiMe3)2}2(THF)2] 
 
CaI2 (1.47g, 5 mmol) was added to K(N(SiMe3)2) (1.99g, 10 mmol) before being dissolved 
in dry THF and allowed to stir for 18 hours under an inert atmosphere. The solution was 
filtered away from the resulting salt precipitate and the solvent removed under reduced 
pressure to yield the white solid [Ca{N(SiMe3)2}2(THF)2]. Further purification was 
achieved by extracting the product into hexane before drying the solid in vacuo over night 
to approximately 2 × 10-2 mbar.5, 6 Data were consistent with that previously reported.7, 8 
 
6.3.2  Preparation of [Ca(NNR){N(SiMe3)2}(py)n] [6a-f] 
 
[Ca{N(SiMe3)2}2(py)2] was prepared from the corresponding analogue 
[Ca{N(SiMe3)2}2(THF)2] (vide supra) via literature proceedures.7 The selected diamine  
4a-j (300 mg, 1.5 mmol) in toluene (20 ml) was added to 1 equivalent of 
[Ca{N(SiMe3)2}2(py)2] (793 mg, 1.5 mmol). The solution was agitated briefly and allowed 
to react for 18 hours at ambient temperature. The resulting complex was typically realised 
as an orange/red powder when dried in vacuo to approximately 4 × 10-2 mbar. The 
absolute configuration at the calcium of the diastereomeric complexes could not be 
determined owing to the highly labile nature observed in the collected spectroscopic data. 
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6.3.2.1 [Ca(NNArF){N(SiMe3)2}(py)] [6a] 
 
1H NMR data (THF-d8, 300.5 MHz, 293 K): δH = 8.57 (2 H, m, o-C5H5N), 7.67 (1 H, app. 
tt, 3JHH = 7.7 Hz, 4JHH = 1.5 Hz, p-C5H5N), 7.26 (2 H, m, m-C5H5N), 6.53 (2 H, app. t,   
3JHH = 8.2 Hz, m-C6H4F), 6.06 (2 H, br. m, o-C6H4F), 2.86 (1 H, app. d, 3JHH = 9.5 Hz, 
NCH2), 2.59 (2 H, br. m, H2NCH and NCH2), 1.65 (1 H, br. m, (CH3)2CH), 0.93 (6 H,  
app. d, 3JHH = 6.1 Hz, CH(CH3)2), 0.04 (18 H, (N(Si(CH3)3)2) ppm. 1H NMR data (THF-d8, 
500.1 MHz, 263 K): δH = 8.59 (2 H, m, o-C5H5N), 7.69 (1 H, app. tt, 3JHH = 7.5 Hz,        
4JHH = 1.8 Hz, p-C5H5N), 7.29 (2 H, m, m-C5H5N), 6.53 (2 H, app. t, 3JHH = 7.7 Hz,           
m-C6H4F), 6.04 (2 H, br. m, o-C6H4F), 2.83 (1 H, br. m, NCH2), 2.58 (2 H, br. m, H2NCH 
and NCH2), 1.66 (1 H, br. m, (CH3)2CH), 0.94 (6 H, app. d, 3JHH = 5.0 Hz, CH(CH3)2), 0.04 
(18 H, (N(Si(CH3)3)2) ppm. 13C{1H} NMR data (THF-d8, 75.5 MHz, 263 K): δC= 157.8 
(ipso-C6H4F), 150.6 (o-C5H5N), 136.2 (p-C5H5N), 127.6 (d, JCF = 274.0 Hz, p-C6H4F), 
124.1 (m-C5H5N), 115.3 (d, JCF = 19.7 Hz, m-C6H4F), 110.7 (o-C6H4F), 60.4 (H2NCH), 
54.7 (CH2), 34.1 ((CH3)2CH), 19.5 (CH3 isopropyl), 18.6 (CH3 isopropyl), 2.4 (N(Si(CH3)3)2) 
ppm. 19F NMR data (THF-d8, 282.8 MHz, 293 K): δF = -141.57 (br. s, p-C6H4F) ppm.     
19F NMR data (THF-d8, 282.8 MHz, 263 K): δF = -141.62 (s, p-C6H4F) ppm. IR data    
(KBr pellet, cm-1): 3341 (br. m), 3254 (br. m), 3061 (w), 3038 (w), 2960 (s), 2874 (s), 1596 
(m), 1510 (s), 1466 (m), 1441 (m), 1389 (w), 1370 (w), 1304 (w), 1261 (m), 1219 (m), 
1156 (w), 1101 (m), 1016 (br. m), 820 (s), 736 (w). 
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6.3.2.2 [Ca(NNArOMe){N(SiMe3)2}(py)] [6b] 
 
1H NMR data (THF-d8, 300.5 MHz, 293 K): δH = 8.52 (2 H, m, o-C5H5N), 7.62 (1 H,    
app. tt, 3JHH = 7.6 Hz, 4JHH = 1.6 Hz, p-C5H5N), 7.23 (2 H, m, m-C5H5N), 6.80-6.58 (3 H, 
m, ArH), 6.43 (1 H, br. s, ArH), 3.62 (3 H, br. s C6H4OCH3), 2.99 (1 H, br. s NCH2), 2.77-
2.48 (2 H, m, H2NCH and NCH2), 1.59 (1 H, br. s, (CH3)2CH), 0.98-0.79 (6 H, br. s, 
CH(CH3)2), 0.04 (18 H, s, (N(Si(CH3)3)2) ppm. 13C{1H} NMR data (THF-d8, 75.5 MHz, 
293 K): δC = 151.7 (p-C6H4OCH3), 150.6 (o-C5H5N), 143.8 (ipso-C6H4OCH3), 136.3       
(p-C5H5N), 124.1 (m-C5H5N), 115.4 (m-C6H4OCH3), 113.8 (o-C6H4OCH3), 57.5 (H2NCH), 
55.9 (C6H4OCH3) 50.7 (CH2), 33.7 ((CH3)2CH), 19.8 (CH3 isopropyl), 18.1 (CH3 isopropyl), 2.7 
(N(Si(CH3)3)2) ppm. IR data (KBr pellet, cm-1): 3353 (br. m), 2961 (s), 2870 (m), 2826 
(m), 2179 (w), 2065 (w), 1590 (w), 1513 (s), 1464 (w), 1415 (w), 1392 (w), 1365 (w), 
1298 (w), 1260 (m), 1238 (m), 1178 (w), 1103 (m), 1036 (m), 869 (w), 819 (m), 745 (w), 
731 (w), 708 (w), 519 (w). 
 
6.3.2.3 [Ca(NNArMe){N(SiMe3)2}(py)] [6c] 
 
1H NMR data (THF-d8, 300.5 MHz, 293 K): δH = 8.53 (2 H, m, o-C5H5N), 7.64 (1 H,    
app. tt, 3JHH = 7.6 Hz, 4JHH = 1.8 Hz, p-C5H5N), 7.23 (2 H, m, m-C5H5N), 6.74-6.54 (2 H, 
m, ArH), 6.35 (2 H, m, ArH), 3.00-2.88 (1 H, m,
 
NCH2), 2.72-2.56 (2 H, m, H2NCH and 
NCH2), 2.07 (3 H, br. s C6H4CH3), 1.66-1.55 (1 H, br. s, (CH3)2CH), 0.93 (3 H, app. dd, 
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3JHH = 6.2 Hz, 3JHH = 6.2 Hz, CH(CH3)2), 0.92 (3 H, app. dd, 3JHH = 8.0 Hz, 3JHH = 6.9 Hz, 
CH(CH3)2), 0.04 (18 H, s, (N(Si(CH3)3)2) ppm. 13C{1H} NMR data (THF-d8, 75.5 MHz, 
293 K): δC = 150.8 (o-C5H5N), 147.2 (ispo-C6H4CH3), 136.3 (p-C5H5N), 130.1               
(m-C6H4CH3), 128.9 (p-C6H4CH3), 124.3 (m-C5H5N), 112.4 (o-C6H4CH3), 59.0 (H2NCH), 
53.2 (CH2), 34.3 ((CH3)2CH), 20.7 (C6H4CH3) 20.5 (CH3 isopropyl), 19.8 (CH3 isopropyl), 2.7 
(N(Si(CH3)3)2) ppm. IR data (KBr pellet, cm-1): 3347 (w), 3275 (w), 2959 (s), 2871 (m), 
2239 (w), 2179 (w), 2096 (w), 1607 (m), 1579 (m), 1516 (s), 1501 (s), 1465 (m), 1388 (w), 
1302 (m), 1260 (s), 1181 (m), 1095 (m), 1017 (s), 976 (br. m), 882 (w), 805 (s), 755 (w), 
702 (w) 445 (w). 
 
6.3.2.4 [Ca(NNPh){N(SiMe3)2}(py)] [6d] 
 
1H NMR data (THF-d8, 300.5 MHz, 293 K): δH = 8.54 (2 H, m, o-C5H5N), 7.66 (1 H, m,  
p-C5H5N), 7.25 (2 H, m, m-C5H5N), 6.76 (2 H, br. m, o-C6H5), 6.13 (2 H, br. m, m-C6H5), 
5.89 (1 H, br. m, p-C6H5), 2.92 (1 H, br. m, NCH2), 2.63 (2 H, br. m, H2NCH and NCH2), 
1.58 (1 H, br. m, (CH3)2CH), 0.91 (6 H, br. m, CH(CH3)2), 0.04 (18 H, s, N(Si(CH3)3)2) 
ppm. 1H NMR data (THF-d8, 300.5 MHz, 243 K): δH = 8.56 (2 H, m, o-C5H5N), 7.73 (1 H, 
m, p-C5H5N), 7.31 (2 H, m, m-C5H5N), 6.78 (2 H, br. m, o-C6H5), 6.78-5.97 (2 H, br. m, 
m-C6H5), 5.87 (1 H, br. m, p-C6H5), 2.87 (1 H, br. m, NCH2), 2.75 (1 H, br. m, H2NCH), 
2.63 (1 H, br. m, and NCH2), 1.50 (1 H, br. m, (CH3)2CH), 0.97 (6 H, br. m, CH(CH3)2), 
0.04 (18 H, s, N(Si(CH3)3)2) ppm. 13C{1H} NMR data (THF-d8, 75.5 MHz, 293 K):           
δC = 160.1 (ipso-C6H5), 150.7 (o-C5H5N), 136.2 (p-C5H5N), 129.2 (o-C6H5), 124.1         
(m-C5H5N), 111.6 (m-C6H5), 107.7 (p-C6H5), 60.4 (H2NCH), 54.1 (CH2), 34.2 ((CH3)2CH), 
20.1 (CH3 isopropyl), 19.5 (CH3 isopropyl), 1.8 (N(Si(CH3)3)2 ppm. 13C{1H} NMR data (THF-d8, 
75.5 MHz, 243 K): δC= 160.6 (ipso-C6H5), 150.6 (o-C5H5N), 136.5 (p-C5H5N), 129.9       
(o-C6H5), 124.4 (m-C5H5N), 116.8 (m-C6H5), 106.9 (p-C6H5), 60.7 (H2NCH), 54.3 (CH2), 
34.1 ((CH3)2CH), 20.2 (CH3 isopropyl), 19.5 (CH3 isopropyl), 2.1 (N(Si(CH3)3)2 ppm. IR data 
(KBr pellet, cm-1): 3339 (br. m), 3257 (m), 3051 (m), 3022 (w), 2957 (s), 2931 (s), 2869 
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(s), 2498 (w), 1927 (w), 1596 (s), 1552 (w), 1484 (s), 1441 (s), 1369 (m), 1303 (m), 1261 
(s), 1182 (m), 1150 (m), 1100 (br. s), 1035 (s), 1010 (s), 879 (w), 804 (m), 750 (s). 
 
6.3.2.5 [Ca(NNiPr){N(SiMe3)2}(py)] [6e] 
 
1H NMR data (THF-d8, 300.5 MHz, 293 K): δH = 8.58 (2 H, m, o-C5H5N), 7.66 (1 H, m,  
p-C5H5N), 7.26 (2 H, m, m-C5H5N), 2.90 (1 H, br. m, NCH2), 2.66 (1 H, br. m, H2NCH), 
2.52 (1 H, br. m, NCH2), 1.67-1.47 (2 H, br. m, (CH3)2CH), 1.24-1.03 (6 H, br. m, 
CH(CH3)2), 0.94-0.76 (6 H, br. m, CH(CH3)2) 0.03 (18 H, s, N(Si(CH3)3)2) ppm. 1H NMR 
data (THF-d8, 300.5 MHz, 263 K): δH = 8.55 (2 H, m, o-C5H5N), 7.69 (1 H, app. tt, 3JHH = 
7.6 Hz, 4JHH = 1.8 Hz, p-C5H5N), 7.28 (2 H, m, m-C5H5N), 3.10-2.80 (2 H, br. m, H2NCH 
and NCH2), 2.65 (1 H, br. m, NCH2), 1.67 (1 H, br. m, (CH3)2CH), 1.37 (1 H, br. m, 
(CH3)2CH), 1.19-1.06 (6 H, br. m, CH(CH3)2), 0.93-0.80 (6 H, br. m, CH(CH3)2) 0.03 (18 
H, s, N(Si(CH3)3)2) ppm. 13C{1H} NMR data (THF-d8, 75.5 MHz, 293 K): δC= 150.6      
(o-C5H5N), 136.2 (p-C5H5N), 124.1 (m-C5H5N), 58.3 (H2NCH), 55.8 (NCH(CH3)2), 49.0 
(CH2), 36.7 ((CH3)2CH), 23.0 (CH3 isopropyl), 22.1 (CH3 isopropyl), 19.9 (CH3 isopropyl), 18.7 
(CH3 isopropyl), 2.4 (N(Si(CH3)3)2) ppm. IR data (KBr pellet, cm-1): 3248 (br. w), 2959 (s), 
2870 (m), 1597 (m), 1553 (m), 1465 (m), 1442 (m), 1386 (m), 1368 (m), 1324 (w), 1259 
(br. m), 1165 (w), 1057 (br. s), 950 (w), 931 (w), 881 (m), 822 (s), 750 (w), 702 (w). 
 
 
 
 
 
 
Chapter Six –Experimental and Characterisation Data 
 
179 
 
6.3.2.6 [Ca(NNtBu){N(SiMe3)2}(py)] [6f] 
 
1H NMR data (THF-d8, 300.5 MHz, 293 K): δH = 8.54 (2 H, m, o-C5H5N), 7.66 (1 H, app. 
tt, 3JHH = 7.6 Hz, 4JHH = 1.9 Hz, p-C5H5N), 7.25 (2 H, m, m-C5H5N), 2.80 (1 H, br. m, 
NCH2), 2.60 (1 H, br. m, H2NCH), 2.45 (1 H, br. m, NCH2), 1.57 (1 H, m, (CH3)2CH), 
1.07 (9 H, br. s, C(CH3)3), 0.88 (6 H, br. t, 3JHH = 6.6 Hz, CH(CH3)2), 0.10 (18 H, s, 
N(Si(CH3)3)2) ppm. 1H NMR data (THF-d8, 300.5 MHz, 263 K): δH = 8.55 (2 H, m,          
o-C5H5N), 7.68 (1 H, app. tt, 3JHH = 7.6 Hz, 4JHH = 1.9 Hz, p-C5H5N), 7.28 (2 H, m,          
m-C5H5N), 2.79 (1 H, br. m, NCH2), 2.59 (1 H, br. m, H2NCH), 2.45 (1 H, br. m, NCH2), 
1.57 (1 H, m, (CH3)2CH), 1.08 (9 H, br. s, C(CH3)3), 0.88 (6 H, br. t, 3JHH = 6.6 Hz, 
CH(CH3)2), 0.10 (18 H, s, N(Si(CH3)3)2) ppm. 13C{1H} NMR data (THF-d8, 75.5 MHz, 
263 K): δC= 150.6 (o-C5H5N), 136.2 (p-C5H5N), 124.2 (m-C5H5N), 58.1 (H2NCH), 50.6 
(NC(CH3)3), 47.2 (CH2), 33.2 ((CH3)2CH), 29.3 ((CH3)3CN), 19.7 (CH3 isopropyl), 17.9 (CH3 
isopropyl), 1.2 (N(Si(CH3)3)2) ppm. IR data (KBr pellet, cm-1): 3338 (br. w), 3247 (br. w), 
2962 (s), 2871 (m), 1597 (w), 1466 (m), 1442 (w), 1393 (w), 1367 (m), 1261 (s), 1234 (w), 
1218 (w), 1098 (br. s), 1021 (br. s), 894 (w), 859 (w), 803 (s), 749 (w).  
 
6.3.3 Preparation of [Ca(NNR)2] [7a-c] 
 
The selected diamine 4a, d or i (50 mg, 0.31 mmol) pre-dissolved in toluene (0.5 ml) was 
added to [Ca{N(SiMe3)2}2(THF)2] (82.0 mg, 0.16 mmol). The solution was agitated briefly 
and allowed to react for 18 hours at ambient temperature. The resulting complex was 
typically realised as a dark orange/magenta powder when dried in vacuo to approximately 
4 × 10-2 mbar. 
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6.3.3.1 [Ca(NNArF)2] [7a] 
 
1H NMR data (THF-d8, 300.5 MHz, 293 K): δH = 6.70 (4 H, br. m, m-C6H5F), 6.42 (4 H, 
br. m, o-C6H4F), 2.99 (2 H, br. m NCH2), 2.67 (4 H, br. m, NCH2 and H2NCH), 1.63 (2 H, 
br. m, (CH3)2CH), 0.92 (12 H, br. m, CH(CH3)2) ppm. 1H NMR data (THF-d8, 300.5 MHz, 
183 K): δH = 6.89 (3 H, br. m, C6H4F), 6.69 (2 H, br. m, C6H4F), 6.57 (2 H, br. m, C6H4F), 
6.38 (1 H, br. m, C6H4F), 3.02 (2 H, br. m NCH2), 2.73 (2 H, br. m, NCH2), 2.55 (2 H, br. 
m, H2NCH), 1.67 (2 H, br. m, (CH3)2CH partially obscured by solvent peak), 0.91 (12 H, 
br. m, CH(CH3)2) ppm. 13C{1H} NMR data (THF-d8, 75.5 MHz, 293 K): δC = 129.4    
(ipso-C6H4F), 127.2 (d, JCF = 216.9 Hz, p-C6H4F), 115.4 (d, JCF = 21.6, m-C6H4F), 113.3 
(o-C6H4F), 59.6* (br. s, H2NCH), 50.5* (br. s, CH2), 33.6 ((CH3)2CH), 19.6 (CH3 isopropyl), 
18.0 (CH3 isopropyl) ppm. *Resonances are broad but comparable to low temperature 
13C{1H} NMR of the homoleptic species. 13C{1H} NMR data (THF-d8, 75.5 MHz, 183 K): 
): δC= 129.5 (ipso-C6H4F), 127.4 (d, JCF = 217.4 Hz, p-C6H4F), 115.7 (d, JCF = 21.8,         
m-C6H4F), 115.0 (o-C6H4F partially obscured m-C6H4F), 56.5 (H2NCH), 49.2 (CH2), 33.3 
((CH3)2CH), 19.4 (CH3 isopropyl), 17.8 (CH3 isopropyl) ppm. 19F NMR data (THF-d8, 282.8 
MHz, 293 K): δF = -141.57 (br. s, p-C6H4F), -130.64 (br. s, p-C6H4F) ppm. 19F NMR data 
(THF-d8, 282.8 MHz, 183 K): δF = -141.09 (s, p-C6H4F), -130.37 (br. s, p-C6H4F) ppm. IR 
data (KBr disc, cm-1): 3343 (br. m), 3234 (br. m), 3058 (m), 3035 (m), 2960 (s), 2931 (s), 
2871 (s), 2045 (w), 1851 (br. w), 1735 (br. w), 1609 (m), 1584 (m), 1510 (s), 1389 (m), 
1369 (m), 1307 (w), 1260 (m), 1218 (s), 1157 (m), 1101 (br. m), 1017 (m), 884 (w),       
820 (s), 736 (m). 
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6.3.3.2 [Ca(NNAr)2] [7b] 
 
1H NMR data (THF-d8, 300.5 MHz, 293 K): δH = 6.94 (6 H, br. m, C6H5), 6.43 (4 H, br. m, 
C6H5), 3.04 (2 H, br. m, NCH2), 2.68 (4 H, br. m, H2NCH and NCH2), 1.52 (2 H, br. m, 
(CH3)2CH partially obscured by other signal), 0.91 (12 H, br. m, CH(CH3)2) ppm.         
Low temperature 1H NMR studies between 273-193 K failed to give additional 
information. 13C{1H} NMR data (THF-d8, 75.5 MHz, 293 K): δC = 160.1 (C6H5), 129.3 
(C6H5), 128.8 (C6H5), 116.7 (C6H5), 113.1 (C6H5), 57.9 (H2NCH), 50.44 (CH2), 33.6 
((CH3)2CH), 19.6 (CH3 isopropyl), 18.0 (CH3 isopropyl) ppm. 13C{1H} NMR data (THF-d8, 75.5 
MHz, 263 K): δC = 160.1 (C6H5), 129.3 (C6H5), 128.8 (C6H5), 116.5 (C6H5), 112.9 (C6H5), 
56.9 (H2NCH), 49.9 (CH2), 33.4 ((CH3)2CH), 19.6 (CH3 isopropyl), 17.9 (CH3 isopropyl) ppm. 
IR data (KBr pellet, cm-1): 3646 (w), 3346 (br. m), 3272 (m), 3050 (m), 3020 (m), 2956 
(br. s), 2869 (s), 2494 (w), 1916 (w), 1823 (w), 1766 (w), 1603 (s), 1549 (m), 1505 (s), 
1387 (m), 1368 (m), 1306 (s), 1262 (s), 1180 (s), 1152 (m), 1109 (s), 1011 (m), 977 (m), 
882 (m), 833 (m), 787 (m), 787 (m), 749 (s), 693 (s), 619 (w), 608 (w), 590 (w), 509 (m), 
421 (m), 406 (m). 
 
6.3.3.3 [Ca(NNtBu)2] [7c] 
 
1H NMR data (THF-d8, 300.5 MHz, 293 K): δH = 2.60 (2 H, br. m, NCH2), 2.43 (2 H, br. 
m, H2NCH), 2.30 (2 H, m, NCH2), 1.57 (2 H, m, (CH3)2CH), 1.07 (18 H, br. s, NC(CH3)3), 
0.88 (12 H, app. t, 3JHH = 6.3 Hz, CH(CH3)2) ppm. 1H NMR data (THF-d8, 300.5 MHz,   
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263 K): δH = 2.59 (2 H, m, NCH2), 2.44 (2 H, br. m, H2NCH), 2.29 (m, 2 H, NCH2), 1.57 
(2 H, m, (CH3)2CH), 1.07 (18 H, br. s, NC(CH3)3), 0.88 (12 H, app. t, 3JHH = 6.5 Hz, 
CH(CH3)2) ppm. 13C{1H} NMR data (THF-d8, 62.9 MHz, 293 K): δC= 58.3 (H2NCH), 50.5 
(NC(CH3)3), 47.4 (CH2), 33.1 ((CH3)2CH), 29.4 ((CH3)3CN), 19.7 (CH3 isopropyl), 17.9    
(CH3 isopropyl) ppm. IR data (KBr pellet, cm-1): 3295 (m), 3241 (m), 2962 (br. m), 2866 (br. 
m), 1586 (br. m), 1470 (m), 1388 (w), 1365 (m), 1257 (br. m), 1232 (m), 1078 (m), 1023 
(w), 898 (w), 824 (w), 746 (w).  
 
6.3.4 General Procedure for Hydroamination Catalysis:  
Both 1-amino 2,2-dimethylpent-4-ene and 1-amino 2,2-diphenylpent-4-ene were prepared 
according to literature methods.9, 10 In a dinitrogen filled glovebox LH (LH = HNNR or    
R-BIM) (0.04 mmol) was predissolved in C6D6 (0.5 ml) and successively added to 
[Ca{N(SiMe)2}2(THF)2] (0.04 mmol). The resulting mixture was agitated by hand and left 
for two minutes. To this solution was added the corresponding amino olefin (0.4 mmol). 
The solution was transferred to a J. Young Teflon valve equipped NMR tube and sealed. 
All catalyst reactions were monitored via 1H NMR periodically to check conversion 
(conversion was determined from notable resonances in the spectra corresponding to the 
pyrrolidine product).11 Upon conversion ceasing, a solution of R-(-)-α-acetylmandelic acid 
acid 2.21 (0.41 mmol) predissolved in a minimal amount of CDCl3 was added to the 
reaction mixture producing the diastereomeric salts. The resulting enantioexcess was then 
determined from 1H NMR spectroscopy.12 
 
6.3.5 Determination of Rate Constants from Conversion Curves: 
The conversion curves were curve fitted to an exponential decay function y=Ae-bx.         
The initial rate, given by the slope at the origin (x=0), were determined by differentiation 
of the equation: dy/dx = -A/b (see Appendix A for data). 
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6.4 Experimental and Characterisation Data for Chapter Four 
6.4.1 Preparation of diethyl malonimidate dihydrochloride [4.7] 
 
Prepared from a modified literature proceedure.13 To a solution of malononitrile (10 g,   
0.15 mol), in dry 1,4-dioxane (200 ml), ethanol (19.70 ml, 0.33 mol) was added. Dry 
HCl(g) was then passed through the solution for 6 hours where upon the system was sealed 
and allowed to stir under an HCl atmosphere for a further 18 hours. The solution was 
filtered away from the resulting diethyl malonimidate dihydrochloride precipitate. The 
precipitate was washed with dry 1,4 dioxane (2 × 20 mls) and dry diethyl ether (20 ml). 
The desired product was then dried in vacuo and stored in a glove box, giving near 
quantitative yields. Data were consistent with those previously reported.13 
1H NMR data ((CD3)2SO, 400.1 MHz, 293 K): δH = 8.40 (4 H, br. s, NH2), 4.46 (2 H, s, 
H2NCCH2CNH2), 4.21 (4 H, app. s, CH3CH2O), 1.32 (6 H, t, 3JHH = 6.7 Hz, CH3CH2O) 
ppm. 13C{1H} NMR data ((CD3)2SO, 62.9 MHz, 293 K): δC = 166.5 (C=N), 60.8 
(CH3CH2O), 41.2 (CH2 bridge), 13.9 (CH3CH2O) ppm. IR data (KBr pellet, cm-1): 2853 
(s), 2644 (s), 2521 (w), 2395 (w), 2363 (w), 2345 (w),2268 (w), 2224 (w), 2189 (w), 2024 
(w), 1959 (w), 1897 (w), 1738 (s), 1662 (s, υC=N), 1565 (m), 1464 (m), 1442 (m), 1390 (s), 
1360 (s), 1300 (m), 1262 (w), 1206 (m),1133 (s), 1092 (s), 1004 (s), 952 (s), 901 (m), 868 
(s), 822 (s), 798 (m), 725 (m), 632(s). Accurate mass ES-MS: no identifiable peaks 
obtained. 
 
 
6.4.2 Procedure for Bisimidazoline Preparation R-BIM [8a-j] 
 
Prepared according to modified literature procedures.14 Under an inert atmosphere, diethyl 
malonimidate dihydrochloride 4.7 (ca. 0.6 g, 26 mmol) and HNNR 4a-j (1 g, 52 mmol) 
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were dissolved in dry dichloromethane and heated at vigorous reflux for 4 days. 
Proceeding such time the solution was allowed to cool and washed with NaHCO3 (10%,    
2 × 25 ml). The organic solution was subsequently reduced in volume under reduced 
pressure. The relevant R-BIM was realized by column chromatography over silica gel 
(typical solvent systems were composed of ethyl acetate or dichloromethane with methanol 
and Et3N (9:1:1 v/v)) to yield the desired R-BIM as a white solid in approximately 35-45% 
yield. Exceptions to this were compounds 8e (ArNO2-BIM) and 8h (iPr-BIM), which were 
crystallised out from hot toluene and from a warm dichlormethane/hexane mixture which 
was subsequently cooled to -18°C respectively. 
 
6.4.2.1 [8a] 
 
1H NMR data (CDCl3, 500.1 MHz, 293 K): δH = 7.06 (4 H, dd, 3JHH = 8.5 Hz, o-C6H4F), 
6.93 (4 H, app. t, 3JHH = 8.5 Hz, m-C6H4F), 3.75 (2 H, m, NCH2), 3.64 (2 H, m, NCH2CH), 
3.39 (2 H, m, NCH2), 1.72 (2 H, m, (CH3)2CH), 1.09 (6 H, br. d, 3JHH = 6.3 Hz, 
CH(CH3)2), 0.93 (6 H, dd, 3JHH = 6.3 Hz, CH(CH3)2), (CH bridge not observed) ppm.          
19F NMR data (CDCl3, 282.8 MHz, 293 K): δF = -118.45 (br. s, p-C6H4F) ppm. 13C{1H} 
NMR data (CDCl3, 125.7 MHz, 293 K): δC = 160.3 (C=N), 159.1 (d, 1JCF = 243.1 Hz,       
p-C6H4F), 138.4 (ipso-C6H4F), 124.3 (d, 3JCF = 7.5 Hz, o-C6H4F), 115.5 (d, 2JCF = 22.4 Hz, 
m-C6H4F), 65.2 (C=NCH imidazoline), 55.8 (CH2 imidazoline), 33.8 ((CH3)2CH), 19.6              
(CH3 isopropyl), 19.1 (CH3 isopropyl), (CH bridge not observed) ppm. IR data (KBr disc, cm-1): 
3111 (w), 3078 (w), 3051 (w), 2959 (s), 2831 (s), 2608 (w), 1876 (w), 1616 (s), 1593 (s), 
1536 (s), 1504 (s), 1469 (m), 1425 (m), 1390 (m), 1363 (m), 1306 (s), 1256 (s), 1232 (s), 
1194 (s), 1168 (m), 1119 (s), 1090 (m), 1046 (m), 1010 (m), 904 (w), 832 (s), 799 (s), 723 
(s), 638 (m), 593 (m), 564 (m), 551 (s), 503 (m), 435 (m). Accurate mass ES-MS for    
[ArF-BIM+H]+: m/z = 425.2509 (calc. for C25H31N2F2: 425.2517). 
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6.4.2.2 [8b] 
 
1H NMR data (CDCl3, 500.1 MHz, 293 K): δH = 7.06 (4 H, d, 3JHH = 8.9 Hz,                     
m-C6H4OCH3), 6.77 (4 H, d, 3JHH = 8.9 Hz, o-C6H4OCH3), 3.75 (6 H, br. s, C6H4OCH3), 
3.73 (2 H, app. t, 3JHH = 8.3 Hz, NCH2), 3.62 (2 H, app. q, 3JHH = 8.5 Hz, NCH2CH), 3.36 
(2 H, app. t, 3JHH = 8.7 Hz, NCH2), 1.71 (2 H, m, (CH3)2CH), 1.10 (6 H, d, 3JHH = 6.6 Hz, 
CH(CH3)2), 0.92 (6 H, d, 3JHH = 6.6 Hz, CH(CH3)2), (CH bridge not observed) ppm. 13C{1H} 
NMR data (CDCl3, 125.7 MHz, 293 K): δC = 160.8 (C=N), 156.0 (p-C6H4OCH3), 135.7 
(ipso-C6H4OCH3), 124.5 (m-C6H4OCH3), 114.1 (o-C6H4CH3), 65.2 (C=NCH imidazoline), 
56.2 (CH2 imidazoline), 55.4 (C6H4OCH3), 33.8 ((CH3)2CH), 19.7 (CH3 isopropyl), 19.1          
(CH3 isopropyl), (CH bridge not observed) ppm. IR data (KBr disc, cm-1): 3447 (br. w), 2992 
(w), 2961 (s), 2866 (w), 2837 (w), 2068 (w), 1917 (w), 1887 (w), 1845 (w), 1607 (s), 1577 
(m), 1538 (s), 1515 (s), 1461 (m), 1438 (w), 1431 (w), 1385 (m), 1365 (w), 1359 (w), 1326 
(w), 1307 (w), 1294 (m), 1277 (m), 1248 (s), 1205 (m), 1177 (m), 1139 (m), 1126 (m), 
1103 (m), 1077 (w), 1039 (s), 973 (w), 962 (w), 917 (w), 904 (w), 835 (s), 808 (m), 783 
(m), 724 (m), 716 (m), 692 (w), 661 (w), 619 (w), 600 (m), 570 (w), 552 (m), 514 (w), 467 
(w), 436 (w), 421 (w), 404 (w). Accurate mass ES-MS for [ArOMeBIM+H]+: m/z = 
449.2906 (calc. for C27H37N4O2: 449.2917). 
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6.4.2.3 [8c] 
 
1H NMR data (CDCl3, 500.1 MHz, 293 K): δH = 7.04 (8 H, app. d, 3JHH = 1.5 Hz,            
m-C6H4CH3 and o-C6H4CH3), 3.79 (2 H, m, NCH2), 3.63 (2 H, m, NCH2CH), 3.44 (2 H, 
m, NCH2), 2.28 (6 H, s, C6H4CH3), 1.72 (2 H, m, (CH3)2CH), 1.09 (6 H, br. d, 3JHH = 6.5 
Hz, CH(CH3)2), 0.93 (6 H, dd, 3JHH = 6.5 Hz, CH(CH3)2), (CH bridge not observed) ppm. 
13C{1H} NMR data (CDCl3, 125.7 MHz, 293 K): δC = 159.9 (C=N), 139.9                       
(ipso-C6H4CH3), 132.5 (p-C6H4CH3), 129.3 (o-C6H4CH3), 122.2 (m-C6H4CH3), 65.0 
(C=NCH
 imidazoline), 55.5 (CH2 imidazoline), 33.8 ((CH3)2CH), 20.7 (C6H4CH3), 19.6             
(CH3 isopropyl), 19.1 (CH3 isopropyl), (CH bridge not observed) ppm. IR data (KBr disc, cm-1): 
3554 (w), 3480 (w), 3413 (w), 3031 (w), 2963 (s), 2917 (m), 2867 (m), 2823 (m), 1895 
(w), 1623 (s), 1601 (s), 1571 (m), 1533 (s), 1509 (s), 1471 (m), 1385 (m), 1324 (m), 1260 
(s), 1194 (m), 1171 (m), 1105 (br. s), 1023 (br. s), 862 (w), 801 (s), 722 (m), 711 (m), 631 
(w), 550 (m), 502 (w). Accurate mass ES-MS for [ArMeBIM+H]+: m/z = 417.3018             
(calc. for C27H37N4: 417.3006). 
 
6.4.2.4 [8d] 
 
1H NMR data (CDCl3, 500.1 MHz, 293 K): δH = 7.23 (4 H, m, m-C6H5), 7.14 (4 H, m,       
o-C6H5), 6.97 (2 H, app. t, 3JHH = 7.3 Hz, p-C6H5), 3.82 (2 H, app. dt, 3JHH = 8.4 Hz,            
3JHH = 6.0 Hz, 4JHH = 2.3 Hz NCH2), 3.65 (2 H, app. q, 3JHH = 8.4 Hz, NCH2CH),                          
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3.48 (2 H, m, NCH2), 1.73 (2 H, m, (CH3)2CH), 1.10 (6 H, dd, 3JHH = 6.6 Hz, 3JHH = 6.6 
Hz, CH(CH3)2), 0.94 (6 H, dd, 3JHH = 6.6 Hz, 3JHH = 6.6 Hz, CH(CH3)2), (CH bridge                 
not observed) ppm. 13C{1H} NMR data (CDCl3, 75.5 MHz, 293 K): δC = 159.8 (C=N), 
159.7 (C=N), 142.4 (ipso-C6H5), 128.9 (m-C6H5), 123.0 (p-C6H5), 122.0 (o-C6H5), 65.1 
(C=NCH
 imidazoline), 64.9 (C=NCH imidazoline), 55.3 (CH2 imidazoline), 55.2 (CH2 imidazoline), 33.9 
((CH3)2CH), 19.7 (CH3 isopropyl), 19.6 (CH3 isopropyl), 19.2 (CH3 isopropyl), (CH bridge                      
not observed) ppm. IR data (KBr disc, cm-1): 3393 (w), 3313 (w), 3061 (w), 3027 (w), 
2960 (s), 2866 (m), 1948 (w), 1619 (s), 1592 (m), 1556 (m), 1536 (s), 1499 (s), 1458 (br. 
m), 1412 (w), 1378 (w), 1362 (w), 1308 (w), 1261 (s), 1201 (w), 1174 (w), 1131 (w), 1077 
(w), 1043 (w), 909 (w), 802 (m), 752 (m), 725 (w), 698 (m), 645 (w), 577 (w), 550 (m), 
504 (w). Accurate mass ES-MS for [ArH-BIM+H]+: m/z = 389.5563 (calc. for C25H32N4: 
389.2702). 
 
6.4.2.5 [8e] 
 
1H NMR data (CDCl3, 500.1 MHz, 293 K): δH = 8.16 (4 H, app. dd, 3JHH = 9.2 Hz,         
3JHH = 2.5 Hz, m-C6H4NO2), 7.19 (4 H, app. dd, 3JHH = 9.2 Hz, 3JHH = 4.4 Hz, o-C6H4NO2), 
4.77 (1 H, app. d, J= 9.2 Hz, CH bridge), 3.93 (2 H, q, 3JHH = 8.8 Hz, NCH2), 3.75 (2 H, q, 
3JHH = 7.5 Hz, NCH2CH), 3.60 (2 H, t, 3JHH = 8.8 Hz, NCH2), 1.82-1.70 (2 H, br. m, 
(CH3)2CH), 1.07 (6 H, t, 3JHH = 6.6 Hz, CH(CH3)2), 0.97 (6 H, dd, 3JHH = 6.6 Hz, 3JHH = 4.2 
Hz, CH(CH3)2) ppm. 13C{1H} NMR data (CDCl3, 125.7 MHz, 293 K): δC = 157.5 (C=N), 
147.5 (p-C6H4NO2), 141.6 (ipso-C6H4NO2), 125.1 (m-C6H4NO2), 119.0 (o-C6H4NO2), 64.7 
(C=NCH
 imidazoline), 64.7 (C=NCH imidazoline), 61.8 (CH bridge), 54.5 (CH2 imidazoline), 33.5 
((CH3)2CH), 18.90 (CH3 isopropyl), 18.87 (CH3 isopropyl) ppm. IR data (KBr disc, cm-1): 3374 
(br. m), 3111 (m), 3079 (m), 2958 (s), 2934 (m), 2867 (m), 2628 (w), 2433 (w), 1623 (s), 
1595 (s), 1549 (s), 1501 (s), 1467 (s), 1430 (m), 1362 (m), 1326 (s), 1275 (s), 1256 (s), 
1186 (s), 1139 (m), 1112 (s), 1069 (m), 1043 (m), 1003 (m), 926 (w), 906 (w), 864 (m), 
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853 (m), 827 (m), 814 (m), 753 (m), 713 (m), 693 (m), 628 (w), 558 (w), 528 (w), 512 (w), 
480 (w), 465 (w), 416 (w). Accurate mass ES-MS for 
[O2N(C6H5)NCH2CH((CH3)2)NH=CH]+: m/z = 234.1239 (calc. for C12H16N3O2: 
234.1243).
 
 
6.4.2.6 [8f] 
 
1H NMR data (CDCl3, 500.1 MHz, 293 K): δH = 6.77 (4 H, s, o-C6H3(CH3)2), 6.64 (2 H, s, 
p-C6H3(CH3)2), 3.77 (2 H, app. t, 3JHH = 8.3 Hz, NCH2), 3.62 (2 H, app. q, 3JHH = 8.5 Hz, 
NCH2CH), 3.43 (2 H, app. t, 3JHH = 8.3 Hz, NCH2), 2.34 (12 H, br. s, C6H3(CH3)2), 1.71    
(2 H, m, (CH3)2CH), 1.10 (6 H, d, 3JHH = 6.6 Hz, CH(CH3)2), 0.94 (6 H, d, 3JHH = 6.6 Hz, 
CH(CH3)2), (CH bridge not observed) ppm. 13C{1H} NMR data (CDCl3, 100.6 MHz, 293 K): 
δC = 160.1 (C=N), 142.3 (ipso-C6H3(CH3)2), 138.3 (m-C6H3(CH3)2), 124.8 (p-C6H3(CH3)2), 
119.9 (o-C6H3(CH3)2), 64.9 (C=NCH imidazoline), 55.5 (CH2 imidazoline), 33.8 ((CH3)2CH), 21.4 
(C6H3(CH3)2), 19.7 (CH3 isopropyl), 19.1 (CH3 isopropyl), (CH bridge not observed) ppm. IR data 
(KBr disc, cm-1): 3011 (w), 2961 (s), 2917 (s), 2861 (s), 1621 (s), 1591 (s), 1541 (s), 1460 
(s), 1375 (m), 1357 (m), 1334 (m), 1312 (w), 1284 (m), 1258 (s), 1227 (w), 1196 (s), 1165 
(w), 1124 (s), 1096 (w), 1078 (w), 1051 (m), 971 (w), 915 (w), 878 (w), 860 (w), 834 (s), 
802 (m), 767 (w), 722 (m), 698 (m), 642 (w), 604 (w), 594 (w), 534 (m), 496 (w), 477 (w), 
458 (w), 418 (w). Accurate mass ES-MS for [Ar3,5Me-BIM+H]+: m/z = 445.3322 (calc.     
for C29H41N4: 445.3331). 
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6.4.2.7 [8g] 
 
1H NMR data (CDCl3, 500.1 MHz, 293 K): δH = 7.34 (4 H, app. t, 3JHH = 7.6 Hz, m-C6H5), 
7.29 (2 H, d, 3JHH = 7.3 Hz, p-C6H5), 7.13 (4 H, d, 3JHH = 7.3 Hz, o-C6H5), 4.53 (2 H, q, 
3JHH = 6.9 Hz, NHCH(CH3)(C6H5)), 3.95 (2 H, m, NCH2CH), 3.70 (1 H, br. s, CH bridge) 
3.49 (2 H, t, 3JHH = 10.0 Hz, NCH2), 3.03 (2 H, dd, 3JHH = 6.8 Hz, 3JHH = 9.6 Hz, NCH2), 
2.15 (2 H, m, (CH3)2CH), 1.42 (6 H, d, 3JHH = 7.0 Hz, NHCH(CH3)(C6H5)), 0.89 (6 H, d, 
3JHH = 6.8 Hz, CH(CH3)2), 0.84 (6 H, d, 3JHH = 6.8 Hz, CH(CH3)2) ppm. 13C{1H} NMR 
data (CDCl3, 125.7 MHz, 293 K): δC = 160.1 (C=N), 140.2 (ipso-C6H5), 128.8 (m-C6H5), 
127.8 (p-C6H5), 126.2 (o-C6H5), 59.5 (NCH2CH), 56.3 (CH bridge), 53.3 (CH(CH3)(C6H5)), 
45.3 (NCH2 imidazoline), 31.5 ((CH3)2CH), 18.6 (CH3 isopropyl), 17.7 (CH(CH3)(C6H5)),        
16.2 (CH3 isopropyl) ppm. IR data (KBr disc, cm-1): 3429 (br. m), 3200 (br s), 3140 (br. s), 
3059 (m), 2956 (s), 2871 (s), 2206 (w), 1972 (w), 1951 (w), 1894 (w), 1878 (w), 1807 (w), 
1739 (m), 1564 (br. s) 1502 (s), 1454 (s), 1388 (m), 1378 (m), 1370 (m), 1332 (s), 1278 
(s), 1231 (m), 1213 (m), 1191 (m), 1130 (m), 1090 (s), 1069 (m), 1025 (s), 990 (m), 979 
(m), 914 (w), 853 (w), 818 (w), 786 (m), 773 (m), 759 (m), 731 (m), 700 (s), 649 (m), 590 
(w), 555 (m), 493 (w). Accurate mass ES-MS for [NHCH(CH3)(C6H5)-BIM+H]+:                   
m/z = 445.3324 (calc. for C29H41N4: 445.3326). 
 
6.4.2.8 [8h] 
 
1H NMR data (CDCl3, 500.1 MHz, 293 K): δH = 3.91 (2 H, m, NCH2CH), 3.78 (2 H, sept., 
3JHH = 6.7 Hz, (CH3)2CHNH), 3.68 (1 H, br. s, CH bridge), 3.41 (2 H, t, 3JHH = 9.7 Hz, 
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NCH2), 3.15 (2 H, dd, 3JHH = 9.5 Hz, 3JHH = 6.6 Hz, NCH2), 2.20 (2 H, m, (CH3)2CH), 1.18 
(12 H, dd, 3JHH = 6.7 Hz, 3JHH = 2.5 Hz, NHCH(CH3)2), 0.94 (6 H, d, 3JHH = 6.7 Hz, 
CH(CH3)2), 0.87 (6 H, d, 3JHH = 6.7 Hz, CH(CH3)2) ppm. 13C{1H} NMR data (CDCl3, 
125.7 MHz, 293 K): δC = 159.7 (C=N), 59.2 (C=NCH imidazoline), 54.7 (CH bridge), 45.7 
(NHCH(CH3)2), 43.3 (CH2 imidazoline), 31.6 ((CH3)2CH), 19.4 (NHCH(CH3)2), 19.3 
(NHCH(CH3)2), 18.7 (CH3 isopropyl), 16.0 (CH3 isopropyl) ppm. IR data (KBr disc, cm-1): 3440 
(br. m), 3210 (br. m), 3144 (br. m), 2953 (s), 2868 (m), 1569 (br. s), 1503 (s), 1479 (m), 
1462 (m), 1443 (m), 1389 (w), 1362 (m), 1332 (s), 1280 (s), 1224 (m), 1201 (m), 1146 (w), 
1124 (m), 1111 (m), 1068 (m), 1017 (w), 984 (w), 925 (w), 884 (w), 816 (w), 736 (m), 657 
(br. w), 513 (w), 453 (w), 436 (w), 404 (w). Accurate mass ES-MS for [iPr-BIM+H]+:    
m/z = 321.3015 (calc. for C19H37N4: 321.3013). 
 
6.4.2.9 [8i] 
 
1H NMR data (CDCl3, 500.1 MHz, 293 K): δH = 3.42 (2 H, app. t, 3JHH = 7.9 Hz, NCH2), 
3.25 (2 H, m, NCH2CH) 2.85 (2 H, app. t, 3JHH = 8.8 Hz, NCH2), 1.54 (2 H, m, (CH3)2CH), 
1.33 (9 H, s, C(CH3)3), 1.00 (6 H, d, 3JHH = 6.5 Hz, CH(CH3)2), 0.83 (6 H, d, 3JHH = 6.5 Hz, 
CH(CH3)2), (CH bridge not observed) ppm. 13C{1H} NMR data (CDCl3, 125.7 MHz, 293 K): 
δC = 162.2 (C=N), 63.8 (C=NCH imidazoline), 52.4 (CH2 imidazoline), 52.0 (C(CH3)3), 33.7 
((CH3)2CH), 28.7 (C(CH3)3) 19.9 (CH3 isopropyl), 19.2 (CH3 isopropyl), (CH bridge not observed) 
ppm. IR data (KBr disc, cm-1): 3465 (br. m), 2964 (br. s), 2867 (m), 2810 (m), 1604 (s), 
1529 (s), 1469 (m), 1391 (m), 1362 (m), 1294 (m), 1264 (s), 1227 (s), 1166 (w), 1122 (m), 
1095 (s), 1065 (m), 1017 (m), 973 (w), 921 (w), 802 (s), 732 (m), 698 (w), 646 (w), 547 
(w), 468 (w). Accurate mass ES-MS for [tBu-BIM+H]+: m/z = 349.3344 (calc. for 
C21H41N4: 349.3331). 
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6.4.2.10 [8j]  
 
1H NMR data (CDCl3, 500.1 MHz, 293 K): δH = 6.85 (4 H, d, 3JHH = 9.0 Hz,                     
m-C6H4N(CH3)2), 6.51 (4 H, d, 3JHH = 9.0 Hz, o-C6H4N(CH3)2), 4.02 (2 H, m, NCH2CH), 
3.76 (2 H, app. t, 3JHH = 9.6 Hz, NCH2), 3.58 (1 H, br. s, CH bridge), 3.48 (2 H, app. q, 3JHH 
= 9.6 Hz, 4JHH = 3.4 Hz, NCH2), 2.87 (12 H, br. s, C6H4N(CH3)2), 2.25 (2 H, m, 
(CH3)2CH), 0.96 (12 H, t, 3JHH = 6.7 Hz, CH(CH3)2). 13C{1H} NMR data (CDCl3, 125.7 
MHz, 293 K): δC = 159.9 (C=N), 149.2 (p-C6H4N(CH3)2), 127.9 (ipso-C6H4N(CH3)2), 
126.5 (m-C6H4N(CH3)2), 112.5 (o-C6H4N(CH3)2), 59.9 (C=NCH imidazoline), 57.7 (CH bridge), 
52.6 (CH2 imidazoline), 40.4 (C6H4N(CH3)2), 31.6 ((CH3)2CH), 18.5 (CH3 isopropyl), 16.1 (CH3 
isopropyl) ppm. IR data (KBr disc, cm-1): 3419 (br. w), 3198 (s), 3117 (br. s), 2956 (s), 2870 
(w), 2805 (s), 2675 (m), 2604 (m), 2531 (w), 2497 (m), 1683 (w), 1569 (s), 1522 (s), 1446 
(s), 1388 (m), 1360 (s), 1337 (s), 1308 (s), 1272 (s), 1226 (s), 1186 (m), 1169 (m), 1145 
(m), 1068 (m), 1028 (m), 999 (w), 979 (w), 945 (m), 815 (s), 760 (w), 746 (w), 725 (w), 
679 (m), 638 (w), 546 (m), 488 (w), 418 (w), 406 (w). Accurate mass ES-MS for          
[ArNMe2-BIM+H]+: m/z = 475.3543 (calc. for C29H43N6: 475.3549). 
 
6.4.3 NMR Scale Preparation of [Ca(R-BIM){N(SiMe3)2}(py)] [10a-j] 
 
[Ca{N(SiMe3)2}2(py)2] was prepared from the corresponding analogue 
[Ca{N(SiMe3)2}2(THF)2] (vide supra) via literature proceedures.7 R-BIM 8a-j            
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(30mg, 0.07 mmol) in dry toluene (0.5ml) was added to 1 equivalent of 
[Ca{N(SiMe3)2}2(py)2] (ca. 0.037 g, 0.07 mmol). The solution was agitated briefly and 
allowed to react for 18 hours at ambient temperature under an inert atmosphere. The 
resulting complex was typically realised as an orange powder when dried in vacuo to 
approximately  4 × 10-2 mbar. 
 
6.4.3.1 [Ca(ArF-BIM){N(Si(CH3)3)2}(py)] [10a] 
 
1H NMR data (THF-d8, 500.1 MHz, 293 K): δH = 8.54 (2 H, m, 2,6-NC5H5), 7.64 (1 H, m, 
4-NC5H5), 7.24 (2 H, m, 3,5-NC5H5), 7.10-7.02 (4 H, m, o-C6H4F), 6.87 (4 H, app. t,         
3J = 8.7 Hz, m-C6H4F), 3.90 (2 H, m, NCH2CH), 3.52 (2 H, NCH2), 3.48 (1 H, s, CH bridge), 
3.40 (2 H, NCH2), 2.04 (2 H, m, (CH3)2CH), 0.89 (6 H, d, 3JHH = 6.8 Hz, CH(CH3)2), 0.78 
(6 H, d, 3JHH = 6.8 Hz, CH(CH3)2), 0.10 (18 H, s, N(Si(CH3)3) ppm. 13C{1H} NMR data 
(THF-d8, 75.5 MHz, 293 K): δC = 164.4 (C=N), 159.2 (d, 1JCF = 239.9 Hz, p-C6H4F), 150.8 
(2,6-NC5H5), 141.9 (d, 4JCF = 2.3 Hz, ipso-C6H4F), 136.3 (4-NC5H5), 125.8 (d, 3JCF =         
7.5 Hz, o-C6H4F), 124.3 (3,5-NC5H5), 115.4 (d, 2JCF = 22.5 Hz, m-C6H4F), 66.5 (C=NCH 
imidazoline), 57.8 (CH bridge), 52.1 (CH2 imidazoline), 34.2 ((CH3)2CH), 20.7 (CH3 isopropyl), 15.7 
(CH3 isopropyl), 2.7 (N(Si(CH3)3)2) ppm. 19F NMR data (THF-d8, 282.8 MHz, 293 K):          
δF = -121.80 (s, p-C6H4F) ppm. IR data (KBr disc, cm-1): 3419 (br. w) 2960 (m), 2873 (w), 
2240 (w), 1621 (m) 1593 (w), 1544 (s), 1479 (w), 1428 (w), 1387 (w), 1316 (w), 1260 (m), 
1222 (m), 1097 (m), 1018 (m), 837 (m), 798 (m), 720 (w), 668 (w), 594 (w), 551 (m), 422 
(w), 417 (w). 
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6.4.3.2 [Ca(ArOMe-BIM){N(SiMe3)2}(py)] [10b] 
 
1H NMR data (d8-THF, 500.1 MHz, 293 K): δH = 8.56 (2 H, m, 2,6-NC5H5), 7.65 (1 H, m, 
4-NC5H5), 7.24 (2 H, m, 3,5-NC5H5), 6.99 (2 H, d, 3JHH = 8.8 Hz, m-C6H4OCH3), 6.95      
(2 H, d, 3JHH = 8.8 Hz, m-C6H4OCH3), 6.68 (4 H, app. dd, 3JHH = 8.8 Hz, 3JHH = 2.7 Hz,     
o-C6H4OCH3), 3.89 (2 H, app. dt, 3JHH = 9.1 Hz, 3JHH = 3.1 Hz, NCH2CH), 3.69 (6 H, br. s, 
C6H4OCH3), 3.48 (2 H, q, 3JHH = 8.8 Hz, NCH2), 3.29 (1 H, s, CH bridge), 3.23 (2 H, m, 
NCH2), 2.06 (1 H, m, (CH3)2CH), 1.86 (1 H, m, (CH3)2CH), 0.88 (4 H, app t, 3JHH = 6.6 
Hz, CH(CH3)2), 0.85 (2 H, d, 3JHH = 6.9 Hz, CH(CH3)2), 0.80 (4 H, d, 3JHH = 6.6 Hz, 
CH(CH3)2), 0.75 (2 H, d, 3JHH = 6.9 Hz, CH(CH3)2), 0.11 (18 H, s, N(Si(CH3)3) ppm. 
13C{1H} NMR data (d8-THF, 75.5 MHz, 293 K): δC = 165.6 (C=N), 165.2 (C=N), 156.6 
(p-C6H5OCH3), 156.5 (p-C6H5OCH3), 150.8 (2,6-NC5H5), 138.5 (ipso-C6H4OCH3), 138.4 
(ipso-C6H4OCH3), 136.3 (4-NC5H5), 125.97 (m-C6H4OCH3), 125.94 (m-C6H4OCH3), 
124.3 (3,5-NC5H5), 114.3 (o-C6H4OCH3), 114.2 (o-C6H4OCH3), 66.6 (C=NCH imidazoline), 
66.5 (C=NCH
 imidazoline), 57.8 (CH bridge), 55.4 (C6H4OCH3), 52.2 (CH2 imidazoline), 52.3            
(CH2 imidazoline), 34.5 ((CH3)2CH), 34.3 ((CH3)2CH), 20.8 (CH3 isopropyl), 20.2 (CH3 isopropyl), 
20.1 (CH3 isopropyl), 2.7 (N(Si(CH3)3)2) ppm. IR data (KBr disc, cm-1): 3376 (br. w), 3039 
(w), 2953 (s), 2868 (s), 2833 (s), 2239 (m), 2186 (w), 2122 (w), 2088 (w), 1869 (w), 1608 
(s), 512 (s), 1464 (w), 1441 (w), 1383 (m), 1365 (m), 1244 (s), 1178 (m), 1144 (m), 1107 
(m), 1040 (s), 970 (w), 932 (m), 882 (m), 831 (s), 783 (m), 752 (w), 721 (w), 703 (w), 660 
(w), 638 (w), 752 (w), 721 (w), 555 (m), 485 (w).  
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6.4.3.3 [Ca(ArMe-BIM){N(SiMe3)2}(py)] [10c] 
 
1H NMR data (THF-d8, 500.1 MHz, 293 K): δH = 8.56 (4 H, m, 2,6-NC5H5), 7.64 (2 H, m, 
4-NC5H5), 7.24 (4 H, m, 3,5-NC5H5), 6.97-6.89 (8 H, m, o-C6H4CH3 and m-C6H4CH3), 
3.89 (2 H, m, NCH2CH), 3.69 (1 H, NCH2), 3.67 (1 H, s, CH bridge), 3.51 (1 H, NCH2), 3.34 
(1 H, NCH2), 3.24 (1 H, NCH2), 2.22 (3 H, br. s, C6H5CH3), 2.20 (3 H, br. s, C6H5CH3), 
1.86 (2 H, m, (CH3)2CH), 0.87 (6 H, m, CH(CH3)2), 0.77 (6 H, app. t, 3JHH = 6.7 Hz, 
CH(CH3)2), 0.11 (18 H, s, N(Si(CH3)3) ppm. 13C{1H} NMR data (THF-d8, 75.5 MHz, 293 
K): δC = 164.8 (C=N), 164.1 (C=N), 150.8 (2,6-NC5H5), 142.7 (ipso-C6H4CH3), 142.1 
(ipso-C6H4CH3), 136.3 (4-NC5H5), 132.0 (p-C6H4CH3), 131.3 (p-C6H4CH3), 129.5          
(o-C6H4CH3), 129.4 (o-C6H4CH3), 124.3 (3,5-NC5H5), 123.9 (m-C6H4CH3), 123.2           
(m-C6H4CH3), 66.5 (C=NCH imidazoline), 66.1 (C=NCH imidazoline), 58.7 (CH bridge), 51.8 (CH2 
imidazoline), 51.2 (CH2 imidazoline), 34.9 ((CH3)2CH), 34.3 ((CH3)2CH), 20.8 (C6H4CH3), 20.2 
(CH3 isopropyl), 15.4 (CH3 isopropyl), 2.7 (N(Si(CH3)3)2) ppm. IR data (KBr disc, cm-1): 3027 
(w), 2936 (s), 2867 (w), 2241 (w), 2179 (w), 2129 (w), 1652 (m), 1515 (s), 1455 (w), 1417 
(w), 1315 (m), 1261 (s), 1100 (s), 1020 (s), 934 (w), 800 (s), 703 (w), 667 (w), 618 (w), 
552 (w), 479 (m). 
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6.4.3.4 [Ca(Ph-BIM){N(SiMe3)2}(py)] [10d] 
 
1H NMR data (THF-d8, 500.1 MHz, 293 K): δH = 8.57 (2 H, m, 2,6-NC5H5), 7.65 (1 H, m, 
4-NC5H5), 7.25 (2 H, m, 3,5-NC5H5), 7.19-7.05 (8 H, m, o/m-C6H5), 6.85-6.73 (2 H, m,     
p-C6H5), 3.93-3.88 (2 H, m, NCH2CH), 3.87 (1 H, br. s, CH bridge), 3.72-3.67 (1 H, m, 
NCH2), 3.56 (2 H, dd, 3JHH = 6.0 Hz, 3JHH = 2.9 Hz, NCH2), 3.28 (1 H, app. dt, 3JHH = 8.8 
Hz, 3JHH = 2.4 Hz, NCH2), 1.93-1.79 (2 H, m, (CH3)2CH), 0.91-0.86 (6 H, m, CH(CH3)2), 
0.80-0.76 (6 H, m, CH(CH3)2), 0.12 (18 H, s, N(Si(CH3)3) ppm. 13C{1H} NMR data     
(THF-d8, 75.5 MHz, 293 K): δC = 164.4 (C=N), 164.0 (C=N), 150.8 (2,6-NC5H5), 145.4            
(ipso-C6H5), 144.3 (ipso-C6H5), 136.4 (4-NC5H5), 129.0 (o-C6H5), 128.96 (o-C6H5), 128.91 
(m-C6H5), 128.8 (m-C6H5) 124.3 (3,5-NC5H5), 124.0 (p-C6H5), 123.7 (p-C6H5), 66.5 
(C=NCH
 imidazoline), 66.3 (C=NCH imidazoline), 58.0 (CH bridge), 50.9 (CH2 imidazoline), 50.6    
(CH2 imidazoline), 34.7 ((CH3)2CH), 34.3 ((CH3)2CH), 20.7 (CH3 isopropyl), 20.0 (CH3 isopropyl), 
15.7 (CH3 isopropyl), 15.3 (CH3 isopropyl), 2.7 (N(Si(CH3)3)2) ppm. IR data (KBr disc, cm-1): 
3060 (w), 3034 (w), 2955 (s), 2870 (m), 2238 (w), 2122 (w), 1935 (w), 1864 (w), 1594 (s), 
1552 (m), 1522 (m), 1497 (s), 1399 (m), 1385 (m), 1365 (m), 1310 (m), 1261 (s), 1197 
(w), 1177 (w), 1144 (w), 1106 (m), 1042 (m), 932 (w), 882 (w), 806 (m), 754 (m),          
695 (m), 617 (w), 551 (w). 
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6.4.3.5 [Ca(ArNO2-BIM){N(SiMe3)2}(py)] [10e] 
 
IR data (KBr disc, cm-1): 3370 (br. w), 3185 (br. w), 3111 (w), 3078 (w), 2956 (m), 2869 
(m), 2727 (w), 2642 (w), 2432 (w), 2233 (w), 2176 (w), 2126 (w), 1925 (w), 1821 (w), 
1594 (s), 1563 (s), 1503 (s), 1429 (m), 1382 (m), 1326 (s), 1262 (s), 1231 (s), 1180 (s), 
1143 (m), 1111 (s), 1073 (m), 1038 (s), 936 (m), 884 (m), 846 (m), 752 (m), 721 (w), 695 
(m), 627 (w), 548 (w), 518 (w), 496 (w). 
 
6.4.3.6 [Ca(Ar3,5Me-BIM){N(SiMe3)2}(py)] [10f] 
 
1H NMR data (THF-d8, 500.1 MHz, 293 K): δH = 8.57 (2 H, m, 2,6-NC5H5), 7.65 (1 H, m, 
4-NC5H5), 7.25 (2 H, m, 3,5-NC5H5), 6.65 (4 H, s, o-C6H3(CH3)2), 6.52 (2 H, s,                 
p-C6H3(CH3)2), 4.01 (1 H, br. s, CH bridge), 3.90-3.86 (2 H, m, NCH2CH), 3.66-3.64 (2 H, 
m, NCH2), 3.29 (2 H, app. dt, 3JHH = 8.7 Hz, 3JHH = 2.0 Hz, NCH2), 2.11 (12 H, s, 
C6H4(CH3)2), 1.90-1.79 (2 H, m, (CH3)2CH), 0.90 (6 H, d, 3JHH = 6.8 Hz, CH(CH3)2), 0.73 
(6 H, d, 3JHH = 6.8 Hz, CH(CH3)2), 0.12 (18 H, s, N(Si(CH3)3) ppm. 13C{1H} NMR data 
(THF-d8, 75.5 MHz, 293 K): δC = 164.7 (C=N), 164.5 (C=N), 150.8 (2,6-NC5H5), 144.7 
(ipso-C6H3CH3), 144.6 (ipso-C6H4CH3), 138.2 (m-C6H3(CH3)2), 136.4 (4-NC5H5), 124.3 
(3,5-NC5H5), 124.0 (p-C6H3(CH3)2), 121.5 (o-C6H3(CH3)2), 66.2 (C=NCH imidazoline), 66.0 
(C=NCH
 imidazoline) 57.7 (CH bridge), 51.5 (CH2 imidazoline), 51.4 (CH2 imidazoline), 34.6 
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((CH3)2CH), 34.5 ((CH3)2CH), 21.5 (C6H3(CH3)2), 21.4 (C6H3(CH3)2), 20.3 (CH3 isopropyl), 
19.9 (CH3 isopropyl), 15.3 (CH3 isopropyl), 15.2 (CH3 isopropyl), 2.7 (N(Si(CH3)3)2) ppm. IR data 
(KBr disc, cm-1): 3380 (br. w), 3011 (w), 2953 (s), 2919 (s), 2868 (s), 2237 (w), 2186 (w), 
2116 (w), 2088 (w), 1595 (s), 1558 (s), 1516 (s), 1475 (s), 1383 (m), 1361 (m), 1312 (w), 
1245 (s), 1201 (w), 1173 (w), 1143 (w), 1108 (w), 1043 (m), 950 (w), 931 (w), 872 (w), 
837 (m), 751 (w), 727 (w), 699 (m), 618 (w), 506 (w), 464 (w), 423 (w), 413 (w). 
 
6.4.3.7 [Ca(PhMeH-BIM){N(SiMe3)2}(py)] [10g] 
 
1H NMR data (THF-d8, 500.1 MHz, 293 K): δH = 8.54 (2 H, m, 2,6-NC5H5), 7.65 (1 H, m, 
4-NC5H5), 7.35-7.19 (10 H, m, 3,5-NC5H5, o-C6H5, m-C6H5,), 7.15-7.10 (2 H, m, p-C5H5), 
4.67 (2 H, q, 3JHH = 6.7 Hz, CH(CH3)(C6H5)), 3.79 (2 H, m, NCH2CH), 3.48 (1 H, br. s CH 
bridge), 2.93 (2 H, t, 3JHH = 9.1 Hz, NCH2), 2.66 (2 H, m, NCH2), 2.05 (2 H, m, (CH3)2CH), 
1.32 (6 H, d, 3JHH = 6.8 Hz, CH(CH3)(C6H5)), 0.73 (6 H, d, 3JHH = 6.9 Hz, CH(CH3)2), 0.67 
(6 H, d, 3JHH = 6.9 Hz, CH(CH3)2) 0.04 (18 H, s, N(Si(CH3)3) ppm. 13C{1H} NMR data 
(THF-d8, 75.5 MHz, 293 K): δC = 167.2 (C=N), 150.8 (2,6-NC6H5), 145.4 (ipso-C6H5), 
136.3 (4-NC6H5), 128.9 (o/m-C6H5), 128.3 (o/m-C6H5), 127.7 (p-C6H5), 124.3                
(3,5-NC6H5), 66.2 (C=NCH imidazoline), 55.0 (CH bridge), 54.0 (CH(CH3)(C6H5)), 43.9 (CH2 
imidazoline), 34.4 ((CH3)2CH), 20.2 (CH3 isopropyl), 15.8 (CH(CH3)(C6H5)), 15.7 (CH3 isopropyl), 
2.7 (N(Si(CH3)3)2) ppm. IR data (KBr disc, cm-1): 3650 (w), 3571 (w), 3377 (w), 3088 (w), 
3060 (w), 3029 (w), 2957 (s), 2870 (s), 2236 (w), 2203 (w), 2128 (w), 1948 (w), 1881 (w), 
1804 (w), 1601 (s), 1494 (s), 1450 (s), 1385 (m), 1368 (m), 1261 (s), 1179 (m), 1095 (m), 
1025 (s), 931 (m), 885 (m), 839 (m), 802 (m), 753 (m), 699 (s), 618 (w), 532 (w). 
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6.4.3.8 [Ca(iPr-BIM){N(SiMe3)2}(py)] [10h] 
 
1H NMR data (THF-d8, 500.1 MHz, 293 K): δH = 8.57 (2 H, m, 2,6-NC6H5), 7.65 (1 H, m, 
4-NC6H5), 7.24 (2 H, m, 3,5-NC6H5), 150.8 (2,6-NC6H5), 136.3 (4-NC6H5), 3.81-3.65       
(4 H, m, NCH(CH3)3 and NCH2CH), 3.31 (1 H, br. s, CH bridge), 2.90 (4 H, br. d, 3JHH = 6.9 
Hz, NCH2), 2.07 (2 H, m, (CH3)2CH), 1.12 (6 H, NCH(CH3)2), 1.00 (6 H, NCH(CH3)2), 
0.82 (6 H, CH(CH3)2), 0.68 (6 H, CH(CH3)2), 0.04 (18 H, s, N(Si(CH3)3) ppm. 13C{1H} 
NMR data (THF-d8, 75.5 MHz, 293 K): δC = 166.9 (C=N), 150.8 (2,6-NC6H5), 136.3       
(4-NC6H5), 124.3 (3,5-NC6H5), 65.9 (C=NCH imidazoline), 54.1 (CH bridge), 46.2 
(NCH(CH3)2), 42.2 (CH2 imidazoline), 34.7 ((CH3)2CH), 21.4 (NCH(CH3)2), 20.4               
(CH3 isopropyl), 17.6 (NCH(CH3)2), 15.6 (CH3 isopropyl), 2.7 (N(Si(CH3)3)2) ppm. IR data (KBr 
disc, cm-1): 3646 (w), 3248 (br. w), 29458 (s), 2870 (s), 1608 (s), 1540 (m), 1487 (m), 
1456 (m), 1386 (w), 1366 (m), 1262 (m), 1177 (w), 1121 (w), 1109 (w), 1077 (w), 1060 
(w), 1029 (m), 974 (w), 953 (w), 930 (w), 886 (w), 837 (w), 822 (w), 741 (w), 618 (w), 
514 (w).  
 
6.4.3.9 [Ca(tBu-BIM){N(SiMe3)2}(py)] [10i] 
 
1H NMR data (THF-d8, 500.1 MHz, 293 K): δH = 8.55 (2 H, m, 2,6-NC5H5), 7.64 (1 H, m, 
4-NC5H5), 7.23 (2 H, m, 3,5-NC5H5), 3.83 (1 H, s, CH bridge), 3.63-3.56 (2 H, m, partially 
obscured by solvent peak, NCH2CH), 3.20-3.12 (2 H, m, NCH2), 3.10-3.02 (2 H, m, 
NCH2), 1.84-1.70 (2 H, m, partially obscured by solvent peak (CH3)2CH), 1.37 (18 H, s, 
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C(CH3)3), 0.85 (3 H, d, 3JHH = 6.9 Hz, CH(CH3)2), 0.81 (3 H, app. t, 3JHH = 6.9 Hz, 
CH(CH3)2), 0.78 (3 H, d, 3JHH = 6.9 Hz, CH(CH3)2), 0.74 (3 H, app. t, 3JHH = 6.9 Hz, 
CH(CH3)2), 0.10 (18 H, N(Si(CH3)2) ppm. 13C{1H} NMR data (THF-d8, 75.5 MHz, 293 
K): δC = 167.0 (C=N), 150.8 (2,6-NC5H5), 136.3 (4-NC5H5), 124.3 (3,5-NC5H5), 64.5 
(C=NCH
 imidazoline), 62.5 (CH bridge), 53.0 (C(CH3)3), 47.7 (CH2 imidazoline), 35.9 ((CH3)2CH), 
29.87 (C(CH3)2), 20.2 (CH3 isopropyl), 15.8 (CH3 isopropyl), 2.7 (N(Si(CH3)3)2) ppm. IR data 
(KBr disc, cm-1): 2960 (s), 2871 (m), 1597 (s), 1528 (m), 1503 (w), 1464 (m), 1444 (w), 
1396 (m), 1361 (m), 1312 (w), 1258 (s), 1229 (s), 1175 (w), 1101 (s), 1047 (s), 1018 (s), 
929 (w), 861 (w), 802 (s), 748 (w), 699 (w), 670 (m), 640 (w), 615 (w), 527 (w), 473 (w). 
 
6.4.3.10 [Ca(ArNMe2-BIM){N(SiMe3)2}(py)] [10j]  
 
1H NMR data (THF-d8, 500.1 MHz, 293 K): δH = 8.56 (2 H, m, 2,6-NC5H5), 7.65 (1 H, m, 
4-NC5H5), 7.24 (2 H, m, 3,5-NC5H5), 6.98 (4 H, d, 3JHH = 6.7 Hz, m-C6H4N(CH3)2), 6.60 
(4 H, d, 3JHH = 6.7 Hz, o-C6H4N(CH3)2), 3.94 (1 H, br. s CH bridge), 3.67 (2 H, t, 3JHH = 8.5 
Hz, NCH2), 3.60-3.52 (2 H, br. m, partially obscured by solvent peak, NCH2CH), 3.32-
3.25 (2 H, br. t, 3JHH = 8.2 Hz, NCH2), 2.83 (12 H, br. s, C6H4N(CH3)2), 1.63 (2 H, m, 
(CH3)2CH), 1.04 (6 H, br. d, 3JHH = 6.6 Hz, CH(CH3)2), 0.91 (6 H, br. d, 3JHH = 6.6 Hz, 
CH(CH3)2) 0.04 (18 H, s, N(Si(CH3)3) ppm. 13C{1H} NMR data (THF-d8, 75.5 MHz, 293 
K): δC = 161.7 (C=N), 150.4 (2,6-NC5H5), 148.4 (p-C6H4N(CH3)2), 136.4 (4-NC5H5), 
129.1 (ipso-C6H4N(CH3)2), 124.5 (3,5-NC6H5) 123.9 (m-C6H4N(CH3)2), 113.5                  
(o-C6H4N(CH3)2), 65.3 (C=NCH imidazoline), 59.5 (CH bridge), 56.3 (CH2 imidazoline), 40.7 
(C6H4N(CH3)2), 34.3 ((CH3)2CH), 19.4 (CH3 isopropyl), 19.1 (CH3 isopropyl), 2.2 (N(Si(CH3)3)2) 
ppm. IR data (KBr disc, cm-1): 3383 (br. w), 3229 (br. w), 3043 (s), 2953 (s), 2867 (s), 
2813 (m), 2235 (w), 2103 (w), 1868 (w), 1611 (s), 1522 (s), 1481 (m), 1386 (m), 1356 (m), 
1315 (m), 1273 (w), 1258 (m), 1187 (w), 1168 (m), 1139 (m), 1110 (m), 1083 (w), 1057 
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(w), 1019 (m), 944 (m), 885 (w), 819 (s), 752 (w), 725 (w), 701 (w), 641 (w), 618 (w), 553 
(m), 496 (w), 469 (w).  
 
6.4.4 NMR Scale Preparation of [Ca(R-BIM)2] [11a-j] 
 
R-BIM 10a-j (50mg, 0.31 mmol) in dry toluene (0.5 ml) was added to 
[Ca{N(SiMe3)2}2(py)2] (82.0mg, 0.16 mmol). The solution was agitated briefly and 
allowed to react for 18 hours at ambient temperature under an inert atmosphere. The 
resulting complex was typically realised as a dark orange powder when dried in vacuo to 
approximately 4 × 10-2 mbar. Despite obtaining spectroscopically pure complexes, and 
repeated recrystallization attempts, satisfactory elemental analyses could not be obtained. 
Given the highly air and moisture sensitive nature of these compounds, and literature 
precedence this is unsurprising. 12,15 
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6.4.4.1 [Ca(ArF-BIM)2] [11a] 
 
1H NMR data (THF-d8, 500.1 MHz, 293 K): δH = 7.07 (6 H, m, m-C6H4F), 6.97 (4 H, m,   
o-C6H4F), 6.88 (6 H, m, m-C6H4F and o-C6H4F), 4.10 (1 H, s, CH bridge), 3.90 (2 H, m, 
NCH2CH), 3.63 (2 H, m, NCH2CH), 3.52 (4 H, NCH2), 3.48 (1 H, s, CH bridge), 3.39 (4 H, 
m, NCH2), 2.05 (2 H, m, (CH3)2CH), 1.66 (2 H, m, (CH3)2CH), 1.04 (6 H, d, 3JHH = 6.7 Hz, 
CH(CH3)2), 0.93 (6 H, d, 3JHH = 6.7 Hz, CH(CH3)2), 0.89 (6 H, d, 3JHH = 6.7 Hz, 
CH(CH3)2), 0.79 (6 H, d, 3JHH = 6.7 Hz, CH(CH3)2) ppm. 13C{1H} NMR data (THF-d8, 
75.5 MHz, 293 K): δC = 164.4 (C=N), 160.6 (C=N), 159.7 (d, 1JCF = 241.7 Hz, p-C6H4F), 
159.2 (d, 1JCF = 239.4 Hz, p-C6H4F), 141.9 (d, 4JCF = 2.3 Hz, ipso-C6H4F), 140.0 (d, 4JCF = 
2.3 Hz, ipso-C6H4F), 125.8 (d, 3JCF = 8.0 Hz, o-C6H4F), 124.7 (d, 3JCF = 8.0 Hz, o-C6H4F), 
116.1 (d, 2JCF = 22.5 Hz, m-C6H4F), 115.4 (d, 2JCF = 22.5 Hz, m-C6H4F), 66.7 (C=NCH 
imidazoline), 66.5 (C=NCH imidazoline), 57.8 (CH bridge), 57.7 (CH bridge), 55.9 (CH2 imidazoline), 
52.1 (CH2 imidazoline), 34.7 ((CH3)2CH), 34.2 ((CH3)2CH), 20.7 (CH3 isopropyl), 19.5 (CH3 
isopropyl), 15.7 (CH3 isopropyl), 15.2 (CH3 isopropyl) ppm. 19F NMR data (THF-d8, 282.8 MHz, 
293 K): δF = -122.29 and -120.80 (s, p-C6H4F) ppm. IR data (KBr disc, cm-1): 3104 (w), 
3051 (w), 2959 (s), 2870 (m), 2238 (m), 2119 (w), 2098 (w), 1886 (w), 1619 (s), 1591 (m), 
1542 (m), 1509 (s), 1427 (m), 1384 (m), 1362 (m), 1309 (m), 1260 (s), 1229 (s), 1171 (w), 
1138 (m), 1122 (m), 1091 (m), 1041 (m), 1011 (m), 836 (s), 797 (s), 719 (m), 664 (w), 632 
(w), 596 (w), 549 (s), 524 (w), 505 (w), 482 (w), 434 (w).  
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6.4.4.2 [Ca(ArOMe-BIM)2] [11b] 
 
1H NMR data (THF-d8, 500.1 MHz, 293 K): δH = 7.05 (4 H, d, 3JHH = 8.9 Hz,                   
m-C6H4OCH3), 6.99 (4 H, d, 3JHH = 8.9 Hz, m-C6H4OCH3), 6.77 (4 H, d, 3JHH = 8.9 Hz,         
o-C6H4OCH3), 6.67 (4 H, d, 3JHH = 8.9 Hz, o-C6H4OCH3), 3.99 (1 H, s, CH bridge), 3.89          
(2 H, app. dt, 3JHH = 8.9 Hz, 3JHH = 2.7 Hz, NCH2CH), 3.71 (2 H, t, 3JHH = 8.4 Hz, NCH2), 
3.69 (12 H, br. s, C6H4OCH3), 3.60 (2 H, app. q, 3JHH = 7.8 Hz, NCH2CH), 3.48 (2 H, t, 
3JHH = 8.6 Hz, NCH2), 3.39 (1 H, s, CH bridge), 3.34 (4 H, m, NCH2), 2.05 (2 H, m, 
(CH3)2CH), 1.65 (1 H, m, (CH3)2CH), 1.04 (6 H, t, 3JHH = 6.7 Hz, CH(CH3)2), 0.92 (6 H, d, 
3JHH = 6.7 Hz, CH(CH3)2), 0.89 (6 H, t, 3JHH = 6.7 Hz, CH(CH3)2), 0.80 (6 H, d, 3JHH = 6.7 
Hz, CH(CH3)2) ppm. 13C{1H} NMR data (THF-d8, 75.5 MHz, 293 K): δC = 165.2 (C=N), 
161.3 (C=N), 157.6 (p-C6H5OCH3), 156.3 (p-C6H5OCH3), 139.1 (ipso-C6H4OCH3), 136.9 
(ipso-C6H4OCH3), 126.0 (m-C6H4OCH3), 124.9 (m-C6H4OCH3), 114.7 (o-C6H4OCH3), 
114.2 (o-C6H4OCH3), 67.2 (C=NCH imidazoline), 65.8 (C=NCH imidazoline), 59.8 (CH bridge), 
57.8 (CH bridge), 56.2 (CH2 imidazoline), 56.4 (CH2 imidazoline), 55.4 (C6H4OCH3), 52.5 (CH2 
imidazoline), 52.2 (CH2 imidazoline), 34.8 ((CH3)2CH), 34.3 ((CH3)2CH), 20.7 (CH3 isopropyl), 19.6 
(CH3 isopropyl), 19.3 (CH3 isopropyl), 15.8 (CH3 isopropyl), 2.7 (N(Si(CH3)3)2) ppm. IR data (KBr 
disc, cm-1): 3043 (w), 2957 (m), 2867 (m), 2835 (m), 2237 (w), 2086 (w), 1607 (s), 1578 
(m), 1537 (s), 1512 (s), 1463 (m), 1441 (w), 1384 (w), 1365 (w), 1277 (w), 1246 (s), 1206 
(w), 1178 (m), 1139 (w), 1103 (w), 1080 (w), 1039 (s), 834 (m), 808 (w), 783 (w), 724 
(w), 691 (w), 600 (w), 554 (m), 513 (w). 
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6.4.4.3 [Ca(ArMe-BIM)2] [11c] 
 
1H NMR data (THF-d8, 500.1 MHz, 293 K): δH = 7.04-6.97 (8 H, m, o-C6H4CH3), 6.96-
6.89 (8 H, m, m-C6H4CH3), 3.96-3.82 (4 H, m, NCH2CH), 3.72 (1 H, s, CH bridge), 3.70     
(1 H, s, CH bridge), 3.68 (2 H, app. t, 3JHH = 4.6 Hz,NCH2), 3.52 (2 H, app. t, 3JHH = 8.4 Hz, 
NCH2), 3.35 (2 H, m, NCH2), 3.26-3.91 (2 H, m, NCH2), 2.21 (6 H, s, C4H5CH3), 2.20      
(6 H, s, C4H5CH3), 2.10-1.96 (2 H, m, (CH3)2CH), 1.94-1.79 (2 H, m, (CH3)2CH), 0.89-
0.82 (12 H, m, CH(CH3)2), 0.81-0.72 (12 H, m, CH(CH3)2) ppm. 13C{1H} NMR data 
(THF-d8, 75.5 MHz, 293 K): δC = 164.4 (C=N), 164.2 (C=N), 163.5 (C=N), 163.4 (C=N), 
143.25 (ipso-C6H4CH3), 143.18 (ipso-C6H4CH3), 142.5 (ipso-C6H4CH3), 142.3             
(ipso-C6H4CH3), 132.7 (p-C6H4CH3), 131.3 (p-C6H4CH3), 130.4 (p-C6H4CH3), 130.0           
(p-C6H4CH3), 129.43 (o-C6H4CH3), 129.40 (o-C6H4CH3), 129. 38 (o-C6H4CH3), 129.37      
(o-C6H4CH3), 124.0 (m-C6H4CH3), 123.9 (m-C6H4CH3), 122.60 (m-C6H4CH3), 122.59        
(m-C6H4CH3), 66.42 (C=NCH imidazoline), 66.40 (C=NCH imidazoline), 66.25 (C=NCH 
imidazoline), 66.24 (C=NCH imidazoline), 55.7 (CH bridge), 52.0 (CH bridge), 51.9 (CH2 imidazoline), 
51.6 (CH2 imidazoline), 50.9 (CH2 imidazoline), 50.6 (CH2 imidazoline), 34.47 ((CH3)2CH), 34.42 
((CH3)2CH), 34.3 ((CH3)2CH), 34.2 ((CH3)2CH), 20.88 (C6H4CH3), 20.80 (C6H4CH3), 20.6 
(CH3 isopropyl), 20.4 (CH3 isopropyl), 15.7 (CH3 isopropyl), 15.4 (CH3 isopropyl) ppm.                       
IR data (KBr disc, cm-1): 3031 (w), 2962 (m), 2868 (w), 1603 (m), 1573 (w), 1515 (m), 
1478 (w), 1386 (w), 1361 (w), 1314 (w), 1260 (s), 1094 (s), 1018 (s), 798 (s), 705 (w), 614 
(w), 551 (m), 499 (w). 
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6.4.4.4 [Ca(Ph-BIM)2] [11d] 
 
1H NMR data (THF-d8, 500.1 MHz, 293 K): δH = 7.22-7.09 (16 H, m, o/m-C6H5), 6.93-
6.88 (2 H, m, p-C6H5), 6.84-6.71 (2 H, m, p-C6H5), 4.41 (1 H, br. s, CH bridge), 3.93-3.85    
(3 H, m, CH bridge and NCH2CH), 3.80 (2 H, t, 3JHH = 8.4 Hz, NCH2), 3.67-3.60 (2 H, m, 
NCH2CH), 3.46 (2 H, t, 3JHH = 8.4 Hz, NCH2), 3.39 (1 H, dd, 3JHH = 8.6 Hz, 3JHH = 2.7 Hz, 
NCH2), 3.31-3.23 (1 H, m, NCH2) 1.95-1.80 (2 H, m, (CH3)2CH), 1.67 (2 H, m, 
(CH3)2CH), 1.05 (6 H, d, 3JHH = 6.6 Hz, CH(CH3)2), 0.95 (6 H, app. t, 3JHH = 6.6 Hz, 
CH(CH3)2), 0.91-0.86 (6 H, m, (CH3)2CH), 0.81-0.77 (6 H, m, (CH3)2CH). 13C{1H} NMR 
data (THF-d8, 75.5 MHz, 293 K): δC = 164.0 (C=N), 163.9 (C=N), 160.1 (C=N), 160.0 
(C=N), 145.4 (ipso-C6H5), 145.3 (ipso-C6H5), 144.7 (ipso-C6H5), 144.6 (ipso-C6H5), 129.7 
(C6H5), 129.4 (C6H5), 129.0 (C6H5), 128.95 (C6H5), 128.9 (C6H5), 128.8 (C6H5), 128.87 
(C6H5), 128.9 (C6H5) 123.8 (p-C6H5), 123.7 (p-C6H5), 123.2 (p-C6H5), 122.4 (p-C6H5), 
67.7 (C=NCH
 imidazoline), 66.4 (C=NCH imidazoline), 65.7 (C=NCH imidazoline), 65.4 (C=NCH 
imidazoline), 60.2 (CH bridge), 57.9 (CH bridge), 55.4 (CH2 imidazoline), 55.3 (CH2 imidazoline), 51.5 
(CH2 imidazoline), 50.5 (CH2 imidazoline), 34.84 ((CH3)2CH), 34.80 ((CH3)2CH), 34.4 
((CH3)2CH), 34.3 ((CH3)2CH), 19.5 (CH3 isopropyl), 19.4 (CH3 isopropyl), 19.3 (CH3 isopropyl), 
19.2 (CH3 isopropyl), 15.8 (CH3 isopropyl), 15.6 (CH3 isopropyl), 15.4 (CH3 isopropyl), 15.2 (CH3 
isopropyl) ppm. IR data (KBr disc, cm-1): 3056 (w), 3037 (w), 2957 (s), 2867 (m), 1938 (w), 
1864 (w), 1787 (w), 1618 (s), 1592 (s), 1535 (s), 1496 (s), 1469 (m), 1405 (w), 1385 (m), 
1338 (w), 1307 (m), 1260 (s), 1199 (m), 1171 (w), 1123 (w), 1107 (w), 1066 (w), 1042 
(w), 903 (w), 800 (m), 752 (m), 723 (w), 695 (m), 647 (w), 553 (m), 503 (w). 
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6.4.4.5 [Ca(ArNO2-BIM)2] [11e] 
 
1H NMR data (THF-d8, 500.1 MHz, 293 K): δH = 8.17 (8 H, d, 3JHH = 8.4 Hz,                    
m-C6H4NO2), 7.34 (8 H, d, 3JHH = 7.6 Hz, o-C6H4NO2), 4.81 (1 H, s, CH bridge), 4.80 (1 H, 
s, CH bridge), 3.98 (4 H, t, 3JHH = 8.5 Hz, NCH2), 3.75 (4 H, m, NCH2CH), 3.65 (4 H, m, 
NCH2), 1.77 (4 H, m, (CH3)2CH), 1.05 (12 H, d, 3JHH = 6.6 Hz, CH(CH3)2), 0.97 (12 H, d, 
3JHH = 6.6 Hz, CH(CH3)2) ppm. 13C{1H} NMR data (THF-d8, 75.5 MHz, 293 K):              
δC = 158.1 (C=N), 148.6 (p-C6H4NO2), 142.4 (ipso-C6H4NO2), 125.7 (m-C6H4NO2), 119.7 
(o-C6H4NO2), 65.4 (C=NCH imidazoline), 65.2 (CH bridge), 55.0 (CH2 imidazoline), 34.6 
((CH3)2CH), 34.42 ((CH3)2CH), 19.2 (CH3 isopropyl), 19.0 (CH3 isopropyl) ppm. IR data (KBr 
disc, cm-1): 3386 (br. w), 3114 (w), 3078 (w), 2949 (m), 2869 (m), 2632 (w), 2438 (w), 
2293 (w), 2222 (w), 1624 (m), 1595 (s), 1549 (m), 1502 (s), 1430 (w), 1382 (w), 1365 (w), 
1327 (s), 1260 (s), 1180 (m), 1140 (w), 1112 (s), 1039 (m), 851 (w), 801 (m), 752 (m), 693 
(w), 661 (w), 627 (w), 547 (w), 512 (w), 483 (w).  
 
6.4.4.6 [Ca(Ar3,5Me-BIM)2] [11f] 
 
1H NMR data (THF-d8, 500.1 MHz, 293 K): δH = 6.78 (4 H, s, o-C6H3(CH3)2), 6.70 (4 H, 
s, o-C6H3(CH3)2), 6.60 (2 H, s, p-C6H3(CH3)2), 6.50 (2 H, s, p-C6H3(CH3)2), 4.33 (1 H, s, 
CH bridge), 4.32 (1 H, s, CH bridge), 3.89 (2 H, m, NCH2CH), 3.74 (2 H, m, NCH2), 3.60      
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(2 H, m, NCH2), 3.59 (2 H, m, NCH2CH), 3.41 (2 H, m, NCH2), 3.32 (2 H, dd, 3JHH = 8.5 
Hz, 3JHH = 2.2 Hz, NCH2), 2.21 (12 H, s, C6H3(CH3)2), 2.12 (12 H, s, C6H3(CH3)2), 2.03    
(2 H, m, (CH3)2CH), 1.65 (2 H, m, (CH3)2CH), 1.04 (6 H, d, 3JHH = 6.6 Hz, CH(CH3)2), 
0.93 (6 H, d, 3JHH = 6.6 Hz, CH(CH3)2), 0.90 (6 H, d, 3JHH = 6.8 Hz, CH(CH3)2), 0.78 (6 H, 
d, 3JHH = 6.8 Hz, CH(CH3)2), 0.11 (18 H, s, N(Si(CH3)3) ppm. 13C{1H} NMR data          
(THF-d8, 75.5 MHz, 293 K): δC = 164.5 (C=N), 164.3 (C=N), 160.6 (C=N), 160.5 (C=N), 
145.5 (ipso-C6H3CH3), 145.3 (ipso-C6H3CH3), 144.6 (ipso-C6H4CH3), 138.2                    
(m-C6H3(CH3)2), 138.0 (m-C6H3(CH3)2), 125.2 (p-C6H3(CH3)2), 124.2 (p-C6H3(CH3)2), 
124.0 (p-C6H3(CH3)2), 123.6 (o-C6H3(CH3)2), 123.5 (o-C6H3(CH3)2), 123.4                       
(o-C6H3(CH3)2), 65.6 (C=NCH imidazoline), 65.4 (C=NCH imidazoline), 66.2 (C=NCH imidazoline), 
66.0 (C=NCH
 imidazoline) 57.6 (CH bridge), 55.7 (CH bridge), 52.0 (CH2 imidazoline), 51.8 (CH2 
imidazoline), 51.6 (CH2 imidazoline), 51.4 (CH2 imidazoline), 34.9 ((CH3)2CH), 34.8 ((CH3)2CH), 
34.4 ((CH3)2CH), 34.3 ((CH3)2CH), 21.6 (C6H3(CH3)2), 21.58 (C6H3(CH3)2), 21.5 
(C6H3(CH3)2), 21.4 (C6H3(CH3)2), 20.8 (CH3 isopropyl), 20.5 (CH3 isopropyl), 19.5 (CH3 isopropyl), 
19.4 (CH3 isopropyl), 15.75 (CH3 isopropyl), 15.71 (CH3 isopropyl), 15.6 (CH3 isopropyl), 15.2 (CH3 
isopropyl) ppm. IR data (KBr disc, cm-1): 3011 (w), 2954 (s), 2919 (s), 2866 (s), 2729 (w), 
1621 (s), 1591 (s), 1541 (s), 1470 (s), 1376 (m), 1335 (w), 1312 (w), 1283 (w), 1258 (m), 
1198 (m), 1165 (w), 1124 (m), 1078 (w), 1044 (m), 950 (w), 926 (w), 871 (w), 834 (m), 
722 (w), 697 (m), 640 (w), 606 (w), 594 (w), 570 (w), 534 (w), 495 (w), 418 (w). 
 
6.4.4.7 [Ca(PhMeH-BIM)2] [11g] 
 
1H NMR data (THF-d8, 500.1 MHz, 293 K): δH = 7.31-7.24 (16 H, m, o- & m-C6H5,),     
7.19-7.14 (4 H, m, p-C5H5), 4.76 (4 H, q, 3JHH = 6.9 Hz, CH(CH3)(C6H5)), 3.96 (1 H, br. s 
CH bridge), 3.95 (1 H, br. s CH bridge), 3.45 (4 H, app. q, 3JHH = 7.9 Hz, NCH2CH), 3.30 (4 H, 
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t, 3JHH = 8.7 Hz, NCH2), 2.66 (4 H, t, 3JHH = 8.2 Hz, NCH2), 1.53 (4 H, m, (CH3)2CH 
partially overlapping with adjacent peak), 1.47 (12 H, d, 3JHH = 6.9 Hz, CH(CH3)(C6H5)), 
0.90 (12 H, d, 3JHH = 6.6 Hz, CH(CH3)2), 0.78 (12 H, d, 3JHH = 6.6 Hz, CH(CH3)2). 
13C{1H} NMR data (THF-d8, 75.5 MHz, 293 K): δC = 163.2 (C=N), 143.1 (ipso-C6H5), 
128.9 (o/m-C6H5), 127.8 (o/m-C6H5), 127.5 (p-C6H5), 65.6 (C=NCH imidazoline), 57.2          
(CH bridge), 52.6 (CH(CH3)(C6H5)), 48.2 (CH2 imidazoline), 34.8 ((CH3)2CH), 19.6              
(CH3 isopropyl), 19.3 (CH(CH3)(C6H5)), 17.6 (CH3 isopropyl) ppm. IR data (KBr disc, cm-1): 
3650 (br. w), 3208 (br. m), 3086 (m), 3060 (m), 3028 (m), 2957 (s), 2869 (s), 2236 (w), 
2193 (w), 1949 (w), 1877 (w), 1806 (w), 1611 (s), 1539 (s), 1494 (s), 1449 (s), 1378 (m), 
1261 (s), 1221 (s), 1179 (m), 1142 (m), 1087 (m), 1065 (m), 1024 (s), 976 (w), 911 (w), 
839 (w), 784 (m), 753 (w), 699 (s), 604 (w), 589 (w), 530 (w). 
 
6.4.4.8 [Ca(iPr-BIM)2] [11h] 
 
1H NMR data (THF-d8, 500.1 MHz, 293 K): δH = 3.71 (6 H, m, NCH(CH3)3 and CH bridge), 
3.41 (4 H, app. q, 3JHH = 8.4 Hz, NCH2CH), 3.25 (4 H, t, 3JHH = 8.4 Hz, NCH2), 2.82 (4 H, 
t, 3JHH = 8.4 Hz, NCH2), 1.56 (4 H, m, (CH3)2CH), 1.13 (12 H, NCH(CH3)2), 1.05 (12 H, 
NCH(CH3)2), 0.96 (12 H, CH(CH3)2), 0.86 (12 H, CH(CH3)2) ppm. 13C{1H} NMR data 
(THF-d8, 75.5 MHz, 293 K): δC = 163.2 (C=N), 65.3 (C=NCH imidazoline), 56.8 (CH bridge), 
47.1 (CH2 imidazoline), 45.7 (NCH(CH3)2), 34.8 ((CH3)2CH), 20.6 (NCH(CH3)2), 19.7            
(CH3 isopropyl), 19.3 (CH3 isopropyl), 18.1 (NCH(CH3)2) ppm. IR data (KBr disc, cm-1): 3329 
(br. w), 3257 (br. w), 3111 (w), 2960 (s), 2868 (m), 2820 (m), 2241 (w), 2126 (w), 1612 
(s), 1563 (s), 1540 (s), 1502 (m), 1469 (m), 1427 (m), 1386 (m), 1361 (m), 1282 (m), 1262 
(s), 1237 (m), 1216 (m), 1177 (w), 1141 (m), 1104 (m), 1062 (s), 1032 (m), 978 (w), 918 
(w), 886 (w), 801 (m), 737 (m), 713 (w), 658 (w), 618 (w), 603 (w), 549 (w), 518 (w), 465 
(w), 437 (w), 417 (w).  
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6.4.4.9 [Ca(tBu-BIM)2] [11i] 
 
1H NMR data (THF-d8, 500.1 MHz, 293 K): δH = 3.70 (2 H, s, CH bridge), 3.50 (4 H, dt, 
3JHH = 9.1 Hz, 4JHH = 2.7 Hz, NCH2CH), 3.14 (4 H, dd, 3JHH = 8.0 Hz, 4JHH = 2.7 Hz, 
NCH2), 3.05 (4 H, app. t, 3JHH = 9.1 Hz, NCH2), 1.83-1.75 (4 H, m, (CH3)2CH), 1.37 (36 H, 
br. s, C(CH3)3), 0.82 (12 H, d, 3JHH = 6.9 Hz, CH(CH3)2), 0.73 (12 H, d, 3JHH = 6.9 Hz, 
CH(CH3)2) ppm. 13C{1H} NMR data (THF-d8, 75.5 MHz, 293 K): δC = 166.6 (C=N), 166.4 
(C=N), 65.3 (C=NCH
 imidazoline), 64.3 (C=NCH imidazoline), 62.0 (CH bridge), 61.8 (CH bridge), 
52.9 (C(CH3)3), 52.7 (C(CH3)3), 47.9 (CH2 imidazoline), 47.8 (CH2 imidazoline), 35.5 ((CH3)2CH), 
35.2 ((CH3)2CH), 30.0 (C(CH3)2), 29.82 (C(CH3)2), 20.9 (CH3 isopropyl), 20.2 (CH3 isopropyl), 
16.2 (CH3 isopropyl), 15.7 (CH3 isopropyl) ppm. IR data (KBr disc, cm-1): 2955 (s), 2866 (s), 
1601 (s), 1526 (s), 1467 (m), 1442 (w), 1393 (m), 1363 (m), 1313 (w), 1259 (s), 1229 (s), 
1174 (w), 1100 (s), 1016 (s), 927 (w), 863 (m), 793 (s), 734 (w), 699 (w), 659 (w), 545 
(w), 520 (w), 466 (w) 
 
6.4.4.10 [Ca(ArNMe2-BIM)2] [11j] 
 
1H NMR data (THF-d8, 500.1 MHz, 293 K): δH = 6.89 (8 H, d, 3JHH = 8.3 Hz,                    
m-C6H4N(CH3)2), 6.54 (8 H, d, 3JHH = 8.3 Hz, o-C6H4N(CH3)2), 3.92-3.86 (4 H, br. m, 
NCH2CH), 3.48-3.41 (6 H, br. m, NCH2 and CH bridge), 3.32-3.25 (4 H, br. t, 3JHH = 8.2 Hz, 
NCH2), 2.83 (24 H, br. s, C6H4N(CH3)2), 2.37-2.25 (4 H, br. m, (CH3)2CH), 0.85 12 H,    
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br. d, 3JHH = 6.7 Hz, CH(CH3)2), 0.77 (12 H, br. d, 3JHH = 6.7 Hz, CH(CH3)2) ppm. 13C{1H} 
NMR data (THF-d8, 75.5 MHz, 293 K): δC = 165.6 (C=N), 147.9 (p-C6H4N(CH3)2), 133.9 
(ipso-C6H4N(CH3)2), 125.86 (m-C6H4N(CH3)2), 113.8 (o-C6H4N(CH3)2), 66.3 (C=NCH 
imidazoline), 57.6 (CH bridge), 52.1 (CH2 imidazoline), 43.0 (C6H4N(CH3)2), 32.0 ((CH3)2CH), 20.4 
(CH3 isopropyl), 14.9 (CH3 isopropyl) ppm. IR data (KBr disc, cm-1): 3434 (br. m), 3222 (br. m), 
2956 (m), 2890 (m), 2866 (m), 2814 (w), 2238 (w), 2116 (w), 1609 (s), 1560 (m), 1546 (s), 
1522 (s), 1471 (m), 1445 (m), 1387 (w), 1375 (w), 1357 (m), 1332 (m), 1316 (m), 1273 
(m), 1258 (m), 1231 (w), 1205 (m), 1188 (m), 1168 (m), 1139 (m), 1111 (m), 1083 (w), 
1057 (m), 943 (w), 819 (m), 799 (m), 750 (w), 725 (w), 668 (w), 636 (w), 581 (w), 553 
(w), 457 (w).  
 
6.5 Experimental and Characterisation Data for Chapter Five 
6.5.1 Preparation of ethyl 2-cyanoacetimidate hydrochloride [4.9] 
 
Prepared from modified literature procedures.16 To a solution of malononitrile (10 g,      
0.15 mol), in dry diethyl ether (300 ml), ethanol (19.70 ml, 0.33 mol) was added. Dry 
HCl(g) was then passed through the solution for 6 hours where upon the system was sealed 
and allowed to stir under an HCl atmosphere for a further 18 hours. The solution was 
filtered away from the resulting white, ethyl 2-cyanoacetimidate hydrochloride precipitate. 
The precipitate was then washed with dry diethyl ether (20 ml) and the washings 
discarded. The solid product was then dried in vacuo and stored in a glove box, giving near 
quantitative yields.16  
1H NMR data ((CD3)2SO, 400.1 MHz, 293 K): δH = 7.77 (2 H, br. s, NH2), 4.15 (2 H, q, 
3JHH = 7.1 Hz, CH3CH2O), 4.01 (2 H, s, CH2C≡N), 1.20 (3 H, t, 3JHH = 7.1 Hz, CH3CH2O) 
ppm. 13C{1H} NMR data ((CD3)2SO, 62.9 MHz, 293 K): δC = 164.3 (C=N), 115.1 (C≡N), 
61.9 (CH3CH2O), 24.5 (CH2C≡N), 13.9 (CH3CH2O) ppm. IR data (KBr pellet, cm-1): 2917 
(s), 2640 (s), 2392 (w), 2302 (w), 2265 (m, υC≡N), 2210 (w), 2060 (w), 1744 (s), 1651(s, 
υC=N), 1560 (m), 1466 (w), 1448 (m), 1383 (s), 1361 (m), 1337 (w), 1311 (m), 1264 (w), 
1200 (m), 1148 (m), 1129 (s), 1077 (s), 1027 (s), 1002 (s), 984 (w), 927 (s), 875 (w), 841 
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(m), 821 (s), 795 (w), 768 (w), 638 (m). Accurate mass ES-MS: no identifiable peaks 
obtained.
 
 
6.5.2 Preparation of Monocyclised imidazolines R-MIM [13a-f] 
Prepared according to modified literature procedures.14,17 Under an inert atmosphere of 
argon, ethyl 2-cyanoacetimidate hydrochloride 4.9 (ca. 0.6 g, 26 mmol) and ethylene 
diamine analogues HNNR 4a-f (1 g, ca. 52 mmol) were dissolved in dry dichloromethane 
and heated at vigorous reflux for 2 days. Proceeding such time the solution was allowed to 
cool and was washed with NaHCO3 (10%, 2 × 25 ml). The organic washings were 
combined and subsequently reduced in volume under reduced pressure. The relevant 
monoimidazoline R-MIM (13a-f) was realised by recrystallisation from dichloromethane 
and n-hexane at -20 °C. 
 
6.5.2.1 [ArF-MIM] [13a] 
 
1H NMR data (CDCl3, 500.1 MHz, 293 K): δH = 7.19 (2 H, dd, 3JHH = 8.9 Hz,                 
4JHF = 4.7 Hz, o-C6H4F), 7.07 (2 H, app. t, 3JHF = 8.3 Hz, m-C6H4F), 3.89 (1 H, t, 3JHH = 8.4 
Hz, NCH2), 3.66 (1 H, m, C=NCH), 3.66 (1 H, t, 3JHH = 8.5 Hz, NCH2), 3.13 (1 H, br. s, 
CH
 bridge), 1.89 (1 H, m, (CH3)2CH), 1.00 (3 H, d, 3JHH = 6.7 Hz, CH3 isopropyl), 0.94 (3 H, d, 
3JHH = 6.8 Hz, CH3 isopropyl) ppm. 19F NMR data (CDCl3, 282.8 MHz, 293 K): δF = -114.81         
(s, p-C6H4F) ppm. 13C{1H} NMR data (CDCl3, 125.75 MHz, 293 K): δC = 162.9 (C=N), 
160.5 (d, 1JCF = 246.8 Hz, p-C6H4F), 135.8 (d, 4JCF = 2.9 Hz, ipso-C6H4F) 126.0                 
(d,              3JCF = 8.5 Hz, o-C6H4F), 123.3 (C≡N), 116.3 (d, 2JCF = 22.9 Hz, m-C6H4F), 59.9                        
(C=NCH
 imidazoline), 55.2 (CH2 imidazoline), 37.3 (CH bridge), 32.5 ((CH3)2CH), 18.5 (CH3 
isopropyl), 18.0 (CH3 isopropyl) ppm. IR data (KBr pellet, cm-1): 3235 (m), 3097 (w), 2963 (s), 
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2871 (w), 2176 (s, υC≡N), 1893 (w), 1731 (m), 1612 (s, υC=N), 1591 (s), 1508 (s), 1485 (m), 
1465 (w), 1415 (w), 1386 (w), 1368 (w), 1344 (w), 1261 (s), 1216 (m), 1095 (s), 1020 (s), 
940 (w), 799 (s), 719 (m), 703 (m), 660 (m), 596 (m), 576 (m), 511 (w). Accurate mass 
ES-MS for [ArF-MIM+H]+, found (calc. for C14H17N3F) 246.1402 (246.1407). 
 
6.5.2.2 [ArOMe-MIM] [13b] 
 
1H NMR data (CDCl3, 500.1 MHz, 293 K): δH = 7.13 (2 H, d, 3JHH = 8.9 Hz,                      
o-C6H4OCH3), 6.89 (2 H, d, 3JHH = 8.9 Hz, m-C6H4OCH3), 3.86 (1 H, t, 3JHH = 8.5 Hz, 
NCH2), 3.81 (3 H, s, C6H5OCH3), 3.63 (1 H, m, C=NCH), 3.52 (1 H, dd, 2JHH = 8.8 Hz, 
3JHH = 7.7 Hz, NCH2), 3.06 (1 H, s, CH bridge), 1.79 (1 H, m, (CH3)2CH), 1.00 (3 H, d, 3JHH 
= 6.7 Hz, CH3 isopropyl), 0.94 (3 H, d, 3JHH = 6.7 Hz, CH3 isopropyl) ppm. 13C{1H} NMR data 
(CDCl3, 125.75 MHz, 293 K): δC = 163.4 (C=N), 158.0 (ipso-C6H4OCH3), 132.6              
(p-C6H4OCH3), 126.1 (o-C6H4OCH3), 123.7 (C≡N), 114.7 (m-C6H4OCH3), 66.1 (C=NCH 
imidazoline), 55.6 (CH2 imidazoline), 55.5 (C6H4OCH3) 36.6 (CH bridge), 32.6 ((CH3)2CH), 18.5 
(CH3 isopropyl), 18.2 (CH3 isopropyl) ppm. IR data (KBr pellet, cm-1): 3268 (s), 2959 (s), 2840 
(m), 2350 (w), 2173 (s υC≡N), 1889 (w), 1770 (w), 1606 (s, υC=N), 1510 (s), 1463 (s), 1418 
(m), 1389 (m), 1371 (m), 1352 (w), 1338 (w), 1326 (w), 1288 (m), 1247 (s), 1180 (m), 
1164 (m), 1143 (w), 1101 (m), 1072 (w), 1038 (s), 937 (w), 839 (s), 822 (m), 746 (w), 727 
(w), 689 (w), 639 (w), 607 (m), 582 (s), 568 (s), 515 (w). Accurate mass ES-MS for                                     
[ArOMe-MIM+H]+, found (calc. for C15H20N3O1) 258.1600 (258.1606). 
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6.5.2.3 [ArMe-MIM] [13c] 
 
1H NMR data (CDCl3, 500.1 MHz, 293 K): δH = 7.16 (2 H, d, 3JHH = 8.1 Hz, m-C6H4CH3), 
7.09 (2 H, d, 3JHH = 8.4 Hz, o-C6H4CH3), 3.89 (1 H, t, 3JHH = 8.4 Hz, NCH2), 3.64 (1 H, m, 
C=NCH), 3.54 (1 H, dd, 2JHH = 8.8 Hz, 3JHH = 7.5 Hz, NCH2), 3.19 (1 H, br. s, CH bridge), 
2.33 (3 H, s, C6H4CH3) 1.79 (1 H, m, (CH3)2CH), 0.99 (3 H, d, 3JHH = 6.7 Hz, CH3 isopropyl), 
0.93 (3 H, d, 3JHH = 6.8 Hz, CH3 isopropyl) ppm. 13C{1H} NMR data (CDCl3, 125.75 MHz, 
293 K): δC = 162.7 (C=N), 137.2 (ipso-C6H4CH3), 135.9 (p-C6H4CH3), 130.0 (m-
C6H4CH3), 125.2 (C≡N), 123.7 (o-C6H4CH3), 59.8 (C=NCH imidazoline), 55.0 (CH2 imidazoline), 
32.8 (CH bridge), 32.6 ((CH3)2CH), 20.8 (C6H4CH3) 18.4 (CH3 isopropyl), 18.0 (CH3 isopropyl) 
ppm. IR data (KBr pellet, cm-1): 3311 (s), 3228 (s), 3105 (w), 3032 (w), 2962 (w), 2926 
(s), 2875 (m), 2852 (m), 2185 (s), 2174 (s, υC≡N), 1911 (w), 1802 (w), 1773 (w), 1734 (w), 
1620 (s, υC=N), 1598 (s, υC=N), 1574 (m), 1512 (s), 1483 (s), 1459 (s), 1422 (m), 1388 (m), 
1370 (m), 1338 (w), 1317 (s), 1303 (s), 1278 (m), 1241 (m), 1208 (w), 1174 (w), 1148 (w), 
1121 (m), 1080 (m), 1040 (m), 1017 (m), 993 (m), 857 (w), 826 (s), 777 (w), 755 (w), 717 
(m), 688 (m), 640 (w), 583 (s), 565 (s), 508 (m). Accurate mass ES-MS for                 
[ArMe-MIM+H]+, found (calc. for C15H20N3) 242.1660 (242.1657). 
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6.5.2.4 [Ph-MIM] [13d] 
 
1H NMR data (CDCl3, 500.1 MHz, 293 K): δH = 7.35 (2 H, app. t, 3JHH = 7.4 Hz, m-C6H5), 
7.21 (2 H, d, 3JHH = 8.6 Hz, o-C6H5), 7.16 (1 H, m, p-C6H5), 3.93 (1 H, t, 3JHH = 8.3 Hz, 
NCH2), 3.64 (1 H, m, C=NCH), 3.60 (1 H, m, NCH2), 3.30 (1 H, br. s, CH bridge), 1.80 (1 H, 
m, (CH3)2CH), 1.00 (3 H, d, 3JHH = 6.7 Hz, CH3 isopropyl), 0.94 (3 H, d, 3JHH = 6.8 Hz, CH3 
isopropyl) ppm. 13C{1H} NMR data (CDCl3, 125.75 MHz, 293 K): δC = 162.3 (C=N), 139.9 
(ipso-C6H5), 129.4 (m-C6H5), 129.3 (p-C6H5), 125.9 (C≡N), 123.6 (o-C6H5), 59.8 (C=NCH 
imidazoline), 54.9 (CH2 imidazoline), 37.3 (CH bridge), 32.6 ((CH3)2CH), 18.5 (CH3 isopropyl), 18.1 
(CH3 isopropyl) ppm. IR data (KBr pellet, cm-1): 3247 (s), 3097 (w), 3040 (w), 2958 (s), 2868 
(s), 2350 (w), 2335 (w), 2259 (w), 2172 (s υC≡N), 1958 (w), 1887 (w), 1828 (w), 1667 (w), 
1612 (s, υC=N), 1589 (s, υC=N), 1498 (s), 1463 (s), 1451 (s), 1388 (m), 1369 (m), 1343 (m), 
1318 (m), 1301 (m), 1283 (m), 1243 (m), 1208 (m), 1179 (m), 1146 (m), 1130 (m), 1074 
(m), 1041 (w), 1023 (w), 1002 (w), 989 (w), 916 (w), 854 (w), 769 (s), 751 (m), 702 (s), 
692 (m). Accurate mass ES-MS for [ArH-MIM+H]+, found (calc. for C14H18N3) 228.1495 
(228.1501). 
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6.5.2.5 [ArNO2-MIM] [13e] 
 
1H NMR data (CDCl3, 500.1 MHz, 293 K): δH = 8.02 (2 H, d, 3JHH = 8.9 Hz, m-C6H4NO2), 
6.05 (2 H, d, 3JHH = 8.9 Hz, o-C6H4NO2), 3.28 (1 H, m, NCH2), 2.90 (1 H, m, NCH2), 2.74 
(1 H, m, C=NCH), 2.27 (1 H, br. s, CH
 bridge), 1.67 (1 H, m, (CH3)2CH), 0.96 (3 H, d, 3JHH 
= 3.3 Hz, CH3 isopropyl), 0.95 (3 H, d, 3JHH = 3.3 Hz, CH3 isopropyl) ppm. 13C{1H} NMR data 
(CDCl3, 125.75 MHz, 293 K): δC = 160.7 (C=N), 153.7 (p-C6H4NO2), 137.5 (ipso-
C6H4NO2), 126.3 (m-C6H4NO2), 125.1 (C≡N), 111.0 (o-C6H4NO2), 60.4 (CH bridge), 55.6 
(C=NCH
 imidazoline), 46.5 (CH2 imidazoline), 32.6 ((CH3)2CH), 19.1 (CH3 isopropyl), 17.8 (CH3 
isopropyl) ppm. IR data (KBr pellet, cm-1): 3349 (w), 3241 (w), 3182 (w), 3048 (w), 2936 
(w), 2924 (w), 2872 (w), 2194 (s υC≡N), 1598 (s, υC=N), 1506 (m), 1466 (m), 1304 (s), 1183 
(m), 1113 (s), 1055 (w), 935 (w), 868 (w), 827 (m), 752 (m), 695 (w), 639 (w). Accurate 
mass ES-MS: no identifiable fragments observed.  
 
6.5.2.6 [Ar3,5Me-MIM] [13f] 
 
1H NMR data (CDCl3, 500.1 MHz, 293 K): δH = 6.83 (1 H, s, p-C6H3(CH3)2), 6.82 (2 H, s, 
m-C6H3(CH3)2), 3.89 (2 H, app. t, 2JHH = 8.4 Hz, NCH2), 3.63 (1 H, m, C=NCH), 3.56 (1 
H, d.d, 2JHH = 8.4 Hz, 3JHH = 7.5 Hz, NCH2), 3.29 (1 H, br. s, CH bridge), 2.30 (6 H, s, 
C6H4(CH3)2, 1.79 (1 H, m, (CH3)2CH), 1.00 (3 H, d, 3JHH = 6.7 Hz, CH3 isopropyl), 0.94 (3 H, 
d, 3JHH = 6.7 Hz, CH3 isopropyl) ppm. 13C{1H} NMR data (CDCl3, 125.75 MHz, 293 K): δC = 
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162.4 (C=N), 139.8 (ipso-C6H3(CH3)2), 139.2 (m-C6H3(CH3)2), 127.6 (p-C6H3(CH3)2), 
123.6 (C≡N), 121.3 (o-C6H3(CH3)2), 59.8 (C=NCH imidazoline), 55.0 (CH2 imidazoline), 37.2 
(CH bridge), 32.6 ((CH3)2CH), 21.2 (C6H3(CH3)2), 18.5 (CH3 isopropyl), 18.1 (CH3 isopropyl) 
ppm. IR data (KBr pellet, cm-1): 3463 (w), 3270 (m), 3237 (m), 3112 (w), 3047 (w), 3012 
(w), 2964 (m), 2915 (w), 2867 (m), 2178 (s υC≡N), 1614 (s, υC=N), 1587 (s) 1480 (s), 1389 
(m), 1369 (m), 1333 (m), 1318 (w), 1305 (w), 1284 (m), 1242 (m), 1228 (w), 1194 (w), 
1179 (w), 1146 (w), 1132 (w), 1076 (w), 1053 (w), 1015 (w), 981 (w), 950 (w), 914 (w), 
893 (w), 847 (s), 803 (w), 700 (m), 689 (m), 655 (w), 608 (m), 596 (m) Accurate mass ES-
MS for [Ar3,5Me-MIM+H]+, found (calc. for C29H41N4) 445.3343 (445.3331). 
 
6.5.2.7 [14] 
 
1H NMR data ((CD3)2SO, 400.1 MHz, 293 K) δH = 7.55 (2 H, d.d, 3JHH = 4.9 Hz, 4JHF = 4.1 
Hz, o-C6H4F), 7.39 (2 H, app. t, 3JHH = 8.7 Hz, m-C6H4F), 4.37 (1 H, t, 3JHH = 10.8 Hz, 
NCH2), 4.18 (1 H, m, C=NCH), 4.07 (1 H, m, NCH2), 1.90 (1 H, m, (CH3)2CH), 0.98 (3 H, 
d, 3JHH = 6.7 Hz, CH3 isopropyl), 0.95 (3 H, d, 3JHH = 6.8 Hz, CH3 isopropyl), (CH bridge not 
observed) ppm. 19F NMR data ((CD3)2SO, 282.8 MHz, 293 K): δF = -111.99 (s, p-C6H4F) 
ppm. 13C{1H} NMR data ((CD3)2SO, 75.5 MHz, 293 K): δC = 165.4 (C=O) 163.6 (C=N), 
161.6 (d, 1JCF = 246.3 Hz, p-C6H4F), 131.9 (d, 4JCF = 2.6 Hz, ipso-C6H4F) 128.0 (d, 3JCF = 
9.0 Hz, o-C6H4F), 116.6 (d, 2JCF = 22.9 Hz, m-C6H4F), 60.9 (C=NCH imidazoline), 55.5 (CH2 
imidazoline), 32.9 (CH bridge), 31.5 ((CH3)2CH), 17.28 (CH3 isopropyl), 17.23 (CH3 isopropyl) ppm. 
IR data (KBr pellet, cm-1): 3335 (br. s), 3185 (br. s), 2964 (s), 2209 (w), 1739 (w), 1668 (s 
υC=O), 1611 (s, υC=N), 1510 (s), 1466 (m), 1395 (m), 1348 (w), 1320 (m), 1286 (m), 1261 
(m), 1225 (s), 1158 (m), 1098 (m), 1070 (w), 1017 (m), 926 (w), 845 (m), 826 (w), 803 
(m), 714 (w), 606 (m), 552 (m). Accurate mass ES-MS [ArF-M+H]+, found (calc. for 
C14H19N3OF) 264.1518 (264.1512). 
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Appendix A: Product Conversion Curves for Chapter Three 
1. [Ca{N(SiMe3)2}2(THF)2] 
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293 K, 10 mol% catalyst, substrate A, initial rate: 5.0(2) ×10-5 mol dm-3 s-1
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2. [Ca(NNArOMe){N(SiMe3)2}(THF)n] [5b] 
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323 K, 10 mol% catalyst, substrate A, initial rate: 2.4(1) ×10-7 mol dm-3 s-1
.
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3. [Ca(NNArMe){N(SiMe3)2}(THF)n] [5c] 
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293 K, 10 mol% catalyst, substrate A, initial rate: 1.1(1) ×10-6 mol dm-3 s-1
.
 
 
 
4. [Ca(NNPh){N(SiMe3)2}(THF)n] [5d] 
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323 K, 10 mol% catalyst, substrate A, initial rate: 5.2(2) ×10-6 mol dm-3 s-1
.
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5. [Ca(NNiPr){N(Si(CH3)3)2}(THF)n] [5e] 
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293 K, 10 mol% catalyst, substrate A, initial rate: 2.3(1) ×10-6 mol dm-3 s-1
.
 
 
6.  [Ca(NNtBu){N(SiMe3)2}(THF)n] [5f] 
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293 K, 10 mol% catalyst, substrate A, initial rate: 5.9(8) ×10-7 mol dm-3 s-1
.
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7. [Ca(NNArOMe){N(SiMe3)2}(THF)n] [5b] 
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293 K, 10 mol% catalyst, substrate B, initial rate: 5.6(3) ×10-5 mol dm-3 s-1
.
 
 
8. [Ca(NNArMe){N(SiMe3)2}(THF)n] [5c] 
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293 K, 10 mol% catalyst, substrate B, initial rate: 4.3(2) ×10-6 mol dm-3 s-1
.
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9. [Ca(NNPh){N(SiMe3)2}(THF)n] [5d] 
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293 K, 10 mol% catalyst, substrate B, initial rate: 3.0(1) ×10-5 mol dm-3 s-1
.
 
 
10. [Ca(NNiPr){N(SiMe3)2}(THF)n] [5e] 
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293 K, 10 mol% catalyst, substrate B, initial rate: 4.9(2) ×10-5 mol dm-3 s-1
.
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11.  [Ca(NNtBu){N(SiMe3)2}(THF)n] [5f] 
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293 K, 10 mol% catalyst, substrate B, initial rate: 1.1(1) ×10-4 mol dm-3 s-1
.
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Appendix B: Product Conversion Curves for Chapter Four 
1. [Ca(ArF-BIM){N(SiMe3)2}(THF)] [9a] 
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293 K, 10 mol% catalyst, substrate A, initial rate: 6.8(3) ×10-8 mol dm-3 s-1
.
 
 
2. [Ca(ArOMe-BIM){N(SiMe3)2}(THF)] [9b] 
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293 K, 10 mol% catalyst, substrate A, initial rate: 7.2(3) ×10-6 mol dm-3 s-1
.
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3. [Ca(ArMe-BIM){N(SiMe3)2}(THF)] [9c]  
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293 K, 10 mol% catalyst, substrate A, initial rate: 5.1(5) ×10-7 mol dm-3 s-1
.
 
 
4. [Ca(Ph-BIM){N(SiMe3)2}(THF)] [9d]  
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293 K, 10 mol% catalyst, substrate A, initial rate: 9.5(4) ×10-8 mol dm-3 s-1
.
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5. [Ca(Ar3,5Me-BIM){N(SiMe3)2}(THF)] [9f] 
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293 K, 10 mol% catalyst, substrate A, initial rate: 8.5(4) ×10-7 mol dm-3 s-1
.
 
 
6. [Ca(tBu-BIM){N(SiMe3)2}(THF)] [9i] 
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293 K, 10 mol% catalyst, substrate A, initial rate: 7.3(4) ×10-7 mol dm-3 s-1
.
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7. [Ca(ArF-BIM){N(SiMe3)2}(THF)] [9a] 
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293 K, 10 mol% catalyst, substrate B, initial rate: 1.8(1) ×10-5 mol dm-3 s-1
.
 
 
8. [Ca(ArF-BIM){N(SiMe3)2}(THF)] [9a] 
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293 K, 20 mol% catalyst, substrate B, initial rate: 4.0(3) ×10-5 mol dm-3 s-1
.
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9. [Ca(ArOMe-BIM){N(SiMe3)2}(THF)] [9b] 
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293 K, 10 mol% catalyst, substrate B, initial rate: 9.7(4) ×10-5 mol dm-3 s-1
.
 
 
10. [Ca(ArMe-BIM){N(SiMe3)2}(THF)] [9c] 
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293 K, 10 mol% catalyst, substrate B, initial rate: 1.0(1) ×10-4 mol dm-3 s-1
.
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11. [Ca(ArMe-BIM){N(SiMe3)2}(THF)] [9c]  
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293 K, 5 mol% catalyst, substrate B, initial rate: 2.5(1) ×10-6 mol dm-3 s-1
.
 
 
12. [Ca(ArMe-BIM){N(SiMe3)2}(THF)] [9c] 
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293 K, 20 mol% catalyst, substrate B, initial rate: 2.2(4) ×10-4 mol dm-3 s-1
.
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13. [Ca(Ph-BIM){N(SiMe3)2}(THF)] [9d] 
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293 K, 10 mol% catalyst, substrate B, initial rate: 1.1(1) ×10-5 mol dm-3 s-1
.
 
 
14. [Ca(Ar3,5Me-BIM){N(SiMe3)2}(THF)] [9f] 
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293 K, 10 mol% catalyst, substrate B, initial rate: 3.1(1) ×10-4 mol dm-3 s-1
.
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15. [Ca(tBu-BIM){N(SiMe3)2}(THF)] [9i] 
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293 K, 10 mol% catalyst, substrate B, initial rate: 6.4(3) ×10-6 mol dm-3 s-1
.
 
 
16. [Ca(tBu-BIM){N(SiMe3)2}(THF)] [9i] 
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293 K, 20 mol% catalyst, substrate B, initial rate: 1.1(1) ×10-4 mol dm-3 s-1
.
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Appendix C: X-ray Structure Analysis of [1] 
1. Crystal data and structure refinement  
Empirical formula   C13H12ClNO3  
Formula weight   265.69  
Crystal description   colourless needle  
Crystal size    0.25 x 0.15 x 0.10 mm  
Temperature    150 K  
Crystal system   Hexagonal  
Space group    P61   
Unit cell dimensions   a = 10.670(2) Å   α = 90 °  
b = 10.670(2) Å   β = 90 °  
c = 19.506(4) Å   γ = 120 °  
Reflections for cell refinement 1971  
Range in theta    4 to 24 °  
Volume, Z    1923.0(5) A3, 6  
Density (calculated)    1.377 mg/m3  
Absorption coefficient   0.297 mm-1  
F(000)     828  
Diffractometer type   Area  
Wavelength    0.71073 A  
Scan type    φ & ϖ scans  
Theta range for data collection 4 to 24  deg.  
Index ranges    -9<=h<=0, 0<=k<=12, -22<=l<=22  
Reflections collected   9106  
Independent reflections  1971 [R(merge) = 0.097]  
Observed reflections   1183  
Absorption correction   Multi-scan (Tmin = 0.96, Tmax = 0.97)  
Structure solution by   direct and Fourier difference maps  
Hydrogen atom location  geometric  
Hydrogen atom treatment  Riding model  
Refinement method   Full-matrix least-squares on F2  
Weighting scheme   Modified ShelX  
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Data / restraints / parameters  1961 / 24/ 164  
Goodness-of-fit on F2   0.9353  
Final R indices [I>2sigma(I)]  R1 = 0.0842, Rw = 0.2066  
Final R indices [all data]  R1 = 0.1271, Rw = 0.2297  
Absolute structure parameter  0.1(2)  
Final maximum delta/sigma  0.000621  
Largest diff. peak and hole  1.90 and -1.16 e.A-3  
   
2.  Bond lengths (Å) and angles (°) 
Cl(1)-C(1) 1.812(10) C(3)-C(5) 1.43(2) 
O(1)-C(1) 1.170(9) C(6)-C(7) 1.489(12) 
O(2)-C(6)              1.187(9) C(7)-C(8) 1.311(12) 
O(3)-C(13) 1.214(10) C(7)-C(12) 1.383(11) 
N(1)-C(2) 1.467(10) C(8)-C(9) 1.468(14) 
N(1)-C(6) 1.409(10) C(9)-C(10) 1.315(13) 
N(1)-C(13) 1.375(10) C(10)-C(11) 1.391(12) 
C(1)-C(2) 1.495(12) C(11)-C(12) 1.377(12) 
C(2)-C(3) 1.53(2) C(12)-C(13) 1.505(12) 
C(3)-C(4) 1.57(2)   
                                  
C(2)-N(1)-C(6) 122.9(6) C(4)-C(3)-C(5) 115.2(12) 
C(2)-N(1)-C(13) 123.6(6) N(1)-C(6)-O(2) 123.4(8) 
C(6)-N(1)-C(13) 113.1(7) N(1)-C(6)-C(7) 104.9(7) 
Cl(1)-C(1)-O(1) 118.7(8) O(2)-C(6)-C(7) 131.7(8) 
Cl(1)-C(1)-C(2) 112.1(7) C(6)-C(7)-C(8) 130.4(8) 
O(1)-C(1)-C(2) 129.2(9) C(6)-C(7)-C(12) 108.5(7) 
C(1)-C(2)-N(1) 111.9(7) C(8)-C(7)-C(12) 121.1(8) 
C(1)-C(2)-C(3) 112.4(8) C(7)-C(8)-C(9) 117.7(9) 
N(1)-C(2)-C(3) 114.7(8) C(8)-C(9)-C(10) 119.4(9) 
C(2)-C(3)-C(4) 105.3(9) C(9)-C(10)-C(11) 123.5(9) 
C(2)-C(3)-C(5) 119.0(10) C(10)-C(11)-C(12) 115.4(9) 
C(7)-C(12)-C(11) 122.8(8) C(12)-C(13)-N(1) 105.3(7) 
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C(7)-C(12)-C(13) 108.1(7) C(12)-C(13)-O(3) 129.6(8) 
C(11)-C(12)-C(13) 129.1(8) N(1)-C(13)-O(3) 125.1(8) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
235 
 
Appendix D: X-ray Structure Analysis of [13a] 
1. Crystal data and structure refinement  
Empirical formula                  C14H16FN3  
Formula weight   245.30  
Crystal description   colourless regular  
Crystal size    0.50 × 0.40 × 0.08 mm  
Temperature    150 K  
Crystal system   Triclinic  
Space group    P 1   
Unit cell dimensions   a = 7.675(2) Å    α = 81.66(3) °  
b = 9.359(2) Å    β = 87.70(3) °                                       
c = 9.395(2) Å    γ = 77.93(3) °  
Reflections for cell refinement 4205  
Range in theta    4 to 28 °  
Volume, Z    652.9(2) Å3, 2  
Density (calculated)   1.248 mg/m3  
Absorption coefficient   0.086 mm-1  
F(000)     260  
Diffractometer type   Area  
Wavelength    0.71073 Å  
Scan type    ϕ & ϖ scans  
Theta range for data collection 4 to 28 °  
Index ranges    -9<=h<=9, -11<=k<=12, 0<=l<=12  
Reflections collected   4205  
Independent reflections  2900 [R(merge) = 0.030]  
Observed reflections   2433  
Absorption correction   Multi-scan (Tmin = 0.97, Tmax = 0.99)  
Structure solution by   direct and Fourier difference maps  
Hydrogen atom location  geometrical  
Hydrogen atom treatment  riding model  
Refinement method   Full-matrix least-squares on F2  
Weighting scheme   modified ShelX  
Data / restraints / parameters  2893 / 39/ 325  
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Goodness-of-fit on F   0.9971  
Final R indices [I>2sigma(I)]  R1 = 0.0658, Rw = 0.1644  
Final R indices [all data]  R1 = 0.0766, Rw = 0.1749  
Final maximum delta/sigma  0.000707  
Largest diff. peak and hole  0.72 and -0.40 e.Å-3  
 
2. Bond lengths (Å) and angles (°) 
F(1)-C(12) 1.349(5) C(6)-C(8) 1.548(6) 
F(2)-C(26) 1.367(6) C(9)-C(10) 1.396(6) 
N(1)-C(1) 1.155(6) C(9)-C(14) 1.386(6) 
N(2)-C(3) 1.353(6) C(10)-C(11) 1.375(7) 
N(2)-C(5) 1.480(5) C(11)-C(12) 1.382(7) 
N(3)-C(3) 1.374(6) C(12)-C(13) 1.382(7) 
N(3)-C(4) 1.456(6) C(13)-C(14) 1.383(7) 
N(3)-C(9) 1.435(6) C(15)-C(16) 1.416(6) 
N(4)-C(15) 1.153(6) C(16)-C(17) 1.374(6) 
N(5)-C(17) 1.357(6) C(18)-C(19) 1.539(8) 
N(5)-C(19) 1.461(6) C(19)-C(20) 1.407(8) 
N(6)-C(17) 1.366(6) C(20)-C(21) 1.527(9) 
N(6)-C(18) 1.463(6) C(20)-C(22) 1.501(8) 
N(6)-C(23) 1.415(6) C(23)-C(24) 1.394(7) 
C(1)-C(2) 1.389(6) C(23)-C(28) 1.377(7) 
C(2)-C(3) 1.375(6) C(24)-C(25) 1.397(8) 
C(4)-C(5) 1.531(6) C(25)-C(26) 1.366(8) 
C(5)-C(6) 1.541(6) C(26)-C(27) 1.357(8) 
C(6)-C(7) 1.546(7) C(27)-C(28) 1.386(7) 
 
C(3)-N(2)-C(5) 111.1(3) C(11)-C(12)-C(13)           122.4(4) 
C(3)-N(3)-C(4) 110.1(4) C(12)-C(13)-C(14)           118.2(4) 
C(3)-N(3)-C(9) 124.5(4) C(9)-C(14)-C(13)            120.5(4)  
C(4)-N(3)-C(9) 120.1(4) N(4)-C(15)-C(16) 177.6(5) 
C(17)-N(5)-C(19) 112.3(4) C(15)-C(16)-C(17) 121.7(4) 
C(17)-N(6)-C(18) 111.3(4) C(16)-C(17)-N(6)            124.4(4)  
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C(17)-N(6)-C(23) 125.4(4) C(16)-C(17)-N(5)            127.1(4)  
C(18)-N(6)-C(23) 123.3(4) N(6)-C(17)-N(5)             108.5(4) 
N(1)-C(1)-C(2) 177.3(5) N(6)-C(18)-C(19)            103.2(4) 
C(1)-C(2)-C(3) 121.9(4) C(18)-C(19)-N(5)            101.8(4) 
C(2)-C(3)-N(3) 124.3(4) C(18)-C(19)-C(20)           120.7(5) 
C(2)-C(3)-N(2) 127.0(4) N(5)-C(19)-C(20)            121.4(5) 
N(3)-C(3)-N(2) 108.7(4) C(19)-C(20)-C(21)           112.6(5) 
N(3)-C(4)-C(5) 102.8(4) C(19)-C(20)-C(22)           115.6(6) 
C(4)-C(5)-N(2) 100.7(3) C(21)-C(20)-C(22)           110.7(5)  
C(4)-C(5)-C(6) 112.0(4) N(6)-C(23)-C(24)            119.8(4)  
N(2)-C(5)-C(6) 110.9(3) N(6)-C(23)-C(28)            120.0(4) 
C(5)-C(6)-C(7) 108.8(4) C(24)-C(23)-C(28)           120.2(4) 
C(5)-C(6)-C(8) 109.8(4) C(23)-C(24)-C(25)           119.4(5) 
C(7)-C(6)-C(8) 108.9(4) C(24)-C(25)-C(26)           118.3(4) 
N(3)-C(9)-C(10) 120.8(4) F(2)-C(26)-C(25)            118.3(5) 
N(3)-C(9)-C(14) 119.3(4) F(2)-C(26)-C(27)            118.7(5) 
C(10)-C(9)-C(14) 119.9(4) C(25)-C(26)-C(27)           123.0(5) 
C(9)-C(10)-C(11) 120.2(4) C(26)-C(27)-C(28) 119.1(5) 
C(10)-C(11)-C(12)           118.7(4) C(27)-C(28)-C(23) 119.9(4) 
F(1)-C(12)-C(13)            118.7(4)    
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Appendix E: X-ray Structure Analysis of [13b] 
1. Crystal data and structure refinement  
Empirical formula                   C15H19N3O  
Formula weight                      257.33  
Crystal description                 colourless prism  
Crystal size                        0.40 x 0.40 x 0.40 mm  
Temperature                         150 K  
Crystal system                      Triclinic  
Space group                         P 1   
Unit cell dimensions                a = 9.867(2) Å    α = 63.10(3) °  
                                          b = 13.137(3) Å   β = 70.19(3) °  
                                          c = 13.140(3) Å   γ = 77.15(3) °  
Reflections for cell refinement    9147  
Range in theta                      4 to 27 deg.  
Volume, Z                           1424.3(7) Å3,  4  
Density (calculated)               1.200 mg/m3  
Absorption coefficient             0.077 mm-1  
F(000)                              552  
Diffractometer type                 Area  
Wavelength                         0.71073 A  
Scan type                           ϕ & ω scans  
Theta range for data collection    4 to 27 °  
Index ranges                        -11<=h<=12, -14<=k<=17, 0<=l<=17  
Reflections collected              9147  
Independent reflections            6440 [R(merge) = 0.043]  
Observed reflections                4476  
Absorption correction              Multi-scan (Tmin = 0.97, Tmax = 0.97)  
Structure solution by               direct and Fourier difference maps  
Hydrogen atom location             geometrical  
Hydrogen atom treatment            riding model  
Refinement method                  Full-matrix least-squares on F2  
Weighting scheme                   modified ShelX  
Data / restraints / parameters     6431 / 3/ 685  
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Goodness-of-fit on F                0.9862  
Final R indices [I>2σ(I)]          R1 = 0.0728, Rw = 0.1586  
Final maximum delta/sigma         0.000324  
Largest diff. peak and hole        0.67 and -0.50 e.A-3    
            
             
2. Bond lengths (Å) and angles (°) 
N(1)-C(1) 1.159(7) C(10)-C(11)      1.372(8)  
N(2)-C(3)            1.365(7) C(11)-C(12)   1.388(8) 
N(2)-C(5) 1.471(6) C(12)-C(13) 1.376(7) 
N(3)-C(3)      1.373(6) C(13)-C(14)     1.388(8) 
N(3)-C(4)             1.468(7) C(16)-C(17)         1.405(8) 
N(3)-C(9)             1.420(6) C(17)-C(18)    1.372(8) 
N(4)-C(16)          1.146(7) C(19)-C(20)     1.526(7) 
N(5)-C(18)          1.351(7) C(20)-C(21)         1.520(7) 
N(5)-C(20)        1.467(7) C(21)-C(22)     1.518(8) 
N(6)-C(18)   1.370(6) C(21)-C(23)      1.515(8) 
N(6)-C(19)     1.452(7) C(24)-C(25)    1.380(8) 
N(6)-C(24)     1.440(7) C(24)-C(29)    1.379(8) 
N(7)-C(31)     1.143(7) C(25)-C(26)    1.399(8) 
N(8)-C(33)     1.361(7) C(26)-C(27)     1.370(8) 
N(8)-C(35)       1.485(6) C(27)-C(28)      1.383(9) 
N(9)-C(33)           1.371(6) C(28)-C(29)      1.377(8) 
N(9)-C(34)         1.468(7)  C(31)-C(32)      1.408(7) 
N(9)-C(39)         1.433(7)  C(32)-C(33)      1.377(7) 
N(10)-C(46)       1.162(7) C(34)-C(35)       1.535(7) 
N(11)-C(48)   1.340(7) C(35)-C(36)      1.516(7) 
N(11)-C(50)        1.458(7) C(36)-C(37) 1.530(8)  
N(12)-C(48)          1.373(7) C(36)-C(38)       1.512(8) 
N(12)-C(49)        1.441(8) C(39)-C(40)   1.383(8)  
N(12)-C(54)  1.416(7) C(39)-C(44)    1.377(7) 
O(1)-C(12)          1.383(6) C(40)-C(41)     1.381(8) 
O(1)-C(15)          1.406(7) C(41)-C(42)     1.389(8)  
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O(2)-C(27)      1.376(7) C(42)-C(43)       1.388(8) 
O(2)-C(30)     1.436(8) C(43)-C(44)     1.415(7)  
O(3)-C(42)         1.364(7) C(46)-C(47)        1.404(7) 
O(3)-C(45)       1.419(8) C(47)-C(48)        1.341(8) 
O(4)-C(57)        1.367(7) C(49)-C(50)           1.556(9) 
O(4)-C(60)      1.427(8) C(50)-C(51)     1.465(9) 
C(1)-C(2)            1.395(8) C(51)-C(52) 1.497(9) 
C(9)-C(14)        1.365(8) C(51)-C(53)    1.520(9) 
C(9)-C(10)       1.528(7) C(54)-C(55)             1.401(7) 
C(6)-C(8)          1.511(7) C(54)-C(59)      1.393(9) 
C(6)-C(7)            1.533(8) C(55)-C(56)      1.382(8) 
C(5)-C(6)            1.525(8) C(56)-C(57)                   1.384(8) 
C(4)-C(5)       1.384(7) C(57)-C(58)   1.387(8) 
C(2)-C(3)      1.378(7) C(58)-C(59)         1.369(8)  
              
C(3)-N(2)-C(5)    111.0(4)  N(6)-C(24)-C(25)      119.9(5) 
C(3)-N(3)-C(4)              110.0(4) N(6)-C(24)-C(29)   119.5(5) 
C(3)-N(3)-C(9)         124.4(5) C(25)-C(24)-C(29)    120.6(5) 
C(4)-N(3)-C(9)          122.1(4) C(24)-C(25)-C(26)    119.7(5) 
C(18)-N(5)-C(20)      111.2(4) C(25)-C(26)-C(27)   119.4(5) 
C(18)-N(6)-C(19)      110.7(4) O(2)-C(27)-C(26)    124.8(6)  
C(18)-N(6)-C(24)      124.1(5) O(2)-C(27)-C(28)       114.7(6)  
C(19)-N(6)-C(24)    122.5(4) C(26)-C(27)-C(28)      120.5(5) 
C(33)-N(8)-C(35)     110.8(4) C(27)-C(28)-C(29)     120.3(6) 
C(33)-N(9)-C(34)    109.2(4) C(24)-C(29)-C(28)    119.6(5) 
C(33)-N(9)-C(39)       125.1(5) N(7)-C(31)-C(32)      179.3(6) 
C(34)-N(9)-C(39)    120.3(4) C(31)-C(32)-C(33)    120.6(5) 
C(48)-N(11)-C(50)   110.9(5) C(32)-C(33)-N(9)      124.4(5) 
C(48)-N(12)-C(49)    111.4(5) C(32)-C(33)-N(8)     126.0(5) 
C(48)-N(12)-C(54)   126.7(5) N(9)-C(33)-N(8)      109.6(5) 
C(49)-N(12)-C(54)   121.9(5) N(9)-C(34)-C(35)      103.7(4) 
C(12)-O(1)-C(15)      117.8(4) C(34)-C(35)-N(8)      100.4(4) 
C(27)-O(2)-C(30)      116.8(6) C(34)-C(35)-C(36)    111.7(4) 
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C(42)-O(3)-C(45)     118.0(5) N(8)-C(35)-C(36)      112.7(4) 
C(57)-O(4)-C(60)      116.6(5) C(35)-C(36)-C(37)    108.7(4) 
N(1)-C(1)-C(2)            179.2(7)  C(35)-C(36)-C(38) 112.3(4) 
C(1)-C(2)-C(3)  121.4(6) C(37)-C(36)-C(38)    108.9(5) 
N(3)-C(3)-N(2)        107.6(5) N(9)-C(39)-C(40)      121.4(5) 
N(3)-C(3)-C(2)          124.5(5) N(9)-C(39)-C(44)      117.5(5) 
N(2)-C(3)-C(2)         127.9(5) C(40)-C(39)-C(44)     121.1(5) 
N(3)-C(4)-C(5)         101.9(4) C(39)-C(40)-C(41)   119.5(5) 
C(4)-C(5)-N(2)         100.1(4) C(40)-C(41)-C(42) 120.6(6) 
C(4)-C(5)-C(6)          115.6(4) C(41)-C(42)-O(3)     115.5(5) 
N(2)-C(5)-C(6)       114.2(4) C(41)-C(42)-C(43)   120.2(5) 
C(5)-C(6)-C(7)         110.0(4) O(3)-C(42)-C(43)     124.2(5) 
C(5)-C(6)-C(8)         110.3(4) C(42)-C(43)-C(44)    119.0(5) 
C(7)-C(6)-C(8)         110.3(5) C(43)-C(44)-C(39)       119.6(6)     
N(3)-C(9)-C(10)       121.7(5)  N(10)-C(46)-C(47)      178.8(6) 
N(3)-C(9)-C(14)       119.3(4) C(46)-C(47)-C(48)      120.4(5) 
C(10)-C(9)-C(14)      119.0(5) N(12)-C(48)-C(47)    125.9(5) 
C(9)-C(10)-C(11)     120.3(5) N(12)-C(48)-N(11)   107.9(5) 
C(10)-C(11)-C(12)    120.5(5) C(47)-C(48)-N(11)    126.2(5)  
C(11)-C(12)-O(1)       115.4(5) N(12)-C(49)-C(50)   99.8(5) 
C(11)-C(12)-C(13)     119.8(5) C(49)-C(50)-N(11)     101.0(5) 
O(1)-C(12)-C(13)      124.8(5) C(49)-C(50)-C(51)   114.9(6) 
C(12)-C(13)-C(14) 119.1(5)  N(11)-C(50)-C(51)    115.9(6) 
C(13)-C(14)-C(9)        121.3(5) C(50)-C(51)-C(52)     111.8(6) 
N(4)-C(16)-C(17)      178.8(6) C(50)-C(51)-C(53)      113.0(6) 
C(16)-C(17)-C(18)    121.0(5) C(52)-C(51)-C(53)     111.0(6) 
C(17)-C(18)-N(6)     124.8(5) N(12)-C(54)-C(55)    120.6(6) 
C(17)-C(18)-N(5)      127.2(5) N(12)-C(54)-C(59)     120.8(5) 
N(6)-C(18)-N(5)       107.9(5) C(55)-C(54)-C(59)      118.5(5)  
N(6)-C(19)-C(20)    102.2(4) C(54)-C(55)-C(56)    120.8(6) 
C(19)-C(20)-N(5)    100.8(4) C(55)-C(56)-C(57)    119.6(5) 
C(19)-C(20)-C(21)     113.9(4) C(56)-C(57)-O(4)      125.4(5) 
N(5)-C(20)-C(21)      114.2(4) C(56)-C(57)-C(58)    120.1(5) 
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C(20)-C(21)-C(22)     111.1(4) O(4)-C(57)-C(58)      114.5(6) 
C(20)-C(21)-C(23)     110.9(4) C(57)-C(58)-C(59)     120.4(6) 
C(22)-C(21)-C(23)      110.6(5) C(54)-C(59)-C(58) 120.7(5) 
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Appendix F: X-ray Structure Analysis of [13c] 
1. Crystal data and structure refinement  
Empirical formula                   C15H19N3  
Formula weight                      241.34  
Crystal description                 colourless regular  
Crystal size                        0.50 × 0.40 × 0.08 mm  
Temperature                         150 K  
Crystal system                      Triclinic  
Space group                         P 1   
Unit cell dimensions                a = 9.604(2) Å   α = 105.03(3) °  
                                          b = 13.097(3) Å    β = 109.34(3) °  
                                          c = 13.115(3) Å   γ = 106.40(3) °  
Reflections for cell refinement    9739  
Range in theta                      4 to 28 °  
Volume, Z                           1375.0(8) Å3, 4  
Density (calculated)                1.166 mg/m3  
Absorption coefficient             0.071 mm-1  
F(000)                             520  
Diffractometer type                 Area  
Wavelength                          0.71073 Å  
Scan type                           ϕ & ϖ scans  
Theta range for data collection    4 to 28  °  
Index ranges                        -12<=h<=11, -16<=k<=16, 0<=l<=17  
Reflections collected               9739  
Independent reflections            6243 [R(merge) = 0.039]  
Observed reflections                4269 
Absorption correction              Multi-scan (Tmin = 0.97, Tmax = 0.99)  
Structure solution by               direct and Fourier difference maps  
Hydrogen atom location            geometrical  
Hydrogen atom treatment            riding model  
Refinement method                  Full-matrix least-squares on F2  
Weighting scheme                   Modified ShelX  
Data / restraints / parameters     6227 / 3/ 649  
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Goodness-of-fit on F                0.9800  
Final R indices [I>2sigma(I)]      R1 = 0.0706, Rw = 0.1604  
Final R indices [all data]          R1 = 0.1034, Rw = 0.1829  
Final maximum delta/sigma         0.008134  
Largest diff. peak and hole        0.79 and -0.55 e.Å-3  
 
2. Bond lengths (Å) and angles (°) 
N(1)-C(1)                   1.140(8)  C(17)-C(18)      1.364(8)  
N(2)-C(3)                     1.368(7)  C(19)-C(20)           1.548(9) 
N(2)-C(5)                     1.475(7) C(20)-C(21)                   1.526(7) 
N(3)-C(3)                     1.363(8) C(21)-C(22)                   1.517(9) 
N(3)-C(4)                     1.456(8)  C(21)-C(23)                   1.503(9) 
N(3)-C(9)                     1.425(8) C(24)-C(25)                 1.389(8)  
N(4)-C(16)                    1.165(8) C(24)-C(29)                   1.391(8) 
N(5)-C(18)                    1.349(7) C(25)-C(26)                 1.399(9)  
N(5)-C(20)                    1.470(7)  C(26)-C(27)                   1.392(9) 
N(6)-C(18)                    1.375(8) C(27)-C(28)                   1.379(9) 
N(6)-C(19)                    1.473(8) C(27)-C(30)                   1.508(8) 
N(6)-C(24)                    1.411(7) C(28)-C(29)                   1.378(9) 
N(7)-C(31)                    1.155(8) C(31)-C(32)                   1.415(9) 
N(8)-C(33)                    1.352(7) C(32)-C(33)                   1.375(8) 
N(8)-C(35)                    1.489(7)  C(34)-C(35)                   1.523(8) 
N(9)-C(33)                    1.372(7)  C(35)-C(36)                   1.536(7) 
N(9)-C(34)                    1.470(7) C(36)-C(37)                   1.537(7) 
N(9)-C(39)                    1.408(7) C(36)-C(38)                   1.539(8) 
N(10)-C(46)                   1.158(8) C(39)-C(40)                   1.405(8) 
N(11)-C(48)                   1.359(7) C(39)-C(44)                   1.371(8) 
N(11)-C(50)                   1.454(7) C(40)-C(41)                   1.393(8) 
N(12)-C(48)                   1.353(8)  C(41)-C(42)                   1.398(9) 
N(12)-C(49)                   1.451(7) C(42)-C(43)                   1.388(9) 
N(12)-C(54)                   1.439(7) C(42)-C(45)                   1.496(9)  
C(1)-C(2)                     1.397(9) C(43)-C(44)                   1.405(9) 
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C(2)-C(3)                     1.377(8) C(46)-C(47)                   1.381(9) 
C(4)-C(5)                     1.494(8) C(47)-C(48)                   1.383(7) 
C(5)-C(6)                     1.503(8) C(49)-C(50)                   1.521(9) 
C(6)-C(7)                     1.540(9) C(50)-C(51)                   1.417(9) 
C(6)-C(8)                     1.519(10) C(51)-C(52)                   1.541(9) 
C(9)-C(10)                  1.386(8) C(51)-C(53)               1.519(10)  
C(9)-C(14)                    1.394(8) C(54)-C(55)                   1.404(8) 
C(10)-C(11)                   1.382(9) C(54)-C(59)                   1.372(7) 
C(11)-C(12)                   1.373(8) C(55)-C(56)                   1.358(8) 
C(12)-C(13)                   1.403(8)  C(56)-C(57)                1.399(8) 
C(12)-C(15)                   1.498(8) C(57)-C(58)                   1.385(9) 
C(13)-C(14)                   1.384(8) C(57)-C(60)                   1.531(9) 
C(16)-C(17)                   1.404(9) C(58)-C(59) 1.380(9) 
 
C(3)-N(2)-C(5)            109.9(5) C(25)-C(24)-C(29)   118.8(6) 
C(3)-N(3)-C(4)   110.5(5)  C(24)-C(25)-C(26) 119.9(6) 
C(3)-N(3)-C(9)              125.3(5) C(25)-C(26)-C(27)           121.1(6) 
C(4)-N(3)-C(9)              124.0(5) C(26)-C(27)-C(28)  117.8(6) 
C(18)-N(5)-C(20)            112.3(5) C(26)-C(27)-C(30)  120.4(6) 
C(18)-N(6)-C(19)    109.6(5) C(28)-C(27)-C(30) 121.8(6) 
C(18)-N(6)-C(24)            125.3(5) C(27)-C(28)-C(29) 121.9(5) 
C(19)-N(6)-C(24)    120.7(5) C(24)-C(29)-C(28)   120.5(6) 
C(33)-N(8)-C(35)            111.0(5) N(7)-C(31)-C(32)   177.6(6) 
C(33)-N(9)-C(34)            109.4(5) C(31)-C(32)-C(33) 119.3(6) 
C(33)-N(9)-C(39)            128.5(5) C(32)-C(33)-N(9)   124.4(5) 
C(34)-N(9)-C(39)            121.3(5) C(32)-C(33)-N(8)  126.0(5) 
C(48)-N(11)-C(50)           110.8(5) N(9)-C(33)-N(8)   109.7(5) 
C(48)-N(12)-C(49)           110.9(5) N(9)-C(34)-C(35)  104.4(5) 
C(48)-N(12)-C(54)           126.7(5) C(34)-C(35)-N(8)  100.7(5) 
C(49)-N(12)-C(54)           122.0(5) C(34)-C(35)-C(36)  110.3(5) 
N(1)-C(1)-C(2)              177.8(6) N(8)-C(35)-C(36)     111.4(4) 
C(1)-C(2)-C(3)              121.6(6) C(35)-C(36)-C(37) 108.1(4) 
C(2)-C(3)-N(2)              126.6(6) C(35)-C(36)-C(38)  111.2(4) 
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C(2)-C(3)-N(3)              125.3(6) C(37)-C(36)-C(38)   109.3(5) 
N(2)-C(3)-N(3)              108.0(5) N(9)-C(39)-C(40)   120.6(5) 
N(3)-C(4)-C(5)              103.6(5)  N(9)-C(39)-C(44)  119.6(5) 
C(4)-C(5)-N(2)              101.4(5) C(40)-C(39)-C(44)  119.8(6) 
C(4)-C(5)-C(6)              116.4(5) C(39)-C(40)-C(41)  119.4(5) 
N(2)-C(5)-C(6)              114.2(4) C(40)-C(41)-C(42) 121.7(5) 
C(5)-C(6)-C(7)              109.9(5) C(41)-C(42)-C(43) 117.6(6) 
C(5)-C(6)-C(8)              112.3(5) C(41)-C(42)-C(45)  121.0(6) 
C(7)-C(6)-C(8)              110.0(5) C(43)-C(42)-C(45) 121.4(6) 
N(3)-C(9)-C(10)             122.7(6) C(42)-C(43)-C(44) 121.5(6) 
N(3)-C(9)-C(14)             118.2(5) C(43)-C(44)-C(39) 120.0(6) 
C(10)-C(9)-C(14)            119.0(6)  N(10)-C(46)-C(47)  178.9(6) 
C(9)-C(10)-C(11)            120.7(6) C(46)-C(47)-C(48)           121.9(6) 
C(10)-C(11)-C(12)           121.2(6) C(47)-C(48)-N(11)           124.4(5) 
C(11)-C(12)-C(13)           118.1(6) C(47)-C(48)-N(12)           126.7(6) 
C(11)-C(12)-C(15)           121.9(5) N(11)-C(48)-N(12)           108.8(5) 
C(13)-C(12)-C(15)           120.1(5) N(12)-C(49)-C(50)           102.3(5) 
C(12)-C(13)-C(14)           121.4(5) C(49)-C(50)-N(11)           102.5(5) 
C(9)-C(14)-C(13)            119.5(5) C(49)-C(50)-C(51) 121.3(6)  
N(4)-C(16)-C(17)            179.8(7) N(11)-C(50)-C(51)  118.5(6) 
C(16)-C(17)-C(18)           121.9(6) C(50)-C(51)-C(52) 112.4(6)  
N(6)-C(18)-C(17)           124.8(6)  C(50)-C(51)-C(53) 115.5(6)  
N(6)-C(18)-N(5)  108.3(5) C(52)-C(51)-C(53)  110.4(6) 
C(17)-C(18)-N(5)  126.9(6) N(12)-C(54)-C(55)   119.3(5)  
N(6)-C(19)-C(20)    102.1(5) N(12)-C(54)-C(59)  121.9(5)  
C(19)-C(20)-N(5)   99.5(4) C(55)-C(54)-C(59) 118.6(5) 
C(19)-C(20)-C(21)  114.8(4) C(54)-C(55)-C(56)  120.9(6) 
N(5)-C(20)-C(21)  114.3(4) C(55)-C(56)-C(57)  120.9(6) 
C(20)-C(21)-C(22)  110.8(5)  C(56)-C(57)-C(58) 117.8(6) 
C(20)-C(21)-C(23) 109.5(5) C(56)-C(57)-C(60)  120.5(6) 
C(22)-C(21)-C(23) 110.3(5) C(58)-C(57)-C(60)  121.7(6) 
N(6)-C(24)-C(25)            119.6(5)  C(57)-C(58)-C(59) 121.5(5) 
N(6)-C(24)-C(29)   121.6(5)  C(58)-C(59)-C(54)  120.3(6) 
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Appendix G: X-ray Structure Analysis of [13f] 
1. Crystal data and structure refinement  
Empirical formula                   C16H21N3  
Formula weight                    255.36  
Crystal description                 colourless regular  
Crystal size                        0.35 x 0.30 x 0.25 mm  
Temperature                         150 K  
Crystal system                      Triclinic  
Space group                         P 1   
Unit cell dimensions                a = 8.270(2) Å    α = 92.88(3) °  
                                          b = 8.574(2) Å    β = 107.69(3) °  
                                          c = 12.369(3) Å   γ = 115.03(3) °  
Reflections for cell refinement    4737  
Range in theta                      4 to 28 °  
Volume, Z                           740.7(4) Å3, 2  
Density (calculated)                1.145 mg/m3  
Absorption coefficient             0.069 mm-1  
F(000)                              276  
Diffractometer type                 Area  
Wavelength                          0.71073 Å  
Scan type                           ϕ & ϖ scans  
Theta range for data collection    4 to 28 °  
Index ranges                        -10<=h<=9, -11<=k<=11, 0<=l<=16  
Reflections collected               4737  
Independent reflections            3369 [R(merge) = 0.032]  
Observed reflections                2722  
Absorption correction              Multi-scan (Tmin = 0.98, Tmax = 0.98)  
Structure solution by               direct and Fourier difference maps  
Hydrogen atom location             Geometrical  
Hydrogen atom treatment            Riding model  
Refinement method                  Full-matrix least-squares on F2  
Weighting scheme                   Modified ShelX  
Data / restraints / parameters     3360 / 3/ 343  
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Goodness-of-fit on F                0.9684  
Final R indices [I>2sigma(I)]      R1 = 0.0652, Rw = 0.1614  
Final R indices [all data]          R1 = 0.0800, Rw = 0.1763  
Final maximum delta/sigma         0.000624  
Largest diff. peak and hole        0.68 and -0.46 e.Å-3  
 
2. Bond lengths (Å) and angles (°) 
N(1)-C(1)      1.158(6) C(10)-C(11)        1.389(6) 
N(2)-C(3)             1.359(5) C(11)-C(12)       1.395(7) 
N(2)-C(5)           1.453(6) C(11)-C(15)        1.512(7) 
N(3)-C(3)               1.360(6) C(12)-C(13)          1.398(7) 
N(3)-C(4)              1.466(6) C(13)-C(14)      1.376(6) 
N(3)-C(9)             1.411(6) C(13)-C(16)      1.523(7) 
N(4)-C(17)              1.150(6) C(17)-C(18)       1.412(7) 
N(5)-C(19)             1.350(5) C(18)-C(19)     1.386(7) 
N(5)-C(21)       1.491(5) C(20)-C(21)       1.517(6)  
N(6)-C(19)      1.380(6) C(21)-C(22)          1.532(5) 
N(6)-C(20)    1.458(6) C(22)-C(23)       1.537(6)  
N(6)-C(25)           1.426(6)  C(22)-C(24)         1.547(6) 
C(1)-C(2)                 1.387(6) C(25)-C(26)       1.392(6) 
C(2)-C(3)               1.375(7) C(25)-C(30)      1.392(6) 
C(4)-C(5)            1.536(6) C(26)-C(27)        1.404(6) 
C(5)-C(6)             1.456(7) C(27)-C(28)          1.389(6) 
C(6)-C(7)             1.537(8) C(27)-C(31)       1.499(7) 
C(6)-C(8)            1.520(7) C(28)-C(29)     1.393(7) 
C(9)-C(10)          1.403(6) C(29)-C(30)     1.395(7) 
C(9)-C(14)         1.400(7) C(29)-C(32)    1.510(7) 
 
C(3)-N(2)-C(5)       112.5(4)  C(12)-C(13)-C(14) 119.7(4) 
C(3)-N(3)-C(4)     110.8(4) C(12)-C(13)-C(16) 120.2(5) 
C(3)-N(3)-C(9)    127.4(4) C(14)-C(13)-C(16)  120.1(5) 
C(4)-N(3)-C(9)       121.3(4) C(9)-C(14)-C(13)  121.0(4)  
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C(19)-N(5)-C(21) 110.6(4) N(4)-C(17)-C(18)  176.2(5)  
C(19)-N(6)-C(20)   109.5(4) C(17)-C(18)-C(19)   120.6(5) 
C(19)-N(6)-C(25)  126.8(4) C(18)-C(19)-N(6)  124.0(4) 
C(20)-N(6)-C(25)  122.4(4) C(18)-C(19)-N(5)  127.5(4) 
N(1)-C(1)-C(2)      177.6(5) N(6)-C(19)-N(5)  108.5(4) 
C(1)-C(2)-C(3)        124.2(4) N(6)-C(20)-C(21)   102.9(4) 
C(2)-C(3)-N(3)     126.2(4)  C(20)-C(21)-N(5)    100.0(3) 
C(2)-C(3)-N(2)   125.2(4) C(20)-C(21)-C(22) 114.3(3)  
N(3)-C(3)-N(2)        108.4(4) N(5)-C(21)-C(22)   112.0(3) 
N(3)-C(4)-C(5) 103.8(4) C(21)-C(22)-C(23) 109.0(3) 
C(4)-C(5)-N(2)     101.3(4)  C(21)-C(22)-C(24)  110.4(3) 
C(4)-C(5)-C(6)  116.9(4) C(23)-C(22)-C(24) 109.5(4) 
N(2)-C(5)-C(6)     118.7(4) N(6)-C(25)-C(26)  119.2(4) 
C(5)-C(6)-C(7)   111.2(4) N(6)-C(25)-C(30)  120.3(4) 
C(5)-C(6)-C(8)   113.8(5) C(26)-C(25)-C(30) 120.4(4)  
C(7)-C(6)-C(8)     109.6(5) C(25)-C(26)-C(27)  120.1(4) 
N(3)-C(9)-C(10)  121.7(4) C(26)-C(27)-C(28)  118.3(4) 
N(3)-C(9)-C(14)  119.4(4) C(26)-C(27)-C(31)   120.9(4) 
C(10)-C(9)-C(14)            118.9(4) C(28)-C(27)-C(31)           120.7(4) 
C(9)-C(10)-C(11)    120.5(4) C(27)-C(28)-C(29) 122.4(4) 
C(10)-C(11)-C(12)   119.6(5)  C(28)-C(29)-C(30) 118.4(4) 
C(10)-C(11)-C(15)   119.7(5) C(28)-C(29)-C(32)  121.5(4) 
C(12)-C(11)-C(15)   120.7(5)  C(30)-C(29)-C(32)           120.1(5) 
C(11)-C(12)-C(13) 120.3(5)         C(29)-C(30)-C(25)  120.3(4) 
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   Appendix H: X-ray Structure Analysis of [15] 
1. Crystal data and structure refinement  
Empirical formula                  C5 H8 N2 O1  
Formula weight                     112.13  
Crystal description                 colourless regular  
Crystal size                        0.30 x 0.30 x 0.20 mm  
Temperature                         150 K  
Crystal system                      Triclinic  
Space group                         P -1   
Unit cell dimensions                a = 5.7473(11) Å   α = 96.45(3)°  
                                          b = 6.3554(13) Å   β = 100.48(3)°  
                                          c = 8.963(2) Å     γ = 109.76(3)°  
Reflections for cell refinement    1326  
Range in theta                     2.353 to 27.458°  
Volume, Z                           297.57(13) Å3,  2  
Density (calculated)                1.251 Mg/m3  
Absorption coefficient             0.090 mm^-1  
F(000)                              120  
Diffractometer type                 Area  
Wavelength                          0.71073 A  
Scan type                           φ and ω  
Theta range for data collection    2.353 to 27.458°  
Index ranges                       -7<=h<=7, -8<=k<=8, 0<=l<=11  
Reflections collected               1934  
Independent reflections            1326 [R(merge) = 0.025]  
Observed reflections                1157 [I>2σ(I)]  
Absorption correction              Multi-scan (Tmin = 0.97, Tmax = 0.98)  
Structure solution by               direct and Fourier difference maps  
Hydrogen atom location             geometrical  
Hydrogen atom treatment            riding model  
Refinement method                  Full-matrix least-squares on F2  
Weighting scheme                   calc  
Data / restraints / parameters     1323 / 0/ 73  
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Goodness-of-fit on F                1.0037  
Final R indices [all data]          R1 = 0.0557, Rw = 0.1253  
Final R indices [I>2sigma(I)]      R1 = 0.0488, Rw = 0.1201  
Final maximum delta/sigma         0.000153  
Largest diff. peak and hole        0.30 and -0.30 e.A^-3  
 
2. Bond lengths (Å) and angles (°)            
O(1)-C(1)                     1.231(2) C(2)-C(3)                     1.478(2) 
N(1)-C(1)        1.332(2)  C(2)-C(4) 1.546(2)  
N(2)-C(3)      1.145(2)  C(2)-C(5)     1.536(2)  
C(1)-C(2)                     1.543(2)   
 
N(1)-C(1)-O(1)   123.12(12)  C(3)-C(2)-C(4) 109.09(11) 
N(1)-C(1)-C(2)              118.58(12)  C(1)-C(2)-C(5)  110.56(11) 
O(1)-C(1)-C(2)              118.20(12) C(3)-C(2)-C(5)  108.79(11)  
C(1)-C(2)-C(3)              111.17(11) C(4)-C(2)-C(5)              110.36(11) 
C(1)-C(2)-C(4)              106.85(11) C(2)-C(3)-N(2)              179.09(14) 
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Appendix I: Summary Sheet of Literature Compounds Included in this Thesis 
 
Chapter One 
 
 
OZr Ca
CH3
N(SiMe3)2
THF
THF
THF
 
1.1 1.2 1.3 
 
 
 
1.4 1.5 1.6 
 
 
 
1.7 1.8 1.9 
 
 
N N
RR Ca
N N THF
NR12
R2 R2
 
1.10 1.11 1.12 
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Chapter Two 
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Appendix J: Summary Sheet of Novel Compounds Presented in this Thesis 
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Chapter Three 
Compounds 5a-f are the THF analogues [Ca(NNR){N(SiMe3)2}(THF)n]                                  
of 6a-f [Ca(NNR){N(SiMe3)2}(py)n] 
 
 
 
6a 6b 6c 
 
 
 
6d 6e 6f 
 
 
 
7a 7b 7c 
 
 
 
7acalc 7bcalc 7ccalc 
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Chapter Four  
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8i  8j 
 
Compounds 9a-j are the THF analogues [Ca(R-BIM){N(Si(Me3)2}(THF)n]                        
of 10a-j [Ca(R-BIM){N(Si(Me3)2}(py)n]. 
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Chapter Five 
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Calcium complexes supported by chiral 1,2-diamines have
been shown to be eﬃcient catalysts for the asymmetric hydro-
amination of amino-oleﬁn substrates; the calcium complexes
[Ca(NNR){N(SiMe3)2}(THF)] (R =
tBu, iPr, Ph, 4-C6H4F)
give enantioselectivities of up to 26% which marks a signiﬁcant
increase based upon literature precedence. The structure of
[Ca(NNPh){N(SiMe3)2}(py)] has been computed with density
functional methods.
Whilst the coordination chemistry of the alkaline earth (AE)
metals is well established, the development of well-deﬁned
complexes which can be successfully adapted to catalysis has
only become apparent in the last few years.1 The primary
reason behind this late development of AE metals in catalysis
is their propensity to undergo rapid Schlenk-type ligand
redistribution processes,2 thus rendering catalytically active
species either inactive, or else removing the possibility of regio-
or stereoselectivity. As such, the rich chemistry associated with
the AE metals has been somewhat neglected outside the
context of stoichiometric reagents.
Advances in the last ﬁve years have demonstrated that
a further understanding of their coordination chemistry is
likely to propel the catalytic applications of the AE metals,
particularly calcium, into new and exciting directions. In this
regard, remarkable advances in the area have been made,
particularly with b-diketiminato ligands which have proven
remarkably successful in supporting well-deﬁned calcium
complexes (Fig. 1a).3 These, and related, AE complexes have
been shown to be active in hydroamination,4 hydrosilylation,5
hydrogenation,6 and ring opening polymerisation3,7 catalysis.
Despite the signiﬁcant advances in this area, the use of
chiral ligands to eﬀect asymmetric catalysis remains much
less developed, particularly in complexes in which strongly
basic amide- or alkyl co-ligands are present.8 Recently
Buch and Harder prepared calcium amide complexes
supported by the ubiquitous bisoxazoline (BOX) ligands,
[Ca(BOX){N(SiMe3)2}(THF)] (Fig. 1b).
9 These complexes
were screened in asymmetric hydroamination and hydrosilylation
catalysis; despite being able to prepare and structurally
characterise these complexes, ligand redistribution proved to
be rapid in solution, reforming the achiral homoleptic complex
Ca{N(SiMe3)2}(THF)2 alongside the catalytically inactive
[Ca(BOX)2], thus rendering the enantioselectivities low
(5–10% ee). Such observations have led to the hypothesis
that ligand redistribution must be completely suppressed in
order to generate acceptable enantioselectivities. Even more
recently, Sadow et al. have reported somewhat higher enantio-
selectivities when using trisoxazoline magnesium and calcium
complexes,10 with the highest enantioselectivities being obtained
with the magnesium complexes at elevated temperatures. It is
in this context that we have sought to prepare simple and
readily available chiral ligands that provide greater stereocontrol
in hydroamination catalysis with calcium.
A series of chiral ethylene diamine derivatives
H2NCH(
iPr)CH2NHR (HNN
R, R = tBu 1a, iPr 1b, Ph 1c
and 4-C6H4F 1d) have been prepared from L-valine according
to Scheme 1. This route utilises the amidation of an acid
chloride with a series of primary amines or anilines. We have
found that using thionyl chloride is the most convenient
method of converting phthalimide-protected valine into the
acid chloride, and does not give rise to epimerisation of the
chiral acid; the protected valinoyl chloride can be readily
prepared on a 100 g scale and is therefore convenient for the
preparation of large quantities of diamines. The acid chloride
can be converted into an N-substituted amide by adding a
primary amine or aniline in THF. The addition of triethylamine
allows this reaction to proceed under ambient conditions,
although the yields are often much improved with the addition
of catalyticN,N-dimethylaminopyridine (DMAP). The reduction
of the amides to aﬀord diamines was eﬀected on a small scale
with BH3(THF) (using commercial 1 M solution). However,
on increasing the scale of the reaction, this required the use of
excessively large quantities of solvent, causing problems with
heat transfer and unnecessary dilution. The reaction was less
eﬀective with BH3(SMe2) (10 M), whilst this enabled the
Fig. 1 Calcium complexes used in hydroamination catalysis.
School of Chemistry, Cardiﬀ University, Main Building, Park Place,
Cardiﬀ CF10 3AT, UK. E-mail: WardBD@Cardiﬀ.ac.uk;
Fax: +44 (0)29 208 74030; Tel: +44 (0)29 208 70302
w Electronic supplementary information (ESI) available: Experimental
procedures, characterising data, and computational methods. See
DOI: 10.1039/c1cc11229e
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reaction to be scaled up safely, these conditions resulted in
signiﬁcantly lower yields, in addition to by-products arising
from the degradation of the THF solvent. Conversely, the use
of NaBH4/Me3SiCl was found to give excellent yields,
11 with
much more control over the reaction concentration; this
procedure has been demonstrated to be successful on a scale
of up to 12 g in 250 ml solvent. This simple multistep method
allows a series of diamines (HNNR) to be prepared in which
the R substituent can be varied in a modular fashion, without
introducing additional synthetic complexity.
Reaction of the protio-ligands 1a–dwith Ca{N(SiMe3)2}2(THF)2
in C6D6 aﬀorded pale yellow precipitates, which although are
suitable precursors for hydroamination catalysis (vide infra),
were diﬃcult to unambiguously characterise since they
were found to be extremely labile in THF-d8, but are insoluble
in hydrocarbon solvents and C6D5Cl, and unstable in
CDCl3 and CD2Cl2. In order to determine the extent of
base coordination, the complexes were prepared using the
pyridine analogue Ca{N(SiMe3)2}2(py)2 in the presence of an
excess of pyridine.12 These complexes are formulated as
[Ca(NNR){N(SiMe3)2}(py)n] (2a–d) (Scheme 2).
As with the THF complexes, the pyridine adducts were
found to be only sparingly soluble in benzene and toluene, and
decomposed in chloroform and dichloromethane. The NMR
spectra in THF-d8 were broad at ambient temperature, but
nevertheless showed three clear signals (albeit without ﬁne
structure) for the diamine backbone protons. The presence of
a single bis(trimethylsilyl)amide moiety was also evident from
the relative integration of the signal at ca. 0 ppm. The ﬂuxional
process, presumably arising from the lability of the NNR
ligands, could not be completely ‘‘frozen out’’ using low
temperature NMR analyses, within our instrumental capability
(500 MHz, 90 1C), however NMR tube scale reactions
carried out in situ demonstrated the elimination of one molar
equivalent of HN(SiMe3)2, thus supporting the formation of a
heteroleptic complex containing one deprotonated diamine
moiety and one remaining bis(trimethylsilyl)amide ligand.
Most noteworthy was the relative intensity of the pyridine,
coordinated to the calcium centre. In each case, the complexes
were dried in vacuo to 4  102 mbar, in order to ensure a
consistent level of base coordination. Remarkably, when the
alkyl-substituted diamines were employed (2a and 2b), the
number of pyridine ligands was less reproducible, ranging
from 0.3–0.6. This suggests that the pyridine is only weakly
bound to the calcium, and so we attempted to prepare the
base-free complex [Ca(NNR){N(SiMe3)2}] by subjecting the
complex to vacuum overnight, but in all cases we were unable
to completely remove the pyridine. In contrast, approximately
one molar equivalent of coordinated pyridine was observed in
complexes 2c and 2d, which decrease less after extended
periods in vacuo. It is unclear as to the observed diﬀerences
in pyridine coordination between alkyl and aryl systems,
although we tentatively suggest that the diﬀerence may lie in
the diﬀerence in steric constraints imposed by the diﬀerent
N-substituents. Given the diﬀerent degrees to which pyridine
coordinates to the calcium and the extremity of the NNR
lability, we cannot categorically rule out the possibility that
complexes 2a–2d, existing as dimers/oligomers; we suggest that
the actual structure could be a complex mixture of monomeric
and oligomeric species. Such a phenomenon is not unexpected,
given the propensity of Grignard reagents to undergo such
redistribution processes.2 Attempts to crystallographically
characterise complexes 2a–2d were unsuccessful, yielding only
redistributed calcium species without the NNR ligand.
When Ca{N(SiMe3)2}2(py)2 was reacted with two equivalents
of HNNR, two equivalents of HN(SiMe3)2 were eliminated,
forming the homoleptic complex [Ca(NNR)2] (R =
tBu 3a or
4-C6H4F 3b). Again, the NMR spectra were broad at both
ambient and low temperatures. Although we cannot completely
rule out the possibility that the homoleptic complexes
[Ca(NNR)2] form in solution from the redistribution of ligands
in 2, it is unlikely that this represents a major component since
complexes 2 were found to be catalytically active in the hydro-
amination/cyclisation of amino-oleﬁns, whereas 3a and 3b were
found to be completely inactive.
In order to gain insight into the structure of the proposed
mononuclear species, and especially to determine which of the
Scheme 1 Synthesis of chiral diamines 1a–d.
Scheme 2 Preparation of [Ca(NNR){N(SiMe3)2}(Py)n] 2a–d.
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amine moieties is likely to be preferentially deprotonated in the
NNR ligands, the structure of the [Ca(NNPh){N(SiMe3)2}(py)]
2ccalc was calculated using density functional methods.w The
computed structure is displayed in Fig. 2. The two possible
structures, with the primary and secondary amines deproto-
nated, were calculated, however the structure with the secondary
amine deprotonated, as shown in Fig. 2, was found to be
signiﬁcantly more stable, by ca. 13 kcal. In addition, the
structure indicates a signiﬁcant deviation of the amido nitrogen
from the expected trigonal planar geometry; the consequence is
that the phenyl ring is orientated so as to provide a chiral
environment at the calcium centre, which may well explain the
eﬀective stereocontrol in hydroamination catalysis.
Complexes 2a–2d were tested as precatalysts for the enantio-
selective hydroamination of the amino-oleﬁn substrates A and B
(Scheme 3). The activities and enantioselectivities of these cata-
lytic reactionsz are summarised in Table 1. For each of the
ligands 2a–2c the reaction proceeded signiﬁcantly slower than
with the homoleptic bis amide complex Ca{N(SiMe3)2}-
(THF)2 (23 h for A and 20 min for B at ambient temperature),
as is expected when adding a sterically demanding spectator
ligand. Interestingly, when the para-ﬂuorophenyl ligand 2d was
employed, no activity was observed at all over a two week period
(entries 7 and 8). The same was true of ligand 2c, although only
with the dimethyl-substrate A (entry 5). Most noteworthy is
catalyst 2c (phenyl N-substituent) with substrate B (entry 6), in
which the chiral pyrrolidine is formed in 26% ee. This level of
enantioselectivity represents a remarkable increase from the
5–10% obtained with calcium BOX complexes8 and is also
higher than the calcium complexes reported by Sadow et al.10
It is thus far unclear as to why the enantioselectivity in this case
far exceeds the other diamine–substrate combinations tested,
however the phenyl-substituted diamine/phenyl-substituted
substrate combination suggests that p–p stacking may be an
important feature in one of the intermediate steps of the catalytic
cycle. Such interactions may well explain the lack of selectivity in
the entries 2 and 4; as well as the lack of selectivity in any entry
involving the methyl-substituted substrate A. It is clear however
that further investigations into the detailed mechanism are
warranted, for such studies will undoubtedly facilitate further
developments in stereoselective catalysis with calcium complexes.
Chiral 1,2-diamines have been shown to be eﬃcient stereo-
directing ligands in the calcium-catalysed intramolecular
hydroamination of amino-oleﬁns. Whilst there is clearly room
for improvement, the enantioselectivities described herein
represent a signiﬁcant advance in calcium-mediated stereo-
selective catalysis. Further work in this area, particularly to
probe the structure of these complexes, is currently underway.
We thank the EPSRC (EP/H012109) and the Royal Society
for ﬁnancial support. Assistance by Dr R. L. Jenkins with
NMR spectroscopic measurements is gratefully acknowledged.
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z 70 mmol [Ca(NNR){(N(SiMe3)2}(THF)], 0.7 mmol substrate, 0.5 ml
C6D6, rt. Reaction progress monitored by
1H NMR spectroscopy.
Enantiomeric excesses determined by 1H NMR spectroscopy after the
addition of R-()-O-acetylmandelic acid. See ref. 13.
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Fig. 2 Calculated structure of [Ca(NNPh){N(SiMe3)2}(py)] 2ccalc.
Scheme 3 Hydroamination catalysis (R0 = Me A or Ph B).
Table 1 Catalytic hydroamination of amino-oleﬁns using
[Ca(N2N
R){N(SiMe3)2}(THF)]z
Entry Ligand Substrate Timea Conv.a % eeb %
1 1a A 7 d 90 0
2 1a B 24 h 499 6
3 1b A 5 d 499 12
4 1b B 1 h 499 5
5 1c A 21 d 0 —
6 1c B 3 d 80 26
7 1d A 14 d 0 —
8 1d B 14 d 0 —
a Determined from 1H NMR spectra when no further conversion
observed. b Determinedby1HNMRusingR-()-O-acetylmandelicacid.13
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Modular ligand variation in calcium bisimidazoline complexes: effects on
ligand redistribution and hydroamination catalysis†
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A series of calcium complexes supported by chiral bisimida-
zoline ligands have been studied in the catalytic intramolec-
ular hydroamination/cyclisation of amino-olefins. The com-
plexes [Ca(R-BIM){N(SiMe3)2}(THF)] (R = 4-C6H4Me, 5a, 4-
C6H4F, 5b and tBu, 5c) have given competitive enantioselectiv-
ities (up to 12%) when compared to current literature studies
involving calcium. Bisimidazolines offer a significant advance
over similar bisoxazoline ligands, by allowing a greater
structural variance through a modular synthetic pathway.
The implementation of alkaline earth (AE) metals in asymmetric
hydroamination catalysis has received increasing interest over
the past few years, particularly with calcium.1,2 Whilst most
studies have involved the b-diketiminato complex (I, Fig. 1),3
the development of chiral derivatives is very much in its infancy.
Few examples of chiral calcium complexes have emerged (II–
IV),4–6 and with enantioselectivities below 30%, this is indicative
of the challenging nature of calcium in asymmetric catalysis.
Whilst signiﬁcant developments have been made within the area,
developments are often hindered by the lability of AE complexes,
exempliﬁed by the eponymous Grignard reagents.2a,2c,7,8 Their
susceptibility to undergo rapid Schlenk-type ligand redistribu-
tion understandably renders complexes catalytically inactive or
greatly inhibits regio- or stereoselectivity, ultimately leading to
poor enantioselectivities. A detailed understanding of how to
suppress/control such redistribution processes is crucial in order
to facilitate the further development of asymmetric catalysis
with the AE metals; we herein report further insight into the
redistribution processes with calcium bisimidazoline complexes,
and the corresponding impact on catalytic performance.
The ﬁrst example of calcium employed in asymmetric hy-
droamination catalysis was contributed by Buch and Harder
employing the bisoxazoline containing complex II,4 giving 4–
6% ee. The low enantioselectivities were attributed to the rapid
redistribution of the ligand in solution giving the unreactive
homoleptic complex [Ca(BOX)2] and the non-selective calcium
amide complex, Ca{N(SiMe3)2}2(THF)2. Work by Sadow et al.5
School of Chemistry, Cardiff University,Main Building, ParkPlace, Cardiff,
UK, CF10 3AT. E-mail: WardBD@Cardiff.ac.uk; Fax: +44 (0)29 208
74030; Tel: +44 (0)29 208 70302
† Electronic supplementary information (ESI) available: Experimental
procedures, characterising data, conversion curves, and kinetics method-
ology. See DOI: 10.1039/c1dt10732a
Fig. 1 Calcium complexes employed in hydroamination catalysis.
using III improved the selectivity to 18% ee; we recently reported
selectivities of up to 26% ee using IV.6 It is apparent from
this trend, that progress towards greater enanatioselectivities is
highly dependent on a judicious choice of supporting ligand, but
may not necessarily depend on completely suppressing the ligand
redistribution processes, since IV was highly labile in solution.
Chiral bisimidazolines (Scheme 1) offer an advantage over the
aforementioned bisoxazolines as a ligand platform for the AE
metals. The incorporation of an additional N–R moiety allows
for alteration of electronic, in addition to the steric, properties
of the ligand;9–11 we have therefore systematically varied the N–R
Scheme 1 Preparation of bisimidazoline ligands (R = 4-C6H4Me 2a,
4-C6H4F 2b, tBu 2c).
This journal is © The Royal Society of Chemistry 2011 Dalton Trans., 2011, 40, 7693–7696 | 7693
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substituent in order to determine the effect on the coordination
chemistry and catalytic ability of the complexes.
A series of chiral bisimidazoline derivatives (R-BIM, R =
4-C6H4Me, 2a, 4-C6H4F, 2b and tBu, 2c) have been prepared
from the condensation of the corresponding diamine (1a–c)6
and Pinner salt12 in reﬂuxing CH2Cl2 for 48 h, as reported
by Pﬂatz et al.13 We have found this method convenient for
preparing the corresponding bisimidazoline in up to 40% yield,
based on starting diamine. Though typically moderate yields were
obtained, higher yields were not realised by extending reaction
times or conducting the reaction in higher boiling point solvents,
for example chloroform or chlorobenzene. This simple method
allows a series of bisimidazolines (R-BIM) to be prepared in
which, in principle, the stereodirecting and R substituents can
be independently varied in a modular fashion via the choice of
amino acid and primary amine in the diamine synthesis, without
introducing additional synthetic complexity. In this report we have
concentrated on the isopropyl derivatives starting from L-valine.
Reaction of the protio-ligands 2a–c with Ca{N(SiMe3)2}2-
(THF)2 in C6D6 afforded orange precipitates, which were found
to be soluble only in THF-d8, insoluble in hydrocarbon sol-
vents, and unstable in chlorinated solvents. The low solubility
of calcium-based complexes is well documented and therefore
unsurprising.1b,6,14 No evidence of ether-cleavage was observed in
THF, even though this has been previously reported in calcium
complexes under similar conditions.14
Although the THF adducts [Ca(R-BIM){N(SiMe3)2}(THF)]
5a–c were employed in hydroamination catalysis (vide infra), for
analysis of the complexes, and in order to determine the extent
of base coordination in THF-d8, the complexes were prepared
using the pyridine analogue Ca{N(SiMe3)2}2(py)2 in the presence
of an excess of pyridine (Scheme 2).15 These complexes are
formulated as [Ca(R-BIM){N(SiMe3)2}(py)] (3a–c). As with the
THF complexes, the pyridine adducts were found to be only
sparingly soluble in benzene and toluene, and decomposed in
chloroform and dichloromethane.
Scheme 2 Preparation of [Ca(R-BIM){N(SiMe3)2}(py)] (R = 4-C6H4Me,
3a, 4-C6H4F, 3b and tBu, 3c).
The NMR spectra of 3a–c in THF-d8 were well-deﬁned at
ambient temperature, but nevertheless showed a mixture of the
heteroleptic species 3 and homoleptic species 4 (Scheme 3). Buch
and Harder report a redistribution ratio of 80 : 20 heteroleptic
to homoleptic respectively in the related bisoxazoline complex
[Ca(BOX){N(SiMe3)}(THF)2];4 however upon varying the N-R
substituent of the bisimidazolines a strong variation in equilibrium
position was observed (Table 1). 1H NMR studies established
that all complexes had reached their irrespective equilibrium
positions within 10 min. Further monitoring over several hours
indicated that no further deviation of the equilibrium position
Table 1 Redistribution of [Ca(R-BIM){N(SiMe3)2}(py)] 3 to
[Ca(BIMR)2] 4 and Ca{N(SiMe3)2}2(py)2 at 293 K
Entry Complex 3:4a Kb DG293 (kJ mol-1)
1 3a 64 : 36 0.31 2.8
2 3b 48 : 52 1.17 -0.4
3 3c 80 : 20 0.06 6.8
a Determined by integration of 1H NMR spectra. b Equilibrium coefﬁcient
determined at 293 K.
Scheme 3 Ligand redistribution of [Ca(R-BIM){N(SiMe3)2}(py)] (R¢ =
iPr, R = 4-C6H4Me, 3a 4-C6H4F, 3b and tBu, 3c).
occurred. The values ofDG293 were calculated from the equilibrium
coefﬁcients, which were found to be small and almost negligible.
The presence of three bis(trimethylsilyl)amide moieties was
evident from the relative integration of the resonances, at
ca. 0 ppm. These can be attributed to the coordinated
bis(trimethylsilyl)amide on the heteroleptic complex 3, the cor-
responding Ca{N(SiMe3)2}2(py)2 redistribution product, and the
liberated amine HN(SiMe3)2.
Although the HN(SiMe3)2, is expected be a highly soluble,
volatile by-product, even after repeated recrystallisation and ex-
tensive drying in vacuo we were unable to fully remove the residue.
This could potentially be attributed to the partial reinsertion of
the HN(SiMe3)2 into the complex when in solution, which has
been previously observed by Ruhlandt-Senge et al.16 In each case,
the complexes were dried in vacuo to 4 ¥ 10-2 mbar, in order to
ensure a consistent level of base coordination, since it is known that
extended exposure to vacuum can remove coordinated pyridine.6
There was consistently only one pyridine ligand bound to the
calcium in the heteroleptic complex 3, which contrasts the BOX
complex II (Fig. 1), in which there were two THF ligands.4
In order to clarify the identity of the homoleptic com-
plexes 4 in the mixture obtained by the redistribution of 3,
Ca{N(SiMe3)2}2(py)2 was reacted with two equivalents of R-
BIM, whereupon two equivalents of HN(SiMe3)2 were eliminated,
forming the homoleptic complex [Ca(R-BIM)2] (R = 4-C6H4Me,
4a, 4-C6H4F, 4b and tBu, 4c). In each case, the complexes were
again dried in vacuo to 4 ¥ 10-2 mbar, which was sufﬁcient to
remove all pyridine traces.
In order to determine the effect of the nitrogen substituent,
and consequently the equilibrium position, on their catalytic
performance, the THF derivatives, 5a–c were employed in the
hydroamination/cyclisation of the amino-oleﬁnsA andB (Scheme
4); the conversions, initial rates and enantioselectivities, are listed
in Table 2.‡ Consistent with our previous observations,6 catalytic
hydroamination of the diphenyl substrate B was found to be
much faster than with the dimethyl substrate A, which mirrors
the observations with Ca{N(SiMe3)2}2(THF)2 (23 h for A and
7694 | Dalton Trans., 2011, 40, 7693–7696 This journal is © The Royal Society of Chemistry 2011
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Table 2 Asymmetric hydroamination of amino-oleﬁns using 10 mol%
[Ca(R-BIM){N(SiMe3)2}(THF)]
Entry Complex Substrate Initial Rate/mol dm-3 s-1 Conv.%a ee%b
1 5a A 5.1(5) ¥ 10-7 8 5
2 5a B 1.0(1) ¥ 10-4 95 0
3 5b A 6.8(3) ¥ 10-8 3 9
4 5b B 1.8(1) ¥ 10-5 >99 9
5 5c A 7.3(4) ¥ 10-7 18 12
6 5c B 6.4(3) ¥ 10-5 >99 12
a Determined from 1H NMR spectra. b Determined by 1H NMR spec-
troscopy using (R)-(-)-O-acetylmandelic acid.18
Scheme 4 Asymmetric hydroamination catalysis (R¢ = Me A, Ph B).
20 min for B at ambient temperature with 10 mol% catalyst),
although all reactions employing complexes 5a–c were signiﬁ-
cantly slower than this, as is expected when using a sterically
demanding spectator ligand. Reactions employing B went to
completion, whereas the analogous reactions with A did not,
reaching only <20% conversion within several days. Despite
this however, the enantioselectivities with a particular catalyst
complex were consistent within error, regardless of the substrate.
This is in stark contrast to the bis-4 and trisoxazoline,5 and
diamine6 complexes which are much more substrate-speciﬁc.
The 4-C6H4Me complex 5a gave the fastest conversion but little
stereoselectivity (entries 1 and 2), whereas the 4-C6H4F and tBu
complexes 5b and 5c gave moderate selectivities, comparable to
those obtained with the trisoxazoline complex III, and higher
than with the structurally related bisoxazoline complex II (entries
3–6). Based upon the measurements in Table 1, 5b is expected
to give the highest amount of Ca{N(SiMe3)2}2(THF)2, and yet
the rate of reaction is signiﬁcantly slower than those of 5a and
5c. This is most likely due to the nature of the equilibrium,
which will be different under catalytic conditions where the
liberated HN(SiMe3)2, catalysis substrate and pyrrolidine product
can take part in the redistribution processes. 5b still invokes a
comparable stereocontrol compared to 5c, suggesting that the
equilibrium position has little effect on the stereoselectivity; this
may suggest that the redistribution process may be more complex
than described by Scheme 3.
The catalytic reactions using 10 and 20 mol% 5a–c were
monitored, and the initial rates are consistent with a ﬁrst order
reaction with respect to catalyst, in agreement with Marks et al.17
However, with 5 mol% catalyst loading the reactions showed little
to no activity. A representative conversion curve is provided in
Fig. 2.
Conclusions
Ligand redistribution is a prominent feature of calcium complexes.
The bisimidazoline complexes described herein are no exception,
but in contrast to the analogous bisoxazoline complexes allow
a greater degree of ligand variation through the presence of
Fig. 2 Conversion for the catalytic hydroamination of substrate B using
[Ca(tBu-BIM){N(SiMe3)2}(THF)] 5c in C6D6 at 293 K.
the additional nitrogen substituent and their modular synthesis;
variation in the N–R substituent occasions a shift of the equi-
librium position, and has a concomitant impact on the catalytic
performance, although not on the stereocontrol offered by the
ligand. We are undertaking further studies in this regard to
ensure that redistribution processes are more fully understood,
in order that a rational design of calcium complexes for catalytic
applications may be achieved.
We thank the EPSRC (EP/H012109), the Royal Society, and
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